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Foreword 
This report describes a project carried out by researchers from the National Food Institute, 
Technical University of Denmark (DTU). 
 
Preliminary structural grouping of 67 brominated flame retardants and a preliminary category 
approach for the purpose of endpoint-specific read-across for a selected group of brominated flame 
retardants has been performed in the project. 
 
The project steering group members were, besides the authors from the DTU, Grete Lottrup Lotus, 
Dorte Lerche Bjerregaard, Magnus Løfstedt and Elisabeth Paludan from the Danish Environmental 
Protection Agency (EPA). 
 
The project was financed by the Danish EPA. 
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Conclusion and Summary 
The aim of this project was to attempt grouping of a number of identified brominated flame 
retardants (BFRs) found in a survey performed in 2014 for the Danish Environmental Protection 
Agency (Danish EPA 2014). The grouping was performed for 67 brominated flame retardants based 
on their chemical structures and resulted in 15 preliminary structural groups and 7 substances 
remaining as “singletons”. (Q)SAR predictions for a number of environmental and health effects 
within these initial groups were generated and investigated. 
 
One of the groups; small linear and branched brominated alkyl alcohols, was chosen for further 
investigation. The category, defined as having 3-5 carbons, 2-3 bromine atoms and 1-2 alcohol 
groups comprised 61 members. 
 
(Q)SAR predictions were performed for the members of the category. Predictions for carcinogenic 
and mutagenic/genotoxic properties indicated that the 61 members in the category of small linear 
and branched brominated alkyl alcohols have a carcinogenic potential with a possible 
mutagenic/genotoxic mode of action. The estimated specificities of the applied (Q)SAR models as 
established by leave-many-out cross-validations are between 85.9% and 95.1%, i.e. the overall false 
positive rates of the models are around 5%- 14%. From the identified alerts in a number of OECD 
(Q)SAR Application Toolbox profilers, there was one alert which was identified in all 61 category 
members, namely the “Aliphatic halogen” alert in the three ISS (Istituto Superiore di Sanita, Rome 
Italy) profilers for in vitro mutagenicity (Ames test), in vivo mutagenicity (Micronucleus, in rats 
and mice) and carcinogenicity (genotoxic and non-genotoxic). From the explanation of the alert 
contained in the OECD (Q)SAR Application Toolbox there does not seem to be one single 
mechanistic interpretation of the ISS aliphatic halogen alert in relation to mutagenicity and cancer. 
The “Aliphatic halogen” alert identified 34% false positives among the mutagenicity training set 
chemicals (Kazius et al. 2005). According to Benigni et al. (2008 and 2010) it has a positive 
predictivity (proportion of substances with the alert that are true positive) for carcinogenicity of 
74%.  
 
A literature search was performed to collect experimental data on human health effects for the 25 
category members with a CAS RN assigned. Relevant experimental data on human health effects 
were only retrieved for two of the category members identified in the preliminary structural group, 
i.e. 2,3-dibromo-1-propanol (2,3-DBPA) and 2,2-bis(bromomethyl)-1,3-propanediol (DBNPG). For 
a third category member identified in the preliminary structural group, i.e. 2,2-bis-(bromomethyl)-
3-bromo-1-propanol (TBNPA), relevant experimental data on human health effects were retrieved 
from the REACH registration dossier.  
 
The critical effect of these three members of the category with relevant experimental data on human 
health effects is the multiple-organ carcinogenic effect, most probably exerted by a genotoxic mode 
of action either by the parent compound itself (2,3-DBPA) or by a metabolite of the parent 
compound (DBNPG and TBNPA). Furthermore, 1,3-dibromo-2-propanol (1,3-DBPA), a REACH 
pre-registered compound for which no experimental data on human health effects were retrieved, 
has a notified classification for a possible carcinogenic potential (Carc. 2 H351). 
 
Possible read-across for the critical effect from the three category members with experimental data 
and the one member with a classification for the identified critical effect to the remaining 57 
structurally similar target analogues in the category is supported by the following observations: 
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a) The experimental data show comparable toxicological effects for the three members of the 
category identified in the preliminary structural group (2,3-DBPA, DBNPG and TBNPA), 
i.e. carcinogenic and mutagenic/genotoxic effects. 
b) The classifications (harmonized or notified) as Muta. 1B H340 / Muta. 2 H341 and/or 
Carc. 1B H350 / Carc. 2 H351 for these three members and for 1,3-DBPA.  
c) The (Q)SAR predictions for carcinogenic and mutagenic/genotoxic properties indicate that 
the 61 category members have a carcinogenic potential with a possible 
mutagenic/genotoxic mode of action. The structural alerts identified in the OECD (Q)SAR 
Application Toolbox indicate that all members share the same genotoxic/mutagenic mode 
of action with some variations in their possible mechanisms of action. Some alerts were 
identified in many or all of the members and/or their metabolites pointing to possible 
common mechanism(s) of action (e.g. metabolic activation to reactive carbonyl 
compounds and aldehyde Schiff base formation of DNA adducts and cross-links).  
 
As there is only experimental information for a small number of the members, an even more robust 
basis for read-across for the category could be pursued by 1) searching the literature for information 
on carcinogenicity and mutagenicity/genotoxicity on structural analogues outside, but structurally 
close to the category, 2) experimental testing for mutagenicity/genotoxicity on representative 
members across the category, as well as 3) further analysis of the underlying mechanisms of action. 
 
Other brominated flame retardants that are metabolised to one of the 61 brominated flame 
retardants in the category of small linear and branched alkyl alcohols may equally likely as these 
members themselves possess the critical effect, i.e. the carcinogenic effect, most probably exerted by 
a mutagenic/genotoxic mode of action. 
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Konklusion og sammenfatning 
Formålet med dette projekt var at forsøge at gruppere et antal bromerede flammehæmmere, som 
blev identificeret i en undersøgelse foretaget i 2014 for Miljøstyrelsen (Danish EPA 2014). 
Grupperingen blev foretaget for 67 bromerede flammehæmmere baseret på deres kemiske 
strukturer og resulterede i 15 præliminære strukturelle grupper og 7 stoffer kategoriseret som 
“enkeltstoffer”. Der blev efterfølgende udarbejdet (Q)SAR forudsigelser for en række miljø- og 
sundhedseffekter for stofferne i de præliminære grupper. 
 
En af grupperne; små lineære og forgrenede bromerede alkylalkoholer, blev udvalgt til yderligere 
undersøgelse. Kategorien blev defineret som stoffer med 3-5 kulstofatomer, 2-3 bromatomer og 1-2 
alkoholgrupper og den bestod af 61 medlemmer. 
 
For alle medlemmer af kategorien blev der foretaget (Q)SAR forudsigelser for en række 
sundhedsskadelige effekter. Forudsigelser for kræftfremkaldende og genotoksiske effekter 
indikerede, at de 61 medlemmer af kategorien havde et potentiale for kræftfremkaldende effekt med 
en mulig mutagen/genotoksisk virkningsmåde. De anvendte (Q)SAR modeller havde ifølge 
krydsvalideringsresultater (“leave-many-out”) beregnede specificiteter mellem 85,9% and 95,1%, 
dvs. ifølge disse resultater var de overordnede falsk-positive rater omkring 5%- 14%. Ud af de 
identificerede strukturelle alerts ved kørsler af “profilers” i OECD (Q)SAR Application Toolbox, var 
der én alert, som blev identificeret i alle 61 medlemmer af kategorien, nemlig “Aliphatic halogen” i 
de tre ISS (Istituto Superiore di Sanita, Rome Italy) profilers for ”in vitro mutagenicity (Ames test)”, 
”in vivo mutagenicity (Micronucleus, in rats and mice)” og ”carcinogenicity (genotoxic and non-
genotoxic)”. Ud fra forklaringerne i OECD (Q)SAR Application Toolbox’en for denne ISS alifatisk 
halogen alert er der tilsyneladende ikke én enkelt mekanistisk fortolkning af alertens relation til den 
mutagene og kræftfremkaldende effekt. Alerten “Aliphatic halogen” identificerede ifølge Kazius et 
al. (2005) 34% falsk positive ud af træningssættet af mutagene kemiske stoffer. Ifølge Benigni et al. 
(2008 and 2010) har alerten en positiv prædiktivitet (andel af stoffer med denne alert som er sande 
positive) for en kræftfremkaldende effekt på 74%.  
 
Der blev foretaget en litteratursøgning for at indsamle eksperimentelle data vedrørende 
sundhedsskadelige effekter for de 25 kategorimedlemmer med et tildelt CAS registreringsnummer. 
Relevante eksperimentelle data blev kun fundet for to kategorimedlemmer fra den præliminære 
strukturelle gruppe, nemlig for 2,3-dibrom-1-propanol (2,3-DBPA) og 2,2-bis(bromomethyl)-1,3-
propandiol (DBNPG). For et tredje kategorimedlem fra den præliminære strukturelle gruppe, 2,2-
bis-(bromomethyl)-3-brom-1-propanol (TBNPA), blev relevante eksperimentelle data indhentet fra 
REACH registreringsdossieret. 
 
Den kritiske effekt for de tre kategorimedlemmer med relevante eksperimentelle data, var en 
kræftfremkaldende effekt i mange væv og organer, sandsynligvis via en mutagen/genotoksisk 
virkningsmåde, forårsaget enten af moderstoffet (2,3-DBPA) eller af en metabolit af moderstoffet 
(DBNPG og TBNPA). Derudover har 1,3-dibrom-2-propanol (1,3-DBPA), et REACH præ-registreret 
kemisk stof for hvilket der ikke blev fundet eksperimentelle data vedrørende sundhedsskadelige 
effekter, en notificeret klassificering for muligt kræftfremkaldende potentiale (Carc. 2 H351). 
 
Anvendelse af read-across for den kritiske effekt fra de tre kategorimedlemmer med 
eksperimentelle data og det ene medlem med en klassificering for den identificerede kritiske effekt 
til de resterende 57 strukturelle analoger i kategorien understøttes af følgende observationer: 
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a) De eksperimentelle data viste sammenlignelige toksiske effekter for de tre 
kategorimedlemmer identificeret i den præliminære strukturelle gruppering (2,3-DBPA, 
DBNPG and TBNPA), dvs. kræftfremkaldende og mutagene/genotoksiske effekter. 
b) Klassificeringerne (harmoniserede eller notificerede) som Muta. 1B H340 / Muta. 2 H341 
og/eller Carc. 1B H350 / Carc. 2 H351 for disse tre medlemmer og for 1,3-DBPA.  
c)  (Q)SAR forudsigelserne for kræftfremkaldende og mutagene/genotoksiske egenskaber 
indikerer, at de 61 kategorimedlemmer har et kræftfremkaldende potentiale med en mulig 
mutagen/genotoksisk virkningsmåde. De strukturelle alerts identificeret i OECD (Q)SAR 
Application Toolbox’en indikerer, at alle medlemmerne udøver deres effekter ved en 
mutagen/genotoksisk virkemåde med nogle variationer i deres mulige 
virkningsmekanismer. Nogle alerts blev identificeret i mange eller alle medlemmer 
og/eller deres metabolitter og peger på mulige fælles virkningsmekanismer (f.eks. 
metabolisk aktivering til reaktive carbonylstoffer og aldehyd Schiff-base-dannelse af DNA 
addukter og krydsbinding). 
 
Da der kun er fundet eksperimentelle data for et lille antal af kategorimedlemmerne, ville et mere 
robust grundlag for read-across for kategorien kunne understøttes ved yderligere information som 
for eksempel 1) litteratursøgning for eksperimentelle data vedrørende kræftfremkaldende og 
mutagene/genotoksiske effekter for stoffer udenfor men strukturelt set tæt på kategorien, 2) 
yderligere testning for mutagene/genotoksiske effekter på repræsentative kategorimedlemmer, og 
3) yderligere analyser vedrørende virkningsmekanismer.  
 
Andre bromerede flammehæmmere, som i kroppen nedbrydes til et af de 61 medlemmer i 
kategorien af små bromerede lineære og forgrenede alkylalkoholer, har sandsynligvis samme 
potentiale for den kritiske effekt som de 61 kategorimedlemmer, dvs kræftfremkaldende effekt 
sandsynligvis via en mutagen/genotoksisk virkningsmåde.  
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1. Introduction 
The aim of this project was to attempt grouping of a number of identified brominated flame 
retardants (BFRs) found in a survey performed in 2014 for the Danish Environmental Protection 
Agency (Danish EPA 2014). The grouping was performed on the basis of the chemical structures, 
and trends in (Q)SAR predictions for a number of environmental and health effects within the 
structural groups were investigated. 
 
From the initial groups, one was chosen and further defined and investigated as a category . All 
theoretical members of the category were considered in terms of both experimental (where CAS 
RNs could be identified) and predicted information. It was assessed if a critical health effect seemed 
to exist based on the available information. Experimental information was available for only three 
of the category members. A preliminary category approach to perform read across for the identified 
critical effect from the members with experimental information to the members without 
experimental information was performed. 
 
With this project the Danish EPA wished to explore the possibility to address BFRs by a grouping 
approach rather than as individual substances, as there are many BFRs with similar chemical 
structures and as the regulation of individual substances may be very time demanding. Addressing 
groups of BFRs in relation to regulation is not new. Polybrominated diphenyl ethers (PBDEs) and 
polybrominated biphenyls (PBBs), both having 209 theoretically possible congeners, are treated as 
groups in the RoHS Directive (EU 2011), where there in the homogeneous materials in electric and 
electronic equipment must be no more than 0.1% in total of either PBDEs or PBBs. Some theoretical 
members of the chosen group in this project may not currently be on the market or even 
synthesized. However, they are relevant to include as they could potentially be used in the future to 
substitute the analogues currently in use. 
 
In the following short introductions to non-testing data, (Q)SAR, grouping and read-across are 
given. The text builds to a large extent on the REACH guidance chapter R.6, where further 
information can be found (European Chemicals Agency 2008).  
 
1.1 Non-testing data 
Non-test methods are non-experimental methods or approaches that can be used to provide data 
for the assessment of chemicals. Non-testing data can be generated by three main approaches: 
 
a) (quantitative) structure-activity relationships, (Q)SARs 
b) grouping approaches, which include structure analogues and formation of chemical 
categories for possible read-across 
c) expert systems 
 
The development and application of all kinds of non-testing methods is based on the similarity 
principle, i.e. the hypothesis that similar compounds should have similar biological activities. 
 
Expert systems are compilations of models consisting of combinations of SARs, QSARs and 
databases and will not be described further in this report, as they were not applied in the project. 
(Q)SARs, grouping and read-across is further described in the following. 
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1.2 (Q)SAR 
SARs and QSARs, collectively referred to as (Q)SARs, are theoretical models that can be used to 
predict in a qualitative or quantitative manner the physical-chemical, biological (e.g. toxicological) 
and environmental fate properties of compounds from knowledge of their chemical structure. The 
two terms can be defined as follows: 
 
A SAR is a qualitative relationship that relates a chemical (sub)structure (“alert”) to the presence or 
absence of a property or activity of interest. The substructure may consist of adjacently bonded 
atoms, or an arrangement of non-bonded atoms that are collectively associated with the property or 
activity. Generally, no applicability domain (AD, see below) is defined for SARs. 
 
A QSAR is a mathematical model (often a statistical correlation) relating one or more quantitative 
parameters (molecular descriptors) derived from the chemical structure to a quantitative measure 
of a property or activity. QSARs are quantitative models yielding a continuous or categorical result. 
Generally, QSARs are associated with a defined AD. 
 
The AD is the physicochemical, structural, or biological space of the training set on which the model 
was developed, and for which it is applicable to make predictions for new compounds. The AD 
should be described in terms of the most relevant parameters, i.e. usually those that are descriptors 
of the model. Ideally, the model should only be used to make predictions within that domain by 
interpolation and not extrapolation. The accuracy of a model is determined within the defined AD, 
i.e. a model can have more than one AD definition, with each their accuracy level. The accuracy is 
determined by robust leave-many-out cross-validation and if possible with external validations with 
a data set representative of the full AD. 
 
1.3 Grouping and read-across 
Category and analogue approaches are techniques for grouping chemicals. Read-across is a 
technique of filling data gaps in either approach. 
 
The term analogue approach is used when the grouping is based on a very limited number of 
chemicals, where trends in properties are not apparent. 
 
A chemical category is a set of chemicals whose physical-chemical and human health and/or 
environmental toxicological properties and/or environmental fate properties are likely to be similar 
or follow a regular pattern as a result of structural similarity (or other similarity characteristic). 
 
Grouping is performed on the basis of chemical structure similarity and possible knowledge of 
properties in relation to the endpoint(s) of interest. (Q)SAR predictions can be included in relation 
to the latter. The (Q)SAR information can be employed to predict trends as well as breakpoints in 
trends, and therefore possible subcategories. As far as possible, the predictions and trends 
established by (Q)SAR methods should be verified by comparison with experimental data. 
 
Experimental and predicted information for the category members are collected and analysed to 
identify possible common behaviour or consistent trends. If present, they are generally associated 
with a common underlying mechanism of action, or a mechanism of action that exhibits intensity 
changes in a consistent manner across the different members of a category. When identified, the 
common behaviour or consistent trends can form basis to make read-across from some category 
members with experimental data (“source substances”) to others that lacks data for an endpoint 
(“target substances”), if the overall data set allows the estimation of the hazard for the missing data 
points. If so, it is possible to extend the use of measured data to similar untested chemicals. 
 
Knowledge of the expected effect(s) of the category together with information on use and exposure 
can help in deciding not only whether additional testing of relevance to the predicted effect(s) is 
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needed, but also the nature and scope of any testing that needs to be carried out. A category test 
plan can be designed to provide information to characterize the group as a whole rather than to fill 
every data point for every chemical in the category. This reflects an approach that is more efficient 
from a testing perspective than test plans for obtaining data on individual chemicals of commercial 
interest.  
 
1.4 Preliminary structural grouping of BFRs 
In this project it was investigated how a number of BFRs identified in the survey for the Danish EPA 
could be grouped dependent on their chemical structure. Within the initial structural groups, 
possible trends in (Q)SAR predictions for a large number of environmental and health effects were 
used to make further endpoint-area specific groupings. Furthermore, it was mapped which of the 
substances had US EPA ToxCast™ and Tox21 in vitro experimental results or were REACH 
registered to give indications of availability of experimental data for members of the initial 
structural groups. One group was chosen for further work to explore a possible category approach. 
 
1.5 Category hypothesis and (Q)SAR predictions for a selected BFR 
group 
A working definition of the chosen category was made and all theoretical structural members were 
identified and predicted by existing (Q)SAR models for relevant health related endpoints. The 
applicability domains for the most relevant models in relation to the members of the category were 
mapped to see how well they covered the span of the category members. 
 
1.6 Evaluation of experimental data and identification of critical effect 
For all the structural members of the chosen category possible CAS numbers were identified. A 
literature search in the scientific literature was performed for all the individual members of the 
group with identified CAS numbers to gather possible experimental information of relevance in 
relation to a number of health endpoints. The focus of the literature search was to identify a critical 
health effect, if possible. 
 
1.7 Preliminary category justification and perspectives 
Based on the (Q)SAR analysis and evaluation of available experimental data for a possible critical 
effect, a preliminary justification to do read-across for the critical effect in a category approach was 
attempted. 
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2. Preliminary structural 
grouping of BFRs 
2.1 Data preparation 
In the Danish Environmental Protection Agency, Environmental Project No. 1536, 2014 “Survey of 
brominated flame retardants” Table 1 contains BFRs which are either pre-registered under REACH 
or imported/produced by EU manufacturers. In total, the table contains 65 substances. The 
substances in Table 1 of the survey are the primary focus of this project. However, a number of 
additional structures were included to get a broader picture of brominated flame retardants used 
worldwide and to support the grouping and possible development of meaningful categories. Hence, 
BFRs listed in Table 2 from the survey report were also included. Table 2 contains 14 BFRs, which 
were identified in the survey, but which are not pre-registered or registered under REACH but 
rather manufactured outside the EU. Furthermore, a quick search for BFRs on the Internet and 
collection of CAS numbers from different sites returned 6 additional BFRs (Fujitsu 2015) not 
covered by Table 1 or 2 of the survey. These were also included. In total these three sources gave a 
brutto list of 85 substances. 
 
Structure information in the form of SMILES1 was retrieved from ChemIDplus or ChemSpider. 
When information could not be found in these sources, the CAS number was searched in SciFinder, 
which links to the Chemical Abstracts Service (“CAS”). SMILES cannot be retrieved directly from 
SciFinder so in five cases the SMILES notations were generated by hand. All the SMILES notations 
were checked to see if the EPI Suite program could read them and if the program displayed the 
correct 2D structures. In a few cases where this was not achieved in the EPI Suite program, the 
SMILES notations were edited manually. 
 
Of the 65 substances in Table 1 of the survey report a total of 48 were included in the project 
exercise as only aromatic, cycloaliphatic and aliphatic BFRs with a defined chemical structure were 
included. The reason was that inorganic substances and polymers cannot be subject to the (Q)SAR 
model systems applied. Furthermore, structure information should be available in order to make 
(Q)SAR predictions.  
 
The remaining 17 substances in the survey report Table 1 were either confidential (7 substances, i.e. 
no structure information), polymers (9 substances: CAS RN 148993-99-1, 158725-44-1, 59447-57-3, 
68441-62-3, 68928-70-1, 71342-77-3, 88497-56-7, 94334-64-2, 1195978-93-8) or the chemical 
structure could not be retrieved as it was not unambiguous and a representative SMILES could not 
be found (1 substance, CAS RN 135229-48-0). However, 5 of the 48 included substances lacked an 
unambiguously defined 2D chemical structure according to SciFinder (CAS RNs 155613-93-7, 
25637-99-4, 32534-81-9, 32536-52-0, 36355-01-8), but for each of these substances a 
representative SMILES was included in the exercise.  
 
                                                                    
1 A prerequisite for making predictions with (Q)SAR software is that structural information in the format of e.g. SMILES strings 
is available for the substances that should be predicted. The Simplified Molecular-Input Line-Entry System (SMILES) is a 
specification in form of a line notation for describing the structure of chemical species using short text strings. 
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Of the 14 substances in the survey report Table 2 a total of 13 were included. The remaining 
substance (CAS RN 168434-45-5) did not have an unambiguous chemical structure and a 
representative SMILES was not included. 
 
Furthermore, as mentioned above, 6 additional BFRs were included. 
 
This gave a final ‘start list’ with 67 substances as listed in Table 1 below. The list including 
information about the source of the substance, possible REACH registration and inclusion in 
ToxCast/Tox21 etc. is given in Appendix 1. In Appendix 2 the 2D structures of the substances are 
given together with predictions of bioavailability (Lipinski’s rule-of-five) and a few physical-
chemical properties. 
 
CAS RN Substance name Abbreviated 
name 
1084889-51-
9 
Octabromotrimethyl- phenyl indane OBTMPI 
1163-19-5 Bis(pentabromophenyl) ether decaBDE 
118-79-6 2,4,6-Tribromophenol TBP 
126-72-7 tris(2,3-dibromopropyl) phosphate TDBPP 
13654-09-6 Decabromo-1,1'-biphenyl DecaBB 
1522-92-5 Tribromoneopentyl alcohol [same substance as CAS RN 36483-
57-5] 
TBNPA 
155613-93-7 1H-Indene, 2,3-dihydro -1,1,3-trimethyl-3-phenyl-, octabromo 
deriv 
OBTMPI 
183658-27-7 2-ethylhexyl-2,3,4,5- tetrabromobenzoate EH-TBB 
19186-97-1 Tri[3-bromo-2,2- bis(bromomethyl)propyl]phosphate. TTBNPP 
20566-35-2 2-(2-Hydroxyethoxy)ethyl 2- hydroxypropyl 3,4,5,6- 
tetrabromophthalate 
HEEHP- 
TEBP 
21850-44-2 1,1'-(Isopropylidene) bis[3,5- dibromo-4-(2,3- 
dibromopropoxy)benzene] 
TBBPA- 
BDBPE 
23488-38-2 2,3,5,6-Tetrabromo-p- xylene TBX 
25327-89-3 1,1'-Isopropylidenebis[4- (allyloxy)-3,5- dibromobenzene] TBBPA- bAE 
25495-98-1 Hexabromocyclodecane HBCYD 
25637-99-4 Hexabromocyclododecane HBCDD 
25713-60-4 1,3,5-Triazine, 2,4,6- tris(2,4,6- tribromophenoxy)- TTBP-TAZ 
26040-51-7 Bis(2-ethylhexyl) tetrabromophthalate BEH-TEBP 
26762-91-4 Tribromo-phenyl-allyl-ether, unspecified  AO-TBB2 
3072-84-2 2,2'-[(1- Methylethylidene)bis[(2,6- dibromo-4,1-phenyle- le- 
ne)oxymethylene]]bisoxiran e 
TBBPA- BGE 
31780-26-4 Dibromostyrene DBS 
3194-55-6 1,2,5,6,9,10- Hexabromocyclododecane HBCDD 
3194-57-8 Cyclooctane, 1,2,5,6- tetrabromo TBCO 
Category approach for selected brominated flame retardants 15 
 
3234-02-4 2,3-Dibromo-2-butene-1,4-diol  DBBD1 
32534-81-9 Diphenyl ether, pentabromo derivative pentaBDE 
32536-52-0 Diphenyl ether, octabromo derivative octaBDE 
32588-76-4 N,N'-ethylenebis(3,4,5,6- tetrabromophthalimide) EBTEBPI 
3278-89-5 2-(allyloxy)-1,3,5-tribromobenzene TBP-AE 
3296-90-0 2,2- bis(bromomethyl)propane-1,3-diol DBNPG 
3322-93-8 1,2-Dibromo-4-(1,2- dibromoethyl)cyclohexane DBE- DBCH 
33798-02-6 4,4'-isopropylidenebis[2,6- dibromophenyl] diacetate TBBPA-bOAc 
34571-16-9 1,2,3,4,7,7-Hexachloro-5- (tetrabromo- 
phenyl)bicyclo[2.2.1]hept-2- ene 
HCTBPH 
35109-60-5 1,3,5-tribromo-2-(2,3- dibromopropoxy)benzene DPTE 
3555-11-1 Allyl pentabromophenyl ether PBPAE 
36355-01-8 Hexabromo-1,1'-biphenyl HexaBB 
36483-57-5 2,2-dimethylpropan-1-ol, tribromo derivative TBNPA 
37419-42-4 Phenol, 4,4′-(1- methylethyli- dene)bis[2,6dibromo-, 
dipropanoate (9CI) 
TBBPA-BP 
37853-59-1 1,1'-[ethane-1,2- diylbisoxy]bis[2,4,6- tribromobenzene] BTBPE 
37853-61-5 Benzene, 1,1′-(1- methylethylidene) bis[3,5-dibromo-4-methoxy TBBPA-BME 
38521-51-6 Benzene, 1,2,3,4,5- pentabromo6- (bromomethyl) PBBB 
39569-21-6 Benzene, 1,2,3,4- tetrabromo-5-chloro-6- methyl- TBCT 
39635-79-5 4,4'-sulphonylbis[2,6- dibromophenol] TBBPS 
4162-45-2 4,4'-isopropylidenebis(2- (2,6- dibromophenoxy)ethanol) TBBPA- BHEE 
42757-55-1 bis[3,5-dibromo-4-(2,3- dibromopropoxy)phenyl] sulphone TBBPS- 
BDBPE 
497107-13-8 Benzene, 1,1′- [oxybis(methylene)]bis [2,3,4,5,6- 
pentabromo(9CI) 
DBDBE 
51936-55-1 7,8-Dibromo-1,2,3,4,11,11- hexachloro-1,4,4a,5,6,7,8,9,10,10a- 
decahydro-1,4- methanobenzocyclooctene 
DBHCTD 
52434-90-9 1,3,5-Tris(2,3- dibromopropyl)-1,3,5- triazine-2,4,6(1H,3H,5H)-
trione 
TDBP-TAZTO 
52907-07-0 Ethylene-bis(5,6-dibromo-norbornane-2,3-dicarboximide)  EBDBNDC2 
55205-38-4 2-Propenoic acid, 1,1′- [(1-methylethylidene) bis(2,6-dibromo-
4,1- phenylene)] ester 
TBBPA-BA 
55481-60-2 Bis(methyl)tetrabromophtalate  BM-TEBP2  
57829-89-7 1-(2,3-Dibromopropyl)-3,5-diallyl-1,3,5-triazine-
2,4,6(1H,3H,5H)-trione 
DBP-TAZTO 
58495-09-3 Benzene, 1,2,3,4,5- pentabromo6- (chloromethyl) PBBC 
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58965-66-5 1,2,4,5-tetrabromo-3,6- Bis(pentabromophenoxy) benzene 4′-PeBPOB-
DE208 
59447-55-1 (Pentabromophenyl)methyl acrylate PBB-Acr 
607-99-8 2,4,6,-tribromoanisol TBA 
608-71-9 Pentabromophenol PBP 
615-58-7 2,4-dibromophenol DBP 
632-79-1 Tetrabromophthalic anhydride TEBP-Anh 
66710-97-2 2-Propenoic acid, 1,1′[(1- methylethylidene)bis[(2,6- dibromo-
4,1phenylene)oxy-2,1-ethanediyl]] ester 
TBBPA- 
BHEEBA 
70156-79-5 Benzene, 1,1′- sulfonylbis[3,5-dibromo-4-methoxy TBPPS-BME 
75790-69-1 TBPA, glycol-and propylene-oxide esters TBPA-esters2 
75795-16-3 1,3-Bis(2,3- dibromopropyl)-5-allyl-1,3,5-triazine-
2,4,6(1H,3H,5H)-trione 
BDBP-TAZTO 
79-94-7 2,2',6,6'-Tetrabromo-4,4'- isopropylidenediphenol TBBPA 
84852-53-9 1,1'-(Ethane-1,2- diyl)bis[pentabromobenzene] DBDPE 
85-22-3 2,3,4,5,6- Pentabromoethylbenzene PBEB 
87-82-1 Hexabromobenzene HBB 
87-83-2 2,3,4,5,6- Pentabromotoluene PBT 
96-13-9 2,3-Dibromo-1-propanol  2,3-DBPA2 
TABLE 1 THE 67 BFRS INCLUDED 
2.2  (Q)SAR predictions 
(Q)SAR models from Leadscope Predictive Data Miner, MultiCASE CASE Ultra, PASS, EPI Suite 
and the (Q)SAR Application Toolbox (profilers) were included. The models covered environmental 
(persistent, bioaccumulative and toxic: PBT and very persistent and very bioaccumulative: vPvB), 
health and mechanistic endpoints (carcinogenicity, genotoxicity, repro-developmental effects, 
endocrine activity, skin sensitization, liver toxicity, cardiotoxicity etc.) and a few endpoints for 
absorption, distribution, metabolism and excretion (ADME). In total, the 67 substances were 
predicted in >150 (Q)SAR models. To assign PBT and vPvB flags the thresholds applied in the 
REACH Guidance on Information Requirements and Chemical Safety Assessment R.11 PBT_vPvB 
assessment (European Chemicals Agency 2014, Tyle et al. 2002) were applied on the basis of 
predictions of biodegradation (Biowin 2 or 6 showed not ready/readily biodegradable and Biowin 3 
< 2.2 meaning ultimate biodegradation in weeks to months), and BCF (B: >2000 and vB: >5000) 
from EPI Suite and acute aquatic toxicity from DTU models for fish, daphnia and algae. A full list of 
the included endpoints is given in Appendix 3. 
 
2.3 Retrieval of ToxCast information 
The publicly available ToxCast data were downloaded from the United States Environmental 
Protection Agency (US-EPA) homepage (ToxCastTM Data 2015). The data is organized into 
different data sets and includes among other things brief descriptions of ToxCast chemicals and 
assays, files summarizing the screening results from ToxCast (high-throughput data from ~1,800 
chemicals), and EPA’s analysis of the chemicals screened through the federal Toxicity Testing in the 
21st century (Tox21) partnership and archived ToxCast data from older data releases and 
Category approach for selected brominated flame retardants 17 
 
publications. The information from ToxCast and Tox21 was used both in the preliminary structural 
grouping of all BFRs and to support the choice of the selected group and the critical effect. 
 
ToxCast data 
Summary files with data for more than 1,800 chemicals and 821 assay endpoints for 20 variables 
such as the activity or hit call, activity concentrations etc. were downloaded. The following file was 
used: AllResults_hitc_Matrix_141121.csv. Six of the 67 substances from Appendix 1 were identified 
in the file (CAS RN 118-79-6, 126-72-7, 26040-51-7, 3194-55-6, 79-94-7, 3296-90-0). They are 
marked in the column “ToxCast” in Appendix 1. 
 
Tox21 data 
EPA’s analysis of the chemicals screened through the federal Toxicity Testing in the 21st century 
(Tox21) which includes EPA’s activity calls from the screening of 8,599 Tox21 unique substances in 
the robotic screening was downloaded. The following file was used: 
ToxCast_Tox21_Level5&6_20141022.csv. Twenty of the 67 substances from Appendix 1 were 
identified in the file (CAS RNs 118-79-6, 126-72-7, 25327-89-3, 26040-51-7, 3194-55-6, 32534-81-9, 
32536-52-0, 3278-89-5, 3322-93-8, 4162-45-2, 608-71-9, 79-94-7, 85-22-3, 87-82-1, 1522-92-5, 
3234-02-4, 96-13-9, 21850-44-2, 3296-90-0, 632-79-1). They are marked in the column “Tox21” in 
Appendix 1. 
 
2.4 Grouping 
Leadscope is a predictive data-mining tool for exploring and filtering chemical data sets based on 
both structural features and associated data. This software contains a predefined library of over 
27,000 chemical functional groups (medicinal chemistry building blocks), which can be applied in 
the analysis of structural similarities within data sets and to perform grouping. 
 
All the generated (Q)SAR predictions and identified training set data, when available, for the 67 
substances were imported into the Leadscope program. Only (Q)SAR predictions which were inside 
the defined applicability domains of the models were imported. Also imported into Leadscope were 
the ToxCast data for 6 substances and Tox21 data for 20 substances. 
 
The 67 substances were upon import organized by Leadscope based on the internal library of 
chemical structural features. This structural organization on top level 1 and 2 in Leadscope is shown 
in Figure 1. The length of the bars indicates the frequency of a structural feature on a logarithmic 
scale from 1 to 100. A structure can have more than one structural feature. 
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FIGURE 1 STRUCTURAL GROUPING OF THE 67 BFRs ON TOP LEVEL 1 AND 2 IN LEADSCOPE  
The program was applied to analyse and attempt possible groupings, denoted as “clusterings” in 
Leadscope, based on structural similarity alone or including (Q)SAR predictions. Clusterings based 
on information from ToxCast/Tox21 experimental data did not result in meaningful groups, likely 
because of the vast amount of information for only a limited part of the 67 substances. 
 
2.5 Identified groups from the preliminary structural grouping 
Leadscope clustering based solely on chemical structure resulted in 15 groups, in Leadscope 
denoted as clusters, which covered 60 out of the 67 structures2. The last 7 structures are denoted 
‘singletons’ in Leadscope, meaning that they did not cluster/group together with any of the other 
structures in the set (see section 2.5.1-2.5.16). 
 
The ID numbers of the structures presented are the CAS numbers prepended by a short 
abbreviation which shows the origin of the substance. ‘Br1_’ denotes that the survey report Table 1 
was the origin of the substance. ‘Br1R_’ likewise denotes that the survey report Table 1 was the 
origin of the substances and furthermore that it was marked as solely reactive flame retardant (‘R’). 
                                                                    
2 The settings applied for the structural clustering in Leadscope were as follows. Analysis type: Similarity of 
structural features, hierarchical (agglomerative nesting) cluster method, cluster described by signature 
(substructure representative of the cluster), average linkage mechanism, cluster threshold distance: 0.5. 
Category approach for selected brominated flame retardants 19 
 
‘Br2_’ denotes that the survey report Table 2 was the origin of the substance. ‘Br3_’ denotes the 6 
additional substances as marked in Appendix 1 with source “3”. 
 
The structure signatures are the substructures that Leadscope chose to build the group around. 
These signatures, or representative substructures, are marked with purple in the members of the 
group. In some cases a member did not contain the substructure but was allocated to the group 
because of high structural similarity. 
 
All the substances included in initial structural groups were checked to see if they were among the 
ToxCast/Tox21 substances and thereby had experimental in vitro data. Six substances were found 
to be in ToxCast and 20 substances were found to be in Tox21 (overlapping the 6 ToxCast 
substances). The ToxCast/Tox21 results were used in the considerations of the choice of a group for 
further work into a possible category. 
 
To give a quick indication of whether further experimental information might be available for the 
members of the clusters it was noted if they were registered under REACH. In the selection of a 
group for a possible category approach, preference was given to groups where REACH registrations 
were made for at least two members, as this indicated possible experimental information, which is 
important to have for a representative number of the members to be able to find possible trends in 
the critical effect and to perform read-across for the full group. For groups without at least two 
REACH registered members there may possibly be experimental information in the scientific 
literature, but a literature search was not made at this stage of the project. 
 
To give rough indications of the possible relevance of the different groups in relation to a number of 
effect areas, (Q)SAR predictions-based clusterings were performed in Leadscope3. The individual 
clusterings were in each case performed for the full set of 67 substances based on (Q)SAR 
predictions for carcinogenicity, genotoxicity, reproductive toxicity effects, endocrine activity and 
skin sensitization. Each (Q)SAR predictions-based clustering produced its own set of clusters. The 
resulting (Q)SAR-based clusterings for the different effect areas are given in Appendix 4, and 
referred to in the tables in section 2.5.1-2.5.16. 
 
A number of models were included within each effect area. For example for carcinogenicity, the 
predictions included were from seven commercial CASE Ultra FDA models (male rat, female rat, 
male mouse, female mouse, rat, mouse, and rodent) and OECD (Q)SAR Application Toolbox 
carcinogenicity relevant profilings (Oncologic primary classification and ISS carcinogenicity alerts). 
 
The Toolbox profilers were run on the parent compounds (i.e. known and simulated metabolites 
were not included because of feasibility) and in order to be able to perform clustering on the results, 
the identified alerts were “binarized”, meaning that every possible positive alert outcome was split 
out as a separate yes/no prediction. The derived Toolbox (TB) fields with individual numbers are 
given in Appendix 4.  
 
For each structural group it was investigated if the members of the group belong to the same 
(Q)SAR predictions-based clusters. Some of the resulting (Q)SAR predictions-based clusters within 
the different effect areas are chemically quite big and broad. This may not be surprising, since 
different molecular structures may for example have similarities in their predicted genotoxicity 
profiles because of common or similar alerts in the applied models even though they have chemical 
differences. 
 
                                                                    
3 The settings applied for the (Q)SAR-based clusterings in Leadscope were as follows. Analysis type: Similarity of 
data, hierarchical (agglomerative nesting) cluster method, cluster described by signature (substructure 
representative of the cluster), average linkage mechanism, cluster threshold distance: 0.5. 
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For each group presented in section 2.5.1-2.5.16, results in relation to the different (Q)SAR-based 
clusters are presented. Furthermore, possible positive (Q)SAR indications for the group as a whole 
are given in brief. More detailed inspections of the (Q)SAR predictions and the ToxCast/Tox21 
results for the individual substances were done for a number of groups, which were considered as 
candidates for a possible category approach, but this is not presented here. 
 
It should be bared in mind that a category hypothesis is endpoint specific, and in theory a given 
category may be relevant for read-across in relation to one effect and not others. When looking at 
how the chemical structures group in the rough (Q)SAR predictions-based cluster outputs, it is also 
very important to remember that not all 67 substances were within the applicability domain (AD) of 
all the applied (Q)SAR models. So the observed differences between the clusters within the different 
effect areas for a given structural group could either be due to differences in predictions (within 
AD), or differences in relation to whether the individual structures were within the ADs of the 
models, or both.  
 
2.5.1 Group 1 (Aromatic substances) 
 
Structure signature 
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Abbreviated names for members 85-22-3: PBEB 
87-82-1: HBB 
87-83-2: PBT 
23488-38-2: TBX 
39569-21-6: TBCT 
84852-53-9: DBDPE 
155613-93-7: OBTMPI 
38521-51-6: PBBB 
58495-09-3: PBBC 
1084889-51-9: OBTMPI 
Members that are REACH registered DBDPE 
Members that are in ToxCast/Tox21 Tox21: HBB  
Members of OECD HPV Chemical 
Categories 
- 
Members of US-EPA New Chemical 
Categories 
Neutral organics: PBEB, HBB, PBT, TBX, TBCT, 
PBBB, PBBC 
Carcinogenicity (Q)SAR-based clustering The two OBTMPI structures are in cluster 5,  
PBEB, HBB, PBT, TBX and TBCT are in cluster 6, and 
PBBB and PBBC are in cluster 12. 
Genotoxicity (Q)SAR-based clustering  OBTMPIs, PBEB, HBB, PBT, TBX and TBCT are in 
cluster 3, and PBBB and PBBC are in cluster 1. 
Reproductive toxicity (Q)SAR-based 
clustering 
PBEB, HBB, PBT, TBCT, DBDPE, OBTMPI (CAS 
155613-93-7), PBBB and PBBC are in cluster 2, and 
TBX and OBTMPI (CAS 1084889-51-9) are singletons. 
Endocrine (Q)SAR-based clustering PBEB, DBDPE, PBBB, PBBC and OBTMPI (CAS 
1084889-51-9) are in cluster 1, 
HBB is in cluster 7, 
PBT, TBX and TBCT are in cluster 6, and 
OBTMPI (CAS 155613-93-7) is in cluster 3. 
Skin sensitization OBTMPIs, PBEB, HBB, PBT, TBX and TBCT are in 
cluster 3, and  
PBBB and PBBC are in cluster 5. 
 
OBTMPI (CAS 155613-93-7) is an incompletely defined substance, and the molecular structure is a 
representative of the substance. 
 
This is chemically a broad structural group, which may not as a whole be suited as a category for 
read-across, but which have common properties and may also have possible relevant subgroups. 
For example, PBBB and PBBC which are chemically quite similar, although one bromine in the first 
is replaced by chlorine in the second, seem according to the rough (Q)SAR-based clusterings to have 
similar predicted profiles for carcinogenicity, genotoxicity, reproductive toxicity effects, endocrine 
activity and skin sensitization. Likewise, the OBTMPIs have not surprisingly according to the 
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applied (Q)SAR models also similar profiles, at least for carcinogenicity, genotoxicity and skin 
sensitization. 
 
Seven members were predicted to be persistent and bioaccumulative (based on bioconcentration 
predictions). Furthermore, all members have some positive indications for genotoxicity and 
carcinogenicity, and all have one or more positive indications for effects within reproductive 
toxicity. Two members have positive indications within the applicability domain for skin 
sensitization. 
 
One member, DBDPE, is found to be REACH registered, and another member, HBB, is found to be 
in Tox21. The identified sources of experimental information are in itself not enough to give 
promise of possible successful read-across for the large group. 
 
2.5.2 Group 2 (dibromo-(2,3- dibromopropoxy)benzene derivatives) 
 
Structure signature 
 
 
 
 
 
 
 
 
 
 
 
Abbreviated names for members 21850-44-2: TBBPA-BDBPE 
35109-60-5: DPTE 
42757-55-1: TBBPS-BDBPE 
70156-79-5: TBPPS-BME  
Members that are REACH registered TBBPA-BDBPE 
Members that are in ToxCast/Tox21 Tox21: TBBPA-BDBPE 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
Neutral organics: DPTE, TBPPS-BME 
Carcinogenicity (Q)SAR-based clustering TBPPS-BME is in cluster 4,  
TBBPA-BDBPE and TBBPS-BDBPE are in cluster 7, 
and  
DPTE is a singleton 
Genotoxicity (Q)SAR-based clustering TBBPA-BDBPE, DPTE and TBBPS-BDBPE are in 
cluster 9, and 
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TBPPS-BME is in cluster 3. 
Reproductive toxicity (Q)SAR-based 
clustering 
TBBPA-BDBPE and DPTE are in cluster 3, and 
TBBPS-BDBPE and TBPPS-BME are in cluster 2. 
Endocrine (Q)SAR-based clustering TBBPA-BDBPE is in cluster 4, and 
DPTE, TBBPS-BDBPE and TBPPS-BME are in cluster 
1. 
Skin sensitization TBBPA-BDBPE, TBBPS-BDBPE and DPTE are in 
cluster 1, and 
TBPPS-BME is in cluster 2. 
 
This group is centered around the cluster signature (dibromo-(2,3- dibromopropoxy)benzene). It is 
noted that TBPPS-BME does not contain the cluster signature. According to the rough (Q)SAR-
based clusterings this substance (TBPPS_BME) falls in different clusterings than the other 
members for carcinogenicity, genotoxicity and skin sensitization. TBBPA-BDBPE, DPTE and 
TBBPS-BDBPE seem to have similar profiles for genotoxicity and skin sensitization. This could 
possibly be a relevant group for the three members containing the signature, if it is the same active 
metabolite, e.g. 2,3-dibromopropanol, which is responsible for the effect for which read-across is 
attempted. 
 
All members were predicted to be persistent, and DPTE and TBPPS-BME were predicted to be 
vPvB. Where the models could make robust predictions, TBBPA-BDBPE, DPTE and TBBPS-BDBPE 
have many positive indications for genotoxicity and carcinogenicity, however also with indication 
that carcinogenicity may possibly be specific to rodents. TBBPA-BDBPE and DPTE have a few 
positive hits for reproductive toxicity. 
 
One member, TBPPA-BDBPE, is found to be both REACH registered and in Tox21. The identified 
sources of experimental information are in itself not enough to give promise of possible successful 
read-across for the group as it only covers one member. 
 
2.5.3 Group 3 (Cycloalkanes) 
 
Structure signature 
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Abbreviated names for members 3194-55-6: HBCDD 
3322-93-8: DBE-DBCH 
25637-99-4: HBCDD 
3194-57-8: TBCO 
25495-98-1: HBCYD 
Members that are REACH registered HBCDD (under CAS No 25637-99-4)  
Members that are in ToxCast/Tox21 ToxCast: HBCDD (CAS 3194-55-6) 
Tox21: HBCDD (CAS 3194-55-6), DBE-DBCH  
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
-  
Carcinogenicity (Q)SAR-based clustering All except DBE-DBCH (which is a singleton) are in 
cluster 3  
Genotoxicity (Q)SAR-based clustering HBCDD (CAS 3194-55-6) and TBCO are in cluster 5, 
DBE-DBCH is a singleton, 
HBCDD (CAS 25637-99-4) is in cluster 3, and 
HBCYD is in cluster 8. 
Reproductive toxicity (Q)SAR-based 
clustering 
HBCDD (CAS 3194-55-6), DBE-DBCH, TBCO and 
HBCYD are in cluster 3, and  
HBCDD (CAS 25637-99-4) is in cluster 2. 
Endocrine (Q)SAR-based clustering HBCDDs and HBCYD are in cluster 1, 
DBE-DBCH is a singleton, and 
TBCO is in cluster 6. 
Skin sensitization HBCDDs, DBE-DBCH and TBCO are in cluster 1, and  
HBCYD is in cluster 2. 
 
HBCDD (CAS 25637-99-4) is an incompletely defined substance, and the molecular structure is a 
representative of the substance. 
 
This is chemically a broad structural group, which need thorough consideration before possible 
read-across between members. The two HBCDDs are chemically the closest analogues, although the 
different positions (alpha/beta vs. alpha/gamma) of the bromine atoms may give different 
activities. According to the rough (Q)SAR-based clusterings the two HBCDDs have similar profiles 
for carcinogenicity, endocrine activity and skin sensitization. HBCDD (CAS 3194-55-6), DBE-
DBCH, TBCO and HBCYD all have bromine in alpha/beta position (however with HBCYD having 
two bromines at the same carbon) and these substances have according to the rough (Q)SAR based 
clusterings similar profiles for reproductive toxicity effects. HBCDD (CAS 3194-55-9) and TBCO 
have similar (Q)SAR-based profiles for carcinogenicity, genotoxicity, reproductive toxicity and skin 
sensitization. 
 
HBCDDs and HBCYD were predicted to be vPvB. HBCDD (CAS 3194-55-6) is included in training 
sets for DTU models with negative experimental results for Ames, AR antagonism and ER agonism. 
BrBr
Br Br
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Br Br
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Where the models could make robust predictions, all members had a number of positive indications 
for genotoxicity. Especially DBE-DBCH had many positive genotoxicity indications. HBCDDs, DBE-
DBCH and TBCO were positive within AD in a number of cancer models. HBCDD (CAS 3194-55-6), 
DBE-DBCH, TBCO and HBCYD had a few positive hits for reproductive toxicity and cardio toxicity. 
 
One member, HBCDD (CAS 3194-55-6), is found to be both REACH registered and in Tox21, and 
DBE-DBCH is found to be in Tox21. The identified sources of experimental information are in itself 
not enough to give promise of possible successful read-across. 
 
2.5.4 Group 4 (Phthalate acid and its anhydride) 
 
Structure signature 
 
 
  
 
Abbreviated names for members 632-79-1: TEBP-Anh 
75790-69-1: TBPA (CAS refers to mixed esters) 
Members that are REACH registered TEBP-Anh 
Members that are in ToxCast/Tox21 Tox21: TEBP-Anh  
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
Anhydrides, Carboxylic acid: TEBP-Anh  
Neutral organics: TBPA 
Carcinogenicity (Q)SAR-based clustering Both are in cluster 11.  
Genotoxicity (Q)SAR-based clustering Both are in cluster 2. 
Reproductive toxicity (Q)SAR-based 
clustering 
Both are in cluster 4. 
Endocrine (Q)SAR-based clustering Both are in cluster 6. 
Skin sensitization TEBP-Anh is a singleton and 
TBPA is in cluster 3. 
 
Please note that for TBPA the CAS refers to mixed esters with diethylene glycol and propylene 
glycol. However, in this exercise the phthalic acid without esters parts was applied in the (Q)SAR 
profiling. 
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The two members are chemically very similar with TEBH-Anh being the anhydride of TBPA. 
According to the rough (Q)SAR-based clusterings they also have similar profiles for carcinogenicity, 
genotoxicity, reproductive toxicity and endocrine activity. 
 
TEBP-Anh is predicted to be PBT and TBPA is predicted to be persistent. TEBP-Anh is included in 
the training set for the DTU Ames model with a negative experimental result. Both have some 
positive indications for carcinogenicity. TEBP-Anh has positive indications of sensitization. Both 
have a few positive indications for reproductive toxicity. 
 
TEBP-Anh is found to be both REACH registered and in Tox21. The identified sources of 
experimental information could maybe be used in an analogue read-across for TBPA. However, as 
the CAS refers to mixed esters of TBPA in this case it would not be relevant. 
 
2.5.5 Group 5 (Phenols and bisphenols) 
 
Structure signature 
 
 
   
  
 
Abbreviated names for members 79-94-7: TBBPA 
118-79-6: TBP 
608-71-9: PBP 
615-58-7: DBP 
39635-79-5: TBBPS 
Members that are REACH registered TBBPA, TBP 
Members that are in ToxCast/Tox21 ToxCast: TBBPA, TBP  
Tox21: TBBPA, TBP, PBP 
Members of OECD HPV Chemical - 
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Categories  
Members of US-EPA New Chemical 
Categories 
Phenols (Acute toxicity): TBBPA, TBP, PBP, DBP, 
TBBPS 
Carcinogenicity (Q)SAR-based clustering TBP and DBP are in cluster 13,  
TBBPA and TBBPS are in cluster 14, and  
PBP is a singleton. 
Genotoxicity (Q)SAR-based clustering TBBPA, TBP, DBP and TBBPS are in cluster 7, and  
PBP is in cluster 3. 
Reproductive toxicity (Q)SAR-based 
clustering 
All are in cluster 2. 
Endocrine (Q)SAR-based clustering TBBPA is in cluster 4, 
TBP and PBP are in cluster 10, 
DBP and TBBPS are singletons. 
Skin sensitization TBBPA, TBP, DBP and TBBPS are in cluster 2, and  
PBP is in cluster 3. 
 
This group contains both phenols and bisphenols, and possible subgrouping may be relevant. 
According to the rough (Q)SAR-based clusterings they all have similar reproductive toxicity 
profiles. TBP and DBP have similar profiles for carcinogenicity, genotoxicity and skin sensitization. 
TBBPA and TBBPS likewise have similar profiles for carcinogenicity, genotoxicity and skin 
sensitization. 
 
TBBPA, TBP, PBP and TBBPS are predicted to be persistent, TBBPA is predicted to be vPvB and 
PBP is predicted to be PBT. TBBPA, TBP and PBP are included in the training set for the DTU Ames 
model with negative experimental results. TBBPA is included with positive experimental results in 
the DTU model for AR antagonism. TBBPA, TBP, PBP and DBP are included with negative 
experimental results in the DTU model for ER binding, and TBBPA and TBP are included in the 
DTU model for ER agonism with negative experimental results. All five members are predicted 
negative for Ames but have some positive indications in other genotoxicity models. TBP, PBP and 
DBP have weak indications for carcinogenicity. All five are predicted positive for thyroperoxidase 
(TPO) inhibition, and DBP is predicted positive in two small DTU models for TR alpha and beta 
binding. TBP, PBP, DBP, TBBPS have positive indications for skin sensitization. 
 
TBBPA and TBP are found to be both REACH registered and in Tox21, and PBP is found to be in 
Tox21. The identified sources of experimental information are in itself not enough to give promise 
of possible successful read-across. 
 
2.5.6 Group 6 (benzyl ethyl oxygen bridge derivatives) 
 
Structure signature 
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Abbreviated names for members 59447-55-1: PBB-Acr 
497107-13-8: DBDBE 
Members that are REACH registered PBB-Acr 
Members that are in ToxCast/Tox21 - 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
Acrylates/Methacrylates (Chronic toxicity)|Esters 
(Chronic toxicity): PBB-Acr (NB) 
Carcinogenicity (Q)SAR-based 
clustering 
PBB-Acr is a singleton and  
DBDBE is in cluster 6. 
Genotoxicity (Q)SAR-based clustering PBB-Acr is in cluster 4 and  
DBDBE is in cluster 3. 
Reproductive toxicity (Q)SAR-based 
clustering 
Both are in cluster 2. 
Endocrine (Q)SAR-based clustering PBB-Acr is in cluster 1 and  
DBDBE is in cluster 3. 
Skin sensitization PBB-Acr is a singleton and  
DBDBE is in cluster 2. 
 
The two members are grouped around the common benzyl ethyl oxygen bridge. However, 
chemically the oxygen bridge is part of an acrylate group for PBB-Acr and for DBDBE it is a 
“simple” ether group. According to the rough (Q)SAR-based clusterings they also have dissimilar 
profiles for carcinogenicity, genotoxicity, endocrine activity and skin sensitization. 
 
PBB-Acr is predicted to be vPvB and DBDBE is predicted to be persistent. PBB-Acr have positive 
indications for genotoxicity, carcinogenicity, reproductive toxicity and skin sensitization. DBDBE 
has positive indications for carcinogenicity and cardiotoxicity. 
 
PBB-Acr is found to be REACH registered. Based on the chemical and (Q)SAR-based dissimilarities 
between the structures read-across between the two members does not seem relevant. 
 
2.5.7 Group 7 (Methoxy dibromobenzene derivatives) 
 
Structure signature 
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Structure signature 
   
  
 
 
Abbreviated names for members 3278-89-5: TBP-AE 
3555-11-1: PBPAE 
37853-59-1: BTBPE 
607-99-8: TBA 
26762-91-4: AO-TBB  
Members that are REACH registered - 
Members that are in ToxCast/Tox21 Tox21: TBP-AE 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
Neutral organics: TBP-AE, PBPAE, TBA, AO-TBB 
Carcinogenicity (Q)SAR-based clustering TBP-AE, TBA and AO-TBB are in cluster 1,  
BTBPE is in cluster 4 and  
PBPAE is in cluster 6. 
Genotoxicity (Q)SAR-based clustering TBP-AE, PBPAE, TBA and AO-TBB are in cluster 3, 
and  
BTBPE is in cluster 2. 
Reproductive toxicity (Q)SAR-based 
clustering 
All are in cluster 2. 
Endocrine (Q)SAR-based clustering TBP-AE, TBA and AO-TBB are in cluster 6, and 
PBPAE and BTBPE are in cluster 1. 
Skin sensitization TBP-AE, BTBPE, TBA and AO-TBB are in cluster 2, 
and  
PBPAE is in cluster 3. 
 
AO-TBB is an incompletely defined substance, and the molecular structure is a representative of the 
substance. 
 
This group is centered around the cluster signature methoxy dibromobenzene. TBP-AE, PBPAE and 
AO-TBB have the same propene ether group. According to the rough (Q)SAR-based clusterings all 
the members have similar reproductive toxicity profiles. TBA-AE, TBA and AO-TBB furthermore 
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fall in the same (Q)SAR-based clusterings for carcinogenicity, genotoxicity, endocrine activity and 
skin sensitization.  
 
All members were predicted to be persistent, PBPAE was furthermore predicted to be 
bioconcentrating, TBP-AE and AO-TBB were predicted to be PBT and PBPAE was predicted to be 
vPvB. BTBPE is included in the training set for the DTU Ames model with negative experimental 
result. All the members have some positive indications for genotoxicity, carcinogenicity and skin 
sensitization. PBPAE, BTBPE and AO-TBB have indications that carcinogenicity may be rodent 
specific. TBP-AE, PBPAE and AO-TBB have weak indications for reproductive toxicity.  
 
None of the members are found to be REACH registered. TBP-AE is found to be in Tox21. The 
identified sources of experimental information are in itself not enough to give promise of possible 
successful read-across for the group or for the brominated benzene propene ethers. 
 
2.5.8 Group 8 (Phthalates/Benzoate) 
 
Structure signature 
 
 
  
  
 
Abbreviated names for members 20566-35-2: HEEHP-TEBP 
26040-51-7: BEH-TEBP 
183658-27-7: EH-TBB 
55481-60-2: Bis(methyl)tetrabromophtalate (BM-TEBP) 
Members that are REACH registered HEEHP-TEBP, BEH-TEBP 
Members that are in ToxCast/Tox21 ToxCast: BEH-TEBP 
Tox21: BEH-TEBP 
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Members of OECD HPV Chemical 
Categories  
High molecular weight phthalate esters: BEH-TEBP 
Members of US-EPA New Chemical 
Categories 
Esters (Acute toxicity)|Nonionic Surfactants: HEEHP- 
TEBP,  
Esters (Chronic toxicity): BM-TEBP 
Carcinogenicity (Q)SAR-based 
clustering 
BM-TEBP is in cluster 11, and  
BEH-TEBP, EH-TBB and BM-TEBP are singletons. 
Genotoxicity (Q)SAR-based clustering All are in cluster 2. 
Reproductive toxicity (Q)SAR-based 
clustering 
EH-TBB is in cluster 3, and 
HEEHP-TEBP, BEH-TEBP and BM-TEBP are singletons 
Endocrine (Q)SAR-based clustering All are in cluster 1. 
Skin sensitizatin All are in cluster 3. 
 
This group is centered around the benzoate cluster signature. However, HEEHP-TEBP, BEH-TEBP 
and BM-TEBP are phthalate esters and EH-TBB is a benzoate and would be expected to have a 
different toxicity profile. According to the rough (Q)SAR-based clusterings all the members have 
similar genotoxicity, endocrine activity and skin sensitization profiles. For carcinogenicity and 
reproductive toxicity profiles none of the members cluster together. 
 
All members were predicted to be persistent but not to be bioconcentrating. All are furthermore 
predicted to have positive indications for carcinogenicity and weak indication for genoxiticy. All 
have positive indications for reproductive toxicity, the phthalate esters having most positive hits. 
 
HEEHP-TEBP and BEH-TEBP are found to be REACH registered, and BEH-TEBP is also in 
ToxCast and Tox21. 
 
2.5.9 Group 9 (TBBPA ethers) 
 
Structure signature 
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Abbreviated names for members 3072-84-2: TBBPA-BGE 
37853-61-5: TBBPA-BME 
66710-97-2: TBBPA-BHEEBA 
4162-45-2: TBBPA-BHEE 
25327-89-3: TBBPA-bAE 
Members that are REACH registered - 
Members that are in ToxCast/Tox21 Tox21: TBBPA-BHEE, TBBPA-bAE 
Members of OECD HPV Chemical 
Categories  
Multifunctional acrylates: TBBPA-BHEEBA 
Members of US-EPA New Chemical 
Categories 
Epoxides: TBBPA-BGE,  
Acrylates/Methacrylates (Acute toxicity): TBBPA-
BHEEBA 
Neutral Organics: TBBPA-BHEE 
Carcinogenicity (Q)SAR-based 
clustering 
TBBPA-BME, TBBPA-BHEE and TBBPA-bAE are in 
cluster 4, TBBPA-BHEEBA are in cluster 15 and  
TBBPA-BGE is a singleton. 
Genotoxicity (Q)SAR-based clustering TBBPA-BGE is a singleton,  
TBBPA-BME and TBBPA-bAE are in cluster 3,  
TBBPA-BHEEBA are in cluster 4, and 
TBBPA-BHEE is in cluster 2. 
Reproductive toxicity (Q)SAR-based 
clustering 
All are in cluster 2. 
Endocrine (Q)SAR-based clustering All are in cluster 4. 
Skin sensitization TBBPA-BME, TBBPA-BHEE and TBBPA-bAE are in 
cluster 2, TBBPA-BHEEBA and TBBPA-BGE are 
singletons. 
 
This group is centered around the TBBPA methyl ether signature. However, the group does not 
seem very chemically homogeneous since TBBPA-BGE contains an epoxy group, TBBPA-BHEEBA 
contains an acrylate group and TBBPA-bAE contains a propene ether group. So it is to be expected 
that some members may be more reactive. According to the rough (Q)SAR-based clusterings all the 
members have similar reproductive toxicity and endocrine activity profiles. For carcinogenicity 
TBBPA-BME, TBBPA-BHEE and TBBPA-bAE cluster together. For genotoxicity only TBBPA-BME 
and TBBPA-bAE cluster together. For skin sensitization TBBPA-BME, TBBPA-BHEE and TBBPA-
bAE cluster together.  
 
All members were predicted to be persistent, TBBPA-BME is bioconcentrating, TBBPA-BGE and 
TBBPA-BHEE are vPvB, and TBBPA-BHEE is also PBT. TBBPA-BHEE is included in the training 
set for the DTU AR antagonism model with negative experimental result. TBBPA-BGE, TBBPA-
BHEEBA and TBBPA-bAE have positive indications for genotoxicity and carcinogenicity with 
TBBPA-BGE having the strongest profile. However, there is also indication that carcinogenicity may 
be rodent specific. All have a few positive reproductive toxicity indications. All have positive 
indications from pregnane X receptor (PXR) binding, ER binding and agonism, and TPO inhibition. 
O
OH
Br Br
O
OH
BrBr
Br1_4162-45-2
Br
O
Br
Br
O
Br
Br1_25327-89-3
Category approach for selected brominated flame retardants 33 
 
TBBPA-BHEE has positive indications from several cardiotoxicity models. TBBPA-BGE, TBBPA-
BME and TBBPA-BHEEBA have positive indications for skin sensitization. 
 
None of the members are found to be REACH registered. TBBPA-BHEE and TBBPA-bAE are found 
to be in Tox21. Apart from the differences in chemical structure between the group members, the 
identified sources of experimental information are also not sufficient to give promise of possible 
successful read-across. 
 
2.5.10 Group 10 (small alkyl alkohols) 
 
Structure signature 
 
 
 
 
 
 
 
 
 
 
 
Abbreviated names for members 3296-90-0: DBNPG 
36483-57-5: TBNPA 
1522-92-5: TBNPA 
96-13-9: 2,3-DBPA 
Members that are REACH registered DBNPG, TBNPA (CAS 36483-57-5)  
Members that are in ToxCast/Tox21 ToxCast: DBNPG 
Tox21: DBNPG, TBNPA, DBPA 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
- 
Carcinogenicity (Q)SAR-based clustering DBNPG and TBNPA are in cluster 10, and  
2,3-DBPA is in cluster 7. 
Genotoxicity (Q)SAR-based clustering DBNPG and TBNPA are in cluster 1, and  
2,3-DBPA is a singleton. 
Reproductive toxicity (Q)SAR-based 
clustering 
TBNPA is in cluster 2, 
2,3-DBPA is in cluster 3, and 
DBNPG is a singleton. 
Endocrine (Q)SAR-based clustering All are in cluster 9. 
Skin sensitization All are in cluster 2. 
 
Br
O
Br
Cluster 10 
OHOH
Br
Br
Br1R_3296-90-0
Br
Br
Br
OH
Br1R_36483-57-5
OHBr
Br
Br
Br2_1522-92-5
Br
Br
OH
Br3_96-13-9
34 Category approach for selected brominated flame retardants 
 
Note that CAS 36483-57-5 and CAS 1522-92-5 have identical molecular structures (TBNPA). 
 
The group consists of three different molecular structures, all being small alkylalcohols, either 
branched or linear. According to the rough (Q)SAR-based clusterings all have similar profiles for 
endocrine activity and skin sensitization. DBNPG and TBNPA are in the same (Q)SAR-based 
clusters for carcinogenicity and genotoxicity. For reproductive toxicity the three structures are in 
separate clusters. 
 
None of the members are predicted to be persistent or bioconcentrating. All three members are 
included in the training set for the DTU Ames model with positive experimental results and 2,3-
DBPA is included with positive experimental results in the DTU models for chromosomal 
aberrations in CHL cells and SHE cell transformation in vitro. All three have positive predicted 
indications in all included models for carcinogenicity. DBNPG and TBNPA have positive predicted 
indications in few models for reproductive toxicity, and 2,3-DBPA have positive predicted 
indications in more reproductive toxicity models. All have positive predicted indications for airway 
allergy. 
 
DBNPG and TBNPA (CAS 36483-57-5) are found to be REACH registered. DBNPG is found to be in 
both ToxCast and Tox21, and TBNPA and 2,3-DBPA are found to be in Tox21. The identified 
sources of experimental information could give promise of possible successful read-across and 
although all three substances do not cluster together in the (Q)SAR based clusterings for 
genotoxicity, carcinogenicity and reproductive toxicity, manual inspection of the predictions 
showed good consistency in the (Q)SAR predictions between the members, especially for 
genotoxicity and carcinogenicity. 
 
2.5.11 Group 11 (TBBPA esters/acrylate) 
 
Structure signature 
 
 
 
 
 
 
 
 
 
Abbreviated names for members 33798-02-6: TBBPA-bOAc 
37419-42-4: TBBPA-BP 
55205-38-4: TBBPA-BA 
Members that are REACH registered - 
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Members that are in ToxCast/Tox21 - 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
Esters (Chronic toxicity): TBBPA-bOAc 
Carcinogenicity (Q)SAR-based clustering TBBPA-bOAc and TBBPA-BP are in cluster 4 and  
TBBPA-BA is in cluster 15. 
Genotoxicity (Q)SAR-based clustering TBBPA-bOAc and TBBPA-BP are in cluster 2. and  
TBBPA-BA is in cluster 4. 
Reproductive toxicity (Q)SAR-based 
clustering 
All three are in cluster 2. 
Endocrine (Q)SAR-based clustering TBBPA-bOAc is in cluster 2, and 
TBBPA-BP and TBBPA-BA are in cluster 4. 
Skin sensitization TBBPA-bOAc and TBBPA-BP are in cluster 6 and  
TBBPA-BA is a singleton. 
 
This group is centered around the TBBPA di-acetate signature, although for TBBPA-BA the ester 
group is part of an acrylate group, which may be expected to be more chemically reactive. TBBPA-
bOAc and TBBPA-BP are structurally very similar being TBBPA di-acetate and di-propionate esters, 
respectively. According to the rough (Q)SAR-based clusterings TBBPA-bOAc and TBBPA-BP have 
similar profiles for carcinogenicity, genotoxicity and skin sensitization. For reproductive toxicity the 
rough (Q)SAR-based clusterings indicated that all three substances have similar profiles. 
 
All members were predicted to be persistent and bioconcentrating, and TBBPA-bOAc is predicted to 
be vPvB. TBBPA-BA has positive indications for genotoxicity, carcinogenicity and reproductive 
toxicity. TBBPA-bOAc and TBBPA-BP have weak indications for genotoxicity. All three have 
positive indications for ER binding, AR antagonism and TPO inhibition. TBBPA-bOAc has 
furthermore positive indications for PXR binding and cardiotoxicity.  
 
None of the members are found to be REACH registered or in ToxCast/Tox21, and there is thereby 
not identified any sources of experimental information for possible read-across. 
 
2.5.12 Group 12 (Phosphates) 
 
Structure signature 
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Abbreviated names for members 126-72-7: TDBPP 
19186-97-1: TTBNPP 
Members that are REACH registered TTBNPP 
Members that are in ToxCast/Tox21 ToxCast: TDBPP 
Tox21: TDBPP 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
- 
Carcinogenicity (Q)SAR-based clustering Both are singletons. 
Genotoxicity (Q)SAR-based clustering Both are singletons. 
Reproductive toxicity (Q)SAR-based 
clustering 
Both are singletons. 
Endocrine (Q)SAR-based clustering Both are in cluster 7. 
Skin sensitization Both are singletons. 
 
This group is centered around the phosphate cluster signature. According to the rough (Q)SAR-
based clusterings the two members have similar endocrine activity profiles, and in all the other 
(Q)SAR-based clusterings they both come out as singletons. 
 
Both members were predicted to be persistent but not to be bioconcentrating. TDBPP is included in 
the training sets for the DTU models for Ames, Ames sub-model for base-pair mechanism, 
chromosomal aberrations in CHL cells, unscheduled DNA synthesis (UDS, in vitro), SHE cell 
transformation (in vitro), Drosophila SLRL (in vivo), sister chromatid exchange (in vivo), strong 
skin irritation with positive experimental results and in DTU models for Ames sub-model for direct 
acting mutagens and possible rodent-specific carcinogenicity with negative experimental results. 
Both members have positive predicted indications in all included models for carcinogenicity, in 
many models for in vitro and in vivo genotoxicity, for PXR binding and TPO inhibition, in many 
models for reproductive toxicity, for severe skin irritation and for skin sensitization. TDBPP has 
positive predicted indications in a few models for cardiotoxicity. 
 
TTBNPP is found to be REACH registered and TDBPP is found to be in ToxCast and Tox21. 
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2.5.13 Group 13 (Triazines) 
 
Structure signature 
 
 
   
 
Abbreviated names for members 52434-90-9: TDBP-TAZTO 
57829-89-7: DBP-TAZTO 
75795-16-3: BDBP-TAZTO 
Members that are REACH registered - 
Members that are in ToxCast/Tox21 - 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
- 
Carcinogenicity (Q)SAR-based clustering All three are in cluster 9. 
Genotoxicity (Q)SAR-based clustering All three are in cluster 10. 
Reproductive toxicity (Q)SAR-based 
clustering 
TDBP-TAZTO is in cluster 3, and 
DBP-TAZTO and BDBP-TAZTO are in cluster 7. 
Endocrine (Q)SAR-based clustering TDBP-TAZTO and BDBP-TAZTO are in cluster 7, and 
DBP-TAZTO is in cluster 6. 
Skin sensitization All three are in cluster 4. 
 
This group is centered around the (2,3- dibromopropyl)-1,3,5- triazine-2,4,6-trione cluster 
signature, however DBP-TAZTO and BDBP-TAZTO also contain two and one allyl groups, 
respectively. According to the rough (Q)SAR-based clusterings the three members have similar 
profiles for carcinogenicity, genotoxicity and skin sensitization. For reproductive toxicity DBP-
TAZTO and BDBP-TAZTO have according to the rough (Q)SAR based clusterings similar profiles, 
and TDBP-TAZTO and BDBP-TAZTO have similar profiles for endocrine activity. 
 
All members were predicted to be bioconcentrating, and TDBP-TAZTO and BDBP-TAZTO were 
predicted to be vPvB. All three members have positive predicted indications in many models for 
genotoxicity, carcinogenicity and reproductive toxicity. However, there are indications that 
carcinogenicity may be rodent specific. TDBP-TAZTO has positive indications for PXR binding, 
TPO inhibition and skin sensitization, and BDBP-TAZTO has positive indications for PXR binding. 
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None of the members were found to be REACH registered or in ToxCast/Tox21.  
 
2.5.14 Group 14 (Biphenyles)  
 
Structure signature 
 
 
 
 
 
 
 
Abbreviated names for members 13654-09-6: DecaBB 
36355-01-8: HexaBB 
Members that are REACH registered - 
Members that are in ToxCast/Tox21 - 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
- 
Carcinogenicity (Q)SAR-based clustering DecaBB is in cluster 8 and  
HexaBB is in cluster 2. 
Genotoxicity (Q)SAR-based clustering Both are in cluster 3. 
Reproductive toxicity (Q)SAR-based 
clustering 
Both are in cluster 6. 
Endocrine (Q)SAR-based clustering DecaBB is a singleton and  
HexaBB is in cluster 2. 
Skin sensitization DecaBB is in cluster 3 and  
HexaBB is in cluster 2. 
 
HexaBB is an incompletely defined substance, and the molecular structure is a representative of the 
substance. 
 
This group contains two brominated biphenyls. These substances are already assessed and treated 
as a group in the RoHS directive, and since the cluster does not contain any other types of chemical 
structures this group would not bring new knowledge applicable in the regulation of groups of 
substances in the RoHS directive.  
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2.5.15 Group 15 (Diphenyl ethers) 
 
Structure signature 
 
 
 
 
 
 
 
 
 
 
 
Abbreviated names for members 1163-19-5: decaBDE 
32534-81-9: pentaBDE 
32536-52-0: octaBDE 
58965-66-5: 4′-PeBPOB-DE208 
Members that are REACH registered decaBDE 
Members that are in ToxCast/Tox21 Tox21: pentaBDE, octaBDE 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
Neutral Organics: pentaBDE,  
Carcinogenicity (Q)SAR-based clustering DecaBDE is in cluster 8,  
pentaBDE is a singleton,  
octaBDE is in cluster 2 and  
4′-PeBPOB-DE208 is in cluster 6. 
Genotoxicity (Q)SAR-based clustering All are in cluster 6. 
Reproductive toxicity (Q)SAR-based 
clustering 
DecaBDE is in cluster 2, and  
pentaBDE, octaBDE and 4′-PeBPOB-DE208 are in 
cluster 5. 
Endocrine (Q)SAR-based clustering DecaBDE, octaBDE and 4′-PeBPOB-DE208 are in 
cluster 5, and  
pentaBDE is in cluster 2. 
Skin sensitization All are in cluster 3. 
 
PentaBDE and octaBDE are incompletely defined substances, and the molecular structures are 
representatives of the substances. 
 
This group contains three brominated diphenyl ethers and one with an extra brominated p-phenyl 
ether fragment. The polybrominated diphenyl ethers are already assessed and treated as a group 
and restricted in the RoHS directive. According to the rough (Q)SAR-based clusterings all the 
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members have similar profiles for genotoxicity and skin sensitization. For reproductive toxicity 4′-
PeBPOB-DE208 clusters together with pentaBDE and octaBDE, and for and for endocrine activity it 
clusters together with DecaBDE and octaBDE. 
 
All members were predicted to be persistent, and pentaBDE was predicted to be PBT and vPvB. 
DecaBDE is included in the training sets for the DTU models for Ames, HGPRT, SHE cell 
transformation and AR antagonism with negative experimental results, and in DTU model for 
mouse micronucleus (bone marrow, in vivo) and rodent specific carcinogenicity with positive 
experimental results. PentaBDE is included in the training set for the DTU model for AR 
antagonism with positive experimental result. All four members have positive predicted indications 
in a few models for genotoxicity and carcinogenicity. However, with indications for all four that 
carcinogenicity may be rodent specific. PentaBDE and octaBDE have positive indications in one 
model for human teratogenicity. All four have positive indications for AR antagonism and TPO 
inhibition, and decaBDE, pentaBDE and 4′-PeBPOB-DE208 have positive indications for ER 
binding.  
 
DecaBDE was found to be REACH registered. PentaBDE and octaBDE were found to be in Tox21.  
 
The polybrominated diphenyl ethers (PBDE) are already assessed and regulated as a group in the 
RoHS directive.  
 
2.5.16 Singletons 
 
Structure signature 
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Abbreviated names for members 25713-60-4: TTBP-TAZ 
31780-26-4: DBS 
32588-76-4: EBTEBPI 
34571-16-9: HCTBPH 
51936-55-1: DBHCTD 
3234-02-4: 2,3-Dibromo-2-butene-1,4-diol 
52907-07-0: Ethylene-bis(5,6-dibromo-norbornane-
2,3-dicarboximide) 
Members that are REACH registered TTBP-TAZ and EBTEBPI 
Members that are in ToxCast/Tox21 Tox21: 2,3-Dibromo-2-butene-1,4-diol 
Members of OECD HPV Chemical 
Categories  
- 
Members of US-EPA New Chemical 
Categories 
Imides (Acute toxicity): Ethylene-bis(5,6-dibromo-
norbornane-2,3-dicarboximide) 
Carcinogenicity (Q)SAR-based clustering DBHCTD and Ethylene-bis(5,6-dibromo-norbornane-
2,3-dicarboximide) are in cluster 3,  
TTBP-TAZ is in cluster 4,  
DBS and EBTEBPI are in cluster 5, and  
HCTBPH and 2,3-Dibromo-2-butene-1,4-diol are 
singletons. 
Genotoxicity (Q)SAR-based clustering TTBP-TAZ is in cluster 3, 
HCTBPH is in cluster 8, 
DBHCTD are in cluster 5, and 
DBS, EBTEBPI, 2,3-Dibromo-2-butene-1,4-diol and 
Ethylene-bis(5,6-dibromo-norbornane-2,3-
dicarboximide) are singletons. 
Reproductive toxicity (Q)SAR-based 
clustering 
DBS and 2,3-Dibromo-2-butene-1,4-diol are in cluster 
1, and  
TTBP-TAZ, EBTEBPI, HCTBPH, DBHCTD and 
Ethylene-bis(5,6-dibromo-norbornane-2,3-
dicarboximide) are singletons. 
Endocrine (Q)SAR-based clustering TTBP-TAZ is a singleton, 
DBS is in cluster 6, 
EBTEBPI and Ethylene-bis(5,6-dibromo-norbornane-
2,3-dicarboximide) are in cluster 8, 
HCTBPH and DBHCTD are in cluster 3, and 
2,3-Dibromo-2-butene-1,4-diol is in cluster 9. 
Skin sensitization DBS is in cluster 2, 
Ethylene-bis(5,6-dibromo-norbornane-2,3-
dicarboximide) is in cluster 4, and 
TTBP-TAZ, EBTEBPI, HCTBPH, DBHCTD and 2,3-
Dibromo-2-butene-1,4-diol are singletons. 
 
These substances are structurally clustered as “singletons” meaning that they did not cluster 
together with any of the other substances included. 
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3. (Q)SAR predictions 
The group of small linear and branched brominated alkyl alcohols was selected for a possible 
category approach. This decision was based on (Q)SAR predicted positive profiles for genotoxicity 
and cancer with positive experimental information in the training sets for a number of the applied 
(Q)SAR models for two of the substances, DBNPG (CAS RN 3296-90-0) and DBPA (CAS RN 96-13-
9). 
 
These two substances were furthermore REACH registered and also for that reason expected 
possibly to have experimental information for a number of endpoints. To enable read-across by the 
category approach for a given effect it is necessary to have experimental information for this effect 
for a representative number of the category members, as a minimum and depending on the size of 
the category, for at least two of the members. 
 
DBNPG and DBPA have been identified by the EU Commission (Oeko-Institut 2014) to have 
highest priority in relation to undergoing further evaluation leading to possible restriction under 
the RoHS directive. In the evaluation by the EU Commission emphasis have been laid on the 
application in electric and electronic equipment. This has been extracted from the REACH dossiers. 
 
3.1 Definition of the category  
The working definition of the category was made on the basis of the span of the four members of the 
structural group identified in the preliminary structural grouping exercise. In the identified group 
the smallest member (DBPA) has 3 carbons, two bromine atoms and one alcohol group, and the two 
biggest members (TBNPA and DPNPA) have 5 carbons, 2-3 bromine atoms and 1-2 alcohol groups. 
The category was therefore defined as small brominated linear and branched alkyl alcohols with 3-5 
carbons, 1-2 alcohol groups, and 2-4 bromine atoms. Four bromine atoms were allowed although 
this was not seen in the members in the preliminary structural group. In correspondence with the 
category members from the preliminary structural group a maximum of one bromine atom or one 
alcohol group was allowed on a carbon, bromine being allowed only on primary or secondary 
carbons. However, chains were allowed to end with a carbon atom without a bromine or alcohol 
group even though this is not seen in the members from the preliminary structural group. The 
purpose of “relaxing” on the chemical specifications in the working definition of the category 
compared to the members in the preliminary structural group was to possibly identify more 
structural analogs for which experimental data might be available. Depending on the findings in a 
later stage it can be decided to narrow down the category. 
 
3.2 Identification of category members 
The chemical structures of the theoretical members of the category were identified and SMILES 
codes were generated. There were 62 in total including the four from the preliminary structural 
group. Of these, 2 were structurally identical but with different CAS RNs, and as the number of 
unique structures is important in this exercise (and as some of the other members also have more 
than one CAS RN) in the following text the category is referred to as containing 61 members. 
Possible CAS RNs for the 58 newly generated members were identified by SMILES lookup in 
SciFinder. For 22 of these one or more CAS RNs could be found in SciFinder. Only CAS RNs for 
isomers not including mixtures or substances with deuterium (2H) or carbon-14 (14C) were 
retrieved. For the remaining members no CAS RN was located. However, these substances were still 
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kept in the category as theoretical members, as they may potentially be used in the future. For the 
members with no CAS RNs no experimental data is expected to be available. 
The full list with the 61 (62) members is presented in Appendix 5 with 2D structures and a few 
physical-chemical descriptors. All the ID numbers, which are given as part of the images, have the 
prefix “BFR_”, which were used in Leadscope to give the structures unique identifiers so that they 
did not merge with other projects stored in the Leadscope server. The ID number follows the prefix. 
The first three digits of the ID numbers encode the number of carbon atoms, bromine atoms and 
alcohol groups in the molecule, followed by a further numbering as there was in many cases more 
than one member with the same first three digits. If a CAS RN was found it is given as the last part 
of the ID number. 
 
3.3 ToxCast/Tox21 
All the identified CAS RNs for the theoretical members of the category were searched to see if they 
were among the substances included in ToxCast or Tox21. However, only the three substances from 
the preliminary structural group which were already identified ToxCast/Tox21 members were 
found. 
 
TBNPA (CAS RN 1522-92-5): 65 assays, 2 hits (AhR, NRF2) 
DBPA (CAS RN 96-13-9):  65 assays, 0 hits 
DBNPG (CAS RN 3296-90-0): 384 assays, 1 hit (COX-2) 
 
3.4 (Q)SAR models applied 
Although the category was chosen based on the genotoxicity and carcinogenicity profiles for the 
members from the preliminary structural group, the 61 category members were predicted in all the 
human health related (Q)SAR models and in the OECD (Q)SAR Application Toolbox profilers (see 
Appendix 3). PBT in relation to environmental endpoints were not predicted as PBT properties for 
the category members were not identified in the preliminary structural group. 
 
3.5 Results from the (Q)SAR predictions 
 
3.5.1 Membership of existing OECD HPV Chemical Categories or US-EPA New 
Chemical Categories 
The OECD (Q)SAR Application Toolbox was used to check whether any of the 61 category members 
were associated with an existing category assessed within the OECD HPV Chemicals Programme or 
a category defined within the new chemical notification scheme and the HPVC challenge 
programme of the US-EPA. None of the category members were associated with either the OECD 
HPV or the US EPA New Chemical Categories. 
 
3.5.2 Bioavailability 
All the 61 category members are bioavailable according to estimated Lipinski’s rule-of-five as 
predicted both in Leadscope and the OECD (Q)SAR Application Toolbox. Human intestinal 
absorption was predicted to be between 90% and 96% for the individual members. 
 
3.5.3 Metabolism / transformation 
The following metabolism profilers in the OECD (Q)SAR Application Toolbox was run: Observed 
Mammalian metabolism, observed microbial metabolism, observed rat in vivo metabolism, 
observed rat liver S9 metabolism, simulated microbial metabolism, and simulated rat liver 
metabolism. One metabolite was identified in the observed rat in vivo metabolism profiler for 
DBNPG (glucuronide metabolite), but none for any of the other members. I.e. this means that for 
DBNPG the Toolbox contains information about a metabolite and it does not contain information 
about metabolites for the remaining members. However, this does not mean that they do not 
possibly have any metabolites. Multiple metabolites were generated for all of the 61 category 
members in both of the two metabolism simulators.  
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3.5.4 Endocrine endpoints 
All 61 category members were predicted to be non-binders in the OECD profiler for Estrogen 
Receptor (ER) binding. All members were furthermore negative or outside AD for in vitro ER 
binding in the DTU model, and in further DTU models all members were predicted negative for in 
vitro ER agonism, Androgen Receptor (AR) antagonism, Pregnane X Receptor (PXR) binding, PXR 
activation and thyroperoxidase (TPO) inhibition. 
 
3.5.5 Repro-developmental toxicity 
The 61 category members were predicted negative or were outside AD in many of the commercial 
suites (Leadscope FDA) for non-human reproductive toxicity (9 models for: Rodent male 
composite, Rat male, Mouse male, Rodent male sperm composite, Rat male sperm, Mouse male 
sperm, Rodent female composite, Rat female and Mouse female). However, in the model for Rat 
male 34 members were predicted positive and the remaining were outside AD, in the model for 
Rodent male sperm composite 33 members had positive predictions, 3 were negative and the 
remaining were outside AD, and in the model for Rodent female composite 9 members had positive 
predictions, 1 was negative and the remaining were outside AD. 
 
The category members were predicted negative or were outside AD in all of the commercial suites 
(Leadscope FDA) for non-human developmental toxicity (27 models within Structural 
dysmorphogenesis, Visceral dysmorphogenesis, Fetal growth retardation, Fetal weight decrease, 
Fetal survival: fetal death, Fetal survival: post-implantation loss and Fetal survival: pre-
implantation loss). However, DBNPG (CAS RN 3296-90-0) had positive experimental results in the 
training sets of many of the models (Growth Retard Mouse, retard rodent (AH1), Wt Dec Mouse, wt 
dec rodent (AI1), Fetal Death Mouse, Fetal Death Rodent, post impl mouse (AG6), post impl rodent 
(AG1), Pre Impl Loss Mouse, Pre Impl Loss Rodent, Repro Mouse Male, Repro Rodent Male, sperm 
mouse(AP5), sperm Eff Rodent) and negative results in others (struct mouse (AL6), struct rodent 
(AL1), Visc Org Mouse, Visc Org Rodent, Repro Mouse Female, Repro Rodent Female). 
 
Commercial CASE Ultra model A49 for human teratogenicity potential: 4 positive predictions and 
many negative. 
 
3.5.6 Organ toxicity 
The category members were outside the AD in commercial suite models for renal toxicity (CASE 
Ultra), hepatotoxicity (Leadscope) and cardiotoxicity (CASE Ultra). 
 
3.5.7 Repeated dose toxicity 
All the category members were identified to belong to Cramer classification scheme for oral 
systemic toxicity (with extensions) class III. 
 
None of the members were categorized in the OECD (Q)SAR Application Toolbox profiler for 
repeated dose toxicity (Hazard Evaluation Support System, HESS). 
 
In a DTU model for human maximum recommended daily dose (in pharmaceutical clinical trials 
employing primarily oral route of exposure and daily treatments, usually for 3-12 months) based on 
US FDA data, and found by the US FDA to be directly related to NOEL in humans, the majority of 
the members were outside the AD and the remaining (9) were predicted negative (positive meaning 
side effects at daily dose below 2.69 mg/kg-bw). 
 
3.5.8 Genotoxicity and carcinogenicity 
All category members were predicted using a number of (Q)SAR models for genotoxicity and 
carcinogenicity. This section presents the predictions from DTU models and commercial models 
implemented in MultiCASE and Leadscope first, preseded by predictions from OECD (Q)SAR 
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Application Toolbox profilers. Heat maps over the (Q)SAR predictions and of the OECD (Q)SAR 
Application Toolbox profilers alerts are included in Appendix 6. 
 
DTU models and commercial models implemented in MultiCASE and Leadscope  
In the commercial MultiCASE CASE Ultra model for Ashby structural alerts for DNA reactivity 
(NTP data) all members were predicted positive, except 1 substance (DBNPG). In a commercial 
CASE Ultra model for Ames mutagenicity (Salmonella typhimurium) all members were predicted 
positive. In a DTU model for Ames mutagenicity predictions within the defined AD could be 
obtained for 47 of the members and they were all predicted positive, and the 3 members (i.e. 
including DBNPG) from the preliminary structural group had positive experimental data. In 
Appendix 6 the predictions for Ashby alerts, and the CASE Ultra commercial and DTU models for 
Ames are included in columns a, b and c, respectively. 
 
The two identified alerts in the DTU Ames model for the different substances were one bromine on 
a primary carbon or one bromine on a secondary carbon. To check the specificity of the models it 
was investigated if two or three bromines on the same carbon would also be alerted, and these 
checked substances (which were not part of the category) were predicted negative with no alert 
found. 
 
In a DTU Ames sub-model for direct acting Ames mutagens (not requiring liver S9) DBNPG and 
DBPA are included in the training set as experimental positives and TBNPA is included as an 
experimental negative. In another DTU Ames sub-model for frameshift mutagenicity DBPA is 
included in the training set as an experimental positive and DBNPG and TBNPA are included as 
experimental negatives. In a third DTU Ames sub-model for base-pair mutagenicity DBPA is 
included in the training set as experimental positive and DBNPG and TBNPA are not included. For 
the DTU Ames sub-model for Base-pair all 48 members within the AD of the model are predicted 
positive. This is illustrated in the heat map for the (Q)SAR predictions in Appendix 6 column f. 
 
None of the 61 members were predicted to be positive for chromosomal aberrations in vitro in 
Chinese hamster ovary cells (1/61 was out of the AD for this model), see column h in the (Q)SAR 
predictions heat map in Appendix 6. One substance (2,3-DBPA) was predicted to be positive for 
chromosomal aberrations in vitro in Chinese hamster lung cells, 8 substances were predicted to be 
negative and the remaining 52 substances were out of the applicability domain (column i in the 
(Q)SAR predictions heat map in Appendix 6).  
 
Regarding the mouse lymphoma assay, all substances were out of the AD in this model. 
 
In the model for the HGPRT test, 5 substances were predicted to be positive and the remaining 56 
substances were out of the AD (column k in the (Q)SAR predictions heat map in Appendix 6). 24 
substances were predicted to be positive for unscheduled DNA synthesis in vitro, while the 
remaining 37 substances were out of the AD (column j in the (Q)SAR predictions heat map in 
Appendix 6). In the in vivo sister chromatid exchange assay, 51 substances were predicted to be 
positive and the remaining 10 substances were out of the AD (column m in the (Q)SAR predictions 
heat map in Appendix 6). In the model for the in vivo bone marrow micronucleus test, 23 
substances were predicted to be negative and the remaining 38 substances were out of the AD for 
this test (column n in the (Q)SAR predictions heat map in Appendix 6). In the in vivo dominant 
lethal test in rodents, 41 substances were predicted to be negative and the remaining 20 substances 
were out of the applicability domain for this test (column o in the (Q)SAR predictions heat map in 
Appendix 6). Increases in sex-linked recessive lethal mutations in male germ cells of Drosophila 
melanogaster were predicted for 44 substances, but not for 13 substances; the remaining 4 
substances were out of the applicability domain for this test (column p in the (Q)SAR predictions 
heat map in Appendix 6). In the model for in vivo Comet assay, there were positive predictions for 
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14 substances, whereas the remaining 47 substances were out of the applicability domain (column q 
in the (Q)SAR predictions heat map in Appendix 6).  
 
In a commercial CASE Ultra FDA cancer suite with 7 models (male rat, female rat, male mouse, 
female mouse, rat, mouse, rodent (columns r-x in the (Q)SAR predictions heat map in Appendix 6)) 
all members had at least four positive predictions within the AD. All members were predicted 
positive in the CASE Ultra FDA RCA algorithm for overall cancer call, which requires at least two 
positive predictions in the four male/female mouse/rat models and overlapping alerts (column y in 
the (Q)SAR predictions heat map in Appendix 6). In a Leadscope DTU model which predicts 
whether carcinogenicity is specific to rodent liver 34 members were predicted negative and 27 were 
outside the AD. DBNPG (CAS RN 3296-90-0) is included as an experimental negative in the 
training set of the model. I.e. according to this model there were no indications that carcinogenicity 
is rodent specific. 
 
All the 61 category members were predicted positive in the MultiCASE commercial model for Ames 
mutagenicity, and all except one (DBNPG) were predicted positive for Ashby structural alerts. In 
further DTU or commercial models for genotoxicity, positive or out-of-AD predictions were 
obtained in the models for in vitro chromosomal aberrations in Chinese hamster ovary cells, 
HGPRT, unscheduled DNA synthesis and in vivo sister chromatid exchange. Negative or out-of-AD 
predictions were obtained in the models for in vivo bone marrow micronucleus in mice and 
dominant lethal test in rodents. 
 
Both positive and negative predictions were obtained in models for in vitro chromosomal 
aberrations in Chinese hamster lung cells and in vivo increases in sex-linked recessive lethal 
mutations in male germ cells of Drosophila melanogaster, so for these particular endpoints the 
models indicate possible differences between the category members.  
 
The fact that robust predictions within the defined ADs of the models could not be obtained for all 
the category members (i.e. some of the chemical structures were out of the AD) does not in itself 
indicate anything about the relevance of the defined category in relation to genotoxicity and cancer. 
It merely means that not all the chemical structures were sufficiently known by the models. It is also 
important to treat the negative predictions with particular care, as the applied systems require more 
statistical significance for “alerts” than for “non-alerts”. All the 61 category members were predicted 
positive in the MultiCASE CASE Ultra commercial FDA suite for carcinogenicity, and no indications 
were found that carcinogenicity may be rodent specific by a Leadscope DTU model. 
 
In other words, the following models gave positive predictions within AD for all category members: 
MultiCASE commercial models for Ames and FDA cancer suites. As these models are commercial 
the identified alerts cannot be presented here due to license restrictions. The outputs from 
commercial (Q)SAR programmes are related to the mode of action. 
 
The overall accuracies of the models in terms of sensitivity and specificity estimated by cross-
validation are presented in Table 2 for the Ashby structural alerts, Salmonella mutagenicity (Ames) 
and cancer models. For the Salmonella mutagenicity model the results were extracted from the 
MultiCASE CASE Ultra model information where it was presented as the result of a ten-fold (i.e. 
10%) cross-validation. For the Ashby structural alerts and cancer models the cross-validation was 
performed by DTU as a 5 times random (but keeping the balance between positives and negatives) 
two-fold (i.e. 50%) cross-validation. Documentation in (Q)SAR Model Reporting Format (QMRF) is 
available for the Ashby structural alerts and cancer models, as well as for the other genotoxicity 
models presented in the heat map in Appendix 6, in the online Danish (Q)SAR database (DTU 
2016). The estimated specificities of the models are between 85.9% and 95.1%, i.e. the overall false 
positive rates of the models are around 5%- 14%.  
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Endpoint N  Cross validation result (%)a 
CU Ashby structural alerts 782 Sens=89.7, Spec=95.1, Conc=91.9 
CU SALM, Salmonella mutagenicity 
(TA97,98,100,1535-1538)) 
10479 Sens=91 ±0.7, Spec=89 ±1.2 
CU FDA RCA cancer male rat  1324 Sens=34.2, Spec=95.0, Conc=63.9 
CU FDA RCA cancer female rat 1321 Sens=44.4, Spec=93.3, Conc=71.6 
CU FDA RCA cancer rat  1379 Sens=41.7, Spec=94.0, Conc=66.9 
CU FDA RCA cancer male mouse 1197 Sens=38.4, Spec=86.1, Conc=66.1 
CU FDA RCA cancer female mouse 1208 Sens=41.5, Spec=85.9, Conc=65.6 
CU FDA RCA cancer mouse 1221 Sens=43.1, Spec=86.9, Conc=66.9 
CU FDA RCA cancer rodent 1530 Sens=51.4, Spec=88.3, Conc=68.2 
TABLE 2. TRAINING SET NUMBERS (N) AND RESULTS FROM CROSS VALIDATIONS.  
SENS: SENSITIVITY; SPEC: SPECIFICITY; CONC: CONCORDANCE. 
 
OECD (Q)SAR Application Toolbox profilers 
In its workflow for read across, the OECD (Q)SAR Toolbox aims to group chemicals into categories 
on the basis of a common molecular initiating event. One common molecular initiating event for 
genetic toxicity and genotoxic carcinogenicity is often the ability of a chemical to bind covalently to 
DNA (OECD 2011). A number of profilers in the OECD (Q)SAR Application Toolbox were applied to 
identify alerts and point to possible mechanisms. 
 
All the category members as well as their observed (Mammalian/Rat S9/in vivo) and simulated 
metabolites (Rat S9/in vivo) were profiled in a number of profilers of relevance for genotoxicity and 
carcinogenicity: 
 
• DNA binding by OECD 
• DNA binding by OASIS v.1.3 
• Protein binding alerts for Chromosomal aberration by OASIS v1.1 
• In vitro mutagenicity (Ames test) alerts by ISS 
• DNA alerts for AMES, MN and CA by OASIS v.1.3 
• In vivo mutagenicity (Micronucleus) alerts by ISS 
• Oncologic Primary Classification 
• Carcinogenicity (genotox and nongenotox) alerts by ISS 
 
The structural alerts-output from the profilers for all the category members is included as a heat 
map in Appendix 6. The rows of the matrix represent structural alerts identified either in the parent 
compound or in one or more metabolites. Each structural alert is associated with one or more 
possible mechanisms in the OECD (Q)SAR Application Toolbox alerts explanations provided in 
Appendix 7 . 
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In the DNA binding OECD profiler, one or more of 5 alerts were identified in each of the 61 category 
members, either in the parent compound or in one or more metabolites (columns A1-A5 in the 
profiler alerts heat map in Appendix 6): 
• Aliphatic halides (identified in 52 members) 
• 1,2-Dihaloalkanes (identified in 34 members) 
• Mono aldehydes (identified in 59 members) 
• Epoxides (identified in 51 members) 
• Mustards (identified in 3 members) 
 
For DNA binding by OASIS v.1.3 one or more of 5 alerts were identified in each of the 61 category 
members, either in the parent compound or in one or more metabolites (columns B1-B5 in the 
profiler alerts heat map in Appendix 6): 
• Haloalkanes Containing Heteroatom (identified in 57 members) 
• Haloalkane Derivatives with Labile Halogen (identified in 23 members) 
• Vicinal Dihaloalkanes (identified in 34 members) 
• Epoxides and Aziridines (identified in 51 members) 
• Haloalcohols (identified in 52 members) 
 
For Protein binding alerts for Chromosomal aberration by OASIS v1.1 one or more of the following 
2 alerts were identified in each of 41 members either in the parent compound and/or in one or more 
metabolites (columns C1-C2 in the profiler alerts heat map in Appendix 6):  
• Halogenated Vicinal Hydrocarbons (identified in 27 members) 
• Alpha-Activated Haloalkanes (identified in 41 members) 
 
In the profiler for in vitro mutagenicity (Ames test) alerts by ISS one or more of the following 3 
alerts were identified in each of the 61 category members either in the parent compound and/or in 
one or more metabolites (columns D1-D3 in the profiler alerts heat map in Appendix 6): 
• Aliphatic halogens (identified in 61 members) 
• Simple aldehyde (identified in 59 members) 
• Epoxides and aziridines (identified in 51 members) 
 
For DNA alerts for Ames, Mouse micronucleus (MN) and chromosomal aberration (CA) by OASIS 
v.1.3 no alert was identified in 7 category members, and in each of the remaining 55 members one 
or more of the following 4 structural alerts were identified either in the parent compound and/or in 
one or more metabolites (columns E1-E4 in the profiler alerts heat map in Appendix 6): 
• Haloalkane Derivatives with Labile Halogen (identified in 20 members) 
• Vicinal Dihaloalkanes (identified in 10 members) 
• Haloalcohols (identified in 44 members) 
• Epoxides and Aziridines (identified in 45 members) 
 
In the profiler for in vivo mutagenicity (Micronucleus) alerts by ISS one or more of the following 4 
alerts were identified in each of the 61 category members either in the parent compound and/or in 
one or more metabolites (columns F1-F4 in the profiler alerts heat map in Appendix 6): 
• Aliphatic halogen (identified in 61 members) 
• Epoxides and aziridines (identified in 51 members) 
• H-acceptor-path3-H-acceptor (identified in 60 members) 
• Simple aldehyde (identified in 59 members) 
 
In the Oncologic Primary Classification profiler one or more of the following 4 alerts were identified 
in 61 category members either in the parent compound and/or in one or more metabolites (columns 
G1-G4 in the profiler alerts heat map in Appendix 6): 
• Aldehyde Type Compounds (identified in 59 members) 
• Alpha, beta-Haloether Reactive Functional Groups (identified in 52 members) 
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• Reactive Ketone Reactive Functional Groups (identified in 25 members) 
• Epoxide Reactive Functional Groups (identified in 51 members) 
 
In the profiler for carcinogenicity (genotox and nongenotox) alerts by ISS one or more of the 
following 5 alerts were identified in each of 61 category members either in the parent compound 
and/or in one or more metabolites (columns H1-H5 in the profiler alerts heat map in Appendix 6):  
• (Poly) Halogenated Cycloalkanes (Nongenotox) (identified in 34 members) 
• Aliphatic halogens (Genotox) (identified in 60 members) 
• Epoxides and aziridines (Genotox) (identified in 51 members) 
• Simple aldehyde (Genotox) (identified in 59 members) 
• Substituted n-alkylcarboxylic acids (Nongenotox) (identified in 6 members) 
 
The OECD (Q)SAR Application Toolbox profilers are expert rule-based systems with defined 
positive alerts (“positive list”). The profilers are not associated with a defined AD. They can be 
applied for positive identification but if no alert is identified it is not a “negative” prediction, but 
absence of identification of a positive alert in that particular profiler. For some but not all of the 
applied profilers the identified structural alerts are associated with mechanistic information. 
 
The OECD (Q)SAR Application Toolbox profilers for genotoxicity identified alerts in all category 
parent members and/or their metabolites in the profilers for DNA binding by OECD, DNA binding 
by OASIS, in vitro mutagenicity (Ames test) alerts by ISS and in vivo mutagenicity (Micronucleus, 
in rats and mice) alerts by ISS. The profilers for DNA alerts for AMES, MN and CA and for protein 
binding for chromosomal aberration, both by OASIS, identified alerts in the majority of the category 
members (55 and 41, respectively). Oncologic Primary Classification identified alerts in all but one 
member (ID number 52125_3). Carcinogenicity (genotox and nongenotox) alerts by ISS identified 
alerts in all parent members and/or their metabolites. 
 
As it appears from the listing above, a number of alerts in the different profilers were identified 
indicating multiple possible genotoxic mechanisms. However, there was overlap in some of the 
identified alerts from the different profilers. Some alerts were identified in fewer members and/or 
their metabolites and some were identified in many or all of the members and/or their metabolites. 
 
One alert was identified in all 61 category members, namely the “Aliphatic halogen” alert in the 
three ISS profilers for in vitro mutagenicity (Ames test), in vivo mutagenicity (Micronucleus, in rats 
and mice) and carcinogenicity (genotox and nongenotox). Furthermore, there was one alert which 
was identified in all but one (ID number 52125_3) category members, namely the “H-acceptor-
path3-H-acceptor” alert in the ISS profiler for in vivo mutagenicity (Micronucleus). The alerts 
“Mono aldehydes” from DNA binding by OECD, “Simple aldehyde” from the three ISS profilers and 
”Aldehyde Type Compounds” from Oncologic Primary Classifications profilers were identified in all 
but two members (ID numbers 52123_213821-20-6 and 52125_3). The explanations for these alerts 
as provided by the Toolbox are shown in Figures 2-6 (see also Appendix 7).  
 
As described above, the “Aliphatic halogen” alert from the three ISS profilers for in vitro 
mutagenicity (Ames test), in vivo mutagenicity (Micronucleus, in rats and mice) and carcinogenicity 
(genotox and nongenotox) was identified in all 61 category members. The explanation for the 
“Aliphatic halogen” alert as provided by the Toolbox for all three ISS profilers is shown in Figure 2. 
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FIGURE 2 OECD (Q)SAR APPLICATION TOOLBOX EXPLANATION OF THE “ALIPHATIC HALOGEN” 
STRUCTURAL ALERT FROM THE THREE ISS PROFILERS 
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According to the alert explanation some aliphatic halogens may be direct alkylating agents while 
metabolic activation may play a role for others. Cytochrome P450 oxidation may as shown in 
reaction 1 lead to reactive carbonyl (aldehyde or ketone) compounds. Reaction 2 gives an example 
of another proposed activation mechanism by glutathione (GSH) conjugation. Reaction 3 in Figure 
2 does not seem relevant for this category of small linear and branched brominated alkyl alcohols, 
since the members were required to have maximum one bromine atom per carbon atom. 
 
As described above, the “H-acceptor-path3-H-acceptor” alert from the ISS profiler for in vivo 
mutagenicity (Micronucleus) was identified in all but one (ID number 52125_3) category members 
and/or their metabolites. The explanation for the “H-acceptor-path3-H-acceptor” alert is shown in 
Figure 3. 
 
 
FIGURE 3 OECD (Q)SAR APPLICATION TOOLBOX EXPLANATION OF THE “H-ACCEPTOR-PATH3-H-
ACCEPTOR” STRUCTURAL ALERT IN THE ISS PROFILER FOR IN VIVO MUTAGENICITY (MICRONUCLEUS) 
According to the explanation in Figure 3 this alert explores the possibility that a chemical interact 
with DNA and/or protein via non-covalent binding.  
 
As described above, the alerts “Mono aldehydes” from DNA binding by OECD, “Simple aldehyde” 
from the three ISS profilers and ”Aldehyde Type Compounds” from Oncologic Primary 
Classifications profilers were identified in metabolites from all but two members (ID numbers 
52123_213821-20-6 and 52125_3). The explanations for the alerts are shown in Figure 4, 5 and 6. 
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FIGURE 4 OECD (Q)SAR APPLICATION TOOLBOX EXPLANATION OF THE “MONO ALDEHYDES” 
STRUCTURAL ALERT FROM THE DNA BINDING BY OECD PROFILER 
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FIGURE 5 OECD (Q)SAR APPLICATION TOOLBOX EXPLANATION OF THE “SIMPLE ALDEHYDE” 
STRUCTURAL ALERT FROM THE THREE ISS PROFILERS 
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FIGURE 6 OECD (Q)SAR APPLICATION TOOLBOX EXPLANATION OF THE ”ALDEHYDE TYPE 
COMPOUNDS” STRUCTURAL ALERT FROM THE ONCOLOGIC PRIMARY CLASSIFICATIONS PROFILER 
According to the explanations in Figure 4 and 5 aldehyde compounds can potentially undergo Schiff 
base formation with a primary amine to form DNA adducts and cross-links. 
 
The OECD (Q)SAR Application Toolbox does not contain information about the accuracy of the 
profilers or the individual alerts. However, it has been assessed by some studies as described below.  
 
In 1988 Ashby and Tennant (Ashby et al. 1988) analysed 222 chemicals evaluated for 
carcinogenicity in mice and rats by the United States NCI/NTP. The structure of each chemical was 
assessed for potential electrophilic (DNA-reactive) sites, its mutagenicity to Salmonella, and the 
level of its carcinogenicity to rodents. A strong correlation of 90% was found between the chemical 
structure and Salmonella mutagenicity across 115 carcinogens, 24 equivocal carcinogens and 83 
non-carcinogens. As part of their well-known poly-carcinogen, aromatic and aliphatic substituted 
primary alkyl halides were identified by Ashby and Tennant to be a structural alert for genotoxic 
carcinogenicity. Tertiary aliphatic halogen substituents and geminal tri- or di-halogen substituents, 
as well as primary aliphatic halocarbons adjoined to a sterically crowded atom (e.g. to a CHCl2 or 
CCl3 substructure) were classified as negative. Such types of compounds are not included in this 
category of small linear and branched brominated alkyl alcohols. 
 
Kazius et al. (2005) analysed a dataset of 4337 molecular structures with corresponding Ames test 
data (2401 mutagens and 1936 nonmutagens). Specific toxicophores were derived and approved by 
employing chemical and mechanistic knowledge in combination with statistical criteria. 
Toxicophores were defined as substructures that indicate an increased potential for mutagenicity, 
whether this is caused by DNA reactivity or not. I.e. a toxicophore represents a reactive substructure 
or a substructure that is prone to either metabolic activation or intercalation. A final set of 29 
toxicophores containing new substructures was assembled that could classify the mutagenicity of 
the investigated dataset with a total classification error of 18%. Furthermore, mutagenicity 
predictions of an independent validation set of 535 compounds were performed with an error 
percentage of 15%. Since these error percentages approach the average interlaboratory 
reproducibility error of Ames tests, which is 15%, it was concluded that these toxicophores can be 
applied to risk assessment processes and can guide the design of chemical libraries for hit and lead 
optimization. 
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As part of this work Kazius et al. identified the aliphatic halide (excluding the fluorine atom) 
substructure to be an alert for mutagens. Out of 416 aliphatic halide compounds, 297 were 
mutagens, corresponding to 71% (p-value <<0.05). If compounds containing other toxicophores 
were excluded, there were 330 aliphatic halide compounds, of which 217 were mutagens, 
corresponding to 66% (p-value <<0.05). I.e. this alert does not discriminate very precisely between 
positives and negatives and identifies 34% false positives among the training set chemicals.  
 
According to Benigni et al. (2008 and 2010) the aliphatic halogen alert from the three ISS profilers 
has a positive predictivity for carcinogenicity of 74% (49 out of 66 substances experimentally tested 
for carcinogenicity and containing the alert fragment had positive results from the carcinogenicity 
studies). 
 
According to Benigni et al. (2010) the hacceptor-path3-hacceptor alert from the ISS in vivo 
mutagenicity (Micronucleus) profiler has a positive predictivity for in vivo micronucleus of 34% (55 
out of 163 substances experimentally tested for in vivo micronucleus and containing the alert 
fragment had positive results from the micronucleus studies). No statistics for positive predictivity 
for carcinogenicity was found. 
 
According to Benigni et al. (2008) the simple aldehyde alert from the three ISS profilers has a 
positive predictivity for carcinogenicity of 88% (7 out of 8 substances experimentally tested for 
carcinogenicity and containing the alert fragment had positive results from the carcinogenicity 
studies). 
 
Additional Toolbox category investigation exercises 
The OECD (Q)SAR Application Toolbox v 3.3.2 was used in a preliminary exercise to investigate 
further sub-category formation possibilities and to find possible analogs with experimental data. 
The chemical structures of all 61 category members were imported into the Toolbox. No 
experimental results in any of the Toolbox inventories were found for the category members.  
 
Mutagenicity and carcinogenicity properties were profiled using the following profilers: DNA alerts 
for Ames, MN and CA by OASIS v.1.3, in vitro mutagenicity (Ames test) alerts by ISS, in vivo 
mutagenicity (Micronucleus) alerts by ISS, Carcinogenicity (genotox and non-genotox) by ISS and 
Oncologic Primary Classification.  
 
It was discovered in the process that the (Q)SAR Application Toolbox does not suggest possible sub-
categorizations when multiple “targets” are processed as a category, in this case the 61 potential 
category members. 
 
As a next step, the category definition function of the (Q)SAR Application Toolbox was used to find 
analogues among chemicals in the contained inventories (analogues chemicals are chemicals that 
are similar to other chemical). The above profilers were selected as filters one by one to retrieve 
possible analogs with high chemical similarity to the category members. The selection has different 
modes of operation, among others, two logical modes (AND and OR) are available, and the OR was 
selected as the AND mode is too restrictive for this size of category and therefore not expected to 
return analogs (confirmed for selected profilers).  
 
This exercise returned thousands of possible analogs, for example:  
- the in vitro mutagenicity (Ames test) alerts by ISS based retrieval of analogs returned 
3,570 analogs, of which 1,108 contained bromine, 
- the Oncologic Primary Classification profiler based retrieval of analogs returned 65,998 
analogs, of which 1,697 contained bromine, and  
- the Carcinogenicity (genotox and nongenotox) alerts by ISS profiler returned 32,474 
analogs of which 1,878 contained bromine.  
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Some of these analogs have experimental information for mutagenicity and cancer in the (Q)SAR 
Application Toolbox, but it requires further analysis to filter the data and retrieve experimental 
information only for the chemically closest analogs, and this was not possible within the scope of 
this project.  
 
Overall (Q)SAR results for genotoxicity and carcinogenicity 
The 61 members in the category of small linear and branched brominated alkyl alcohols were 
predicted by a number of (Q)SAR models to be positive for carcinogenic and genotoxic properties 
indicating that they have a carcinogenic potential with a possible mutagenic/genotoxic mode of 
action. The estimated specificities of the models as established by leave-many-out cross-validations 
are between 85.9% and 95.1%, i.e. the overall false positive rates of the models are around 5%- 14%. 
 
From the identified alerts in a number of OECD (Q)SAR Application Toolbox profilers, there was 
one alert which was identified in all 61 category members, namely the “Aliphatic halogen” alert 
identified in the three ISS profilers for in vitro mutagenicity (Ames test), in vivo mutagenicity 
(Micronucleus, in rats and mice) and carcinogenicity (genotox and nongenotox). This alert 
identified 34% false positives among the mutagenicity training set chemicals (Kazius et al. 2005). 
According to Benigni et al. (2008 and 2010) this alert has a positive predictivity for carcinogenicity 
of 74%.  
 
From the explanation of the alert contained in the OECD (Q)SAR Application Toolbox it does not 
seem that there is one single mechanistic interpretation of the ISS aliphatic halogen alert in relation 
to mutagenicity and cancer. Specific read-across hypotheses on the molecular level for different 
sub-categories within the category may possibly be based on in-depth analysis of the mechanistic 
interpretations of the remaining identified alerts in the OECD (Q)SAR Application Toolbox 
profilers. However, this was outside the scope of this project. 
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4.  Experimental data  
This phase of the project consisted of a literature search to collect experimental data on human 
health effects and an evaluation of the retrieved data with focus on identification of a critical human 
health effect for the members of the category of brominated flame retardants selected for this phase, 
i.e. the category of small linear and branched alkyl alcohols. 
 
4.1 Data collection and evaluation of data 
The literature search was performed for the three members of the category identified in the 
preliminary structural grouping, i.e. 2,3-DBPA (CAS RN 96-13-9, 83165-36-0, 83165-35-9), DBNPG 
(CAS RN 3296-90-0) and TBNPA (CAS RN 1522-92-5, 36483-57-5), as well as for the 22 new 
category members identified in the definition of the category, which have a CAS RN assigned. 
 
The literature search was performed in the databases SciFinder, PubMed and Scopus with selected 
search terms, e.g. substance name, CAS RN and combinations (e.g. ‘propanol AND dibromo’; 
‘hydroxypropane AND dibromo’) etc. as documented in the literature search document, see 
Appendix 8.  
 
All the retrieved data from the literature search were checked in order to identify relevant data on 
human health effects. For the purpose of this project, i.e. to perform a category approach and read 
across for the critical effect across all or some of the theoretical members of the category, the 
relevant data on human health effects are: human data and animal data on repeated dose toxicity, 
genotoxicity, carcinogenicity and reproductive toxicity, as well as in vitro data on genotoxicity, 
endocrine activity and other mode/mechanisms of action. 
 
Data were retrieved for 24 of the 25 category members with a CAS RN assigned. Relevant data on 
human health effects were only retrieved for two of these members, i.e. for two of the three 
members of the category identified in the preliminary structural grouping, 2,3-DBPA (CAS RN 96-
13-9) and DBNPG (CAS RN 3296-90-0), see Table 3. 
 
Two of the three members of the category identified in the preliminary structural grouping are 
registered in REACH, i.e. DBNPG (CAS RN 3296-90-0) and TBNPA (CAS RN 36483-57-5). The 
third member of the category identified in the preliminary structural grouping is pre-registered in 
REACH, i.e. 2,3-DBPA (CAS RN 96-13-9). Two of the 22 category members with a CAS RN assigned 
identified in the preliminary structural grouping are also pre-registered in REACH, i.e. 1,3-
dibromo-2-propanol (CAS RN 96-21-9) and 1,4-dibromo-2-butanol (CAS RN 19398-47-1).  
 
For the two substances registered under REACH, the REACH registrations in the publicly accessible 
part of the REACH Registration Dossier Database, hosted on the ECHA website, were checked in 
order to identify eventual additional relevant information. For TBNPA (CAS RN 36483-57-5), the 
REACH registration was the only source of information. For DBNPG (CAS RN 3296-90-0), no 
additional relevant information was identified in the REACH registration. 
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Substance name CAS RN Data found Relevant data REACH 
Members of the category identified in the preliminary structural grouping 
2,3-Dibromo-1-propanol (2,3-DBPA) 96-13-9 
83165-36-0 
83165-35-9 
Yes 
Yes 
Yes 
Yes  
No 
No 
Pre-registered 
No 
No  
2,2-Bis(bromomethyl)-1,3-
propanediol (DBNPG) 
3296-90-0 Yes Yes Registered  
2,2-Bis-(bromomethyl)-3-bromo-1-
propanol (TBNPA) 
1522-92-5 
36483-57-5 
Yes 
Yes  
No 
No  
No 
Registered 
New members identified in the definition of the category 
1,3-Dibromo-2-propanol 96-21-9 Yes  No  Pre-registered 
2,3,4-Tribromo-1-butanol  855236-37-2 Yes  No  No  
1,2,4-Tribromo-3-butanol 87018-38-0 Yes  No  No  
3,4-Dibromo-1,2-butanediol 35330-59-7 Yes  No No  
1,4-Dibromo-2,3-butanediol 14396-65-7 
299-70-7 
1947-59-7 
15410-44-3 
Yes 
Yes 
Yes 
Yes  
No  
No 
No 
No  
No  
No 
No 
No  
3-Bromo-2-(bromomethyl)-1-
propanol 
106023-63-6 Yes  No No  
1,4-Dibromo-2-butanol 19398-47-1 
64028-90-6 
1360729-08-3 
Yes 
Yes 
Yes  
No 
No 
No 
Yes 
No 
No 
3,4-Dibromo-2-butanol 79033-40-2 Yes  No  No  
2,3-Dibromo-1-butanol 4021-75-4 
54899-03-5 
70528-70-0 
Yes  
Yes 
Yes  
No  
No  
No  
No  
No  
No  
3,4- Dibromo-1-butanol 87018-30-2 Yes  No  No  
2,2-Bis(bromomethyl)-1-propanol 105100-80-9 Yes  No  No  
4,5-Dibromo-2-pentanol 213821-22-8 Yes  No  No  
1,2-Dibromo-3-pentanol 408319-76-6 Yes  No  No  
1,4-dibromo-(R*,R*)-(9CI)-3-
pentanol 
159475-15-7 
159475-16-8 
Yes 
Yes  
No 
No  
No 
No 
2,4-Dibromo-3-pentanol 343268-04-2 
72770-99-1 
Yes 
Yes  
No 
No  
No 
No 
3,4-Dibromo-(2R*,3S*,4S*)- (9CI)-2-
pentanol 
76377-07-6 
76420-11-6 
Yes 
Yes  
No 
No  
No 
No 
4,5-Dibromo-1-pentanol 59287-66-0 Yes  No  No  
2,5-Dibromo-1-pentanol 856991-78-1 No No  No  
1,5-Dibromo-2-pentanol 100606-66-4 
1092554-97-6 
Yes 
Yes  
No 
No  
No 
No 
2,5-Dibromo-2-pentanol 213821-20-6 
159475-17-9 
159475-18-0 
Yes 
Yes 
Yes  
No 
No 
No 
Yes 
No 
No 
4-Bromo-2-(bromomethyl)- 1-
butanol 
98069-26-2 Yes  No  No  
4-Bromo-2-(bromomethyl)- 1,3-
butanediol 
44804-46-8 Yes  No  No  
TABLE 3 SUMMARY OF THE RESULTS OF THE DATA COLLECTION AND EVALUATION FOR THE 25 
CATEGORY MEMBERS WITH A CAS RN ASSIGNED 
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For one of the three members of the category identified in the preliminary structural grouping, 
there is a harmonised classification. For the two other members of the category identified in the 
preliminary structural grouping, there are notified classifications. Also for two of the new members 
of the category identified in the definition of the category, there are notified classifications. The 
classifications for these substances are summarised in Table 4. 
 
Substance name CAS RN C&L Inventory 
Members of the category identified in the preliminary structural grouping 
2,3-Dibromo-1-propanol (2,3-
DBPA) 
96-13-9 
 
 
 
 
 
 
 
Harmonised classification: 
Acute Tox. 4 H302 
Acute Tox. 3 H311 
Acute Tox. 4 H332 
Carc. 1B H350 
Repr. 2 H361f *** 
Aquatic Chronic 3 H412 
2,2-bis(bromomethyl)-1,3-
propanediol (DBNPG) 
3296-90-0 Notified classification: 
Acute Tox. 4 H302 
Skin Irrit. 2 H315 
Eye Irrit 2 H319 
STOT SE 3 H335 (respiratory system) 
STOT RE 2 H373 (kidney, bladder - oral) 
Muta. 1B H340 / Muta. 2 H341 
Carc. 1B H350 / Carc. 2 H351 
Aquatic Chronic 4 H413 
 
2,2-Bis-(bromomethyl)-3-
bromo-1-propanol (TBNPA) 
1522-92-5 
 
 
 
 
 
 
36483-57-5 
Notified classification: 
Acute Tox. 4 H302 
Acute Tox. 4 H312 
Acute Tox. 4 H332 
Skin Irrit. 2 H315 
Eye Irrit 2 H319 
 
Notified classification: 
Acute Tox. 4 H302 
Eye Irrit 2 H319 
Muta. 1B H340 / Muta. 2 H341 
Carc. 1B H350 
Aquatic Chronic 3 H412 
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New members identified in the definition of the category 
1,3-Dibromo-2-propanol 96-21-9 Notified classification: 
Flam. Liq. 3 H226 
Acute Tox. 3 H301 
Skin Irrit. 2 H315 
Eye Irrit 2 H319 
STOT SE 3 H335  
Carc. 2 H351 
 
1,4-Dibromo-2,3-butanediol 14396-65-7 Notified classification: 
Skin Irrit. 2 H315 
Eye Dam 1 H318 
STOT SE 3 H335  
TABLE 4 HARMONISED / NOTIFIED CLASSIFICATION AVAILABLE FOR THE MEMBERS OF THE 
CATEGORY 
 
4.2 Experimental studies on repeated dose toxicity and carcinogenicity 
Experimental studies examining repeated dose toxicity and carcinogenicity are summarised in 
Table 5.  
 
Method 
 
Results Reference 
2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
 
Test substance: FR-1138 technical 
grade (with a composition of 78.6% 
2,2-bis(bromomethyl)- propane-
1,3-diol, 6.6% 2,2-
bis(hydroxymethyl)-1-bromo-3-
hydroxypropane, 6.9% 2,2- 
bis(bromomethyl)-1-bromo-3-
hydroxypropane, 0.2% 
pentaerythritol and 7.7% dimers 
and structural isomers) 
 
Sub-chronic repeated dose toxicity 
study 
 
Test substance administered in the 
feed for 13 weeks 
 
F344/N rats (10 per sex per group): 
0, 1,250, 2,500, 5,000, 10,000, 
20,000 ppm (corresponding to 
approximately 0, 100, 200, 400, 
800, 1700 mg/kg bw/day for males 
and 0, 100, 200, 400, 800, 1600 
mg/kg bw/day for females) 
 
Rats: 
No rats died during the study. 
Final mean body weights and weight gains of 5,000, 
10,000, and 20,000 ppm males and females were 
significantly lower than those of the controls. 
Chemical-related differences in clinical pathology 
parameters included increased urine volumes 
accompanied by decreased urine specific gravity and 
minimally increased protein excretion in 10,000 and 
20,000 ppm males; in females, urine parameters were 
less affected than males. Serum protein and albumin 
concentrations in female rats exposed to 2,500 ppm and 
higher were slightly lower than those of the controls. 
Renal papillary degeneration was present in 5,000 and 
10,000 ppm males, and in 20,000 ppm males and 
females.  
Hyperplasia of the urinary bladder was present in 20,000 
ppm males.  
 
Mice: 
One control female, two males and one female receiving 
625 ppm, one female receiving 1,250 ppm, one female 
receiving 2,500 ppm, one female receiving 5,000 ppm, 
and three males receiving 10,000 ppm died during the 
study. 
NTP (1996) 
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B6C3F1 mice (10 per sex per 
group): 0, 625, 1,250, 2,500, 5,000, 
10,000 ppm (corresponding to 
approximately 0, 100, 200, 500, 
1300, 3000 mg/kg bw/day for 
males and 0, 140, 300, 600, 1200, 
2900 mg/kg bw/day for females) 
 
Final mean body weights and body weight gains of males 
and females receiving 1,250, 2,500, 5,000, or 10,000 ppm 
and of females receiving 625 ppm were significantly lower 
than those of the controls. 
Feed consumption by exposed mice was generally higher 
than that by controls throughout the study. 
Clinical findings included abnormal posture and 
hypoactivity in 10,000 ppm male and female mice. 
Blood urea nitrogen concentrations of 5,000 ppm females 
and 10,000 ppm males and females were greater than 
those of controls. Also, urine specific gravity was lower in 
10,000 ppm females. 
Differences in organ weights generally followed those in 
body weights. 
Papillary necrosis, renal tubule regeneration, and fibrosis 
were observed in the kidneys of 2,500 and 5,000 ppm 
males and 10,000 ppm males and females. 
Urinary bladder hyperplasia was observed in 5,000 and 
10,000 ppm males and females. 
 
Test substance: FR-1138 technical 
grade (78.6% pure according to 
IARC (2000); no information in the 
article). As the feed study is 
included in the NTP (1996) report, 
the composition of the test 
substance for gavage 
administration is probably the same 
as for the feed study 
 
Sub-chronic repeated dose toxicity 
study 
 
Test substance administered in the 
feed or by gavage (in corn oil, 5 
days a week) for 13 weeks 
 
F344/N rats (10 per sex per group) 
Gavage: 0, 50, 100, 200, 400, 800 
mg/kg bw  
Feed: 0, 1,250, 2,500, 5,000, 
10,000, 20,000 ppm 
(corresponding to approximately 0, 
100, 200, 400, 800, 1700 mg/kg 
bw/day for males and 0, 100, 200, 
400, 800, 1600 mg/kg bw/day for 
females) 
 
B6C3F1 mice (10 per sex per group) 
Gavage: 0, 25, 50, 100, 200, 400 
mg/kg bw 
Feed: 0, 625, 1,250, 2,500, 5,000, 
10,000 ppm (corresponding to 
Rats – test substance administered by gavage: 
2/10 high-dose males died during the study. 
Dose-related clinical signs of toxicity included inactivity 
or lethargy after dosing at 400 and 800 mg/kg in males 
and females. 
Final mean body weights of 800 mg/kg bw males and 
females were significantly lower than those of the 
controls. 
Renal papillary degeneration was present in 800 mg/kg 
bw males.  
Hyperplasia of the urinary bladder was present in 40 and 
800 mg/kg bw males.  
 
Mice – test substance administered by gavage: 
3/10 high-dose males died during the study. 
Dose-related clinical signs of toxicity included inactivity 
or lethargy after dosing at 400 mg/kg in males and 
females.  
Final mean body weights of 200 and 400 mg/kg bw 
males and of 400 mg/kg bw females were significantly 
lower than those of the controls. 
Papillary necrosis and renal tubule regeneration were 
observed in the kidneys of 200 (renal tubule 
regeneration) and 400 mg/kg bw males, and renal tubule 
regeneration in the kidneys of 400 mg/kg bw females. 
Urinary bladder hyperplasia was observed in 200 and 
400 mg/kg bw males and in 400 mg/kg bw females. 
 
Rats and mice - test substance administered in the feed: 
See previous reference as the feed study is included in the 
NTP (1996) report.  
 
Elwell et al. (1989) 
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approximately 0, 100, 200, 500, 
1300, 3000 mg/kg bw/day for 
males and 0, 140, 300, 600, 1200, 
2900 mg/kg bw/day for females)  
 
Test substance: FR-1138 (with a 
composition of 80% 2,2-
bis(bromomethyl)propane-1,3-diol, 
8% 2,2′-bis(bromomethyl)-1-
bromo-3-hydroxypropane and 
6% 2,2-bis(hydroxymethyl)-1-
bromo-3-hydroxypropane) 
 
Combined repeated dose and 
carcinogenicity study 
 
Test substance in the feed for 2 
years 
 
Sprague-Dawley rats (49-50 per sex 
per dose): 0, 5, 100 mg/kg bw/day  
 
Survival was not significantly different among the groups; 
most rats died or were killed at between 17 and 24 
months. 
 
100 mg/kg bw/day: 
Slight reduction in body weight was noted in males. 
Slight increase in bromide content was noted in the 
tissues. 
Degenerative changes were noted in the liver, eye and 
possibly thyroid gland. 
No treatment-related effects on tumour incidence were 
noted. 
 
5 mg/kg bw/day: 
Marginal increase in bromide content of some tissues was 
noted, with most values in the same range as the controls. 
 
Keyes et al. (1980) 
Test substance: FR-1138 technical 
grade (with a composition of 78.6% 
2,2-bis(bromomethyl)- propane-
1,3-diol, 6.6% 2,2-
bis(hydroxymethyl)-1-bromo-3-
hydroxypropane, 6.9% 2,2- 
bis(bromomethyl)-1-bromo-3-
hydroxypropane, 0.2% 
pentaerythritol and 7.7% dimers 
and structural isomers) 
 
Combined repeated dose and 
carcinogenicity study 
 
Test substance administered in the 
feed for 2 years (104-105 weeks) 
 
F344/N rats (60 per sex per group): 
0, 2,500, 5,000, 10,000 ppm - 
‘continuous exposure’ 
(corresponding to approximately 0, 
100, 200, 430 mg/kg bw/day for 
males and 0, 115, 230, 460 mg/kg 
bw/day for females) 
 
An additional group of 70 male rats 
received 20,000 ppm 
(corresponding to approximately 
800 mg/kg bw/day) for three 
months and which animals received 
un-dosed feed for the remainder of 
Rats:  
Survival of 5,000 and 10,000 ppm ‘continuous-exposure’ 
males and females and 20,000 ppm ‘stop-exposure’ 
males was significantly lower than that of the controls. 
Mean body weights of exposed male and female rats 
receiving 10,000 ppm and ‘stop-exposure’ males 
receiving 20,000 ppm were lower than those of the 
controls throughout most of the study. 
In the ‘continuous-exposure’ study, feed consumption by 
exposed rats was generally similar to that by controls 
throughout the study; in 20,000 ppm ‘stop-exposure’ 
males, the feed consumption was lower than that by 
controls. 
Clinical findings included skin and/or subcutaneous 
masses on the face, tail, and the ventral and dorsal 
surfaces of exposed rats. 
 
In males, neoplastic effects were observed in the skin, 
mammary gland, Zymbal gland, oral cavity, esophagus, 
forestomach, small and large intestines, mesothelium, 
urinary bladder, lung, thyroid gland, hematopoietic 
system, and seminal vesicle. 
Non-neoplastic effects in the kidney, lung, thyroid gland, 
seminal vesicle, pancreas, urinary bladder, and 
forestomach were also observed. 
 
In females, neoplastic effects were observed in the oral 
cavity, esophagus, mammary gland, and thyroid gland. 
Non-neoplastic effects in the kidney were also observed.  
 
Mice: 
NTP (1996), 
Dunnick et al. 
(1997) 
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the 2-year study period (21 months) 
- ‘stop-exposure’ 
 
Ten animals from the male control 
group and the 20,000 ppm ‘stop-
exposure’ were evaluated at 3 
months; nine or 10 control animals 
and five to nine animals from each 
of the ‘continuous-exposure’ were 
evaluated at 15 months. 
 
B6C3F1 mice (60 per sex per 
group): 0, 312, 625, 1,250 ppm 
(corresponding to approximately 0, 
35, 70, 140 mg/kg bw/day for males 
and 0, 40, 80, 170 mg/kg bw/day 
for females) 
 
Eight to 10 animals from each 
group were evaluated at 15 months 
 
Survival of 1,250 ppm males and females was significantly 
lower than that of the controls. 
Clinical findings included tissue masses involving the eye 
in exposed mice. 
 
In males, neoplastic effects were observed in the 
Harderian gland, lung, and kidney. 
 
In females, neoplastic effects were observed in the 
Harderian gland, lung, and skin. 
Non-neoplastic effects in the lung were also observed.  
 
2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
 
Test substance: 2,3-DBPA (98% 
pure) 
 
Sub-acute repeated dose toxicity 
study 
 
Test substance administered by 
dermal application (in 95% ethanol, 
5 days a week) for 16 days 
 
F344/N rats, B6C3F1 mice, (5 per 
sex per group): 0, 44, 88, 177, 375, 
750 mg/kg bw 
 
Rats: 
One male and one female receiving 750 mg/kg bw died 
before the end of the study. 
The mean body weight gains and final mean body weights 
of dosed rats were similar to those of the controls. 
There were no clinical findings or gross lesions associated 
with chemical application. 
 
Mice: 
Four males and one female receiving 750 mg/kg bw died 
before the end of the study. 
The mean body weight gains and final mean body weights 
of dosed mice were similar to those of the controls. 
There were no clinical findings or gross lesions associated 
with chemical application. 
 
NTP (1993) 
Test substance: 2,3-DBPA (98% 
pure) 
 
Sub-chronic repeated dose toxicity 
study 
 
Test substance administered by 
dermal application (in 95% ethanol, 
5 days a week) for 13 weeks 
 
F344/N rats, B6C3F1 mice, (10 per 
sex per group): 0, 44, 88, 177, 375, 
750 mg/kg bw 
 
Rats: 
All rats survived until the end of the study. 
The mean body weight gain for rats in the 750 mg/kg bw 
group was lower than that of the controls.  
The mean absolute and relative liver weights were 
increased in males receiving 375 or 750 mg/kg bw and of 
females receiving 750 mg/kg bw. 
Chemical-related lesions occurred in the kidney of male 
rats and in the liver of female rats. The average severity of 
nephropathy was slightly increased in males receiving 
750 mg/kg bw, and individual cell necrosis was observed 
in the liver of all female rats in the 750 mg/kg bw group. 
 
Mice: 
NTP (1993) 
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Eight male mice receiving 750 mg/kg bw died during the 
study, while all female mice survived. 
The final mean body weights of dosed and control mice 
were similar. 
The mean absolute and relative liver weights were 
increased in males receiving 375 or 750 mg/kg bw and of 
females receiving 750 mg/kg bw. 
Chemical-related lesions occurred in the liver and lung of 
mice. Centrilobular hepatocellular necrosis occurred in all 
males in the 750 mg/kg bw group that died during the 
study, while individual cell necrosis was observed in the 
liver of females receiving 177, 375, or 750 mg/kg bw. 
Pleomorphism of the epithelium in pulmonary 
bronchioles occurred with a dose-related increased 
incidence in males and females. Necrosis of the 
bronchiolar epithelium was observed in males receiving 
750 mg/kg bw. 
 
Test substance: 2,3-DBPA (98% 
pure) 
 
Combined repeated dose and 
carcinogenicity study 
 
Test substance administered by 
dermal application (in 95% ethanol, 
5 days a week) for 48-51 weeks 
(male rats), 52-55 weeks (female 
rats), 36-39 weeks (male mice), and 
39-42 weeks (female mice) 
 
F344/N rats (50 per sex per group): 
0, 188, 375 mg/kg bw 
 
B6C3F1 mice (50 per sex per 
group): 0, 88, 177 mg/kg bw 
 
Rats: 
The survival of 375 mg/kg bw male and female rats was 
significantly lower than that of the controls (males: 
50/50, 41/50, 16/50; females: 48/50, 38/50, 24/50). 
The final mean body weight was lower than that of the 
controls in the 375 mg/kg bw group. 
In male rats, the incidences of neoplasms of the skin, 
nose, Zymbal gland, oral cavity, esophagus, and small and 
large intestines were significantly increased in the low- 
and high-dose groups, while the incidences of neoplasms 
of the forestomach and liver were significantly increased 
only in the high-dose group. Neoplasms of the kidney, 
vascular neoplasms of the spleen, and mesotheliomas in 
males occurred with a significant positive trend. 
In female rats, the incidences of benign or malignant 
neoplasms of the nose, Zymbal gland, oral cavity, 
esophagus, large intestine, and liver were significantly 
increased in the low- and high-dose groups, while the 
incidences of neoplasms of the skin, forestomach, small 
intestine, mammary gland, and clitoral gland were 
significantly increased in the high-dose group only. 
Neoplasms of the kidney in females occurred with a 
significant positive trend. 
Non-neoplastic lesions included increased incidences of 
hyperkeratosis in the skin, forestomach, and esophagus, 
epithelial dysplasia in the nose, pleomorphism and 
basophilic and clear cell changes in the liver, and nuclear 
enlargement in the kidney. There were also chemical-
related increases in the incidences of forestomach ulcers 
and acanthosis, angiectasis in the liver, and renal 
hyperplasia in male rats and epithelial dysplasia of the 
forestomach and bileduct hyperplasia in the liver in 
female rats. 
 
Mice: 
NTP (1993) 
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All mice (except two low-dose females) survived until 
study termination. 
In male and female mice, the incidences of benign or 
malignant neoplasms of the forestomach were 
significantly increased in the low- and high-dose groups, 
while the incidences of neoplasms of the skin were 
significantly increased only in the high-dose groups. The 
incidences of liver and lung neoplasms were increased in 
high-dose males. 
Non-neoplastic lesions included increased incidences of 
hyperplasia in the skin, epithelial dysplasia of the 
forestomach, and bronchiolar epithelial pleomorphism 
and hyperplasia in male and female mice and in the 
incidence of eosinophilic cytoplasmic change in the liver 
in males. 
 
2,2-Bis-(bromomethyl)-3-bromo-1-propanol (TBNPA) (CAS RN 36483-57-5) 
 
Test substance: 2,2-
Dimethylpropan-1-ol, tribromo 
derivative (98.4% pure) 
 
Sub-acute repeated dose toxicity 
study 
 
Test substance administered by 
gavage (in corn oil) daily for 14 days 
(except high-dose males, 4 
consecutive days) 
 
Crl:CD(SD) rats (5 per sex per 
group): 0, 100, 300, 1000 mg/kg 
bw/day  
 
 
All males receiving 1000 mg/kg bw/day were killed for 
welfare reasons on day 4 of treatment. Clinical signs 
included abnormal gait, unresponsive, underactive, flat 
posture, prostrate posture and high levels of urine 
staining. Macroscopic examination revealed abnormal 
contents and pallor of the jejunum in 3/5 animals. 
 
Clinical signs in females revealed urine staining during 
the treatment period in 3/5 animals at 1000 mg/kg 
bw/day. 
 
No other treatment-related findings were noted. 
Study report – cited 
from REACH 
Registration 
Dossier Database 
Test substance: 2,2-
Dimethylpropan-1-ol, tribromo 
derivative (98.4% pure) 
 
Sub-acute repeated dose toxicity 
study 
 
Test substance administered in feed 
for 30 days  
 
Sprague-Dawley rats (5 per sex per 
group): 0, 10, 30, 100, 300 mg/kg 
bw/day  
 
A decrease in serum glutamic pyruvic transaminase 
(SPGT) was noted at 100 and 300 mg/kg bw/day, and an 
increase in blood urea nitrogen (BUN) was noted in males 
at 300 mg/kg bw/day. 
 
Renal tubular damage and generalized hyperplasia of the 
mucosal lining of the urinary bladder were observed in 
males at 100 and 300 mg/kg bw/day. 
Study report – cited 
from REACH 
Registration 
Dossier Database 
TABLE 5. STUDIES ON REPEATED DOSE TOXICITY AND CARCINOGENICITY 
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In the repeated dose toxicity and carcinogenicity studies summarised in Table 5, several possible 
target organs and tissues were identified. The findings are summarised in Table 6 and further 
detailed in the following sections. 
 
Target organ 96-13-9 3296-90-0 36483-57-5 
Liver  Lesions / necrosis / 
neoplasms 
Degeneration / 
neoplasms 
- 
Kidney  Necrosis / fibrosis/ 
neoplasms 
Hyperplasia/ 
degeneration / 
necrosis / 
neoplasms 
Tubular damage 
Urinary bladder  Hyperplasia Hyperplasia / 
neoplasms 
Hyperplasia 
Oral cavity Neoplasms  Neoplasms  - 
Esophagus  Neoplasms / non-
neoplastic changes 
Neoplasms  - 
Forestomach  Neoplasms/ non-
neoplastic changes 
Neoplasms / non-
neoplastic changes 
- 
Intestines, small and 
large  
Neoplasms  Neoplasms  - 
Hematopoietic system - Neoplasms  - 
Spleen  Neoplasms  -  - 
Thyroid gland - Degeneration/ 
neoplasms / non-
neoplastic changes 
- 
Pancreas  - Neoplasms / non-
neoplastic changes 
- 
Mammary gland Neoplasms  Neoplasms  - 
Clitoral gland Neoplasms  - - 
Seminal vesicle - Neoplasms / non-
neoplastic changes 
- 
Nose Neoplasms / non-
neoplastic changes 
- - 
Lung  Necrosis / 
neoplasms 
Neoplasms / non-
neoplastic changes 
- 
Skin  Neoplasms / non-
neoplastic changes 
Neoplasms  - 
Zymbal gland Neoplasms Neoplasms  - 
Harderian gland - Neoplasms  - 
Eye  - Degeneration  - 
Mesothelium  Increased incidence Increased incidence - 
TABLE 6. POSSIBLE TARGET ORGANS IN RATS AND MICE 
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4.2.1 Liver 
 
4.2.1.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), there were treatment-related increased incidences 
of neoplasms in the liver.  
 
In the two-year study with administration of technical grade FR-1138 containing 80% of DBNPG 
(CAS RN 3296-90-0) in the diet to rats (Keyes et al. 1980), degenerative changes in the liver 
(increased centrilobular homogeneity of the hepatocellular cytoplasm) were observed. 
 
4.2.1.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 13-week studies with administration of 2,3-DBPA to rats and mice by dermal application 
(NTP 1993), liver lesions were observed in female rats and male and female mice. 
Male mice were more sensitive to the acute toxic effects of this chemical than were rats or female 
mice. Eight of 10 male mice receiving dermal applications of 750 mg/kg bw died during the 13-week 
study, but there were no deaths in rats or female mice receiving up to 750 mg/kg bw 2,3-dibromo-l-
propanol for 13weeks. Male mice dying as a result of treatment with 2,3-dibromo-l-propanol had 
generalized centrilobular necrosis of the liver. 
In contrast to male mice, female mice and female rats receiving dermal applications of 750 mg/kg 
2,3- dibromo-1-propanol exhibited slight individual cell necrosis in the liver.  
 
In the 2-year studies with administration of 2,3-DBPA to rats and mice by dermal application (NTP 
1993), there was a significantly increased incidence of neoplasms in the liver of male and female 
rats and in the liver of male mice. 
 
4.2.2 Kidney and urinary bladder 
 
4.2.2.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In both 13-week studies with administration of technical grade FR-1138 containing 78.6% of 
DBNPG to rats and mice by gavage or in the diet (NTP 1996, Elwell et al. 1989), treatment-related 
lesions were limited to the kidney (papillary degeneration and necrosis) and urinary bladder 
(hyperplasia of the transitional-cell epithelium) of treated rats and mice.  
Mice were more sensitive than rats. Male rats and mice were more sensitive than females to the 
development of renal papillary degeneration or necrosis. At similar dose levels, on a mg/kg bw 
basis, treatment-related lesions in rats were similar in the gavage and feed studies. Lesions 
developed at a slightly lower dose level in mice treated by gavage than in those given the test 
substance in the diet. 
 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats (NTP 1996), non-neoplastic effects observed in the kidney of rats 
included papillary degeneration, increases in the incidences of hyperplasia of the renal papilla 
epithelium, hyperplasia of the transitional epithelium lining the renal pelvis and focal renal tubule 
atrophy in male rats. In male rats, transitional-cell hyperplasia of the urinary bladder was also 
present.  
Neoplastic effects observed in the kidney of male rats included four renal tubule adenomas (one in 
the 5,000 ppm group and three in the 10,000 ppm group). These neoplasms are uncommon in 
males (mean: 2%) and may have been related to chemical administration. There was no evidence 
for a carcinogenic response in the kidney of the female rat. (NTP 1996). 
There were increased incidences of urinary bladder transitional cell neoplasms in male rats. These 
incidences were low, but these neoplasms rarely occur in untreated animals (mean: 0.2%), and 
these neoplasms were considered to be related to treatment. Only 10 chemicals studied by the NTP 
have caused treatment-related urinary bladder neoplasms in male rats. It has been suggested that 
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some of these chemicals caused the urinary bladder neoplasms by formation of calculi, subsequent 
irritation, and tumour formation, but this does not appear to be the mechanism for the 
development of urinary bladder neoplasms observed in the present study. The early occurrence of 
transitional cell hyperplasia suggests that 2,2-bis(bromomethyl)-l,3-propanediol or its metabolites 
have a direct toxic effect on the urinary bladder in male rats. (NTP 1996). 
 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to mice (NTP 1996), the toxicity observed in the urinary bladder and kidney of 
mice in the 13-week study was not seen in this 2-year study. However, the highest dose in the 2-year 
study (1,250 ppm) was below the level at which these lesions were seen in the 13-week study where 
there was renal toxicity characterized by papillary necrosis and increased tubule regeneration. 
Although the highest dose in the 2-year study was half the dose causing these lesions in the 13-week 
study, there was a small increase in the incidence of renal tubule adenoma in male mice. In NTP 
studies of approximately 450 chemicals, only seven other chemicals have been identified as causing 
kidney neoplasms in the male mouse. Two of these were brominated chemicals 
(bromodichloromethane and tris(2,3-dibromopropyl)phosphate). (NTP 1996). 
 
In another two-year study with administration of technical grade FR-1138 containing 80% of 
DBNPG in the diet to rats (Keyes et al. 1980), no effects in the kidney or urinary bladder were 
reported. 
 
4.2.2.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 13-week studies with administration of 2,3-DBPA to rats and mice by dermal application 
(NTP 1993), there was a slight increase in the severity of nephropathy, primarily in the 750 mg/kg 
bw group.  
Although it is apparent that 2,3-DBPA has some effect on the kidneys, these findings confirm 
previous studies indicating that 2,3-dibromo-l-propanol is not the primary metabolite responsible 
for the acute renal tubule necrosis associated with the administration of tris(2,3-dibromopropyl) 
phosphate to rats. Chemical-induced nephrotoxicity in rats and mice in NTP studies has been 
associated with exposure to many short-chain halogenated hydrocarbons, but no consistent sex- or 
species-related differences in response were found. In general, however, rats seem to be more 
susceptible to the nephrotoxic effects of these compounds than mice, and male rats appear to be 
more susceptible than female rats. (NTP 1993). 
 
In the 2-year study with administration of 2,3-DBPA to rats by dermal application (NTP 1993), 
there was a marginally increased incidence of neoplasms in the kidney of male and female rats. 
 
4.2.2.3 2,2-Bis-(bromomethyl)-3-bromo-1-propanol (TBNPA) (CAS RN 36483-57-5) 
Non-neoplastic changes were observed in the kidney and urinary bladder  
 
In the 30-day study with administration of TBNPA to rats by gavage (study report, cited from the 
REACH Registration Dossier Database), renal tubular damage and generalized hyperplasia of the 
mucosal lining of the urinary bladder were observed in male rats. 
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4.2.3 Oral cavity, esophagus, forestomach, and small and large intestines 
 
4.2.3.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), there were treatment-related increased incidences 
of squamous cell neoplasms in the oral cavity (tongue and pharynx) and esophagus in male and 
female rats. In addition, there were treatment-related squamous cell neoplasms of the forestomach 
and adenoma and carcinoma of the small and large intestine in male rats.  
 
Minimal increases in the incidences of neoplasms of the forestomach were seen in male and female 
mice. There was no treatment-related increase in the incidence of hyperplasia of the forestomach 
squamous epithelium. Because the number of forestomach neoplasms was within or just above the 
historical control range, it was uncertain if this increase was related to treatment. (NTP 1996). 
 
The presence of neoplasms in the gastrointestinal tract of exposed rats suggests that the chemical 
may interact directly with the mucosal epithelium. Although the increased incidence in intestinal 
neoplasms was limited to male rats, this effect was seen primarily in the ‘stop-exposure’ group, 
which did not include females. Other brominated chemicals also cause intestinal neoplasms in rats 
suggesting that these brominated chemicals may be acting by a similar mechanism. (NTP 1996). 
 
Other chemicals which have been found to cause oral cavity neoplasms in rats are also genotoxic 
chemicals. Rats are more susceptible than mice to the formation of oral cavity neoplasms, and oral 
cavity neoplasms have previously been reported only in one NTP mouse study. Chemical-related 
esophageal neoplasms have previously been observed in rats in only two other NTP studies. (NTP 
1996). 
 
4.2.3.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 2-year studies with administration of 2,3-DBPA to rats and mice by dermal application (NTP 
1993), there was a significantly increased incidence of neoplasms in the oral mucosa, esophagus, 
forestomach, and small and large intestine of male and female rats and in the forestomach of male 
and female mice. 
 
The pattern of neoplasm response in the stratified squamous epithelium of the upper 
gastrointestinal tract of rats suggests that the chemical induction of neoplasms in the oral mucosa, 
esophagus, and forestomach may be related to oral exposure through grooming behavior rather 
than from dermal absorption. The incidences of squamous cell neoplasms and the proportion of 
malignant to benign neoplasms decreased as the distance from the oral cavity increased. Of these 
three sites, the incidence of squamous cell neoplasms and the proportion of carcinomas was highest 
in the oral mucosa. The incidence of squamous cell neoplasms in the esophagus was intermediate 
between those of the oral cavity and forestomach, and few carcinomas were observed. The lowest 
incidence of neoplasms occurred in the forestomach, and no carcinomas were observed. (NTP 
1993). 
 
4.2.4 Hematopoietic system 
 
4.2.4.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), the incidences of mononuclear cell leukemia in 
treated male rats were significantly greater than that in the control group.  
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4.2.5 Spleen 
 
4.2.5.1 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 2-year study with administration of 2,3-DBPA to rats and mice by dermal application (NTP 
1993), there was a marginally increased incidence of neoplasms in the spleen of male rats. 
 
4.2.6 Thyroid gland 
 
4.2.6.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
No histopathological changes in the thyroid gland were reported at any dose level in either rats or 
mice following administration of FR-1138 containing 78.6% of DBNPG in the diet (NTP 1996, 
Elwell et al. 1989) or by gavage (Elwell et al. 1989) for 13 weeks. 
 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), the incidence of follicular cell adenoma or 
carcinoma were significantly greater in the male and female rats.  
The occurrence of these neoplasms in the absence of diffuse thyroid gland hyperplasia supports the 
hypothesis that 2,2-bis(bromomethyl)-1,3- propanediol causes a direct thyroid response that is not 
likely secondary to sustained high concentrations of thyroid stimulating hormone. (NTP 1996). 
 
A statistically significant increase in the incidence of thyroid retention cyst formation was seen in 
male rats administered 100 mg/kg bw/day FR-1138 containing 80% of DBNPG for 2 years (Keyes 
et al. 1980). According to the authors, this effect may or may not have been treated-related as there 
was no increase in follicular hypertrophy or hyperplasia. 
 
The carcinogenic effect DBNPG was not thyroid specific, as the compound was also a clear 
carcinogen in many other tissues in both rats and mice. Overall, it is concluded that DBNPG is not a 
thyroid gland toxicant in mice and rats. 
 
4.2.7 Pancreas 
 
4.2.7.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG (CAS RN 3296-90-0) in the diet to rats and mice (NTP 1996), a marginal increase in the 
incidence of acinar cell adenoma of the pancreas was observed in exposed groups of male rats. Focal 
acinar cell hyperplasia was significantly increased in all exposure groups.  
Because there was no dose-related increase in the incidence of adenomas, and all incidences were 
within the NTP historical control range, it was uncertain if these neoplasms were related to 
treatment (NTP 1996). 
 
4.2.8 Mammary gland 
 
4.2.8.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG (CAS RN 3296-90-0) in the diet to rats and mice (NTP 1996), the incidence of mammary 
gland neoplasms was increased in rats. The treatment-related increase in mammary gland 
fibroadenoma was greater in female than in male rats. However, there was a significant increase in 
subcutaneous fibroma in exposed groups of male rats. 
In exposed groups of female mice there were only four mammary gland carcinomas (one in the 625 
ppm group and three in the 1,250 ppm group). Because the incidences for these neoplasms were 
within the historical range, it was uncertain if the increase was related to chemical administration. 
(NTP 1996). 
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Other chemicals which have caused an increase in the incidences of mammary gland neoplasms in 
female rats have also been associated with an increased incidence in fibroma, or a combination of 
fibroma and fibroadenoma in male rats. The chemicals that cause mammary gland neoplasms in 
rats are frequently genotoxic chemicals suggesting that genetic damage may contribute to this 
neoplastic response. (NTP 1996). 
 
4.2.8.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 2-year study with administration of 2,3-DBPA rats and mice by dermal application (NTP 
1993), there was a significantly increased incidence of neoplasms in the mammary gland of female 
rats. 
 
4.2.9 Clitoral gland 
 
4.2.9.1 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 2-year study with administration of 2,3-DBPA to rats and mice by dermal application (NTP 
1993), there was a significantly increased incidence of neoplasms in the clitoral gland of female rats. 
 
4.2.10 Seminal vesicle 
 
4.2.10.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), there was an adenoma and a carcinoma of the 
seminal vesicle in the male ‘stop-exposure’ group.  
The spontaneous development of these neoplasms is extremely rare in control rats, but treatment-
related increases in hyperplasia and neoplasms have been reported in other strains of rats. Because 
of the rarity of these neoplasms in control rats and the presence of a dose-related increase in 
hyperplasia, the neoplasms in the ‘stop-exposure’ group were considered to be related to treatment. 
(NTP 1996). 
 
4.2.11 Nose 
 
4.2.11.1 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 2-year study with administration of 2,3-DBPA to rats and mice by dermal application (NTP 
1993), there was a significantly increased incidence of neoplasms in the nose of male and female 
rats. 
Exposure by inhalation may have contributed to the induction of neoplasms of the nasal mucosa. 
 
4.2.12 Lung 
 
4.2.12.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), the incidences of lung neoplasms were increased in 
exposed in both species.  
 
Lung neoplasms have been observed in mice (but not in rats) in several NTP studies with 
halogenated hydrocarbons. It is not known why the mouse lung is particularly responsive to the 
effects from these halogenated hydrocarbons, but this response could be due to differences in 
metabolism between species. (NTP 1996). 
 
 
 
 
 
72 Category approach for selected brominated flame retardants 
 
4.2.12.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
 
In the 13-week study with administration of 2,3-DBPA to mice by dermal application (NTP 1993), 
lung lesions were observed in both male and female mice. 
 
Five of the eight male mice receiving 750 mg/kg bw that died during the 13-week study had necrosis 
of the bronchial and bronchiolar epithelium, while males and females exhibited cytologic alterations 
(pleomorphism) in the distal airway epithelium. Because there may have been some volatilization of 
2,3-dibromo-l-propanol after dermal application, inhalation exposure in the group-housed mice 
may have contributed to the lesions in the pulmonary airways. It is unknown why the 
intrapulmonary airways were more sensitive to 2,3-DBPA than the nasal and tracheal epithelium, 
but the secondary bronchi and bronchioles contain fewer goblet cells and a higher proportion of 
Clara cells, which are known to contain microsomal cytochrome P-450. The differences in cell 
population and in airflow pattern and velocity are thought to contribute to the regional specificity of 
airway lesions caused by chemicals. (NTP 1993). 
 
In the 2-year study with administration of 2,3-DBPA to mice by dermal application (NTP 1993), 
there was a significantly increased incidence of neoplasms in the lung of male mice. A slight 
increase in lung neoplasms in female mice may also have been chemical induced.  
 
4.2.13 Skin and Zymbal gland 
 
4.2.13.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), the incidences of skin tumors in male rats were 
significantly greater than those in the control group, and included increased incidences of 
squamous cell papilloma, keratoacanthoma, basal cell adenoma, sebaceous gland adenoma, and 
trichoepithelioma. There was also an increased incidence of neoplasms in the Zymbal gland (a 
modified sebaceous gland) in male rats. 
 
The Zymbal gland and skin are related epithelial tissues. Most of the chemicals inducing Zymbal 
gland and skin neoplasms also caused neoplasms at other sites. These chemicals are generally 
genotoxic in the Salmonella assay system, and chemically induced genetic damage is thought to be 
the underlying mechanism for development of skin and Zymbal gland neoplasms. (NTP 1996). 
 
Another study with 2,3-dibromo-l-propanol (CAS RN 96-13-9) has shown that genotoxic chemicals 
administered orally can cause skin tumors in rats, and the incidence for these tumors is generally 
greater in male rats than in female rats. The mechanism for this sex difference could not be 
determined from this study but may be due, in part, to metabolic differences between the sexes. 
 
4.2.13.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 2-year studies with administration of 2,3-DBPA to rats and mice by dermal application (NTP 
1993), there was a significantly increased incidence of neoplasms in the skin and Zymbal gland of 
male and female rats and in the skin of male and female mice. 
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4.2.14 Harderian gland 
 
4.2.14.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), the incidences of Harderian gland neoplasms were 
increased in male and female mice.  
Other chemicals causing these neoplasms are usually multispecies/site carcinogens (NTP 1996). 
 
4.2.15 Eye 
 
4.2.15.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year study with administration of technical grade FR-1138 containing 80% of DBNPG 
in the diet to rats (Keyes et al. 1980), degenerative changes in the eye (bilateral diffuse opacity of the 
lenses) were observed. 
 
4.2.16 Mesothelioma 
 
4.2.16.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats (NTP 1996), there was a treatment-related increased incidence of 
mesothelioma in male rats.  
 
Mesothelioma typically arises in the abdominal peritoneal cavity of F344 rats and is seen almost 
exclusively in males. Treatment-related increases of mesothelioma observed in previous NTP 
studies have also been in male rats. Other chemicals which have caused a marked increase in the 
incidence of mesotheliomas in male rats have also caused increases in mammary gland neoplasms 
in females, as is also the case for DBNPG (NTP 1996). 
 
4.2.16.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the 2-year study with administration of 2,3-DBPA to rats by dermal application (NTP 1993), 
there was a marginally increased incidence of mesothelioma in male rats. 
 
4.2.17 Other tumors 
 
4.2.17.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP study with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to mice (NTP 1996), there was a significant increase in hemangiosarcoma and 
hemangioma (combined) in the female 1,250 ppm group. Two of the hemangiosarcomas were in the 
subcutis, which was also a site for treatment-related sarcomas in female mice. Since the combined 
total number of neoplasms marginally exceeded the historical control range, it is uncertain if the 
increase in the incidence of these neoplasms was related to treatment. 
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4.3 Experimental studies on reproductive toxicity  
 
Only one study examining reproductive toxicity was retrieved. This study was performed with the 
substance, 2,2-bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0), see Table 7. 
 
Method 
 
Results Reference 
Continuous breeding 
RACB, Swiss CD-1 mice 
 
0.1, 0.2, 0.4% in feed 
(approximately 141, 274, 
589 mg/kg bw) 
 
At high dose:  
F0 and F1: Reduced litter size, reduced dam 
and pup body weight (also seen in crossover 
mating trial indicating a maternal effect) 
F0: Reduced number of small follicles 
(primordial and primary). No effect on sperm 
end points or vaginal cyclicity. Reduced body 
weight and absolute weight of seminal vesicle 
and epididymis 
F1: reduced pup body weight, relative liver 
weight, absolute testis weight. Increased 
prostate weight at middle dose Reduced sperm 
density. No change in estrous cyclicity 
 
At middle dose: :  
F1: Reduced number of small follicles 
(primordial and primary) 
Gulati 1986. 
Treinen 1989.  
Bolon 1997.  
Lamb 1997. 
(Reviewed by 
Moorman 2000, 
Beranger et al., 
2012, Morrissey 
1988a, 1988b, 
1989) 
TABLE 7 STUDY ON REPRODUCTIVE TOXICITY 
 
Overall, DBNPG is considered a reproductive toxicant with effects on the female reproductive 
system (reduced number of small follicles (primordial and primary) in F0 and F1 generation mice 
and fewer and lighter offspring). Additionally, DBNPG may be a developmental toxicant with effects 
on reproductive organs of male offspring. 
 
As only data on one category member was retrieved, category members cannot be compared with 
respect to this endpoint. Therefore, reproductive and developmental effects are not selected as a 
critical health effect for the purpose of this project.  
 
4.4 Experimental studies on toxicokinetics  
Data on absorption, distribution, metabolism and excreting are available for one of the three 
members of the category identified in the preliminary structural grouping, 2,2-bis(bromomethyl)-
1,3-propanediol (DBNPG) (CAS RN 3296-90-0). 
 
After a single oral administration of 10 or 100 mg/kg bw, >80% of the low dose and 48% of the high 
dose were excreted within 12 hours in the urine predominantly as a glucuronide metabolite. After 
repeated daily oral doses for 5 or 10 days, route and rate of elimination were similar to those 
obtained after single administrations of the substance. In all studies, the recovery in faeces was low 
(<15%). The total amount of the substance remaining in tissues at 72 hours after a single oral 
administration of 100 mg/kg bw was less than 1% of the dose, and repeated daily dosing did not 
lead to retention in tissues. After iv administration, the amount of test substance found in blood 
decreased rapidly; excretion profiles were similar to those after oral administration. The parent 
compound and the glucuronide of the parent compound were present in blood plasma after oral or 
iv dosing. After an iv dose of 15 mg/kg bw the hepatic glucuronide of the parent compound was 
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primarily excreted into the bile (>50% within 6 hours), but it underwent enterohepatic recycling 
with subsequent elimination in the urine. (Hoehle et al. 2009). 
 
4.5 Studies of mode/mechanisms of action  
 
4.5.1 Genotoxicity 
 
4.5.1.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
A positive result was obtained in Salmonella typhimurium TA100 only when S9 from the liver of 
Aroclor-induced male Syrian hamsters was used for metabolic activation at a concentration of 30%; 
negative results were observed when rat liver S9 was used for metabolic activation, as well as with a 
lover concentration of hamster liver S9 (10%). In other strains of Salomonella typhimurium, no 
mutagenic activity was detected. (NTP 1996, IARC 2000b). 
 
In cytogenetic tests with cultured Chinese hamster ovary cells, DBNPG did not induce sister 
chromatid exchanges, with or without rat liver S9 (NTP 1996; the result was judged to be equivocal 
by IARC 2000b), but a dose-related increase in chromosomal aberrations was observed in cultured 
Chinese hamster ovary cells in the presence of rat liver S9 (NTP 1996; only at doses that caused 
significant cytotoxicity according to IARC 2000b). Both tests were conducted up to doses which 
induced marked cytotoxicity. A majority of the breaks were located in the heterochromatic region of 
the long arm of chromosome X, but the reasons for this are unclear (NTP 1996, IARC 2000b). Also, 
the type of damage pattern seen with DBNPG (induction of chromosomal aberrations but not sister 
chromatid exchanges) is unusual; most chemicals which induce chromosomal aberrations also 
induce sister chromatid exchanges (NTP 1996). 
 
DBNPG was also shown to be genotoxic in vivo. Significant increases in micronucleated 
normochromatic erythrocytes were observed in peripheral blood samples obtained from male and 
female mice exposed for 13 weeks via the diet (NTP 1996, IARC 2000b). However, in tests for 
micronucleus formation in mouse bone marrow, results were positive for females but inconsistent 
for males (routes of administration were different) (NTP 1996, IARC 2000b) and therefore, the 
results were concluded to be equivocal (NTP 1996). 
 
In conclusion, DBNPG was shown to be mutagenic/genotoxic in vitro and in vivo, inducing gene 
mutations in Salmonella typhimurium strain TA100, chromosomal aberrations in cultured Chinese 
hamster ovary cells, and micronuclei in peripheral erythrocytes of male and female mice. The in 
vitro responses required the presence of a metabolic activation system. 
 
4.5.1.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
2,3-DBPA was mutagenic in several strains of Salmonella typhimurium both in the presence and in 
the absence of exogenous metabolic systems. It also gave positive results in the mouse lymphoma 
assay in the absence of S9 activation; it was not tested with S9. Increases in sister chromatid 
exchanges and chromosomal aberrations were induced in cultured Chinese hamster ovary cells both 
with and without rat liver S9. 2,3-DBPA induced significant increases in sex-linked recessive lethal 
mutations and reciprocal translocations in male germ cells of Drosophila melanogaster. However, 
the substance did not increase the frequency of micronucleated polychromatic erythrocytes in the 
bone marrow in male mice. (NTP 1993, IARC 2000a). 
 
4.5.1.3 2,2-Bis-(bromomethyl)-3-bromo-1-propanol (TBNPA) (CAS RN 36483-57-5) 
TBNPA showed no evidence of mutagenic activity in the absence or presence of rat liver S9, but 
showed a clear evidence of mutagenic activity in strains Ta100 and TA1535 in the presence of 
hamster liver S9. It also gave positive results in the mouse lymphoma assay in the presence of rat 
liver S9. Increases in chromosomal aberrations were induced in cultured peripheral human 
lymphocytes in the presence of metabolic activation, and at the highest test substance concentration 
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in the absence of metabolic activation. The substance did not induce any marked or significant 
increases in the incidence of cells undergoing unscheduled DNA synthesis in isolated rat liver cells 
following in vivo exposure and therefore, the substance was considered to be non-genotoxic in this 
study. Furthermore, the substance did not increase the frequency of micronucleated polychromatic 
erythrocytes in the bone marrow in mice. (Study reports, cited from the REACH Registration 
Dossier Database). 
 
4.5.2 Endocrine activity 
No data regarding an endocrine activity of the members of the category of brominated flame 
retardants selected for this phase have been located in the literature search. 
 
Several brominated flame retardants have been shown to cause adverse effects in the thyroid gland 
secondary to interference with the thyroid hormones. Exposure to 2,2-bis(bromomethyl)-1,3-
propanediol (DBNPG) for 2 years caused neoplasms of the thyroid gland in male and female rats. 
The occurrence of these neoplasms in the absence of diffuse thyroid gland hyperplasia supports the 
hypothesis that 2,2-bis(bromomethyl)-1,3- propanediol causes a direct thyroid response that is not 
likely secondary to sustained high concentrations of thyroid stimulating hormone (NTP 1996). 
 
4.6 Identification of critical effect(s) 
Relevant experimental data on human health effects were retrieved for three of the 25 members of 
the category of brominated flame retardants selected for this phase, i.e. for the three members of 
the category identified in the preliminary structural grouping, 2,3-DBPA (CAS RN 96-13-9), 
DBNPG (CAS RN 3296-90-0) and TBNPA (CAS RN 36483-57-5). No relevant experimental data 
were retrieved for the 22 new members of the category with a CAS RN assigned and identified in the 
definition of the category. 
 
4.6.1 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG) (CAS RN 3296-90-0) 
In the two-year NTP studies with administration of technical grade FR-1138 containing 78.6% of 
DBNPG in the diet to rats and mice (NTP 1996), significant dose-related increases in the incidences 
of neoplasms were observed at numerous sites in male and female rats and, to a lesser extent, in 
mice. Thus, these studies show that this flame retardant is a multi-site, multispecies carcinogen 
(NTP 1996). 
 
DBNPG, as well as other brominated chemicals have been shown to be genotoxic in a spectrum of 
tests. It is hypothesized that the carcinogenic activity of brominated chemicals is due to genotoxic 
mechanisms (NTP 1996). 
Based on the findings from the stop-exposure study with DBNPG in male rats, genetic damage 
appears to occur within the first few months of exposure. This genetic damage is irreversible, and 
neoplasms develop in the absence of a toxic response. (NTP 1996) 
 
Of the 11 aliphatic and three aromatic brominated chemicals studied by the NTP in 2-year rodent 
studies, 13 of 14 chemicals were carcinogenic (NTP 1996).  
It would be expected that C-Br bonds in DBNPG would be cleaved more readily than C-Cl bonds in 
halogenated compounds because of a lower bond energy (bond strengths: C-Cl, 95 kCal; C-Br, 67 
kCal). Once the C-Br bond is broken, a free radical is available that can participate in various 
chemical reactions. It has been shown that eosinophils contain a lysosomal peroxidase that oxidizes 
halides to highly reactive and toxic hypohalous acids. Even though chloride is found at 1,000 times 
the concentration of bromide, the eosinophils used bromide preferentially to form the 
hypobromous acid. Bromide was shown to bind more readily to cellular proteins and 
macromolecules than other halide ions. (NTP 1996). 
 
Two hypotheses for the carcinogenic activity of brominated chemicals are: 1) bromine causes 
oxidative damage to DNA and other cellular constituents and 2) the C-Br bond is broken and the 
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remaining carbon-containing electrophilic group forms DNA adducts with subsequent DNA damage 
(NTP 1996). 
Studies with potassium bromate have shown that this chemical administered in drinking water at 
250 or 500 ppm to F344 rats caused renal and intestinal neoplasms in male and female rats and 
mesotheliomas of the peritoneum in male rats. Following oral administration of potassium bromate 
a significant increase of 8-hydroxydeoxyguanosine was observed in DNA. 8-
Hydroxydeoxyguanosine is one of the DNA-damage products formed by oxygen radicals, and this is 
thought to be one of the DNA lesions involved in potassium bromate carcinogenesis. (NTP 1996). 
 
Common sites for carcinogenic activity from the brominated chemicals studied by the NTP include 
oral cavity, forestomach, intestine, lung, and kidney. Treatment-related lesions are generally not 
seen at these sites early in the study, but develop with time. In the DBNPG ‘stop-exposure’ study, 
neoplasm development in the male rat required only 3 months of exposure, and while lesions were 
not seen in the target organ at the end of this 3-month exposure period, the essential damage to the 
cell had been done, and carcinogenic lesions developed with time. (NTP 1996). 
Non-neoplastic lesions were observed in the pancreas, seminal vesicles, thyroid gland, lung, kidney, 
and urinary bladder in male rats; in the kidney of female rats; and in the lung of female mice. A 
carcinogenic response was observed in some of these organs; however, there were many sites where 
a carcinogenic response was observed in the absence of non-neoplastic lesions. (NTP 1996). 
 
DBNPG is classified (notified classification): Muta. 1B H340 / Muta. 2 H341; Carc. 1B H350 / Carc. 
2 H351. 
 
In conclusion, the critical effect of DBNPG is considered to be the multi-site, multispecies 
carcinogenic effect, most probably caused by a genotoxic metabolite of the parent compound, as the 
in vitro mutagenic/genotoxic responses were shown to require the presence of a metabolic 
activation system. 
 
4.6.2 2,3-Dibromo-1-propanol (2,3-DBPA) (CAS RN 96-13-9) 
In the two-year NTP studies with administration of 2,3-DBPA by dermal application to rats and 
mice (NTP 1993), caused significant dose-related increases in the incidences of neoplasms at 
numerous sites in male and female rats and, to a lesser extent, in mice.  
 
The results of these studies showed that 2,3-DBPA is a multiple-organ carcinogen in rats and mice, 
as are its parent compound tris(2,3-dibromo-propyl)phosphate and the structurally related 
halogenated three-carbon 1,2-dibromo-3-chloropropane compounds, 1,2-dibromo-3-
chloropropane, 1,2-dichloropropane and 1,3-dichloropropene. However, the number of sites 
affected by the dermal application of 2,3-DBPA was greater than the number of sites affected by the 
dosed feed or gavage administration of tris(2,3-dibromopropyl)phosphate and other three-carbon 
halogenated compounds. Although differences in dose level, strains of animals, route of 
administration, and duration of dose employed in the various studies could have contributed to the 
variation in response to these chemicals, the results suggest that 2,3-DBPA is the most potent 
carcinogen of these chemicals. (NTP 1993). 
 
Among the short-chain hydrocarbons, including the halogenated hydrocarbons, are chemicals that 
are direct-acting carcinogens, such as epoxides and halo ethers, and others that are considered 
indirect-acting carcinogens, which require metabolic activation to the ultimate carcinogen in tissues 
such as the liver, stomach, lung, or kidney.  
Epoxide intermediates are demonstrated metabolites of trichloroethylene (epoxy-1,1,2-
trichloroethane), allyl chloride (epichlorohydrin and glycidaldehyde), and 1,2-dibromo-3-chloro-
propane (1,1-epoxypropane). 2,3-Dibromo-l-propanol is a direct-acting mutagen, producing gene 
mutations in Salmonella typhimurium and gene mutation and chromosomal damage in cultured 
mammalian cells. It also produced sex-linked recessive lethal mutations and reciprocal 
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translocations in germ cells of Drosophila melanogaster. Moreover, the metabolism of 2,3-DBPA 
also appears to involve the formation of reactive intermediates including 2-bromoacrolein, 2,3-
dibromopropanal, and 3-bromo-1,2-propaneepoxide. The first two inter-mediates are direct 
mutagens in Salmonella typhimurium and are potent inducers of DNA single-strand breaks in rat 
hepatoma cells. This mutagenic and chemical profile is consistent with the pattern of carcinogenic 
activity observed in these studies, that is, the induction of an early onset of neoplasms at multiple 
sites. (NTP 1993). 
 
2,3-DBPA is classified (harmonised classification): Carc. 1B H350. 
 
In conclusion, the critical effect of 2,3-DBPA is considered to be the multi-site, multispecies 
carcinogenic effect, most probably caused by a direct genotoxic action of the parent compound, as 
the in vitro mutagenic/genotoxic responses were shown both in the absence and the presence of a 
metabolic activation system. 
 
4.6.3 2,2-Bis-(bromomethyl)-3-bromo-1-propanol (TBNPA) (CAS RN 36483-57-5) 
The available repeated dose toxicity studies on TBNPA include a 14-day and a 30-day study. No 
target organs were identified in the 14-day study. In the 30-day study, kidney and urinary bladder 
were identified as target organs with renal tubular damage observed in the kidney and generalized 
hyperplasia in the urinary bladder. 
Whether TBNPA has carcinogenic properties cannot be evaluated based on the available data as no 
long-term studies have been located. 
 
TBNPA showed mutagenic/genotoxic activity in vitro in the presence of a metabolic activation 
system. 
 
TBNPA is classified (notified classification): Muta. 1B H340 / Muta. 2 H341; Carc. 1B H350. 
 
In conclusion, the critical effect of TBNPA is considered to be a possible carcinogenic effect, most 
probably caused by a genotoxic metabolite of the parent compound, as the in vitro 
mutagenic/genotoxic responses were shown to require the presence of a metabolic activation 
system. 
 
4.6.4 Conclusion on the critical effect, experimental studies 
Based on the findings in the two 2-year NTP studies with 2,3-dibromo-l-propanol (2,3-DBPA) (NTP 
1993) and 2,2-bis(bromomethyl)-1,3-propanediol (DBNPG) (NTP 1996), as well as the discussion 
on the underlying mode / mechanism(s) of action for the carcinogenic effect of these two 
brominated flame retardants provided in the NTP reports (NTP 1996, 1993), and the 
harmonized/notified classification(s), the critical effect of these two brominated flame retardants is 
the multiple-organ carcinogenic effect, most probably exerted by a genotoxic mode of action either 
by the parent compound itself (2,3-DBPA) or by a metabolite of the parent compound (DBNPG). 
 
Supportive evidence for the critical effect of the brominated flame retardants in the category of 
small linear and branched alkyl alcohols being the carcinogenic effect (most probably exerted by a 
genotoxic action) comes from the limited available data, as well as the classification (notified) on 
the third member of the category identified in the preliminary structural grouping, 2,2-bis-
(bromomethyl)-3-bromo-1-propanol (TBNPA). 
 
Furthermore, the notified classification (Carc. 2 H351) for one of the new members identified in the 
definition of the category, 1,3-dibromo-2-propanol also supports that the critical effect of the 
brominated flame retardants in the category of small linear and branched alkyl alcohols is the 
carcinogenic effect. 
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5. Category approach for 
read-across 
The category of small brominated linear and branched alkyl alcohols was a priori defined as 
chemical structures very similar to the three members identified in the preliminary structural 
grouping. The category was thus limited to 61 substances with 3-5 carbons, 2-3 bromine atoms and 
1-2 alcohol groups. 
 
A literature search was performed for the 25 category members with a CAS RN assigned. Relevant 
experimental data on human health effects were only retrieved for two of the members (2,3-DBPA 
and DBNPG). For a third member (TBNPA), relevant data were retrieved from the REACH 
registration dossier. No relevant experimental data were retrieved for the remaining members. The 
61 category members were predicted in a number of human health related (Q)SAR models and in a 
number of OECD (Q)SAR Application Toolbox profilers. 
 
An experimental study on toxicokinetics is available for DBNPG. After a single oral administration 
of 10 or 100 mg/kg bw, more than 80% of the low dose and 48% of the high dose were excreted 
within 12 hours in the urine predominantly as a glucuronide metabolite. This indicates that the 
substance is moderately to highly bioavailable following oral administration depending on the dose 
level. Toxicokinetic studies were not retrieved for the remaining category members. However, all 
category members were predicted to be bioavailable according to Lipinski’s rule-of-five and were 
predicted by (Q)SAR to have high human intestinal absorption. 
 
Based on the findings in the 2-year NTP studies with 2,3-DBPA (NTP 1993) and DBNPG (NTP 
1996), as well as the discussion on the underlying mode/mechanisms of action for the carcinogenic 
effect of these two brominated flame retardants provided in the NTP reports (NTP 1996, 1993), and 
harmonised/notified classification(s), the critical effect of these two brominated flame retardants is 
the multiple-organ carcinogenic effect, most probably exerted by a genotoxic mode of action either 
by the parent compound itself (2,3-DBPA) or by a metabolite of the parent compound (DBNPG). 
 
A comparison of the potency between the two substances could not be performed based on the 
available data. One reason is that tumours were observed at all dose levels for both substances. 
Another reason is that two different administration routes were used in the two studies, i.e., oral 
administration for DBNPG and dermal administration for 2,3-DBPA, and toxicokinetic information 
was only available for one of the substances (DBNPG). 
 
The available experimental data and a notified classification (Muta. 1B H340 / Muta. 2 H341, Carc. 
1B H350) for TBNPA, as well as a notified classification (Carc. 2 H351) for 1,3-DBPA indicate that 
the critical effect for these two substances may also be the carcinogenic effect. 
 
An information matrix for the four source substances DBNPG, TBNPA, 2,3-DBPA and 1,3-DBPA 
covering the experimental data, harmonised/notified classifications, the (Q)SAR predictions and 
the identified OECD (Q)SAR Application Toolbox profiler alerts is presented in Appendix 9. 
 
80 Category approach for selected brominated flame retardants 
 
Experimental data on genotoxicity for DBNPG, TBNPA and 2,3-DBPA indicate both similarities and 
differences between these three substances. All three substances were positive in the Ames test in 
some Salmonella typhimurium strains. Two of the substances (2,3-DBPA and TBNPA) gave 
positive results in the in vitro mouse lymphoma assay. Two of the substances (DBNPG and 2,3-
DBPA) increased chromosomal aberrations in cultured CHO cells, and one substance (TBNPA) 
increased chromosomal aberrations in cultured peripheral human lymphocytes. One substance 
(2,3-DBPA) increased sister chromatid exchanges in cultured CHO cells. Two substances (2,3-
DBPA and TBNPA) were negative in the in vivo mouse micronucleus bone marrow study while 
DBNPG gave equivocal results for induction of micronuclei in the bone marrow of mice, but positive 
results in the peripheral blood samples. In general, DBNPG and TBNPA required metabolic 
activation in the in vitro assays whereas 2,3-DBPA was positive also in the absence of metabolic 
activation. 
 
The (Q)SAR predictions for carcinogenic and mutagenic/genotoxic properties for the category of 
small linear and branched brominated alkyl alcohols indicate that all the 61 members have a 
carcinogenic potential with a possible mutagenic/genotoxic mode of action with all members being 
predicted positive in the CU FDA RCA overall cancer call and in the CU Ames model. The estimated 
specificities of the applied (Q)SAR models as established by leave-many-out cross-validations are 
between 85.9% and 95.1%, i.e. the overall false positive rates of the models are around 5%- 14%. 
 
A number of profilers of relevance for mutagenicity/genotoxicity and cancer were applied using the 
OECD (Q)SAR Application Toolbox. The profilers identified a number of structural alerts in the 
parent compound and/or in metabolites. This could indicate that all members share the same 
mutagenic/genotoxic mode of action, but also that there may be variations in their possible 
mechanisms of action. Some alerts were identified in fewer members and/or their metabolites while 
others were identified in many or all of the members and/or their metabolites.  
 
One alert was identified in all 61 members of the category, namely the “aliphatic halogen” in the ISS 
profilers for in vitro mutagenicity (Ames test), in vivo mutagenicity (micronucleus) and 
carcinogenicity (genotoxic and non-genotoxic mode of action). According to the Toolbox alert 
explanation some aliphatic halogens may be direct alkylating agents while metabolic activation may 
play a role for others, where one proposed mechanism is that cytochrome P450 oxidation leads to 
reactive carbonyl (aldehyde or ketone) compounds. Aldehyde alerts from five profilers (DNA 
binding by OECD, the three ISS profilers and Oncologic Primary Classifications) were identified in 
the metabolites of all but two members (ID numbers 52123_213821-20-6 and 52125_3). According 
to the Toolbox explanation, aldehyde compounds can potentially undergo Schiff base formation 
with a primary amine to form DNA adducts and cross-links. Furthermore, the alert H-acceptor-
path3-H-acceptor from the ISS profiler for in vivo mutagenicity (Micronucleus) was identified in all 
but one member and/or their metabolites (ID number 52125_3). According to the Toolbox 
explanation compounds containing the alert may interact with DNA and/or protein via non-
covalent binding. 
 
According to Benigni et al. (2011), ‘Numerous haloalkanes have been tested for carcinogenic and 
mutagenic activities. In general, the genotoxic potential is dependent on the nature, number, and 
position of halogen(s) and the molecular size of the compound’. Kazius et al. (2005) identified the 
aliphatic halide (excluding the fluorine atom) substructure to be an alert for Ames mutagens. Out of 
416 aliphatic halide compounds, 297 were mutagens, corresponding to 71% (p-value <<0.05). If 
compounds containing other toxicophores were excluded, there were 330 aliphatic halide 
compounds, of which 217 were mutagens, corresponding to 66% (p-value <<0.05). I.e. this alert 
identified 34% false positives among the mutagenicity training set chemicals (Kazius et al. 2005). 
According to Benigni et al. (2010) this alert has a positive predictivity for carcinogenicity of 74%, i.e. 
74% of the substances experimentally tested for carcinogenicity and containing the alert fragment 
had positive results from the carcinogenicity studies.  
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The aldehyde structural alert, which was identified in the metabolites of 60 out of the 61 members 
in five profilers (DNA binding by OECD, the three ISS profilers for in vitro and in vivo mutagenicity 
and carcinogenicity, and the Oncologic primary classification) has according to Benigni et al. 
(2008) a positive predictivity for carcinogenicity of 88% (7 out of 8 substances experimentally 
tested for carcinogenicity and containing the alert had positive results from the carcinogenicity 
studies). 
 
5.1 Future perspectives 
One way to establish an even more robust basis for read-across across the category could be to 
search the literature for information on carcinogenicity and mutagenicity/genotoxicity for 
structural analogues outside, but close to the category. Information on carcinogenic and 
mutagenic/genotoxic effects of other substances very close to, but outside the defined category were 
noticed in the literature search for the 25 category members and might be useful in relation to an 
evaluation of possible similarities or dissimilarities with the category members. 
 
Other ways to further strengthen the read-across basis could be to perform experimental testing for 
mutagenicity/genotoxicity on selected representative category members, as well as further 
analysisof the underlying mechanisms of action.  
 
Another brominated flame retardant identified in the preliminary structural grouping, tris(2,3-
dibromopropyl)phosphate (group 12, phosphates) is also a multiple-organ carcinogen in rats and 
mice (NTP 1993). The carcinogenic effect of tris(2,3-dibromopropyl)phosphate is exerted by its 
metabolite, 2,3-DBPA – one of three members in the category of small linear and branched alkyl 
alcohols for which experimental data are available (described in chapter 4). Other brominated flame 
retardants identified in the preliminary structural grouping, e.g. three of the members of group 2 
(dibromo-(2,3-dibromopropoxy)benzene derivatives), may possibly also be metabolised to 2,3-
DBPA. Therefore, brominated flame retardants that may possibly be metabolised to 2,3-DBPA or 
one of the other members in the category of small linear and branched alkyl alcohols may equally 
likely as these members themselves possess the critical effect, i.e. the carcinogenic effect, most 
probably exerted by a mutagenic/genotoxic mode of action. 
 
5.2 Conclusion 
The category of small brominated linear and branched alkyl alcohols was defined as chemical 
structures very similar to the members identified in the preliminary structural group. The category 
was thus limited to 61 substances with 3-5 carbons, 2-3 bromine atoms and 1-2 alcohol groups.  
 
Relevant experimental data on human health effects were retrieved for three of the category 
members, i.e. for the three members of the group identified in the preliminary structural group, 2,3-
DBPA, DBNPG and TBNPA. No relevant experimental data were retrieved for the remaining 22 
category members with CAS RN. Furthermore, 1,3-DBPA, a REACH pre-registered compound for 
which no experimental data on human health effects were retrieved, has a notified classification for 
a possible carcinogenic potential (Carc. 2 H351). 
 
The critical effect of the three members with relevant experimental data is the multiple-organ 
carcinogenic effect, most probably exerted by a genotoxic mode of action either by the parent 
compound itself (2,3-DBPA) or by a metabolite of the parent compound (DBNPG and TBNPA). 
 
Possible read-across for the critical effect from the three category members with experimental data 
and the one member with a classification for the identified critical effect to the remaining 57 
structurally similar target analogues in the category is supported by the following observations: 
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a) The experimental data show comparable toxicological effects for the three members of the 
category identified in the preliminary structural grouping (2,3-DBPA, DBNPG and 
TBNPA), i.e. carcinogenic and mutagenic/genotoxic effects. 
b) The classifications (harmonized or notified) as Muta. 1B H340 / Muta. 2 H341 and/or 
Carc. 1B H350 / Carc. 2 H351 for these three members and for 1,3-DBPA.  
c) The (Q)SAR predictions for carcinogenic and mutagenic/genotoxic properties indicate that 
the 61 category members have a carcinogenic potential with a possible 
mutagenic/genotoxic mode of action. The structural alerts identified in the OECD (Q)SAR 
Application Toolbox indicate that all members share the same genotoxic/mutagenic mode 
of action with some variations in their possible mechanisms of action. Some alerts were 
identified in many or all of the members and/or their metabolites pointing to possible 
common mechanism(s) of action (e.g. metabolic activation to reactive carbonyl 
compounds and aldehyde Schiff base formation of DNA adducts and cross-links).  
 
An even more robust basis for assessing the accuracy of the read across for the category could be 
pursued by searching the literature for information on carcinogenicity and 
mutagenicity/genotoxicity on structural analogues outside, but close to the category, by 
experimental testing for mutagenicity/genotoxicity on representative members across the category, 
as well as further analysis of the underlying mechanisms of action. 
 
Other brominated flame retardants that may possibly be metabolised to one of the 61 brominated 
flame retardants in the category of small linear and branched alkyl alcohols may equally likely as 
these members themselves possess the critical effect, i.e. the carcinogenic effect, most probably 
exerted by a mutagenic/genotoxic mode of action. 
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Appendix 1: Start list with 67 
substances 
CAS No EC No Substance name 
Abbrevia-
ted name R/A
1
 
Tox
Cast Tox21 
REACH 
registered 
SMILES applied for (Q)SAR 
prediction 
Notes on CAS and 
SMILES
2
 Source
3
 
1163-19-5 214-604-9 
Bis(pentabromophenyl) 
ether decaBDE A     * 
c1(c(c(c(Br)c(c1Br)Br)Br)Br)
Oc1c(c(c(Br)c(c1Br)Br)Br)Br   1 
118-79-6 204-278-6 2,4,6-Tribromophenol TBP A/R * * * c1(c(cc(Br)cc1Br)Br)O   1 
126-72-7 204-799-9 
tris(2,3-dibromopropyl) 
phosphate TDBPP A * * - 
P(=O)(OCC(CBr)Br)(OCC(C
Br)Br)OCC(CBr)Br   1 
13654-09-6 237-137-2 
Decabromo-1,1'-
biphenyl DecaBB A     - 
c1(c2c(c(c(Br)c(c2Br)Br)Br)
Br)c(c(c(Br)c(c1Br)Br)Br)Br   1 
155613-93-7 605-018-8 
1H-Indene, 2,3-dihydro- 
1,1,3-trimethyl-3-phenyl-
, octabromo deriv. OBTMPI A     - 
CC1(c2c(c(c(c(c2Br)Br)Br)B
r)C(C1(Br)Br)(C)c3cccc(c3B
r)Br)C 
SciFinder: 
incompletely defined 
substance. The 
SMILES included is 
a representative of 
the substance. 1 
183658-27-7 - 
2-ethylhexyl-2,3,4,5- 
tetrabromobenzoate EH-TBB A     
Not 
preregiste
red 
CCCCC(CC)COC(=O)c1cc(
c(c(c1Br)Br)Br)Br   1 
19186-97-1 606-254-4 
Tri[3-bromo-2,2- 
bis(bromomethyl)propyl]
phosphate. TTBNPP A     * 
C(C(CBr)(CBr)CBr)OP(=O)(
OCC(CBr)(CBr)CBr)OCC(C
Br)(CBr)CBr   1 
20566-35-2 243-885-0 
2-(2-
Hydroxyethoxy)ethyl 2- 
hydroxypropyl 3,4,5,6- 
tetrabromophthalate 
HEEHP- 
TEBP A     * 
CC(COC(=O)c1c(c(c(c(c1Br
)Br)Br)Br)C(=O)OCCOCCO
)O   1 
23488-38-2 245-688-5 
2,3,5,6-Tetrabromo-p- 
xylene TBX A     - 
c1(c(c(c(C)c(c1Br)Br)Br)Br)
C   1 
25327-89-3 246-850-8 
1,1'-Isopropylidenebis[4- 
(allyloxy)-3,5- 
dibromobenzene] 
TBBPA- 
bAE A/R   * - 
C(C)(C)(c1cc(c(c(c1)Br)OC
C=C)Br)c1cc(c(c(c1)Br)OC
C=C)Br   1 
25637-99-4 247-148-4 
Hexabromocyclododeca
ne HBCDD A     * 
C1C(CC(CC(CC(CC(CC1Br
)Br)Br)Br)Br)Br 
SciFinder: 
incompletely defined 
substance. 
ChemSpider ("found 
by approved 
synonym"): The 
SMILES included is 
a representative, 
1,3,5,7,9,11- 
Hexabromocyclodod
ecane, of the 
substance. 1 
25713-60-4 607-784-9 
1,3,5-Triazine, 2,4,6- 
tris(2,4,6- 
tribromophenoxy)- 
TTBP-
TAZ A     * 
c1c(cc(c(c1Br)Oc2nc(nc(n2)
Oc3c(cc(cc3Br)Br)Br)Oc4c(
cc(cc4Br)Br)Br)Br)Br 
Ok according to 
SciFinder. 
ChemSpider ("found 1 
CAS No EC No Substance name 
Abbrevia-
ted name R/A
1
 
Tox
Cast Tox21 
REACH 
registered 
SMILES applied for (Q)SAR 
prediction 
Notes on CAS and 
SMILES
2
 Source
3
 
by approved 
synonym"): 
26040-51-7 247-426-5 
Bis(2-ethylhexyl) 
tetrabromophthalate 
BEH-
TEBP A * * * 
CCCCC(CC)COC(=O)c1c(c
(c(c(c1Br)Br)Br)Br)C(=O)O
CC(CC)CCCC   1 
31780-26-4 250-802-1 Dibromostyrene DBS A/R     - c1(ccccc1)\C=C(\Br)Br   1 
3194-55-6 221-695-9 
1,2,5,6,9,10- 
Hexabromocyclododeca
ne HBCDD A * * 
Preregiste
red – 
HBCDD 
registered 
under 
CAS No 
25637-99-
4 
C1CC(C(CCC(C(CCC(C1Br
)Br)Br)Br)Br)Br   1 
32534-81-9 251-084-2 
Diphenyl ether, 
pentabromo derivative pentaBDE A   * - 
c1cc(c(cc1Br)Br)Oc2cc(c(cc
2Br)Br)Br 
SciFinder: 
incompletely defined 
substance. The 
SMILES is a 
representative of the 
substance. 1 
32536-52-0 251-087-9 
Diphenyl ether, 
octabromo derivative octaBDE A   * - 
c1c(c(c(c(c1Br)Br)Br)Br)Oc2
cc(c(c(c2Br)Br)Br)Br 
SciFinder: 
incompletely defined 
substance. The 
SMILES from 
ChemSpider is a 
representative of the 
substance which is in 
itself a category! 1 
32588-76-4 251-118-6 
N,N'-ethylenebis(3,4,5,6- 
tetrabromophthalimide) EBTEBPI A     * 
c12c(C(=O)N(C1=O)CCN1
C(c3c(c(Br)c(c(c3C1=O)Br)
Br)Br)=O)c(c(Br)c(c2Br)Br)B
r   1 
3278-89-5 221-913-2 
2-(allyloxy)-1,3,5-
tribromobenzene TBP-AE A/R   * - 
O(c1c(cc(cc1Br)Br)Br)CC=
C   1 
3322-93-8 222-036-8 
1,2-Dibromo-4-(1,2- 
dibromoethyl)cyclohexa
ne 
DBE- 
DBCH A   * - 
C1[C@@H](CC[C@@H]([C
@@H]1Br)Br)[C@@H](CBr
)Br   1 
33798-02-6 251-681-8 
4,4'-
isopropylidenebis[2,6- 
dibromophenyl] 
diacetate 
TBBPA-
bOAc A     - 
O=C(Oc1c(cc(cc1Br)C(c1cc
(c(OC(=O)C)c(Br)c1)Br)(C)
C)Br)C   1 
34571-16-9 252-097-6 
1,2,3,4,7,7-Hexachloro-
5- (tetrabromo- HCTBPH A     - 
Cl[C@@]12C([C@@](Cl)(C
[C@@H]1c1c(c(c(c(c1)Br)B   1 
CAS No EC No Substance name 
Abbrevia-
ted name R/A
1
 
Tox
Cast Tox21 
REACH 
registered 
SMILES applied for (Q)SAR 
prediction 
Notes on CAS and 
SMILES
2
 Source
3
 
phenyl)bicyclo[2.2.1]hep
t-2- ene 
r)Br)Br)C(=C2Cl)Cl)(Cl)Cl 
35109-60-5 252-372-0 
1,3,5-tribromo-2-(2,3- 
dibromopropoxy)benzen
e DPTE A     - 
O(c1c(cc(cc1Br)Br)Br)C[C
@@H](Br)CBr   1 
3555-11-1 222-610-8 
Allyl pentabromophenyl 
ether PBPAE A/R     - 
c1(c(c(c(Br)c(c1Br)Br)Br)Br)
OCC=C   1 
36355-01-8 252-994-2 
Hexabromo-1,1'-
biphenyl HexaBB A     - 
c1cc(c(c(c1c2ccc(c(c2Br)Br)
Br)Br)Br)Br 
SciFinder: 
incompletely defined 
substance. The 
SMILES is a 
representative of the 
substance. 1 
37853-59-1 253-692-3 
1,1'-[ethane-1,2- 
diylbisoxy]bis[2,4,6- 
tribromobenzene] BTBPE A     - 
c1(c(cc(Br)cc1Br)Br)OCCOc
1c(cc(Br)cc1Br)Br   1 
39569-21-6 254-522-0 
Benzene, 1,2,3,4- 
tetrabromo-5-chloro-6- 
methyl- TBCT A     - 
c1(c(c(c(Br)c(c1Br)Br)Br)Cl)
C   1 
39635-79-5 254-551-9 
4,4'-sulphonylbis[2,6- 
dibromophenol] TBBPS A/R     - 
S(=O)(=O)(c1cc(c(c(c1)Br)O
)Br)c1cc(c(c(c1)Br)O)Br   1 
4162-45-2 224-005-4 
4,4'-isopropylidenebis(2- 
(2,6- 
dibromophenoxy)ethanol
) 
TBBPA- 
BHEE A/R   * 
 
c1(C(c2cc(c(OCCO)c(c2)Br)
Br)(C)C)cc(c(OCCO)c(c1)Br
)Br   1 
42757-55-1 255-929-6 
bis[3,5-dibromo-4-(2,3- 
dibromopropoxy)phenyl] 
sulphone 
TBBPS- 
BDBPE A     - 
c1c(cc(c(c1Br)OCC(CBr)Br)
Br)S(=O)(=O)c2cc(c(c(c2)Br
)OCC(CBr)Br)Br   1 
51936-55-1 257-526-0 
7,8-Dibromo-
1,2,3,4,11,11- 
hexachloro- 
1,4,4a,5,6,7,8,9,10,10a- 
decahydro-1,4- 
methanobenzocycloocte
ne DBHCTD A     - 
Br[C@@H]1[C@@H](Br)C
C[C@@H]2[C@@]3(C(=C([
C@@]([C@@H]2CC1)(Cl)
C3(Cl)Cl)Cl)Cl)Cl   1 
52434-90-9 257-913-4 
1,3,5-Tris(2,3- 
dibromopropyl)-1,3,5- 
triazine-
2,4,6(1H,3H,5H)-trione 
TDBP-
TAZTO A     - 
C(C(CBr)Br)n1c(=O)n(c(=O)
n(c1=O)CC(CBr)Br)CC(CBr
)Br   1 
58965-66-5 261-526-6 
1,2,4,5-tetrabromo-3,6- 
Bis(pentabromophenoxy
) benzene 
4′-
PeBPOB-
DE208 A     - 
Brc1c(Br)c(Oc2c(Br)c(Br)c(
Br)c(Br)c2Br)c(Br)c(Br)c1Oc
1c(Br)c(Br)c(Br)c(Br)c1Br   1 
615-58-7 210-436-5 2,4-dibromophenol DBP A/R     - c1(c(ccc(c1)Br)O)Br   1 
CAS No EC No Substance name 
Abbrevia-
ted name R/A
1
 
Tox
Cast Tox21 
REACH 
registered 
SMILES applied for (Q)SAR 
prediction 
Notes on CAS and 
SMILES
2
 Source
3
 
608-71-9 210-167-3 Pentabromophenol PBP A/R   * - 
c1(c(c(c(Br)c(c1Br)Br)Br)Br)
O   1 
79-94-7 201-236-9 
2,2',6,6'-Tetrabromo-
4,4'- 
isopropylidenediphenol TBBPA A/R * * * 
C(c1cc(c(O)c(c1)Br)Br)(c1c
c(c(O)c(c1)Br)Br)(C)C   1 
84852-53-9 284-366-9 
1,1'-(Ethane-1,2- 
diyl)bis[pentabromobenz
ene 
] DBDPE A     * 
C(Cc1c(c(c(c(c1Br)Br)Br)Br)
Br)c2c(c(c(c(c2Br)Br)Br)Br)
Br   1 
85-22-3 201-593-0 
2,3,4,5,6- 
Pentabromoethylbenzen
e PBEB A   * - 
c1(c(c(c(Br)c(c1Br)Br)Br)Br)
CC   1 
87-82-1 201-773-9 Hexabromobenzene HBB A   * - 
c1(c(c(c(Br)c(c1Br)Br)Br)Br)
Br   1 
87-83-2 201-774-4 
2,3,4,5,6- 
Pentabromotoluene PBT A/R     - 
c1(c(c(c(Br)c(c1Br)Br)Br)Br)
C   1 
1084889-51-9 - 
Octabromotrimethyl- 
phenyl indane OBTMPI NA     
 
CC1(CC(c2c1c(c(c(c2Br)Br)
Br)Br)(C)c3cc(c(c(c3Br)Br)B
r)Br)C 
Found in 
ChemSpider by 
synonym 2 
1522-92-5 - 
Tribromoneopentyl 
alcohol [same substance 
as CAS No 36483-57-5] TBNPA NA   * 
 
C(CO)(CBr)(CBr)CBr 
SciFinder: 2 CAS 
RN's from Table 1 
refer to same 
substance (the other 
CAS is 36483-57-5) 2 
25495-98-1 - Hexabromocyclodecane HBCYD NA     
 
C1(C(C(CCCCCCC1)(Br)Br
)(Br)Br)(Br)Br   2 
3194-57-8 - 
Cyclooctane, 1,2,5,6- 
tetrabromo TBCO NA     
 
C1CC(C(CCC(C1Br)Br)Br)B
r   2 
37419-42-4 - 
Phenol, 4,4′-(1- 
methylethyli- 
dene)bis[2,6dibromo-, 
dipropanoate (9CI) 
TBBPA-
BP NA     
 
C(c1cc(c(OC(=O)CC)c(c1)B
r)Br)(c1cc(c(OC(=O)CC)c(c
1)Br)Br)(C)C 
Ok according to 
SciFinder, SMILES 
generated 2 
38521-51-6 253-985-6 
Benzene, 1,2,3,4,5- 
pentabromo6- 
(bromomethyl) PBBB NA     
 
C(c1c(c(c(c(c1Br)Br)Br)Br)B
r)Br   2 
497107-13-8 - 
Benzene, 1,1′- 
[oxybis(methylene)]bis 
[2,3,4,5,6- 
pentabromo(9CI) DBDBE NA     
 
 
C(c1c(c(c(c(c1Br)Br)Br)Br)B
r)OCc2c(c(c(c(c2Br)Br)Br)Br
)Br 
ChemSpider (found 
by synonyms): 2 
55205-38-4 - 
2-Propenoic acid, 1,1′- 
[(1-methylethylidene) 
bis(2,6-dibromo-4,1- 
phenylene)] ester 
TBBPA-
BA NA     
 
c1(C(c2cc(c(OC(C=C)=O)c(
c2)Br)Br)(C)C)cc(c(OC(C=C
)=O)c(c1)Br)Br   2 
CAS No EC No Substance name 
Abbrevia-
ted name R/A
1
 
Tox
Cast Tox21 
REACH 
registered 
SMILES applied for (Q)SAR 
prediction 
Notes on CAS and 
SMILES
2
 Source
3
 
57829-89-7 - 
1-(2,3-Dibromopropyl)- 
3,5-diallyl-1,3,5-triazine- 
2,4,6(1H,3H,5H)-trione 
DBP-
TAZTO NA     
 
N1(CC=C)C(=O)N(CC(Br)C
Br)C(=O)N(CC=C)C1(=O) 
Ok according to 
SciFinder. SMILES 
generated. 2 
58495-09-3 - 
Benzene, 1,2,3,4,5- 
pentabromo6- 
(chloromethyl) PBBC NA     
 
c1(CCl)c(Br)c(Br)c(Br)c(Br)c
1(Br) 
Ok according to 
SciFinder. SMILES 
generated. 2 
607-99-8 - 2,4,6,-tribromoanisol TBA NA     
 
c1(c(cc(Br)cc1Br)Br)OC   2 
70156-79-5 - 
Benzene, 1,1′- 
sulfonylbis[3, 
5-dibromo-4-methoxy 
TBPPS-
BME NA     
 
S(=O)(=O)(c1cc(c(OC)c(c1)
Br)Br)(c1cc(c(OC)c(c1)Br)Br
) 
Ok according to 
SciFinder. CAS RN 
not in ChemID or 
ChemSpider. 
SMILES generated 2 
75795-16-3 - 
1,3-Bis(2,3- 
dibromopropyl)-5-allyl- 
1,3,5-triazine- 
2,4,6(1H,3H,5H)-trione 
BDBP-
TAZTO NA     
 
N1(CC=C)C(=O)N(CC(Br)C
Br)C(=O)N(CC(Br)CBr)C1(=
O) 
Ok according to 
SciFinder. SMILES 
generated. 2 
3234-02-4   
2,3-Dibromo-2-butene-
1,4-diol  DBBD NA   * 
 
C(C(=C(CO)Br)Br)O 
SMILES from 
ChemSpider 3 
26762-91-4   
Tribromo-phenyl-allyl-
ether, unspecified  AO-TBB NA     
 
C=CCOc1ccc(c(c1Br)Br)Br 
SMILES from 
Chemspider for Allyl 
2,3,4-tribromophenyl 
ether. The SMILES 
included is a 
representative of the 
substance. 3 
52907-07-0   
Ethylene-bis(5,6-
dibromo-norbornane-
2,3-dicarboximide)  
EBDBND
C 
NA     
 
C1C2C3C(C1C(C2Br)Br)C(
=O)N(C3=O)CCN4C(=O)C5
C6CC(C5C4=O)C(C6Br)Br 
SMILES from 
ChemSpider 3 
55481-60-2   
Bis(methyl)tetrabromoph
talate  BM-TEBP  NA     
 
COC(=O)c1c(c(c(c(c1Br)Br)
Br)Br)C(=O)OC 
SMILES from 
ChemSpider 3 
75790-69-1   
TBPA, glycol-and 
propylene-oxide esters ’   NA     
 
c1(c(c(c(c(c1Br)Br)Br)Br)C(
=O)O)C(=O)O 
Mixed esters with 
diethylene glycol and 
propylene glycol, 
here the SMILES is 
only for phthalate 
acid part.  3 
96-13-9 
 202-480-
9 Dibromo-propanol  DBPA NA   * 
 
C(Br)C(Br)CO 
SMILES without 3D 
(note the chiral 
center) 3 
21850-44-2 
244-617-
5 
1,1'-(Isopropylidene) 
bis[3,5- dibromo-4-
(2,3- 
TBBPA- 
BDBPE R   * * 
c1c(Br)c(c(Br)cc1C(C)(C)c
1cc(Br)c(c(c1)Br)OC[C@
@H](CBr)Br)OC[C@@H](   1 
CAS No EC No Substance name 
Abbrevia-
ted name R/A
1
 
Tox
Cast Tox21 
REACH 
registered 
SMILES applied for (Q)SAR 
prediction 
Notes on CAS and 
SMILES
2
 Source
3
 
dibromopropoxy)ben
zene] 
CBr)Br 
3072-84-2 
221-346-
0 
2,2'-[(1- 
Methylethylidene)bis[
(2,6- dibromo-4,1- 
phenyle- le- 
ne)oxymethylene]]bis
oxiran e 
TBBPA- 
BGE R     - 
C(C)(C)(c1cc(c(c(c1)Br)OC
[C@@H]1OC1)Br)c1cc(c(
c(c1)Br)OC[C@@H]1OC1
)Br   1 
3296-90-0 
221-967-
7 
2,2- 
bis(bromomethyl)pro
pane- 
1,3-diol DBNPG R * * * C(CO)(CO)(CBr)CBr   1 
36483-57-5 
253-057-
0 
2,2-dimethylpropan-
1-ol, tribromo 
derivative TBNPA R     * BrCC(CBr)(CBr)CO   1 
37853-61-5 
253-693-
9 
Benzene, 1,1′-(1- 
methylethylidene) 
bis[3,5-dibromo-4-
methoxy 
TBBPA-
BME R     - 
C(c1cc(c(OC)c(c1)Br)Br)(c
1cc(c(OC)c(c1)Br)Br)(C)C   1 
59447-55-1 
261-767-
7 
(Pentabromophenyl)
methyl acrylate PBB-Acr R     * 
c1(c(c(Br)c(c(c1Br)Br)Br)
Br)COC(C=C)=O   1 
632-79-1 
211-185-
4 
Tetrabromophthalic 
anhydride 
TEBP-
Anh R   * * 
c12c(c(c(c(c1Br)Br)Br)Br)
C(=O)OC2=O   1 
66710-97-2 
266-455-
4 
2-Propenoic acid, 
1,1′[(1- 
methylethylidene)bis[
(2,6- dibromo-
4,1phenylene)oxy- 
2,1-ethanediyl]] ester 
TBBPA- 
BHEEBA R     - 
O=C(OCCOc1c(cc(cc1Br)C
(c1cc(c(OCCOC(=O)C=C)c
(Br)c1)Br)(C)C)Br)C=C   1 
1 A: Additive and R: Reactive 
2
 CAS look-up in SciFinder, and SMILES look-up in ChemIDplus and ChemSpider 
3 1 and 2 refer to Table 1 and 2 in the survey report; Danish Ministry of the Environment 2014, and 3 refers to substances from Fujitsu 2015 
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Appendix 2: Start list 
substances with pictures 
  
Structure ALogP Hydrogen Bond Acceptors Hydrogen Bond Donors Lipinski Score Molecular Weight Parent Atom Count Parent Molecular Weight Polar Surface Area Rotatable Bonds
4,05 2 0 0 463,7 15 463,7 43,37 0
6,62 4 0 2 656 29 656 43,52 8
0,75 2 2 0 261,9 9 261,9 40,46 4
10,14 2 0 2 943,6 31 943,6 18,46 10
2,15 1 1 0 324,8 9 324,8 20,23 4
7,08 2 0 2 571,9 23 571,9 18,46 4
5,73 1 0 2 556,7 17 556,7 26,3 4
7,28 4 0 2 740,1 35 740,1 71,06 14
6,47 2 2 2 543,9 21 543,9 40,46 2
6,06 0 0 2 500,6 13 500,6 0 1
6,26 0 0 2 551,5 12 551,5 0 0
5,81 0 0 1 486,6 12 486,6 0 0
3,68 1 1 0 330,8 10 330,8 20,23 0
4,55 1 0 1 697,6 20 697,6 44,76 12
5,2 1 1 1 488,6 12 488,6 20,23 0
2,92 1 1 0 251,9 9 251,9 20,23 0
11,1 0 0 2 959,2 23 959,2 9,23 2
6,92 0 0 2 641,7 18 641,7 0 0
4,54 1 0 0 370,9 13 370,9 9,23 3
4,47 0 0 0 427,8 12 427,8 0 2
6,06 1 0 2 528,7 15 528,7 9,23 3
5,8 4 2 2 632 27 632 58,92 8
10,98 0 0 2 943,2 22 943,2 0 1
7,59 1 0 2 1018 29 1018 44,76 18
3,44 5 2 1 627,9 26 627,9 102,3 11
5,35 0 0 1 421,8 12 421,8 0 0
8,19 2 0 2 624 27 624 18,46 8
6,92 0 0 2 641,7 18 641,7 0 0
12 3 0 2 1067 36 1067 66,36 6
9,48 2 0 2 706,1 32 706,1 52,6 16
3,77 0 0 0 261,9 10 261,9 0 1
7,29 0 0 2 564,7 18 564,7 9,23 2
9,58 0 0 2 801,4 21 801,4 9,23 2
7,68 4 0 2 951,5 32 951,5 74,76 3
6,91 2 0 2 627,9 27 627,9 52,6 6
9,06 0 0 2 692,5 23 692,5 0 1
5,51 1 0 2 530,7 15 530,7 9,23 4
7,93 0 0 2 627,6 18 627,6 0 1
7,72 2 0 2 687,6 22 687,6 18,46 5
5,7 0 0 1 442,2 12 442,2 0 0
4,98 4 2 1 565,9 21 565,9 74,6 2
8,64 4 0 2 965,6 31 965,6 52,6 10
7,17 0 0 2 540,8 21 540,8 0 0
4,74 3 0 1 728,7 24 728,7 60,93 9
12 0 0 2 1367 34 1367 18,46 4
11,1 0 0 2 971,2 24 971,2 0 3
10,34 0 0 2 867,5 26 867,5 0 1
7,11 1 0 2 549,9 21 549,9 26,3 8
3,98 1 0 0 344,8 11 344,8 9,23 1
2,15 1 1 0 324,8 9 324,8 20,23 4
4,61 0 0 0 427,8 12 427,8 0 0
7,19 0 0 2 613,6 16 613,6 0 0
7,69 2 0 2 656 29 656 52,6 8
6,39 0 0 2 565,5 13 565,5 0 1
7,25 2 0 2 652 29 652 52,6 8
2,8 3 0 0 409,1 20 409,1 60,93 7
6,24 0 0 2 521,1 13 521,1 0 1
5,59 4 0 2 593,9 23 593,9 52,6 4
3,77 3 0 1 568,9 22 568,9 60,93 8
11,03 1 0 2 987,2 25 987,2 9,23 4
10,77 0 0 2 867,5 26 867,5 0 1
1,14 1 1 0 217,9 6 217,9 20,23 2
0,97 2 2 0 245,9 8 245,9 40,46 2
4,54 1 0 0 370,9 13 370,9 9,23 3
2,54 4 0 1 672 30 672 74,76 3
4,31 2 0 1 509,8 18 509,8 52,6 4
4,13 4 0 0 481,7 16 481,7 74,6 2
Category approach for selected brominated flame retardants 87 
 
Appendix 3: (Q)SAR models 
  
EPI Suite endpoints (from tabular output only)
Molecular weight
Estimated Log Kow 
Estimated Water Sol. (mg/L)
WATERNT frag Water Sol estimate
BIOWIN1 (Linear Model) Probability 
BIOWIN2 (Non-Linear Model) Probability 
BIOWIN3 numerical output 
BIOWIN4 numerical output
BIOWIN5 (Linear MITI Model) Probability
BIOWIN6 (Non-Linear MITI Model) Probability
Ready biodegradability prediction
PBT_P ((BIOWIN2<.5 OR BIOWIN6<.6) AND BIOWIN3<2.2)
Estimated Log BCF
Estimated BCF
PBT fields derived from EPI Suite and LS DTU aquatic toxicity models
PBT_B (BCF>2000)
PBT_vB (BCF>5000)
PBT_PB (PBT_P AND PBT_B)
PBT_vPvB (PBT_P AND PBT_vB)
PBT_PB NOT vPvB 
PBT_PBT AQ (PBT_P AND PBT_B AND (DK Daphnia m. 48h EC50<1 mg/L OR DK Fathead m. 96h LC50 <1 mg/L OR Algae 72h EC50<1 mg/L)
Case Ultra (CU) commercial models
HEART_ARRHYTHM (Human cardiac arrhythmia) Model Version: 1.5.2.0.1610.500
HEART_BRADY (Human bradycardia) Model Version: 1.5.2.0.1610.500
HEART_CONDUCT (Human cardiac conduction disorders) Model Version: 1.5.2.0.1610.500
HEART_CORONARY (Human coronary artery disorders) Model Version: 1.5.2.0.1610.500
HEART_ECG (Human electrocardiogram disorders) Model Version: 1.5.2.0.1610.500
HEART_FAIL (Human cardiac failure) Model Version: 1.5.2.0.1610.500
HEART_INFARCT (Human myocardial infarction) Model Version: 1.5.2.0.1610.500
HEART_MYOCARD (Human myocardial disorders) Model Version: 1.5.2.0.1610.500
HEART_PALPIT (Human cardiac palpitations) Model Version: 1.5.2.0.1610.500
HEART_QT (Human cardiac QT-prolongation) Model Version: 1.5.2.0.1610.500
HEART_RATE (Human cardiac rate rhythm disorders) Model Version: 1.5.2.0.1610.500
HEART_TACHY (Human tachycardia) Model Version: 1.5.2.0.1610.500
HEART_TORSADES (Human cardiac Torsades de pointes) Model Version: 1.5.2.0.1610.500
RENAL_NPATHY (Human nephropathy) Model Version: 1.5.2.0.1569.500
A48 (Developmental toxicants, human) Model Version: 1.5.2.0.119.500
RP_AN1 (Female fertility, rodent) Model Version: 1.5.2.0.960.500
RP_AN5 (Female fertility, rat) Model Version: 1.5.2.0.895.500
RP_AN9 (Female fertility, mouse) Model Version: 1.5.2.0.151.500
RP_AO1 (Male fertility, rodent) Model Version: 1.5.2.0.784.500
RP_AO4 (Male fertility, rat) Model Version: 1.5.2.0.715.500
RP_AO7 (Male fertility, mice) Model Version: 1.5.2.0.146.500
RP_AP1 (Sperm toxicity, rodent) Model Version: 1.5.2.0.906.500
RP_AP4 (Sperm toxicity, rat) Model Version: 1.5.2.0.722.500
RP_AP7 (Sperm toxicity, mouse) Model Version: 1.5.2.0.262.500
RP_AQ1 (Newborn behavioral toxicity, rodent) Model Version: 1.5.2.0.666.500
RP_AQ4 (Newborn behavioral toxicity, rat) Model Version: 1.5.2.0.622.500
RP_AQ9 (Newborn behavioral toxicity, mice) Model Version: 1.5.2.0.173.500
SALM (Salmonella mutagenicity (TA97,98,100,1535-1538)) Model Version: 1.5.1.8.10479.500
A2E - Ashby structural alerts for DNA reactivity (NTP data)
A61 Chromosomal aberrations in vitro in CHO cells
A33 - Allergic contact dermatitis in guinea pig and human
A49 - Teratogenic potential in humans
AF1 - Carcinogenicity in male rats   
AF2 - Carcinogenicity in female rats 
AF3 - Carcinogenicity in male mice
AF4 - Carcinogenicity in female mice
AFU - Carcinogenicity in rodents
AFV - Carcinogenicity in rats 
AFW - Carcinogenicity in mice
RCA call
DTU models
Ames (all strains)
Ames_sub_Direct_(S9)
Ames_sub_Potency_>_10x_ctrl.
Ames_sub_Base-pair
Ames_sub_Frame_shift
Mouse_lymphoma, in vitro
Chromosomal_aberrations_CHL, in vitro
UDS_rat_hepatocytes, in vitro
SHE_cell_transformation, in vitro
HGPRT, in vitro
SCE_mouse, in vivo
Mouse_micronucleus, in vivo
Comet_assay, in vivo
Rodent dominant_lethal, in vivo
Drosophila_SLRL
Rodent hepatocarcinogenicity (only)
hERG blocking
MRTD
ER binding, METI all data
ER binding, METI balanced training set
ER agonism, METI agonism data
ER agonism, US EPA CERAPP data
AR antagonism
Thyroid alpha binding
Thyroid beta binding
TPO, Thyroid peroxidase, US EPA data
PXR binding
Airway_allergy
Skin_irritation (severe vs. mild)
CYP_2D6_substrate
CYP_2C9_substrate
Biodegradation
Fathead minnow 96h LC50
Daphnia 48h EC50
72h EC50 (growth)
Pseudokirchneriella subcapitata algae 72h EC50 (growth inhibition)
Leadscope (LS) commercial models
Growth Retard Mouse 
Growth Retard Rabbit 
Growth Retard Rat 
retard rodent (AH1) 
Wt Dec Mouse 
Wt Dec Rabbit 
wt dec rodent (AI1) 
weight dec. rat 
Fetal Death Mouse 
Fetal Death Rabbit 
Fetal Death Rat 
Fetal Death Rodent 
post impl mouse (AG6) 
Post Impl Loss Rabbit 
Post Impl Loss Rat 
post impl rodent (AG1) 
Pre Impl Loss Mouse 
Pre Impl Loss Rabbit 
Pre Impl Loss Rat 
Pre Impl Loss Rodent 
struct mouse (AL6) 
Dysmorph Rabbit 
Dysmorph Rat 
struct rodent (AL1) 
Visc Org Mouse 
Visc Org Rat 
Visc Org Rodent 
Repro Mouse Female 
Repro Rat Female 
Repro Rodent Female 
Repro Mouse Male 
Repro Rat Male 
Repro Rodent Male 
sperm mouse(AP5) 
Sperm Eff Rat
Sperm Eff Rodent 
Bile Duct Disorder 
Gall Bladder Disorder 
Jaundice 
Liver Damage 
Liver Enzyme Abnorm 
OECD QSAR Application Toolbox profilers
Simulator name
Metabolite
Database Affiliation
Inventory Affiliation
OECD HPV Chemical Categories
Substance Type
US-EPA New Chemical Categories
Biodeg BioHC half-life (Biowin)
Biodeg primary (Biowin 4)
Biodeg probability (Biowin 1)
Biodeg probability (Biowin 2)
Biodeg probability (Biowin 5)
Biodeg probability (Biowin 6)
Biodeg probability (Biowin 7)
Biodeg ultimate (Biowin 3)
DNA binding by OASIS v.1.3
DNA binding by OECD
DPRA Cysteine peptide depletion
DPRA Lysine peptide depletion
Estrogen Receptor Binding
Hydrolysis half-life (Ka, pH 7)(Hydrowin)
Hydrolysis half-life (Ka, pH 8)(Hydrowin)
Hydrolysis half-life (Kb, pH 7)(Hydrowin)
Hydrolysis half-life (Kb, pH 8)(Hydrowin)
Hydrolysis half-life (pH 6.5-7.4)
Ionization at pH = 1
Ionization at pH = 4
Ionization at pH = 7.4
Ionization at pH = 9
Protein binding by OASIS v1.3
Protein binding by OECD
Protein binding potency
Superfragments
Toxic hazard classification by Cramer (extension)
Toxic hazard classification by Cramer (original)
Ultimate biodeg
Acute aquatic toxicity classification by Verhaar (Modified)
Acute aquatic toxicity MOA by OASIS
Aquatic toxicity classification by ECOSAR
Bioaccumulation - metabolism alerts
Bioaccumulation - metabolism half-lives
Biodegradation fragments (BioWIN MITI)
Carcinogenicity (genotox and nongenotox) alerts by ISS
DART scheme v.1.0
DNA alerts for AMES, MN and CA by OASIS v.1.3
Eye irritation/corrosion Exclusion rules by BfR
Eye irritation/corrosion Inclusion rules by BfR
in vitro mutagenicity (Ames test) alerts by ISS
in vivo mutagenicity (Micronucleus) alerts by ISS
Keratinocyte gene expression
Oncologic Primary Classification
Protein binding alerts for Chromosomal aberration by OASIS v1.1
Protein binding alerts for skin sensitization by OASIS v1.3
Respiratory sensitisation
Retinoic Acid Receptor Binding
rtER Expert System ver.1 - USEPA
Skin irritation/corrosion Exclusion rules by BfR
Skin irritation/corrosion Inclusion rules by BfR
Chemical elements
Groups of elements
Lipinski Rule Oasis
Organic Functional groups
Organic Functional groups (nested)
Organic functional groups (US EPA)
Organic functional groups, Norbert Haider (checkmol)
Tautomers unstable
Repeated dose (HESS)
88 Category approach for selected brominated flame retardants 
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Carcinogenicity (Q)SAR-based clustering 
 
Clustering - Clusters (Run #1) 
 
Project Name: Br_67  
Structure Count: 67  
 
Name for this run: Clusters (Run #1) 
Project: Br_67 
# structures: 67 
Analysis type: Clustering (Agglomerative Nesting) 
Date: Tue Nov 24 11:23:48 CET 2015 
Owner: ebawe 
Create signatures: true 
Group singletons: true 
Cluster by: Data ( CU_P_Cancer_Female_Mouse CU_P_Cancer_Female_Rat 
CU_P_Cancer_Male_Mouse CU_P_Cancer_Male_Rat CU_P_Cancer_Mouse CU_P_Cancer_Rat 
CU_P_Cancer_Rodent TB_120 TB_121 TB_122 TB_123 TB_124 TB_125 TB_126 TB_127 TB_128 
TB_50 TB_51 TB_52 TB_53 TB_54 TB_55 TB_56 TB_57 TB_58 TB_59 TB_60 TB_61 ) 
Linkage mechanism: Average Linkage 
Cluster height: 0.5 
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Genotoxicity (Q)SAR-based clustering 
 
 
Clustering - Clusters (Run #3) 
 
Project Name: Br_67  
Structure Count: 67  
 
Name for this run: Clusters (Run #3) 
Project: Br_67 
# structures: 67 
Analysis type: Clustering (Agglomerative Nesting) 
Date: Fri Nov 27 18:55:39 CET 2015 
Owner: ebawe 
Create signatures: true 
Group singletons: true 
Cluster by: Data ( CU_P_Ashby CU_P_CA_CHO CU_P_MN_in_vivo CU_P_SALM 
LS_R_DK_Ames_test LS_R_DK_Chromosomal_aberrations_CHL LS_R_DK_Comet_assay 
LS_R_DK_Dominant_lethal LS_R_DK_Drosophila_SLRL LS_R_DK_HGPRT 
LS_R_DK_Mouse_lymphoma LS_R_DK_Mouse_micronucleus LS_R_DK_SCE_mouse 
LS_R_DK_SHE_cell_transformation LS_R_DK_UDS_rat_hepatocytes TB_107 TB_108 TB_109 
TB_110 TB_111 TB_112 TB_212 TB_213 TB_214 TB_215 TB_216 TB_217 TB_218 TB_219 TB_220 
TB_221 TB_222 TB_223 TB_224 TB_225 TB_226 TB_227 TB_228 TB_46 TB_47 TB_48 TB_49 
TB_70 TB_71 TB_72 TB_73 TB_74 TB_75 TB_76 TB_77 TB_78 TB_79 TB_80 ) 
Linkage mechanism: Average Linkage 
Cluster height: 0.5 
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Reproductive toxicity (Q)SAR-based clustering 
 
Clustering - Clusters (Run #3) 
 
Project Name: Br_67  
Structure Count: 67  
 
Name for this run: Clusters (Run #3) 
Project: Br_67 
# structures: 67 
Analysis type: Clustering (Agglomerative Nesting) 
Date: Fri Nov 27 18:25:52 CET 2015 
Owner: ebawe 
Create signatures: true 
Group singletons: true 
Cluster by: Data ( CU_P_RP_Female_fertility_mouse CU_P_RP_Female_fertility_rat 
CU_P_RP_Female_fertility_rodent CU_P_RP_Male_fertility_mouse CU_P_RP_Male_fertility_rat 
CU_P_RP_Male_fertility_rodent CU_P_RP_Newborn_behavioral_mouse 
CU_P_RP_Newborn_behavioral_rat CU_P_RP_Newborn_behavioral_rodent 
CU_P_RP_Sperm_toxicity_mouse CU_P_RP_Sperm_toxicity_rat 
CU_P_RP_Sperm_toxicity_rodent CU_P_Teratogenicity LS_R_Dysmorph_Rabbit 
LS_R_Dysmorph_Rat LS_R_Fetal_Death_Mouse LS_R_Fetal_Death_Rabbit 
LS_R_Fetal_Death_Rat LS_R_Fetal_Death_Rodent LS_R_Growth_Retard_Mouse 
LS_R_Growth_Retard_Rabbit LS_R_Growth_Retard_Rat LS_R_Post_Impl_Loss_Rabbit 
LS_R_Post_Impl_Loss_Rat LS_R_post_impl_mouse_(AG6) LS_R_post_impl_rodent_(AG1) 
LS_R_Pre_Impl_Loss_Mouse LS_R_Pre_Impl_Loss_Rabbit LS_R_Pre_Impl_Loss_Rat 
LS_R_Pre_Impl_Loss_Rodent LS_R_Repro_Mouse_Female LS_R_Repro_Mouse_Male 
LS_R_Repro_Rat_Female LS_R_Repro_Rat_Male LS_R_Repro_Rodent_Female 
LS_R_Repro_Rodent_Male LS_R_retard_rodent_(AH1) LS_R_Sperm_Eff_Rat 
LS_R_Sperm_Eff_Rodent LS_R_sperm_mouse(AP5) LS_R_struct_mouse_(AL6) 
LS_R_struct_rodent_(AL1) LS_R_Visc_Org_Mouse LS_R_Visc_Org_Rat LS_R_Visc_Org_Rodent 
LS_R_weight_dec._rat LS_R_Wt_Dec_Mouse LS_R_Wt_Dec_Rabbit LS_R_wt_dec_rodent_(AI1) 
TB_113 TB_114 TB_115 TB_116 TB_117 TB_118 TB_119 ) 
Linkage mechanism: Average Linkage 
Cluster height: 0.5 
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Endocrine (Q)SAR-based clustering 
 
Clustering - Clusters (Run #3) 
 
Project Name: Br_67  
Structure Count: 67  
 
Name for this run: Clusters (Run #3) 
Project: Br_67 
# structures: 67 
Analysis type: Clustering (Agglomerative Nesting) 
Date: Sat Nov 28 22:02:42 CET 2015 
Owner: ebawe 
Create signatures: true 
Group singletons: true 
Cluster by: Data ( LS_R_DK_Anti-androgenicity LS_R_DK_CERAPP_agonist 
LS_R_DK_Estrogen_binding_all LS_R_DK_Estrogen_binding_bal. 
LS_R_DK_Estrogen_reporter_gene LS_R_DK_PXR LS_R_DK_TPO TB_196 TB_197 TB_198 
TB_199 TB_200 ) 
Linkage mechanism: Average Linkage 
Cluster height: 0.5 
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Skin sensitization (Q)SAR-based clustering 
 
Clustering - Clusters (Run #3) 
 
Project Name: Br_67  
Structure Count: 67  
 
Name for this run: Clusters (Run #3) 
Project: Br_67 
# structures: 67 
Analysis type: Clustering (Agglomerative Nesting) 
Date: Fri Nov 27 18:17:02 CET 2015 
Owner: ebawe 
Create signatures: true 
Group singletons: true 
Cluster by: Data ( CU_P_Skin_allergy TB_163 TB_164 TB_165 TB_166 TB_167 TB_168 TB_169 
TB_170 TB_171 TB_172 TB_173 TB_174 TB_175 TB_176 TB_177 TB_178 TB_179 TB_180 TB_181 
TB_182 TB_183 TB_184 TB_185 TB_186 TB_187 TB_188 TB_189 TB_190 TB_191 TB_192 TB_193 
TB_194 TB_195 TB_201 TB_202 TB_203 TB_204 TB_205 TB_206 TB_207 TB_208 TB_209 TB_210 
TB_211 TB_33 TB_34 TB_35 TB_36 TB_37 TB_38 TB_39 TB_40 TB_41 TB_42 TB_43 TB_44 
TB_45 TB_62 TB_63 TB_64 TB_65 TB_66 TB_67 TB_68 TB_69 ) 
Linkage mechanism: Average Linkage 
Cluster height: 0.5 
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Appendix 5: Category 
members 
 
Structure ALogP
H-bond 
Acceptors
H-bond 
Donors
Lipinski 
Score Mol. Weight
Polar 
Surface 
Area
Rotatable 
Bonds
1,14 1 1 0 217,9 20,23 2
1,14 1 1 0 217,9 20,23 2
1,38 1 1 0 231,9 20,23 3
1,53 1 1 0 231,9 20,23 3
1,53 1 1 0 231,9 20,23 2
1,53 1 1 0 231,9 20,23 2
1,53 1 1 0 231,9 20,23 3
0,5 2 2 0 247,9 40,46 3
0,5 2 2 0 247,9 40,46 3
1,9 1 1 0 310,8 20,23 3
1,9 1 1 0 310,8 20,23 3
1,77 1 1 0 245,9 20,23 3
1,92 1 1 0 245,9 20,23 3
1,92 1 1 0 245,9 20,23 3
1,92 1 1 0 245,9 20,23 3
1,91 1 1 0 245,9 20,23 2
1,91 1 1 0 245,9 20,23 2
1,92 1 1 0 245,9 20,23 4
1,92 1 1 0 245,9 20,23 4
1,92 1 1 0 245,9 20,23 4
1,92 1 1 0 245,9 20,23 4
1,92 1 1 0 245,9 20,23 3
1,77 1 1 0 245,9 20,23 4
1,77 1 1 0 245,9 20,23 3
1,77 1 1 0 245,9 20,23 3
1,77 1 1 0 245,9 20,23 4
1,77 1 1 0 245,9 20,23 3
0,75 2 2 0 261,9 40,46 4
0,89 2 2 0 261,9 40,46 3
0,89 2 2 0 261,9 40,46 4
0,89 2 2 0 261,9 40,46 4
0,89 2 2 0 261,9 40,46 3
0,89 2 2 0 261,9 40,46 3
0,89 2 2 0 261,9 40,46 3
0,89 2 2 0 261,9 40,46 4
0,75 2 2 0 261,9 40,46 4
0,75 2 2 0 261,9 40,46 4
0,75 2 2 0 261,9 40,46 4
0,75 2 2 0 261,9 40,46 4
2,15 1 1 0 324,8 20,23 4
2,15 1 1 0 324,8 20,23 4
2,29 1 1 0 324,8 20,23 4
2,29 1 1 0 324,8 20,23 4
2,29 1 1 0 324,8 20,23 4
2,29 1 1 0 324,8 20,23 3
2,29 1 1 0 324,8 20,23 3
2,29 1 1 0 324,8 20,23 4
2,29 1 1 0 324,8 20,23 3
2,29 1 1 0 324,8 20,23 4
2,29 1 1 0 324,8 20,23 3
2,29 1 1 0 324,8 20,23 4
2,15 1 1 0 324,8 20,23 4
2,15 1 1 0 324,8 20,23 4
2,15 1 1 0 324,8 20,23 4
1,26 2 2 0 340,8 40,46 4
1,26 2 2 0 340,8 40,46 4
1,26 2 2 0 340,8 40,46 4
1,26 2 2 0 340,8 40,46 4
1,26 2 2 0 340,8 40,46 4
2,66 1 1 0 403,7 20,23 4
2,66 1 1 0 403,7 20,23 4
2,66 1 1 0 403,7 20,23 4
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Appendix 6: Heat maps of 
(Q)SAR results  
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APPENDIX 6/FIGURE 1 HEAT MAP OF (Q)SAR PREDICTIONS OF CARCINOGINICITY AND GENOTOXICITY 
 
DTU and commercial CASE Ultra (CU) (Q)SAR models: 
a CU Ashby structural alerts 
b CU SALM, Salmonella mutagenicity (TA97,98,100,1535-1538) (in vitro) 
c DTU Ames Salmonella (TA98, 100, 1535 and either TA1537 or TA97) (in vitro) 
d DTU Ames sub-model Direct (S9 not required) (in vitro) 
e DTU Ames sub-model Potency > 10x ctrl. (in vitro) 
f DTU Ames sub-model Base-pair (in vitro) 
g DTU Ames sub-model Frame shift (in vitro) 
h CU Chromosomal aberrations CHO (in vitro) 
i DTU Chromosomal aberrations CHL (in vitro) 
j DTU UDS rat hepatocytes (in vitro) 
k DTU HGPRT (in vitro) 
l DTU SHE cell transformation (in vitro) 
m DTU SCE mouse (in vivo) 
n DTU Mouse micronucleus (bone marrow) (in vivo) 
o DTU Dominant lethal (in vivo) 
p DTU Drosophila SLRL (in vivo) 
q DTU Comet assay (in vivo) 
r CU FDA RCA cancer male rat (in vivo) 
s CU FDA RCA cancer female rat (in vivo) 
t CU FDA RCA cancer male mouse (in vivo) 
u CU FDA RCA cancer female mouse (in vivo) 
v CU FDA RCA cancer rodent (in vivo) 
w CU FDA RCA cancer rat (in vivo) 
x CU FDA RCA cancer mice (in vivo) 
y CU FDA RCA overall cancer call 
APPENDIX 6/TABLE 1 EXPLANATION OF COLUMNS IN THE HEAT MAP OF (Q)SAR PREDICTIONS OF 
CARCINOGINICITY AND GENOTOXICITY. CU: CASE ULTRA, DTU: TECHNICAL UNIVERSITY OF DENMARK, 
FDA: U.S. FOOD AND DRUG ADMINISTRATION, RCA: RESEARCH COLLABORATION AGREEMENT 
  
The heat map above shows (Q)SAR genotoxicity and carcinogenicity hits for the 61 category 
members with associated X and Y legend information in the table. Substances marked in bold 
originate from the initial group. Red means ‘hit’, white means ‘not hit’ and grey means ‘out-of-the-
applicability-domain’. 
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APPENDIX 6/FIGURE 2 HEAT MAP OF OECD (Q)SAR APPLICATION TOOLBOX PROFILER ALERTS 
 
DNA binding by OECD 
A1 Aliphatic halides 
A2 1,2-Dihaloalkanes 
A3 Mono aldehydes 
A4 Epoxides 
A5 Mustards 
DNA binding by OASIS v.1.3 B1 Haloalkanes Containing Heteroatom 
A1 A2 A3 A4 A5 B1 B2 B3 B4 B5 C1 C2 D1 D2 D3 E1 E2 E3 E4 F1 F2 F3 F4 G1 G2 G3 G4 H1 H2 H3 H4 H5
32102_96-13-9
32103_96-21-9
42104_106023-63-6
42105_19398-47-1
42106_79033-40-2
42107_4021-75-4
42108_87018-30-2
42209_35330-59-7
42210_14396-65-7
43111_855236-37-2
43112_87018-38-0
52113_105100-80-9
52114_213821-22-8
52115_408319-76-6
52116_159475-15-7
52117_343268-04-2
52118_76377-07-6
52119_59287-66-0
52120_1
52121_856991-78-1
52122_100606-66-4
52123_213821-20-6
52124_2
52125_3
52126_4
52127_98069-26-2
52128_5
52229_3296-90-0
52230_20
52231_21
52232_22
52233_23
52234_24
52235_25
52236_26
52237_44804-46-8
52238_27
52239_28
52240_29
53141_1522-92-5
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53149_12
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53154_17
53155_18
53256_31
53257_32
53258_33
53259_35
53260_36
54161_37
54162_38
54163_39
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B2 
Haloalkane Derivatives with Labile Halogen 
B3 Vicinal Dihaloalkanes 
B4 Epoxides and Aziridines 
B5 Haloalcohols 
Protein binding alerts for 
Chromosomal aberration by OASIS 
v1.1 
C1 Halogenated Vicinal Hydrocarbons 
C2 Alpha-Activated Haloalkanes 
In vitro mutagenicity (Ames test) alerts 
by ISS 
D1 Aliphatic halogens 
D2 Simple aldehyde 
D3 Epoxides and aziridines 
DNA alerts for AMES, MN and CA by 
OASIS v.1.3 
E1 
Haloalkane Derivatives with Labile Halogen 
E2 Vicinal Dihaloalkanes 
E3 Haloalcohols 
E4 Epoxides and Aziridines 
In vivo mutagenicity (Micronucleus) 
alerts by ISS 
F1 Aliphatic halogen 
F2 Epoxides and aziridines 
F3 H-acceptor-path3-H-acceptor 
F4 Simple aldehyde 
Oncologic Primary Classification 
G1 
Aldehyde Type Compounds 
G2 Alpha, beta-Haloether Reactive Functional 
Groups 
G3 
Reactive Ketone Reactive Functional Groups 
G4 Epoxide Reactive Functional Groups 
Carcinogenicity (genotox and 
nongenotox) alerts by ISS 
H1 (Poly) Halogenated Cycloalkanes 
(Nongenotox) 
H2 Aliphatic halogens (Genotox) 
H3 Epoxides and aziridines (Genotox) 
H4 Simple aldehyde (Genotox) 
H5 Substituted n-alkylcarboxylic acids 
(Nongenotox) 
APPENDIX 6/TABLE 2 EXPLANATION OF COLUMNS IN THE HEAT MAP OF OECD (Q)SAR APPLICATION 
TOOLBOX PROFILER ALERTS 
The heat map above shows the identified OECD (Q)SAR Application Toolbox profiler structural 
alerts hits for the 61 category members with associated X legend information in the table. 
Substances marked in bold originate from the initial group. The rows of the matrix represent 
structural alerts identified either in the parent compound or in one or more metabolites, and each 
associated with one or more possible mechanisms in the OECD (Q)SAR Application Toolbox 
individual alerts explanations provided in Appendix 6.  
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Appendix 7: OECD (Q)SAR 
Application Toolbox profiler 
alerts explanations 
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A. Profiler: DNA Binding by OECD 
 
Structural alert: Aliphatic halide 
 
 
 
R = hydrogen, any carbon except the following: 
X = Cl, Br, I 
 
 
 
Excluded structures (alternative alert as shown): 
 
 
 
X = halogen 
 
 
 
 
Mechanism 
 
An SN 2 mechanism has been proposed as the primary method of DNA alkylation (Sobol et al 
2007). 
 
 
 
Nu = biological nucleophile 
 
 
 
 
Structural alert mitigating factors 
 
• The carbon being attacked by the biological nucleophile cannot be tertiary 
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• Fluorine is excluded due to the strength of the C-F bond 
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• 1,2-dihaloalkanes are excluded as they react via an episulfonium ion 
 
 
 
 
References 
 
Sobol Z et al (2007) Mutation Research 633, 80-94 
Structural alert: 1,2-Dihaloalkanes  
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X = Cl, Br, I 
 
R = hydrogen, sp3 carbon 
 
 
 
 
Mechanism 
 
It has been suggested that 1,2-dihaloalkanes undergo an initial attack by glutathione followed by 
internal cyclisation resulting in the formation of a reactive episulfonium ion. This ion can then 
undergo an SN 2 type ring opening reaction (Granville et al 2005). 
 
 
 
Structural alert mitigating factors 
 
• The carbon being attacked by the biological nucleophile cannot be tertiary 
 
• Fluorine is excluded due to the strength of the C-F bond 
 
 
 
 
References 
 
Granville CA et al (2005) Mutation Research, 572, 98-112 
Structural alert: Mono-aldehydes  
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R = sp3 carbon, hydrogen 
 
 
 
 
Mechanism 
 
Mono aldehydes undergo Schiff base formation (Garcia et al 2009, Hecht et al 2001). 
 
 
 
R = DNA chain 
 
 
 
 
 
 
Sructural alert mitigating factors 
 
• No mitigating factors have been reported for the chemicals in this mechanistic alert. 
 
 
 
 
References 
 
Garcia CL et al (2009) Mutation Research, 662, 3-9 
 Appendix 7/ 7 
 
Mechanistic Alert: Direct Acting Epoxides and Related 
 
Several structural alerts have been identified as being able to form DNA adducts via a ring 
opening SN 2 reaction. These structural alerts are as follows: 
 
 
 
 
Structural alert: Epoxides Epoxides and related 
 
 
 
 
 
 
Mechanism 
 
Alkylation occurs via an SN 2 ring opening mechanism (Sawatari et al 2001). 
 
 
 
 
 
 
Nu = biological nucleophile 
 
 
 
 
Structural alert: Aziridines 
 
 
 
 
 
 
Mechanism 
 
Alkylation occurs via an SN 2 ring opening mechanism (Sawatari et al 2001). 
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Nu = biological nucleophile 
 
 
 
 
Structural alert: Sulfuranes 
 
 
 
 
 
 
Mechanism 
 
Alkylation occurs via an SN 2 ring opening mechanism (Sawatari et al 2001). 
 
 
 
 
 
 
Nu = biological nucleophile 
 
 
 
 
Mechanistic alert mitigating factors 
 
•  All structural alerts in this mechanistic alert: The carbon being attacked by the biological 
nucleophile cannot be tertiary 
 
 
 
 
References 
 
Sawatari KY et al (2001) Industrial Health, 39, p341-345 
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Structural alert: Mustards  
 
 
 
Y = nitrogen, sulphur (any oxidation state of sulphur is allowed as long as a lone pair remains 
free for the cyclisation reaction) 
 
X = Cl, Br, I 
 
R = sp3 carbon, hydrogen 
 
 
 
 
Mechanism 
 
Mustards have been suggested to undergo an intra-molecular cyclisation to form an electrophilic 
reactive episulfonium ion. The episulfonium ion is then susceptible to SN 2 attack by biological 
nucleophiles (Noll et al 2006, Smith et al 1995). 
 
 
 
 
 
 
Nu = biological nucleophile. 
 
 
 
 
Structural alert mitigating factors 
 
• The carbon being attacked by the biological nucleophile cannot be tertiary 
 
• Fluorine is excluded due to the strength of the C-F bond 
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References 
 
Noll DM et al (2006) Chemical Reviews, 106, 277-301 
 
Smith KJ et al (1995) Journal of the American Academy of Dermatology, 32, 765-776. 
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B. Profiler: DNA Binding by OASIS 
 
Haloalkanes Containing Heteroatom 
 
 
Principal and characteristic active structural fragments: 
 
(X = Cl, Br, I) 
 
Mechanistic Domain: SN 2 
Mechanistic Alert: Alkylation, nucleophilic substitution at sp3 carbon atom 
 
Mechanistic Domain: Radical 
Mechanistic Alert: Generation of ROS by glutathione depletion (indirect) 
 
A.  Compounds with halogen at beta-position with respect to a heteroatom 
 
Mustards and beta-haloethers belong to this sub-class of compounds, and are alkylating 
agents. Generally, there is no need for metabolic activation, and the presence of labile halogen at 
α- or β-position with respect to a heteroatom in the open chain determines biological activity. The 
primary mechanism of action is an electrophilic attack on the nucleophilic sites of DNA. Most 
nitrogen and oxygen positions on DNA bases can be alkylated under appropriate conditions but 
guanine O6 or N7 (preferably), cytosine O2 and adenine N1 and N3 are the most vulnerable 
targets [1 - 3]. Some examples for the formation of such adducts with guanosine are given below: 
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2-Chloro-N,N-dimethylethylamine is structurally similar to nitrogen mustards and 
possesses both the mutagenic and carcinogenic potency [4]. The stabilization of the transition 
state, responsible for the DNA alkylating activities can be outlined as follows: 
 
 
On the other hand, 2-(β)-haloalkylamines such as the compound N-[4-(2- 
bromoethylmethylamino)-2-butynyl]-2-pyrrolidone: 
 
 
 
also  show  biological  activity,  due  to  a  rapid  cyclization  to  the  pharmacologically  active 
aziridinium ion, according to the following scheme: 
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Thus the genotoxicity of this compound when administered to mouse has been explained (see 
also Nitrogen Mustards) [5]. 
 
B.  Compounds with Halogen in Alpha-Position with Respect to a Heteroatom 
 
The general mechanism of action of such chemicals is believed to be similar to that of 
mustards and other direct-acting alkylating agents (see above). For example, bis(2-chloroethyl) 
ether (BCEE), bis(chloromethyl) ether (BCME) and chloromethyl methyl ether (CMME) are 
chemicals from a large class known as chloroalkyl ethers: 
 
 
 
Carcinogenicity studies in experimental animals (mice and rats) exposed to, e.g., BCME 
have shown significantly elevated incidence of pulmonary adenomas and respiratory tumours. In 
mice, inhalation exposure also indicated evidence of lung tumours. The chemicals are mutagens 
in the Ames test [6]. The structure of bis(chloromethyl) ether predicts that it would be direct 
alkylating agent, which is consistent with its ability to react in vitro with DNA bases [7]. 
The fungicide captan: 
 
 
 
 
 
 
 
 
 
takes specific position among this class of chemicals. It is likely to exert its mutagenicity as 
parent chemical [8] by different mechanism, i.e., probably by generation of reactive oxygen 
species (ROS) by thiols (glutathione) depletion [9, 10]: 
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Mechanistic Domain: SN 2 
Mechanistic Alert: Alkylation, nucleophilic substitution at sp3-carbon atom 
 
Mechanistic Domain: AN 2 
Mechanistic Alert: Shiff base formation for aldehydes 
 
Mechanistic Domain: SN 2 
Mechanistic Alert: Acylation involving a leaving group 
 
Structural alert: Haloalkane Derivatives with Labile Halogen 
 
Principal and characteristic active structural fragments: 
 
A. Primary haloalkane derivatives with labile halogen at alpha-position towards other groups: 
 
 
 
 
 
 
 
 
 
 
 
 
B. Primary haloalkane derivatives with labile halogen at beta-position towards other groups: 
 
 
 
 
 
 
 
 
 
 
 
 
“Mask”: 
 
 
Mechanistic Domain: SN 2 
Mechanistic Alert: Alkylation, nucleophilic substitution at sp3-carbon atom 
 
Mechanistic Domain: AN 2 
Mechanistic Alert: Shiff base formation for aldehydes 
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Mechanistic Domain: SN 2 
Mechanistic Alert: Acylation involving a leaving group 
 
A. Haloalkane derivatives with labile halogen at alpha-position towards other groups 
Many of these compounds represent disinfection by-products, some of which are rather 
toxic. They include halonitriles, some halocarbonyl- and halocarboxyl-compounds, 
halonitroalkanes,  etc.  Short-chain monohalogenated  alkanes  and  their derivatives,  containing 
such electron-withdrawing substituents are potential direct-acting alkylating agents, particularly 
if the halogen is at the terminal end of the carbon chain or at allylic (benzylic) position (primary 
halogenoalkane derivatives). For example, acetonitrile is not carcinogenic in rodents and is only 
weakly or marginally mutagenic. For halogenated acetonitriles, positive mutagenicity is expected, 
due to the strong –I effect of the neighboring nitrile group, however, bacterial toxicity hinders the 
expression of positive mutagenic potential. 
Generally, the introduction of halogen to alpha- or terminal carbon atoms with the above- 
mentioned structural neighbors is expected to increase the genotoxic potential by making it an 
alkylating and/or cross-linking agent. On the basis of the alkylating activity, the brominated 
compounds are expected to be more reactive than chlorinated ones, and iodoacetic acid is the 
most  toxic  and  genotoxic  disinfection  by-product  in  mammalian  cells  reported  [1,  3].  For 
example, bromoacetic acid is far more mutagenic than the chloroacetic acid [2]. The toxicity of 
brominated and chlorinated acetic acids, however, decreases as the number of halo-substituents 
increases [4]. Haloaldehydes with mono-substitution at the alpha- or terminal carbon atom are 
also expected to be potential alkylating agents [1]. For example, the reaction of the strong 
mutagen, chloroacetaldehyde, a reactive metabolite of the carcinogenic vinyl chloride (and 
bifunctional compound) with DNA produces 1,N6-ethenoadenine, 3,N4-ethenocytosine and, 
particularly, N2,3-ethenoguanine [5]. Therefore, if the substituent Y represents the reactive 
aldehyde (e.g., formyl) group), the following scheme of formation of one of the DNA adducts has 
been proposed [6]: 
 
 
 
In this case, the reactivities of both the formyl and chlorine functional groups have been 
involved in the formation of the DNA adduct. 
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If Y is allylic or benzylic moiety, direct attack on DNA has also been suggested [7, 8]: 
 
 
Unfortunately, little information has been available, concerning directly formed DNA 
adducts  for  the  cases,  where  Y  represent  –NO2 ,  –COOH/COOR,  –CN  and  other  electron- 
withdrawing substituents. Chloroacetonitrile has been proposed to possess direct-acting DNA- 
alkylating capability, which does not manifest itself to bacterial mutagenicity, due to cytotoxicity. 
However, metabolic activation is also possible [9]. As far as benzyl- and allyl halides are 
concerned, which also belong to this class of compounds, benzyl chloride has been found to show 
mutagenicity in the Salmonella/microsome mutagenesis assay [17]. On the other hand, allyl 
halides such as allyl chloride and allyl bromide showed positive results in the Ames mutagenicity 
assay and have established DNA alkylating properties [18 - 20]. Similarly to the mechanistic 
schemes outlined above, direct attack on the purine/pyrimidine bases [18, 19] (“alkylation”) has 
been suggested. For these compounds, minimum steric hindrance effects are important in order to 
show direct mutagenicity. 
Bromonitromethane and chloronitromethane have been found to be mutagenic in the 
Salmonella typhimurium bioassay in the presence of S9 system. The halonitromethanes (e.g. 
chloropicrin) are significantly more potent mutagens and toxicants than the dihalomethanes in the 
Salmonella typhimurium TA100 preincubation assay, and conjugation with glutathione is also 
involved [10, 11]. The following mechanism for the glutathione-dependent (enzymatic) 
bioactivation and attack on DNA could be suggested, by analogy with the published data [11]: 
 
 
 
 
Halogenated acetonitriles, on the other hand, can be metabolized via oxidative 
dehalogenation, and this first step of the biotransformation is catalyzed by a mixed function 
oxidase such as cytochrome P450. It has been proposed that halocyanoalcohols formed by the 
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oxidative  dehalogenation  are  converted  to  haloformaldehydes  (formyl  halides),  which  are 
mutagenic metabolites [1, 9]: 
 
 
Monobromoacetic acid was evaluated as mutagenic in Salmonella typhimurium [12]. 
Possible metabolic transformation of haloacetic acids such as dichloroacetic acid takes place via 
dehalogenation and one of the intermediary metabolites is glyoxylate, which is mutagenic. The 
primary metabolic pathway for dichloroacetic acid involves oxidative dechlorination to form 
glyoxylate. This reaction, once thought to be microsomal, Cytochrome P-450 mediated, has 
now been shown to be NADPH- and GSH-dependent, and occurs predominantly in the cytosol 
[13, 14]. Based upon the above considerations, the following scheme for possible bioactivation 
can be expertly assumed for haloacetates: 
 
 
 
B. Haloalkane derivatives with labile halogen at beta-position towards other groups 
 
These chemicals are assumed to be direct-acting mutagens, eliciting mutagenicity by 
alkylation of DNA fragments. For example, 3-chloropropionic acid binds DNA in mouse 
skin. Mutagenicity has also been suggested for methyl 3-bromopropionate, 3-chlorobutanoic 
acid, 3-chloropropanoic acid, etc. These compounds contain a nucleophilic center such a 
carboxyl  ester  group  in  beta-position  with  respect  to  the  halogen.  In  each  case,  a 
conformation  may  be  envisioned,  in  which  the  nucleophilic  substituent  stabilizes  the 
transition state of the biological alkylating agent and the possible alkylation of DNA sub- 
fragments is facilitated [15]: 
 
7-Carboxyethylguanine was suggested a possible DNA adduct for 3-chloropropanoic acid  
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[16]: 
 
 
 
The following scheme for formation of DNA adducts can be expertly suggested: 
 
 
 
REFERENCES 
 
1.  Woo, Y. T., D. Lai, J. L. McLain, M. Ko Manibusan, V. Dallarco, Use of Mechanism- 
Based Structure-Activity Relationships in Carcinogenic Potential Ranking for Drinking 
Water Disinfection By-Products,  Environ. Health Persp. 110 (2002), 75 – 87. 
2.  Kargalioglu, Y., B. J. McMillan, R. A. Minear, M. J. Plewa, Analysis of the Cytotoxicity 
and Mutagenicity of Drinking Water Disinfection By-Products in Salmonella typhimurium, 
Teratog. Carcinog. Mutag. 22(2) (2002), 113-128; 
http://onlinelibrary.wiley.com/doi/10.1002/tcm.10010/abstract;jsessionid=BFC80F2B0989 
BAF938AE8DA5D8B15DDE.d01t01. 
 
3.  Plewa, M. J., E. D. Wagner, S. D. Richardson, A. D. Thruston, Y. T. Woo, A. B. McKague, 
Chemical and Biological Characterization of Newly Discovered Iodoacid Drinking Water 
Disinfection By-Products,  Environ. Sci Technol. 38(18), 2004, pp. 4713-4722; 
http://cfpub.epa.gov/si/si_public_record_report.cfm?dirEntryId=86035. 
 
4. Giller, S., F. Le Curtieux, F. Erb, D. Marzin, Comparative Genotoxicity of Halogenated 
Acetic Acids Found in Drinking Water, Mutagenesis 12(5) (1997), 321 - 328. 
 
5.  Oesch, Fr., G. Doerjer, Detection of N2, 3-Ethenoguanine in DNA After Treatment With 
Chloroacetaldehyde In Vitro,  Carcinogenesis 3 (6) (1982), 663 – 665; 
http://carcin.oxfordjournals.org/content/3/6/663.abstract. 
6. Cheng, K. C., B. D. Preston, D. S. Cahill, M. K. Dosanjuh, B. Singer, L. A. Loeb, The Vinyl  
Appendix 7/ 10 
 
Chloride DNA Derivative N2,3-Ethenoguanine Produces G → A Transitions in Escherichia 
Coli, Proc. Natl. Acad. Sci USA 88 (1991), 9974 - 9978. 
 
7. Fall, M., H. Haddouk, J. P. Morin, R. Forster, Mutagenicity of Benzyl Chloride in the 
Salmomella/Microsome  Mutagenesis  Assay  Depends  on  Exposure  Conditions,  Mutat.  Res. 
633(1) (2007), 13 – 20; http://www.ncbi.nlm.nih.gov/pubmed/17631040 
 
8. Eder, E., D. Henschler, T. Neudecker, Mutagenic Properties of Allylic and Alpha,beta- 
Unsaturated Compounds: Consideration of Alkylating Mechanisms Xenobiotica 12(12), 1982, 
831-848; http://pubget.com/paper/6763406. 
9.  Lin,  E.  L.  C.,  F.  B.  Daniel,  S.  L.  Herren-Freund,  M.  A.  Pereira,  Haloacetonitriles: 
Metabolism, Genotoxicity, and Tumor-Initiating Activity, Environ. Health Persp. 69 (1986), 67 – 
71. 
 
10.  Kundu,  B.,  S.  D.  Richardson,  P.  D.  Swartz,  P.  P.  Matthews,  A.  M.  Richard,  D.  M. 
DeMarini, Mutagenicity in Salmonella of Halonitromethanes: A Recently Recognized Class of 
Disinfection By-Products in Drinking Water,  Mutat. Res. 562(1-2) (2004), 39-65. 
 
11. Schneider, M., G. B. Quistad, J. E. Casida, Glutathione Activation of Chloropicrin in the 
Salmonella Mutagenicity Test,  Mutat. Res. 439(2) (1999), 233 - 238. 
 
12. Brominated Acetic Acids in Drinking Water (Background Document for Development of 
WHO       Guidelines      for       Drinking       Water       Quality,       WHO/SDE/WSH/03.04/79 
(2004); http://www.who.int/water_sanitation_health/dwq/chemicals/brominatedaceticacids.pdf 
 
13. Toxicological Review of Dichloroacetic Acid (CAS No. 79-43-6), In Support of Summary 
Information on the Integrated Risk Information Systme (IRIS), US EPA, Washington DC, 
August 2003; http://www.epa.gov/iris/toxreviews/0654tr.pdf. 
 
14. Monochloroacetic Acid in Drinking Water (Background Document for Development of 
WHO Guidelines for Drinking Water Quality), WHO/SDE/WSH/03.04/85, WHO, 
2004; http://www.who.int/water_sanitation_health/dwq/chemicals/monochloroaceticacid.pdf. 
 
15. Theiss, J. C., M. B. Shimkin, L. A. Poirer, Induction of Pulmonary Adenomas in Strain A 
Mice by Substituted Organohalides, Canc. Res. 39, 1979, 391 - 395. 
 
16. Colburn, N. H., R. K. Boutwell, The Binding of Beta-Propiolactone and Some Related 
Alkylating Agent to DNA, RNA, and Protein of Mouse Skin; Relation Between Tumor-Initiating 
Power of Alkylating Agents and Their Binding to DNA, Canc. Res. 28 (1968), 653  –  660. 
17. Fall, M., H. Haddouk, J. P. Morin, R. Forster, Mutagenicity of Benzyl Chloride in the  
Appendix 7/ 11 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
  
  
 
 
 
 
 
 
  
 
 
  
 
 
 
Salmomella/Microsome Mutagenesis Assay Depends on Exposure Conditions, Mutat. 
Res. 633(1) (2007), 13 – 20; http://www.ncbi.nlm.nih.gov/pubmed/17631040. 
 
 
18. Allyl Bromide CAS No. 106-95-6, CSWG Evaluation (12/16/94); 
http://ntp.niehs.nih.gov/ntp/htdocs/Chem_Background/ExSumPdf/AllylBromide.pdf 
 
 
19. Eder, E., D. Henschler, T. Neudecker, Mutagenic Properties of Allylic and Alpha,beta- 
Unsaturated Compounds: Consideration of Alkylating Mechanisms Xenobiotica 12(12), 
1982, 831-848; http://pubget.com/paper/6763406. 
 
20. McCoy, E. C., L. Burrows, H. S. Rosenkranza, Genetic Activity of Allyl Chloride, Mutat. 
Res./Fund. Molec. Mechan. Mutag. 57(1) (1978), 11 – 
15; http://www.sciencedirect.com/science/article/pii/0027510778902294. 
 Appendix 7/ 12 
 
 
 
Mechanistic Domain: SN 2 
Mechanistic Alert: Internal SN 2 reaction with aziridinium and/or cyclic sulfonium ion 
formation (enzymatic) 
 
Mechanistic Domain: SN 2 
Mechanistic Alert: DNA alkylation 
 
Structural alert: Vicinal Dihaloalkanes 
 
 
 
Principal structural fragments: 
 
 
 
 
 
 
 
 
Characteristic active fragments: 
 
 
 
 
(Y is –H, -(CH2 )n H (n = 1, 2), -O(CH2 )n H (n = 0 -2), -CH2 -O-, C{acy}{sp2}; 
No other halogens bound to Y) 
 
 
In vitro metabolic activation (bioactivation) is believed to be the main mutagenicity- 
eliciting process via glutathione-mediated generation of electrophilic species. 
For example, 1,2-dichloroethane is reasonably anticipated to be a human carcinogen, 
based on sufficient evidence of carcinogenicity in experimental animals. In vivo and in vitro 
studies in rodents have revealed that the primary metabolic pathway for 1,2-dichloroethane 
probably involves conjugation with glutathione, and the compound shows bacterial 
mutagenicity.  This  is  SN 2  (bimolecular  nucleophilic  attack)  of  glutathione  GSH  on  the 
electron-deficient carbon of 1,2-dichloroethane (also for 1,2-dibromoethane, 1,2- 
dichloropropane, etc.) and S-(2-chloroethyl)-glutathione adduct is formed. One of the further 
possible metabolic pathways is the loss of chloride ion with the formation of episulfonium ion, 
which is highly reactive. This ion is believed to be the reactive electrophilic intermediate that 
results in covalent reaction with biopolymers such as DNA, and is believed to determine the 
mutagenic potential of this class of organic halides [1 – 4, 6]: 
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The major product of this reaction is S-[2-(N
7
-guanyl)ethyl]glutathione, but N
2
- and 
O
6
-guanyl adducts are also formed, and all three adducts are potentially mutagenic [3]: 
 
 
 
Similar mechanism of in vitro metabolic activation by forming episulfonium cation as 
reactive intermediate has also been suggested for structurally similar short-chain compounds 
such as 1,2-dibromo-3-chloropropane [5]. 
Beside 1,2-dichloroethane, 1,2-dibromoethane belonging to this class of compounds 
was also found to possess bacterial mutagenicity [7]. Short-chain vicinal dihalolakanes with 
halogen attached to terminal carbon atom are assumed to act by direct alkylation mechanism, 
too. Other short-chain vicinal haloalkane derivatives with electron-withdrawing heteroatoms 
adjacent to the –CHX fragment such as 1-methoxy-1,2-dichloroethane, 2,3-dibromo-propanol, 
etc., are believed to cause also direct mutagenicity by alkylation mechanism: 
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Mechanistic Domain: SN 2 
Mechanistic Alert: Alkylation, direct acting epoxides and related 
 
Structural alert: Epoxides and Aziridines 
 
 
 
Principal structural fragments: 
 
 
 
Mono-substituted epoxides have two elecrophilic carbon atoms (α- and β-carbons). The 
site of nucleophilic attack on alkyl epoxides under physiological conditions occurs principally at 
the less substituted, sterically more accessible β-carbon atom. However, epoxides with vicinal 
aromatic or vinyl group such as styrene epoxide and butadiene monoepoxide can react through 
both  C-atoms,  due  to  substituent  effects  leading  to  increase  of  positive  charge  on  the  α- 
carbon.           Under physiological conditions, the main alkylation sites for simple alkyl epoxides 
are N7 guanine, N1-and N3-adenine, and N3-cytosine, since these heterocyclic ring nitrogens are 
the most nucleophilic sites for attack. Therefore, for the epoxide structural fragments, direct 
alkylation mechanisms have been proposed. Epoxides such as ethylene oxide, propylene oxide 
and glycydol are known carcinogens that are widely used in industrial chemistry. Mutagenic and 
carcinogenic  epoxides  can  also  be  formed  metabolically  from  alkenes  such  as  ethylene, 
butadiene, propylene and styrene and from vinyl monomers like acrylonitrile and acrylamide. 
Simple epoxides react with nucleic acid bases to form 2-hydroxy-2-alkyl adducts. These are 
fairly unstable, due to the presence of a charged quaternary nitrogen at the site of alkylation and 
frequently undergo “depurination” to remove the charge. This leads to the formation of highly 
mutagenic sites. The final form of adduct is uncharged and stable. It is mutagenic and contributes 
to the toxicological hazards of exposure to simple epoxides [1]: 
 
 
 
Epoxides such as styrene oxide and butadiene monoepoxide can also modify exocyclic 
groups as shown below [1]: 
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However, epichlorohydrin, unlike many other epoxides, acts as bifunctional alkylating 
agent. For alkylation of adenine, for example, the epoxide undergoes first ring opening; then 
cyclization and loss of HCl via the attack on N6, and the carbon, carrying chlorine contributes to 
the formation of 1,N6-2-hydroxypropanoadenine adduct [2]: 
 
 
 
In substructures, about which more than ten test results have been reported, the epoxide 
fragment is most highly correlated with mutagenicity, and the percentage of positive compounds 
was found to be 65 – 70. Therefore, compounds that contain or are metabolically activated to 
products with the highly-strained epoxide fragment in the structure can be considered as suspect 
carcinogens [3]. For example, the well-known carcinogen (and bacterial mutagen) Aflatoxin B1 
is metabolically activated to aflatoxin B1 exo-8,9-epoxide by CYP 450 monooxygenase, which 
then reacts with N7 of guanine to form the primary DNA adduct [4]: 
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The mutagenicity of a series of 13 epoxide compounds has been studied. Mono-substituted 
epoxides such as allyl glycidyl ether, n-butyl glycidyl ether, vinyl cyclohexene diepoxide, 
glycidol, glycidaldehyde, diglycidyl ether, diepoxybutane and diglycidyl ether of substituted 
glycerine were mutagenic in TA100 strain. The mutagenic compounds had linear structure, 
without any groups causing steric hindrance. On the contrary, dieldrin was inactive, due to its 
relatively high molecular weight, specific molecular structural envelope, and, possibly, large 
number   of   chlorine   atoms   causing   excessive   hydrophobicity.   Higher-molecular   weight 
derivatives of diglycidyl bisphenol-A were also negative in the Ames bacterial mutagenicity test, 
due to the high molecular mass and branched structure [5]. Similar results, associated with the 
molecular structure of epoxides were obtained, according to another publication, dealing with 45 
epoxides of large structural diversity, of which mono-substituted epoxides such as 
epichlorohydrin, epibromohydrin, 1,2-epoxibutane, propylene oxide, glycidol, glycidaldehyde, 
1,2,3,4-diepoxybutane, styrene oxide, etc. produced positive Ames test results [6]. 
According to another publication, halogenated derivatives of simple monosubstituted 
epoxides such as epichlorohydrin and epibromohydrin had much stronger DNA alkylating 
capability and bacterial mutagenicity than propylene oxide, butylene oxide, etc. The electron- 
withdrawing effects of the haloalkyl groups in the halogenated derivatives apparently contributes 
to higher epoxide reactivity [7]. 
The in vitro genotoxicity of 51 epoxides has been studied by employing the Ames test with 
Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537. Approximately, 75 – 80 % 
of all tested epoxides (mostly mono-substituted ones) were found to show positive bacterial 
mutagenicity [8], and their principal sub-structures are given below: 
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1,2-Disubstituted cycloaliphatic epoxides with one or two oxirane ring fragments such as 
cyclopentane- and cyclohexane oxide, diepoxycyclooctane, vinylcyclohexane dioxide, 
cyclopentene- and cyclohexene-3,4-epoxides, etc., were also found to show, at least, weak 
bacterial mutagenicity effects in the base-pair indicator strains TA100 and TA1535 [9]. Some 
1,1- and 1,2-disubstituted epoxides such as 2,3-epoxybutane and oxaspiro-epoxides have also 
shown Ames mutagenicity, and the structural requirements associated with minimal steric 
hindrance in the vicinity of epoxide group fully apply [10, 11]. 
According to another publication, none of the tested chemicals such as epoxysteroids, vitamin 
K epoxides, pesticides (dieldrin, eldrin, heptachlor epoxides), and, also, some natural products, 
metabolites and antibiotics such as oleandomycin, anticapsin and asperlin, carbamazepine-9,10- 
oxide, diethylstilbestrol-α,β-oxide, scopolamine, etc. showed any mutagenic activity in the Ames 
test.  This  indicates  that  epoxides  with  complex  molecular  structures  and  more  than  one 
substituent at the epoxide moiety, which are relatively more inert and stable, and, especially, 
more sterically hindered, are inactive in the Ames mutagenicity assay. In contrast, benzo[a]pyrene 
4,5-oxide,  benzo[e]pyrene  4,5-oxide  and  7,12-dimethylbenz[a]-anthracene  5,6-oxide,  derived 
from polycyclic aromatic hydrocarbons (PAH) are potent mutagens [12]. 
Halogenated epoxides as metabolites of some haloalkenes such as vinylidene chloride and 
vinyl   chloride,   are   also   bacterial   mutagens   [13].   Non-allylic   chloropropenes   and   their 
homologues, being chloro-substituted in vinyl position are mutagenic in the presence of S9 
metabolic activation system. This has been explaineded by the polarizing –I and M-effects of 
halogen and the alkyl substituents bound to the C=C bond. The metabolic activation of such 
chemicals was associated with the epoxide formation [14]. In these cases, the lack of significant 
steric hindrance effects is essential for the mutagenic activity. 
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According to another publication, 2,3-epoxyaldehydes are also genotoxic chemicals. These 
compounds may exist as parents but, more probably, can be formed as metabolites of alpha-beta- 
unsaturated aldehydes. The structure of their adducts with guanosine can be outlined as follows 
[15]: 
 
 
 
 
 
Aziridine (ethyleneimine) reacts with DNA in vitro mainly at the N7 position of guanine 
and N3 of adenine; then imidazole ring opening of the modified guanine fragment results in the 
formation of formamidopyrimidine adducts [16]. Possible scheme for the formation of such 
adducts [17] is outlined below: 
 
 
 
Arene imines, also containing aziridine structural fragment were shown to be very strong 
mutagens in bacterial and mammalian cells [18]. 
 
Conclusions: 
 
I. Structurally generalized active alerting groups for epoxides: 
 
o Monosubstituted epoxides: 
 
 
 
 
 
o Simple cycloaliphatic epoxides: 
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o 1,1-Disubstituted epoxides and spiro-epoxides: 
 
 
 
o 1,2-Disubstitured epoxides (including cycloaliphatic epoxides): 
 
 
 
o Other terminal polarized epoxides: 
 
 
 
o Polycyclic Aromatic Hydrocarbons (PAH)-derived epoxides: 
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II. Structurally-generalized active alerting groups for aziridines: 
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Haloalcohols 
  
Principal structural fragments and alerting groups eliciting in vitro 
bacterial mutagenicity: 
  
 
  
(X = Cl, Br, J) 
  
 
  
Mechanistic Domain: E2 (elimination reaction) 
            Mechanistic Alert: E2 reaction with epoxide formation 
  
             Mechanistic Domain: Radical 
             Mechanistic Alert: ROS formation after GSH depletion  
  
A.1. Direct-acting mutagens: alkylation of DNA by epoxide formed by bacterial 
dehalogenase – no external S9 metabolic activation system required 
  
The metabolism of 1,3-dichloropropan-2-ol is likely to produce a reactive epoxide intermediate 
that could damage DNA, and this compound was found to be mutagenic to Salmonella typhimurium 
strains TA1535 and/or TA 100. 2,3 Dichloropropan-1-ol, on the other hand, was also mutagenic in 
vitro in Salmonella typhimurium strains TA 100 and TA 1535 in a study with and without metabolic 
activation [1]. The formation of epoxide intermediate (mutagenicity alert group) can be influenced by 
haloalcohol dehalogenases which are bacterial enzymes that catalyze the cofactor-independent 
dehalogenation of vicinal haloalcohols. Typical example in this respect is again the genotoxic 
environmental pollutant 1,3-dichloro-2-propanol, which produces epoxide, chloride ion and  proton 
[2]. Then the epoxide is likely to exert its DNA alkylation capability [3]: 
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A.2. Mutagens requiring metabolic activation (S9, etc.). 
  
Some authors have assumed genotoxicity mechanism, associated with glutathione depletion 
as glutathione S-transferase was used as the enzyme source, especially with bromohydrins such 
as 1,3-dibromopropanol [4]. It is likely that the protection afforded by glutathione against the 
toxicity of this chemical is mediated through the activity of cytosolic glutathione S-transferase. 
While 1,3-dichloro-2-propanol is relatively poor substrate for glutathione S-transferase, the 
dibromo-analogue causes extensive glutathione depletion [4]. According to another study, 
dichloropropanols such as 1,3-dichloropropan-2-ol, 2,3-dichloropropan-1-ol, 1,3-
dibromopropan-2-ol, 1,4-dibromopropan-2-ol, 1-bromopropan-2-ol, other haloalcohols and their 
metabolites such as epichlorohydrin have been proved to deplete glutathione when incubated 
with liver fractions obtained from rats. However, difluoropropanols did not deplete glutathione 
[5].  
It is therefore expertly assumed that glutathione depletion would further give rise to 
formation of ROS and DNA adducts: 
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C. Profiler: Protein binding alerts for Chromosomal aberration by 
OASIS v1.1 
Mechanistic domain: SN 2 
Mechanistic   alert:  Nucleophilic  type   substitution  together   with  ring-opening   of  an 
episulfonium ion intermediate 
 
 
Mechanistic domain: AN 2 
Mechanistic alert: Michael type nucleophilic addition and Schiff base formation 
 
 
Structural alert: Halogenated Vicinal Hydrocarbons 
 
 
 
 
Halogenated chemicals have many uses in industrial processes as solvents, precursors of vinyl 
monomers, pesticides, gasoline additives and synthetic building blocks [1]. 
Dihalogenated vicinal compounds can be presented by the following general structure: 
 
 
where: X1  and X2  = Br, Cl, I;  C1 and C2  = Csp
3  
(acy or scy);  Y = H, Csp
3  
(acy or 
scy), OH, O-P
+5 
and S
+2
 
 
 
First mechanism – GSH-dependent activation of vicinal dihaloalkanes 
 
Mechanistic domain: SN 2 
Mechanistic   alert:   Nucleophilic  type   substitution  together   with  ring-opening   of  an 
episulfonium ion intermediate 
 
All halogenated hydrocarbons can be acutely toxic at high doses due to their general 
anesthetic properties. A significant and dose-dependent increase in the frequency of 
chromosomal aberrations was observed in the cultures treated with 1,2-dibromoethane 
(ethylene dibromide (EDB)), 1,2-dichloroethane (ethylene dichloride (EDC)), 1-bromo-2- 
chloroethane (BCE), 1,2-dibromo-3-chloroethane (DBCE), 2,3-dichloro-1-propanol (DCP- 
OH),  2,3-dibromo-1-propanol  (DBP-OH),  tris(2,3-dibromo-1-propyl)phosphate  (tris-DBP- 
Ph), bis(2,3-dibromo-1-propyl)phosphate (bis-DBP-Ph) and captafol [2-6]. Both 1,2- 
dibromoethane  and  1,2-dibromo-3-chloroethane  induced  cancer  in  rats  and  mice  [2]. 
Moreover, a series of studies on the biological activity of 1,2-dibromoethane, 1,2- 
dichloroethane and 1,2-dibromo-3-chloroethane was performed and evidence was obtained 
that  this  chemicals  became  bound  to  cellular  macromolecules  such  as  DNA,  RNA  and 
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proteins [1-3]. 
1,2-Dichloroethane, 1,2-dibromoethane,  and the mixed 1-bromo-2-chloroethane can be 
activated  to  electrophilic  species  by  either  oxidative  metabolism  or  conjugation  with 
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glutathione [1-3]. Although conjugation is generally a route of detoxification, in this case it 
leads to genetic damage. EDC has been shown to induce DNA adduct formation as a result of 
GSH-dependent bioactivation [7]. The major DNA adduct formed from EDB in vitro has been 
identified as S-[2-(N
7
-guanyl)ethyl]glutathione, which is believed to arise via GSH half- 
mustard  (GS-CH2 -CH2 -X)  [1,3].  The  mechanism  of  alkylation  is  associated  with  an 
episulfonium (tiiranium) ion formation involving GSH half-mustard and the subsequent 
binding with the N7-position of guanine to yield a bulky DNA adduct via the depurination 
reaction (Scheme 1). 
 
Scheme 1 
 
 
 
The other known GSH-ethylene conjugates that have been found with BrCH2 CH2 Br are 
N
2
- and O
6
-guanyl derivatives. However, only with the N7-guanyl adduct depurination occurs, 
which  could  result  in  respective  mutations  [1].  For  the  series  of  10  direct  alkylating 
halogenated  hydrocarbons  a  positive  relationship  between  carcinogenicity  and  the  initial 
ratios of O
6
/N7-alkylguanine formed with double-stranded DNA was found in vitro [8]. 
In vitro evidence for some DNA adduct formation via the GSH-conjugation pathway 
could be obtained for 1,2-dibromo-3-chloropropane, 2,3-dibromo-1-propanol and tris(2,3- 
dibromopropyl)phosphate [1], although the contribution of oxidative pathways seems to be 
more important [9]. 
 
Second mechanism – Oxidative activation of vicinal dihaloalkanes 
 
Mechanistic domain: AN 2 
Mechanistic alert: Michael type nucleophilic addition and Schiff base formation 
It  is  conceivable,  that  the  induction  of  chromosomal  aberrations  in  the  superoxide-  
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generating system may be directly or indirectly due to hydrogen peroxide formed in the 
cultured medium as a result of the spontaneous dismutation reaction of superoxide [10]. 2,3- 
Dibromo-1-propanol formed as a result of hydrolysis of tris-DBP-Ph and DBP-OH are able to 
undergo oxidation and oxidative dehalogenation to the corresponding unsaturated aldehyde 
(2-bromoacrolein) in the presence of hydrogen peroxide [10]. 2-Bromoacrolein formed, as an 
α,β-unsatured aldehyde, can participate in Michael type addition reaction as well as in the 
reaction of Schiff base formation. DCP-OH is able to form protein adducts in the same 
mechanisms as DBP-OH. All these consecutive transformations are shown in Scheme 2. 
 
Scheme 2 
 
Michael type addition reaction 
 
 
 
 
Schiff base formation 
 
Det t e bil l ede kan  ikke  vis es i øjebl i kket . 
 
 
 
 
 
 
 
 
References 
 
 
1.   F.P. Guengerich, Activation of dihaloalkanes by thiol-dependent mechanisms. J. Biochem. 
Mol. Biol., 2003, 36(1), 20-27. 
2.  H. Tezuka, N. Ando, R. Suzuki, M. Terahata, M. Moriya, Y. Shirasu, Sister-chromatide 
exchanges and chromosomal aberrations in cultured Chinese hamster cells treated with 
pesticides positive in microbial reversion assays. Mutat. Res., 1980, 78(2), 177-191. 
3.  F.P.  Guengerich,  L.A.  Peterson,  J.L.  Cmarik,  N.  Koga,  P.B.Inskeep,  Activation  of 
dihaloalkanes by glutathione conjugation and formation of DNA adducts. Environ. Health 
Perspect., 1987, 76, 15-18. 
4.   G.J. van Esch, Tris(2,3-dibromopropyl)phosphate and bis(2,3-dibromopropyl) phosphate. 
International Programme on Chemical Safety, Environmental Health Criteria 173. World 
Health Organization, Geneva, 1995, pp. 18-21. 
5.  A. Nakamura, T. Noriyuki, S. Kojima, M. Kaniwa, T. Kawamura, The mutagenicity of 
halogenated alkanols and their phosphoric acid esters for Salmonella typhimurium. Mutat. 
Res., 1979, 66(4), 373-380. 
6. T. Sofuni, M. Ishidate Jr., Induction of chromosomal aberrations in cultured Chinese  
Appendix 7/ 4 
 
hamster cells in a superoxide-generating system. Mutat. Res., 1984, 140(1), 27-31. 
7.   M.R. Gwinn, D.O. Johns, T.F. Bateson, K.Z. Guyton, A review of the genotoxicity of 1,2- 
dichloroethjane. Mutat. Res., 2011, 727(1-2), 42-53. 
8.  H.M.  Bolt,  R.J.  Laib,  H.  Peter,  H.  Ottenwälder,  DNA  adducts  of  halogenated 
hydrocarbons. J. Cancer Res. Clin. Oncol., 1986, 112(), 92-96. 
9.   P.B. Inskeep, F.P Guengerich, Glutathione-mediated binding of dibromoalkanes to DNA: 
specificity  of  rat  glutathione-S-transferases  and  dibromoalkane  strucrures. 
Carcinogenesis, 1984, 5(6), 805-808. 
10. E.J. Søderlund, W.P. Gordon, S.D. Nelson, J.G. Omichinski, E. Dybing, Metabolism in 
vitro of tris(2,3-dibromopropyl) phosphate: Oxidative debromination and bis(2,3- 
dibromopropyl)phosphate formation as correlates to mutagenicity and covalent protein 
binding. Biochem. Pharmacol., 1984, 33(24), 4017-4023. 
 Appendix 7/ 5 
 
Mechanistic domain: SN 2 
Mechanistic alert: Alkylation by nucleophilic substitution at sp
3
-Carbon atom. 
 
 
 
Structural alert: alpha-Activated Haloalkanes 
 
 
 
alpha-Activated haloalkanes possess electron-withdrawing groups or sp
2
(sp)-carbon atoms, 
directly bound to the alpha-carbon atom and can be presented with the following general 
structures: 
 
 
where  Hal = Cl, Br, I; Y = Csp
2
(vinyl,acy), Csp, or Oxygen atom; 
R = H, OH, Nsp
3
(acy)–Csp2(aryl); R1 = H, Csp3(acy), Csp3–Hal (Hal = F, Cl, Br, I) 
 
 
 
The  chemicals  such  as  1,3-dichloropropene,  3,4-dichloro-1-butene,  2-bromopropanoic 
acid, alachlor and butachlor have been tested in in vitro chromosomal aberration assays with 
and without metabolic activation. Positive results have been obtained in the Chinese hamster 
ovary or lung cells without and in some cases with metabolic activation [1-4]. 
The compounds containing an allylic or propargylic moiety (such as 1,3-dichloropropene 
and 3,4-dichloro-1-butene, propargyl bromide) possess chemically good leaving groups 
(halogen atoms) and show direct mutagenic activity in the absence of S9 mix. This effect is 
theoretically explained by nucleophilic substitution reactions (mainly SN 2-type), leading to 
the alkylation of DNA and proteins [5]. 
The other compounds with a carbonyl group adjacent to the halogen atom (alachlor and 
butachlor) can also undergo displacement reactions with a strong nucleophiles [6]. It was 
shown that they are able to form glutathione conjugates through nucleophilic attack on the 
alpha-carbon atom [7]. In addition, alachlor S-cysteinyl-protein adducts were examined as 
potential biomarkers of alachlor exposure, a genotoxic and carcinogenic herbicide [8]. 
The SN 2 reaction mechanism between α-activated haloalkanes and protein thiolate ion is 
shown in Scheme1. 
 
 
Scheme 1 
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D. Profiler: In vitro mutagenicity (Ames test) alerts by ISS 
 
Aliphatic halogens 
 
 
R = any atom/group 
 
Numerous haloalkanes have been tested for carcinogenic and mutagenic activities. In general, 
the genotoxic potential is dependent on the nature, number, and position of halogen(s) and the 
molecular size of the compound (Woo et al. 2002). Although some aliphatic halogens have 
been shown to directly alkylate macromolecules (Bolt and Gansewendt 1993), 
biotransformation may also play an important role in their toxicity. Cytochrome P450 
oxidation may produce gem-halohydrins that spontaneously dehydrohalogenate to reactive 
carbonyl compounds (Guengerich 1991), (see reaction 1). Alternatively, glutathione (GSH) 
conjugation via GSH transferases, has been proposed as an activation mechanism for several 
halogenated alkanes (Guengerich 2003b); (Guengerich 2003a) (as an example for 
dihaloethanes see Reaction 2). 
 
1. 
 
 
 
 
 
 
 
 
 
2. 
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Fully halogenated haloalkanes tend to act by free radical or nongenotoxic mechanisms (Woo 
et al. 2002). In the case of CCl4 (see reaction 3.), P450 reduces CCl4 to the trichloromethyl 
radical which can bind to cellular molecules (nucleic acid, protein, lipid), impairing crucial 
cellular processes. 
 
 
3. 
 
Adduct formation between CCl3* and DNA is thought to function as initiator in the case of 
hepatic cancer. This radical can also react with oxygen to form highly reactive species, the 
trichloromethylperoxy radical CCl3OO*, that may initiate the chain reaction of lipid 
peroxidation, and ultimately generate phosgene (Guengerich 1991). 
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R= aliphatic or aromatic carbon 
alpha, beta-unsaturated aldehydes are excluded 
 
All compounds carrying an aldehydic group can potentially undergo Schiff base formation 
with a primary amine. They are to be considered potentially genotoxic, as demonstrated in 
vivo ability to react with nucleobases, without metabolic activation, forming  adducts, 
interbase cross-links (both intra and inter-strand), and DNA-protein crosslinks The length of 
carbon chain for aliphatic aldehydes, and in general molecular size, can strongly modulate the 
formation of every type of cross-link and even the accessibility of the DNA nucleobases 
(Romano Zito, personal communication). DNA-protein crosslinks have been reported as the 
primary DNA damage induced by formaldehyde (Speit et al. 2007). The initial step of the 
reaction probably involves formation of an unstable Schiff base with the exocyclic amino 
group of deoxyguanosine dG (1a). In the case of acetaldehyde, this intermediate (1b) could be 
stabilized by reduction, producing N2-ethyl-dG (2), or alternatively may react with a second 
molecule of acetaldehyde forming a new aldehyde adduct (3) that ultimately cyclize in an 8- 
hydroxypropano adduct (4). The latter exists in equilibrium with its ring-opened aldehyde 
form, and may undergo condensation with another guanine to form imine-linked bis- 
nucleoside (5) which in turn cyclizes to pyrimidopurinone (6) (Wang et al. 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some aldehydes may also induce hydroxyalkyl adducts in DNA, but the relevance of these 
DNA modifications for  mutagenicity is unclear (Speit et al. 2007). 
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Epoxides and Aziridines 
 
or  
R = any atom/group 
 
 
 
Due to the large ring strain associated with the three-membered ring, epoxides are highly 
reactive molecules. They may react with nucleophilic centers of DNA molecules, giving rise 
to alkylated products. 
 
 
 
Because of their reactivity they are important intermediates in chemical industry, especially in 
polymer production. Furthermore, epoxides may be produced endogenously by the enzymatic 
oxidation of other chemicals, many of which are common environmental pollutants (such as 
PAH, alkenes). Consequently considerable human exposure arises. The most likely route of 
exposure to these agents is by inhalation, although the possibility of dermal and oral 
absorption should also be considered. The site of alkylation of the DNA constituents is mainly 
determined by the ionic character of the epoxide (Koskinen and Plná 2000); (Barlow and 
Dipple 1998) Reactions at the ring nitrogen positions follow a bimolecular displacement 
mechanism whereas modification of the exocyclic groups requires some degree of substrate 
ionization for reaction to occur (Barlow and Dipple 1998). Simple alkyl epoxides, that are not 
able to stabilize an ionic charge to any great extent, react predominantly at endocyclic base 
nitrogens, giving rise, preferentially, to -hydroxyethyl derivatives of cytosine-N3, adenine- 
N1 and N3, and guanine-N7. Molecules that are more efficient in stabilizing an ionic charge, 
may modify also exocyclic groups (i.e., styrene oxide, butadiene monoepoxide, PAH 
(Koskinen and Plná 2000); (Barlow and Dipple 1998). Aziridines are extremely reactive 
alkylating agents that may react by ring-opening reactions similar to those of epoxides. 
There are several classes of aziridine-containing natural products that exhibit potent biological 
activity. Among them, the mitomycins, that exhibit both anti-tumour and antibiotic activity 
(Sweeney 2002). Another class of naturally-occurring aziridine derivatives possessing potent 
cytotoxic and antitumor activities, is the Azinomycin family. The activity of these compounds 
lies in their ability to act as DNA cross-linking agents, via nucleophilic ring-opening of the 
aziridine and epoxide moieties by N-7 positions of purines (Zang and Gates 2000). It is not 
clear at present which ring opening reaction takes precedence in the cross-linking event. 
The PBI (pyrrolo[1,2-a]benzimidazole) class of natural products, represents another type of 
DNA-alkylating species containing an aziridine moiety. In these compounds, the aziridine 
undergoes ring-opening by nucleophilic attack of the DNA phosphate backbone, resulting in 
formation of a hydrolytically labile phosphotriester (that may eventually cause DNA 
cleavage) (Schultz et al. 1995). 
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E. Profiler: DNA alerts for AMES, MN and CA by OASIS v.1.3 
Mechanistic Domain: SN 2 
Mechanistic Alert: Alkylation, nucleophilic substitution at sp3-carbon atom 
 
Mechanistic Domain: AN 2 
Mechanistic Alert: Shiff base formation for aldehydes 
 
Mechanistic Domain: SN 2 
Mechanistic Alert: Acylation involving a leaving group 
 
Structural alert: Haloalkane Derivatives with Labile Halogen 
 
 
 
Principal and characteristic active structural fragments: 
 
 
 
groups: 
 
 
 
 
 
 
 
 
 
 
 
 
 
groups: 
A. Primary haloalkane derivatives with labile halogen at alpha-position towards other 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.  Primary  haloalkane derivatives with  labile halogen  at beta-position  towards other 
 
 
 
“Mask”: 
 
 
 
 
A. Haloalkane derivatives with labile halogen at alpha-position towards other groups 
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Many of these compounds represent disinfection by-products, some of which are rather 
toxic. They include halonitriles, some halocarbonyl- and halocarboxyl-compounds, 
halonitroalkanes,  etc.  Short-chain monohalogenated  alkanes  and  their derivatives,  containing 
such electron-withdrawing substituents are potential direct-acting alkylating agents, particularly 
if the halogen is at the terminal end of the carbon chain or at allylic (benzylic) position (primary 
halogenoalkane derivatives). For example, acetonitrile is not carcinogenic in rodents and is only 
weakly or marginally mutagenic. For halogenated acetonitriles, positive mutagenicity is expected, 
due to the strong –I effect of the neighboring nitrile group, however, bacterial toxicity hinders the 
expression of positive mutagenic potential. 
Generally, the introduction of halogen to alpha- or terminal carbon atoms with the above- 
mentioned structural neighbors is expected to increase the genotoxic potential by making it an 
alkylating and/or cross-linking agent. On the basis of the alkylating activity, the brominated 
compounds are expected to be more reactive than chlorinated ones, and iodoacetic acid is the 
most  toxic  and  genotoxic  disinfection  by-product  in  mammalian  cells  reported  [1,  3].  For 
example, bromoacetic acid is far more mutagenic than the chloroacetic acid [2]. The toxicity of 
brominated and chlorinated acetic acids, however, decreases as the number of halo-substituents 
increases [4]. Haloaldehydes with mono-substitution at the alpha- or terminal carbon atom are 
also expected to be potential alkylating agents [1]. For example, the reaction of the strong 
mutagen, chloroacetaldehyde, a reactive metabolite of the carcinogenic vinyl chloride (and 
bifunctional compound) with DNA produces 1,N6-ethenoadenine, 3,N4-ethenocytosine and, 
particularly, N2,3-ethenoguanine [5]. Therefore, if the substituent Y represents the reactive 
aldehyde (e.g., formyl) group), the following scheme of formation of one of the DNA adducts has 
been proposed [6]: 
 
 
 
In this case, the reactivities of both the formyl and chlorine functional groups have been 
involved in the formation of the DNA adduct. 
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If Y is allylic or benzylic moiety, direct attack on DNA has also been suggested [7, 8]: 
 
 
Unfortunately, little information has been available, concerning directly formed DNA 
adducts  for  the  cases,  where  Y  represent  –NO2 ,  –COOH/COOR,  –CN  and  other  electron- 
withdrawing substituents. Chloroacetonitrile has been proposed to possess direct-acting DNA- 
alkylating capability, which does not manifest itself to bacterial mutagenicity, due to cytotoxicity. 
However, metabolic activation is also possible [9]. As far as benzyl- and allyl halides are 
concerned, which also belong to this class of compounds, benzyl chloride has been found to show 
mutagenicity in the Salmonella/microsome mutagenesis assay [17]. On the other hand, allyl 
halides such as allyl chloride and allyl bromide showed positive results in the Ames mutagenicity 
assay and have established DNA alkylating properties [18 - 20]. Similarly to the mechanistic 
schemes outlined above, direct attack on the purine/pyrimidine bases [18, 19] (“alkylation”) has 
been suggested. For these compounds, minimum steric hindrance effects are important in order to 
show direct mutagenicity. 
Bromonitromethane and chloronitromethane have been found to be mutagenic in the 
Salmonella typhimurium bioassay in the presence of S9 system. The halonitromethanes (e.g. 
chloropicrin) are significantly more potent mutagens and toxicants than the dihalomethanes in the 
Salmonella typhimurium TA100 preincubation assay, and conjugation with glutathione is also 
involved [10, 11]. The following mechanism for the glutathione-dependent (enzymatic) 
bioactivation and attack on DNA could be suggested, by analogy with the published data [11]: 
 
 
 
 
Halogenated acetonitriles, on the other hand, can be metabolized via oxidative 
dehalogenation, and this first step of the biotransformation is catalyzed by a mixed function 
oxidase such as cytochrome P450. It has been proposed that halocyanoalcohols formed by the 
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oxidative  dehalogenation  are  converted  to  haloformaldehydes  (formyl  halides),  which  are 
mutagenic metabolites [1, 9]: 
 
 
Monobromoacetic acid was evaluated as mutagenic in Salmonella typhimurium [12]. 
Possible metabolic transformation of haloacetic acids such as dichloroacetic acid takes place via 
dehalogenation and one of the intermediary metabolites is glyoxylate, which is mutagenic. The 
primary metabolic pathway for dichloroacetic acid involves oxidative dechlorination to form 
glyoxylate. This reaction, once thought to be microsomal, Cytochrome P-450 mediated, has 
now been shown to be NADPH- and GSH-dependent, and occurs predominantly in the cytosol 
[13, 14]. Based upon the above considerations, the following scheme for possible bioactivation 
can be expertly assumed for haloacetates: 
 
 
 
B. Haloalkane derivatives with labile halogen at beta-position towards other groups 
 
These chemicals are assumed to be direct-acting mutagens, eliciting mutagenicity by 
alkylation of DNA fragments. For example, 3-chloropropionic acid binds DNA in mouse 
skin. Mutagenicity has also been suggested for methyl 3-bromopropionate, 3-chlorobutanoic 
acid, 3-chloropropanoic acid, etc. These compounds contain a nucleophilic center such a 
carboxyl  ester  group  in  beta-position  with  respect  to  the  halogen.  In  each  case,  a 
conformation  may  be  envisioned,  in  which  the  nucleophilic  substituent  stabilizes  the 
transition state of the biological alkylating agent and the possible alkylation of DNA sub- 
fragments is facilitated [15]: 
 
7-Carboxyethylguanine was suggested a possible DNA adduct for 3-chloropropanoic acid  
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[16]: 
 
 
 
The following scheme for formation of DNA adducts can be expertly suggested: 
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Mechanistic Domain: SN 2 
Mechanistic Alert: Internal SN 2 reaction with aziridinium and/or cyclic sulfonium ion 
formation (enzymatic) 
 
Mechanistic Domain: SN 2 
Mechanistic Alert: DNA alkylation 
 
Structural alert: Vicinal Dihaloalkanes 
 
 
 
Principal structural fragments: 
 
 
 
 
 
 
 
 
Characteristic active fragments: 
 
 
 
 
(Y is –H, -(CH2 )n H (n = 1, 2), -O(CH2 )n H (n = 0 -2), -CH2 -O-, C{acy}{sp2}; 
No other halogens bound to Y) 
 
 
In vitro metabolic activation (bioactivation) is believed to be the main mutagenicity- 
eliciting process via glutathione-mediated generation of electrophilic species. 
For example, 1,2-dichloroethane is reasonably anticipated to be a human carcinogen, 
based on sufficient evidence of carcinogenicity in experimental animals. In vivo and in vitro 
studies in rodents have revealed that the primary metabolic pathway for 1,2-dichloroethane 
probably involves conjugation with glutathione, and the compound shows bacterial 
mutagenicity.  This  is  SN 2  (bimolecular  nucleophilic  attack)  of  glutathione  GSH  on  the 
electron-deficient carbon of 1,2-dichloroethane (also for 1,2-dibromoethane, 1,2- 
dichloropropane, etc.) and S-(2-chloroethyl)-glutathione adduct is formed. One of the further 
possible metabolic pathways is the loss of chloride ion with the formation of episulfonium ion, 
which is highly reactive. This ion is believed to be the reactive electrophilic intermediate that 
results in covalent reaction with biopolymers such as DNA, and is believed to determine the 
mutagenic potential of this class of organic halides [1 – 4, 6]: 
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The major product of this reaction is S-[2-(N
7
-guanyl)ethyl]glutathione, but N
2
- and 
O
6
-guanyl adducts are also formed, and all three adducts are potentially mutagenic [3]: 
 
 
 
Similar mechanism of in vitro metabolic activation by forming episulfonium cation as 
reactive intermediate has also been suggested for structurally similar short-chain compounds 
such as 1,2-dibromo-3-chloropropane [5]. 
Beside 1,2-dichloroethane, 1,2-dibromoethane belonging to this class of compounds 
was also found to possess bacterial mutagenicity [7]. Short-chain vicinal dihalolakanes with 
halogen attached to terminal carbon atom are assumed to act by direct alkylation mechanism, 
too. Other short-chain vicinal haloalkane derivatives with electron-withdrawing heteroatoms 
adjacent to the –CHX fragment such as 1-methoxy-1,2-dichloroethane, 2,3-dibromo-propanol, 
etc., are believed to cause also direct mutagenicity by alkylation mechanism: 
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Mechanistic Domain: SN 2 
Mechanistic Alert: Alkylation, direct-acting epoxide formed after E2 reaction 
 
Mechanistic Domain: Radical 
Mechanistic Alert: ROS formation after GSH depletion (indirect) 
 
Structural alert: Haloalcohols 
 
Principal structural fragments and alerting groups eliciting in vitro bacterial mutagenicity: 
 
 
 
(X = Cl, Br, J) 
 
 
 
The metabolism of 1,3-dichloropropan-2-ol is likely to produce a reactive epoxide 
intermediate that could damage DNA, and this compound was found to be mutagenic to 
Salmonella typhimurium strains TA1535 and/or TA 100. 2,3 Dichloropropan-1-ol, on the other 
hand, was also mutagenic in vitro in Salmonella typhimurium strains TA 100 and TA 1535 in a 
study with and without metabolic activation [1]. The formation of epoxide intermediate 
(mutagenicity alert group) can be influenced by haloalcohol dehalogenases which are bacterial 
enzymes that catalyze the cofactor-independent dehalogenation of vicinal haloalcohols. Typical 
example in this respect is again the genotoxic environmental pollutant 1,3-dichloro-2-propanol, 
which produces epoxide, chloride ion and  proton [2]. Then the epoxide is likely to exert its DNA 
alkylation capability [3]: 
 
 
 
Some authors have assumed genotoxicity mechanism, associated with glutathione depletion 
as glutathione S-transferase was used as the enzyme source, especially with bromohydrins such 
as 1,3-dibromopropanol [4]. It is likely that the protection afforded by glutathione against the 
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toxicity of this chemical is mediated through the activity of cytosolic glutathione S-transferase. 
While 1,3-dichloro-2-propanol is relatively poor substrate for glutathione S-transferase, the 
dibromo-analogue causes extensive glutathione depletion [4]. According to another study, 
dichloropropanols such as 1,3-dichloropropan-2-ol, 2,3-dichloropropan-1-ol, 1,3-dibromopropan- 
2-ol, 1,4-dibromopropan-2-ol, 1-bromopropan-2-ol, other haloalcohols and their metabolites such 
as epichlorohydrin have been proved to deplete glutathione when incubated with liver fractions 
obtained from rats. However, difluoropropanols did not deplete glutathione [5]. 
It  is  therefore  expertly  assumed  that  glutathione  depletion  would  further  give  rise  to 
formation of ROS and DNA adducts: 
 
 
 
Such mechanistic scheme could also apply to haloalcohols of the type: 
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Mechanistic Domain: SN 2 
Mechanistic Alert: Alkylation, direct acting epoxides and related 
 
Structural alert: Epoxides and Aziridines 
 
 
 
Principal structural fragments: 
 
 
 
Mono-substituted epoxides have two elecrophilic carbon atoms (α- and β-carbons). The 
site of nucleophilic attack on alkyl epoxides under physiological conditions occurs principally at 
the less substituted, sterically more accessible β-carbon atom. However, epoxides with vicinal 
aromatic or vinyl group such as styrene epoxide and butadiene monoepoxide can react through 
both  C-atoms,  due  to  substituent  effects  leading  to  increase  of  positive  charge  on  the  α- 
carbon.           Under physiological conditions, the main alkylation sites for simple alkyl epoxides 
are N7 guanine, N1-and N3-adenine, and N3-cytosine, since these heterocyclic ring nitrogens are 
the most nucleophilic sites for attack. Therefore, for the epoxide structural fragments, direct 
alkylation mechanisms have been proposed. Epoxides such as ethylene oxide, propylene oxide 
and glycydol are known carcinogens that are widely used in industrial chemistry. Mutagenic and 
carcinogenic  epoxides  can  also  be  formed  metabolically  from  alkenes  such  as  ethylene, 
butadiene, propylene and styrene and from vinyl monomers like acrylonitrile and acrylamide. 
Simple epoxides react with nucleic acid bases to form 2-hydroxy-2-alkyl adducts. These are 
fairly unstable, due to the presence of a charged quaternary nitrogen at the site of alkylation and 
frequently undergo “depurination” to remove the charge. This leads to the formation of highly 
mutagenic sites. The final form of adduct is uncharged and stable. It is mutagenic and contributes 
to the toxicological hazards of exposure to simple epoxides [1]: 
 
 
 
Epoxides such as styrene oxide and butadiene monoepoxide can also modify exocyclic 
groups as shown below [1]: 
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However, epichlorohydrin, unlike many other epoxides, acts as bifunctional alkylating 
agent. For alkylation of adenine, for example, the epoxide undergoes first ring opening; then 
cyclization and loss of HCl via the attack on N6, and the carbon, carrying chlorine contributes to 
the formation of 1,N6-2-hydroxypropanoadenine adduct [2]: 
 
 
 
In substructures, about which more than ten test results have been reported, the epoxide 
fragment is most highly correlated with mutagenicity, and the percentage of positive compounds 
was found to be 65 – 70. Therefore, compounds that contain or are metabolically activated to 
products with the highly-strained epoxide fragment in the structure can be considered as suspect 
carcinogens [3]. For example, the well-known carcinogen (and bacterial mutagen) Aflatoxin B1 
is metabolically activated to aflatoxin B1 exo-8,9-epoxide by CYP 450 monooxygenase, which 
then reacts with N7 of guanine to form the primary DNA adduct [4]: 
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The mutagenicity of a series of 13 epoxide compounds has been studied. Mono-substituted 
epoxides such as allyl glycidyl ether, n-butyl glycidyl ether, vinyl cyclohexene diepoxide, 
glycidol, glycidaldehyde, diglycidyl ether, diepoxybutane and diglycidyl ether of substituted 
glycerine were mutagenic in TA100 strain. The mutagenic compounds had linear structure, 
without any groups causing steric hindrance. On the contrary, dieldrin was inactive, due to its 
relatively high molecular weight, specific molecular structural envelope, and, possibly, large 
number   of   chlorine   atoms   causing   excessive   hydrophobicity.   Higher-molecular   weight 
derivatives of diglycidyl bisphenol-A were also negative in the Ames bacterial mutagenicity test, 
due to the high molecular mass and branched structure [5]. Similar results, associated with the 
molecular structure of epoxides were obtained, according to another publication, dealing with 45 
epoxides of large structural diversity, of which mono-substituted epoxides such as 
epichlorohydrin, epibromohydrin, 1,2-epoxibutane, propylene oxide, glycidol, glycidaldehyde, 
1,2,3,4-diepoxybutane, styrene oxide, etc. produced positive Ames test results [6]. 
According to another publication, halogenated derivatives of simple monosubstituted 
epoxides such as epichlorohydrin and epibromohydrin had much stronger DNA alkylating 
capability and bacterial mutagenicity than propylene oxide, butylene oxide, etc. The electron- 
withdrawing effects of the haloalkyl groups in the halogenated derivatives apparently contributes 
to higher epoxide reactivity [7]. 
The in vitro genotoxicity of 51 epoxides has been studied by employing the Ames test with 
Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537. Approximately, 75 – 80 % 
of all tested epoxides (mostly mono-substituted ones) were found to show positive bacterial 
mutagenicity [8], and their principal sub-structures are given below: 
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1,2-Disubstituted cycloaliphatic epoxides with one or two oxirane ring fragments such as 
cyclopentane- and cyclohexane oxide, diepoxycyclooctane, vinylcyclohexane dioxide, 
cyclopentene- and cyclohexene-3,4-epoxides, etc., were also found to show, at least, weak 
bacterial mutagenicity effects in the base-pair indicator strains TA100 and TA1535 [9]. Some 
1,1- and 1,2-disubstituted epoxides such as 2,3-epoxybutane and oxaspiro-epoxides have also 
shown Ames mutagenicity, and the structural requirements associated with minimal steric 
hindrance in the vicinity of epoxide group fully apply [10, 11]. 
According to another publication, none of the tested chemicals such as epoxysteroids, vitamin 
K epoxides, pesticides (dieldrin, eldrin, heptachlor epoxides), and, also, some natural products, 
metabolites and antibiotics such as oleandomycin, anticapsin and asperlin, carbamazepine-9,10- 
oxide, diethylstilbestrol-α,β-oxide, scopolamine, etc. showed any mutagenic activity in the Ames 
test.  This  indicates  that  epoxides  with  complex  molecular  structures  and  more  than  one 
substituent at the epoxide moiety, which are relatively more inert and stable, and, especially, 
more sterically hindered, are inactive in the Ames mutagenicity assay. In contrast, benzo[a]pyrene 
4,5-oxide,  benzo[e]pyrene  4,5-oxide  and  7,12-dimethylbenz[a]-anthracene  5,6-oxide,  derived 
from polycyclic aromatic hydrocarbons (PAH) are potent mutagens [12]. 
Halogenated epoxides as metabolites of some haloalkenes such as vinylidene chloride and 
vinyl   chloride,   are   also   bacterial   mutagens   [13].   Non-allylic   chloropropenes   and   their 
homologues, being chloro-substituted in vinyl position are mutagenic in the presence of S9 
metabolic activation system. This has been explaineded by the polarizing –I and M-effects of 
halogen and the alkyl substituents bound to the C=C bond. The metabolic activation of such 
chemicals was associated with the epoxide formation [14]. In these cases, the lack of significant 
steric hindrance effects is essential for the mutagenic activity. 
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According to another publication, 2,3-epoxyaldehydes are also genotoxic chemicals. These 
compounds may exist as parents but, more probably, can be formed as metabolites of alpha-beta- 
unsaturated aldehydes. The structure of their adducts with guanosine can be outlined as follows 
[15]: 
 
 
 
 
 
Aziridine (ethyleneimine) reacts with DNA in vitro mainly at the N7 position of guanine 
and N3 of adenine; then imidazole ring opening of the modified guanine fragment results in the 
formation of formamidopyrimidine adducts [16]. Possible scheme for the formation of such 
adducts [17] is outlined below: 
 
 
 
Arene imines, also containing aziridine structural fragment were shown to be very strong 
mutagens in bacterial and mammalian cells [18]. 
 
Conclusions: 
 
I. Structurally generalized active alerting groups for epoxides: 
 
o Monosubstituted epoxides: 
 
 
 
 
 
o Simple cycloaliphatic epoxides: 
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o 1,1-Disubstituted epoxides and spiro-epoxides: 
 
 
 
o 1,2-Disubstitured epoxides (including cycloaliphatic epoxides): 
 
 
 
o Other terminal polarized epoxides: 
 
 
 
o Polycyclic Aromatic Hydrocarbons (PAH)-derived epoxides: 
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II. Structurally-generalized active alerting groups for aziridines: 
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F. Profiler: In vivo mutagenicity (Micronucleus) alerts by ISS 
 
Aliphatic halogens 
 
 
R = any atom/group 
 
Numerous haloalkanes have been tested for carcinogenic and mutagenic activities. In general, 
the genotoxic potential is dependent on the nature, number, and position of halogen(s) and the 
molecular size of the compound (Woo et al. 2002). Although some aliphatic halogens have 
been shown to directly alkylate macromolecules (Bolt and Gansewendt 1993), 
biotransformation may also play an important role in their toxicity. Cytochrome P450 
oxidation may produce gem-halohydrins that spontaneously dehydrohalogenate to reactive 
carbonyl compounds (Guengerich 1991), (see reaction 1). Alternatively, glutathione (GSH) 
conjugation via GSH transferases, has been proposed as an activation mechanism for several 
halogenated alkanes (Guengerich 2003b); (Guengerich 2003a) (as an example for 
dihaloethanes see Reaction 2). 
 
1. 
 
 
 
 
 
 
 
 
 
2. 
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Fully halogenated haloalkanes tend to act by free radical or nongenotoxic mechanisms (Woo 
et al. 2002). In the case of CCl4 (see reaction 3.), P450 reduces CCl4 to the trichloromethyl 
radical which can bind to cellular molecules (nucleic acid, protein, lipid), impairing crucial 
cellular processes. 
 
 
3. 
 
Adduct formation between CCl3* and DNA is thought to function as initiator in the case of 
hepatic cancer. This radical can also react with oxygen to form highly reactive species, the 
trichloromethylperoxy radical CCl3OO*, that may initiate the chain reaction of lipid 
peroxidation, and ultimately generate phosgene (Guengerich 1991). 
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or 
R = any atom/group 
 
 
 
Due to the large ring strain associated with the three-membered ring, epoxides are highly 
reactive molecules. They may react with nucleophilic centers of DNA molecules, giving rise 
to alkylated products. 
 
 
 
Because of their reactivity they are important intermediates in chemical industry, especially in 
polymer production. Furthermore, epoxides may be produced endogenously by the enzymatic 
oxidation of other chemicals, many of  which are common environmental pollutants (such as 
PAH, alkenes). Consequently considerable human exposure arises. The most likely route of 
exposure to these agents is by inhalation, although the possibility of dermal and oral 
absorption should also be considered. The site of alkylation of the DNA constituents is mainly 
determined by the ionic character of the epoxide (Koskinen and Plná 2000); (Barlow and 
Dipple 1998) Reactions at the ring nitrogen positions follow a bimolecular displacement 
mechanism whereas modification of the exocyclic groups requires some degree of substrate 
ionization for reaction to occur (Barlow and Dipple 1998). Simple alkyl epoxides, that are not 
able to stabilize an ionic charge to any great extent, react predominantly at endocyclic base 
nitrogens, giving rise, preferentially, to -hydroxyethyl derivatives of cytosine-N3, adenine- 
N1 and N3, and guanine-N7. Molecules that are more efficient in stabilizing an ionic charge, 
may modify also exocyclic groups (i.e., styrene oxide, butadiene monoepoxide, PAH 
(Koskinen and Plná 2000); (Barlow and Dipple 1998). Aziridines are extremely reactive 
alkylating agents that may react by ring-opening reactions similar to those of epoxides. 
There are several classes of aziridine-containing natural products that exhibit potent biological 
activity. Among them, the mitomycins, that exhibit both anti-tumour and antibiotic activity 
(Sweeney 2002). Another class of naturally-occurring aziridine derivatives possessing potent 
cytotoxic and antitumor activities, is the Azinomycin family. The activity of these compounds 
lies in their ability to act as DNA cross-linking agents, via nucleophilic ring-opening of the 
aziridine and epoxide moieties by N-7 positions of purines (Zang and Gates 2000).  It is not 
clear at present which ring opening reaction takes precedence in the cross-linking event. 
The PBI (pyrrolo[1,2-a]benzimidazole) class of natural products, represents another type of 
DNA-alkylating species containing an aziridine moiety. In these compounds, the aziridine 
undergoes ring-opening by nucleophilic attack of the DNA phosphate backbone, resulting in 
formation of a hydrolytically labile phosphotriester (that may eventually cause DNA 
cleavage) (Schultz et al. 1995). 
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Hacceptor-path3-Hacceptor  
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A= Any atom, except Hydrogen 
H-bond-Acc= Any atom that is a potential Hydrogen bond acceptor 
 
This alert explores the possibility that a chemical interacts with DNA and/or proteins via non- 
covalent binding, such as DNA intercalation or groove-binding (Snyder et al. 2006). Among 
the descriptors potentially accounting for non-covalent interactions, the present molecular 
framework representing two bonded atoms connecting two H bond acceptors (calculated with 
software Leadscope Enteprise 2.4.15-6) resulted in an increased sensitivity/specificity for 
what concerns the Micronucleus training set. 
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Simple Aldehydes 
 
R= aliphatic or aromatic carbon 
alpha, beta-unsaturated aldehydes are excluded 
 
All compounds carrying an aldehydic group can potentially undergo Schiff base formation 
with a primary amine. They are to be considered potentially genotoxic, as demonstrated in 
vivo ability to react with nucleobases, without metabolic activation, forming adducts, 
interbase cross-links (both intra and inter-strand), and DNA-protein crosslinks The length of 
carbon chain for aliphatic aldehydes, and in general molecular size, can strongly modulate the 
formation of every type of cross-link and even the accessibility of the DNA nucleobases 
(Romano Zito, personal communication). DNA-protein crosslinks have been reported as the 
primary DNA damage induced by formaldehyde (Speit et al. 2007). The initial step of the 
reaction probably involves formation of an unstable Schiff base with the exocyclic amino 
group of deoxyguanosine dG (1a). In the case of acetaldehyde, this intermediate (1b) could be 
stabilized by reduction, producing N2-ethyl-dG (2), or alternatively may react with a second 
molecule of acetaldehyde forming a new aldehyde adduct (3) that ultimately cyclize in an 8- 
hydroxypropano adduct (4). The latter exists in equilibrium with its ring-opened aldehyde 
form, and may undergo condensation with another guanine to form imine-linked bis- 
nucleoside (5) which in turn cyclizes to pyrimidopurinone (6) (Wang et al. 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some aldehydes may also induce hydroxyalkyl adducts in DNA, but the relevance of these 
DNA modifications for  mutagenicity is unclear (Speit et al. 2007). 
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G. Profiler: Oncologic Primary Classification 
 
Category: Aldehyde Type Compounds 
 
Component:  Aldehyde 
 
 
 
 
 
 
R1 : aliphatic (alkyl chain); 
alicyclic (cycloaliphatic); 
aromatic (aromatic ring system 1-2 rings); 
other types (H, benzyl, phenylethyl, COOH, COO-, C(O)Cn, etc.). 
 
Substituents:  The following substituents may be placed on R1 groups: hydroxyl (OH), 
carboxylic acid (COOH), sulfonic acid (SO3H), halogens (Cl, Br, I, F), Other, and, 
additionally, alkyl (Cn) groups on aromatic rings. 
 
Exceptions: Heteroatoms can not replace carbon atoms in the alkyl chain nor can oxo groups 
be added. The degradation products of these compounds should be considered separately. If 
the R group contains heteroatoms and degradation products are not known, replace the 
heteroatoms with carbon atoms. 
Category: Alpha, beta-Haloether Reactive Functional Groups  
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Component: : alpha-beta-Haloether (direct-acting alkylating agent) 
 
 
 
 
 
 
R1 : aliphatic (alkyl chain); 
alicyclic (cycloaliphatic); 
aromatic (aromatic ring system 1-4 rings); 
other types (H, benzyl, phenylethyl) 
 
X1 : F, Cl, Br, I 
 
Substituents:  The following substituents may be placed on alkyl R groups : hydroxyl (OH), 
carboxylic acid (COOH), sulfonic acid (SO3H), halogens (Cl, Br, I, F), and Other.  In 
addition to these, aryl R group my have vinyl and allyl groups as well as alkyl (Cn) on 
aromatic rings.  The methylene/ethylene moiety (C-X/C-C-X) may be substituted with the 
following: OH, COOH, SO3H, Cl, Br, I, F, Cn. 
 
 
 
Exceptions: Additional substituents, may not be added to alkyl chains of the 
methylene/ethylene moiety.  Heteroatoms can not be replace the carbon atoms in the R1 alkyl 
chain nor can keto groups be added 
Category: Reactive Ketone Reactive Functional Groups  
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Component:  Reactive Ketones (direct-acting alkylating agent) 
 
 
 
 
 
R1 : aliphatic (alkyl chain) 
alicyclic (cycloaliphatic) 
aromatic (aromatic ring system 1-4 rings) 
other types (benzyl, phenylethyl) 
 
X1 : Must be replaced with a halogen 
 
Substituents:  The following substituents may be placed on alkyl R groups: hydroxyl (OH), 
carboxylic acid (COOH), sulfonic acid (SO3H), halogens (Cl, Br, I, F), and Other.   In 
addition to these, aryl R group my have vinyl and allyl groups as well as alkyl (Cn) on 
aromatic rings.  The methylene/ethylene moiety (C-X/C=C) may be substituted with the 
following: OH, COOH, SO3H, Cl, Br, I, F, Cn, and Other. 
 
Exceptions: Unsaturated alkyl chains, other than vinyl and allyl, are treated as saturated alkyl 
groups. Additional substituents, may not be added to alkyl chains of the methylene/ethylene 
moiety.  Heteroatoms can not be replace the carbon atoms in the R1 alkyl chain nor can keto 
groups be added. 
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Category: Epoxide Reactive Functional Groups 
 
Component:  Epoxides (direct-acting alkylating agent) 
 
 
 
 
 
 
R1 /R2 : aliphatic (alkyl chain); 
alicyclic (cycloaliphatic); 
aromatic (aromatic ring system 1-4 rings); 
other types (H, benzyl, phenylethyl) 
 
Substituents:  The following substituents may be placed on alkyl R groups : hydroxyl (OH), 
carboxylic acid (COOH), sulfonic acid (SO3H), halogens (Cl, Br, I, F), and Other.   In addition 
to these, aryl R group may have vinyl and allyl groups as well as alkyl (Cn) on aromatic rings.  
The epoxide carbons may be substituted with the following: OH, COOH, SO3H, Cl, Br, I, F, 
alkyl (Cn), alkoxy (OCn) and acyloxy (O(O)Cn). 
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H. Profiler: Carcinogenicity (genotox and nongenotox) alerts by ISS 
(Poly) Halogenated Cycloalkanes (nongenotoxic) 
 
Any cycloalkane skeleton with three or more halogens directly bound to the same ring 
The mechanisms of carcinogenic action of this class of compouds is unclear. Several possible 
epigenetic mechanisms have been proposed which include (i) inhibition of intercellular 
communication, (ii) degranulation of the rough endoplasmic reticulum, and (iii) hormonal 
imbalance (Woo and Lai 2005);(Woo et al. 1995). 
Production of reactive oxygen species by organochlorine pesticides has been also implicated in 
the toxicity and carcinogenicity of these compounds; however, the mechanism by which these 
agents stimulate the production of oxygen radicals is unknown (Tithof et al. 2000). Among 
them, Dieldrin, an organochlorine insecticide, has also been demonstrated to be genotoxic and 
evidences of relationships between genotoxicity and oxidative stress have been reported  
(Cicchetti and Argentin 2003). 
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Aliphatic halogens (genotoxic) 
 
 
R = any atom/group 
 
Numerous haloalkanes have been tested for carcinogenic and mutagenic activities. In general, 
the genotoxic potential is dependent on the nature, number, and position of halogen(s) and the 
molecular size of the compound (Woo et al. 2002). Although some aliphatic halogens have 
been shown to directly alkylate macromolecules (Bolt and Gansewendt 1993), 
biotransformation may also play an important role in their toxicity. Cytochrome P450 
oxidation may produce gem-halohydrins that spontaneously dehydrohalogenate to reactive 
carbonyl compounds (Guengerich 1991), (see reaction 1). Alternatively, glutathione (GSH) 
conjugation via GSH transferases, has been proposed as an activation mechanism for several 
halogenated alkanes (Guengerich 2003b); (Guengerich 2003a) (as an example for 
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dihaloethanes see Reaction 2). 
 
1. 
 
 
 
 
 
 
 
 
 
2. 
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Fully halogenated haloalkanes tend to act by free radical or nongenotoxic mechanisms (Woo 
et al. 2002). In the case of CCl4 (see reaction 3.), P450 reduces CCl4 to the trichloromethyl 
radical which can bind to cellular molecules (nucleic acid, protein, lipid), impairing crucial 
cellular processes. 
 
 
3. 
 
 
 
 
 
Adduct formation between CCl3* and DNA is thought to function as initiator in the case of 
hepatic cancer. This radical can also react with oxygen to form highly reactive species, the 
trichloromethylperoxy radical CCl3OO*, that may initiate the chain reaction of lipid 
peroxidation, and ultimately generate phosgene (Guengerich 1991). 
 
 
 
References Cited 
 
 
Bolt, H. M. and Gansewendt, B. (1993). Mechanisms of Carcinogenicity of Methyl Halides. Crit.Rev.Toxicol. 23, 
237-253. 
 
Guengerich, F. P. (1991). Oxidation of Toxic and Carcinogenic Chemicals by Human Cytochrome P-450 Enzymes. 
Chem.Res.Toxicol. 4, 391-407. 
 
Guengerich, F. P. (2003a). Activation of Dihaloalkanes by Thiol-dependent Mechanisms. J.Biochem.Mol.Biol. 36, 
20-27. 
 
Guengerich, F. P. (2003b). Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation 
and related reactions. Arch.Biochem.Biophys. 409, 59-71. 
 
Woo, Y. T., Lai, D. Y., McLain, J. L., Ko Manibusan, M., and Dellarco, V. (2002). Use of mechanism-based 
structure-activity relationships analysis in carcinogenic potential ranking for drinking water disinfection by- 
products. Environ.Health Perspect. 110, 75-87. 
Epoxides and Aziridines (genotoxic)  
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or 
R = any atom/group 
 
 
 
Due to the large ring strain associated with the three-membered ring, epoxides are highly 
reactive molecules. They may react with nucleophilic centers of DNA molecules, giving rise 
to alkylated products. 
 
 
 
Because of their reactivity they are important intermediates in chemical industry, especially in 
polymer production. Furthermore, epoxides may be produced endogenously by the enzymatic 
oxidation of other chemicals, many of  which are common environmental pollutants (such as 
PAH, alkenes). Consequently considerable human exposure arises. The most likely route of 
exposure to these agents is by inhalation, although the possibility of dermal and oral 
absorption should also be considered. The site of alkylation of the DNA constituents is mainly 
determined by the ionic character of the epoxide (Koskinen and Plná 2000); (Barlow and 
Dipple 1998) Reactions at the ring nitrogen positions follow a bimolecular displacement 
mechanism whereas modification of the exocyclic groups requires some degree of substrate 
ionization for reaction to occur (Barlow and Dipple 1998). Simple alkyl epoxides, that are not 
able to stabilize an ionic charge to any great extent, react predominantly at endocyclic base 
nitrogens, giving rise, preferentially, to -hydroxyethyl derivatives of cytosine-N3, adenine- 
N1 and N3, and guanine-N7. Molecules that are more efficient in stabilizing an ionic charge, 
may modify also exocyclic groups (i.e., styrene oxide, butadiene monoepoxide, PAH 
(Koskinen and Plná 2000); (Barlow and Dipple 1998). Aziridines are extremely reactive 
alkylating agents that may react by ring-opening reactions similar to those of epoxides. 
There are several classes of aziridine-containing natural products that exhibit potent biological 
activity. Among them, the mitomycins, that exhibit both anti-tumour and antibiotic activity 
(Sweeney 2002). Another class of naturally-occurring aziridine derivatives possessing potent 
cytotoxic and antitumor activities, is the Azinomycin family. The activity of these compounds 
lies in their ability to act as DNA cross-linking agents, via nucleophilic ring-opening of the 
aziridine and epoxide moieties by N-7 positions of purines (Zang and Gates 2000).  It is not 
clear at present which ring opening reaction takes precedence in the cross-linking event. 
The PBI (pyrrolo[1,2-a]benzimidazole) class of natural products, represents another type of 
DNA-alkylating species containing an aziridine moiety. In these compounds, the aziridine 
undergoes ring-opening by nucleophilic attack of the DNA phosphate backbone, resulting in 
formation of a hydrolytically labile phosphotriester (that may eventually cause DNA 
cleavage) (Schultz et al. 1995). 
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Simple Aldehydes (genotoxic)  
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R= aliphatic or aromatic carbon 
alpha, beta-unsaturated aldehydes are excluded 
 
All compounds carrying an aldehydic group can potentially undergo Schiff base formation 
with a primary amine. They are to be considered potentially genotoxic, as demonstrated in 
vivo ability to react with nucleobases, without metabolic activation, forming adducts, 
interbase cross-links (both intra and inter-strand), and DNA-protein crosslinks The length of 
carbon chain for aliphatic aldehydes, and in general molecular size, can strongly modulate the 
formation of every type of cross-link and even the accessibility of the DNA nucleobases 
(Romano Zito, personal communication). DNA-protein crosslinks have been reported as the 
primary DNA damage induced by formaldehyde (Speit et al. 2007). The initial step of the 
reaction probably involves formation of an unstable Schiff base with the exocyclic amino 
group of deoxyguanosine dG (1a). In the case of acetaldehyde, this intermediate (1b) could be 
stabilized by reduction, producing N2-ethyl-dG (2), or alternatively may react with a second 
molecule of acetaldehyde forming a new aldehyde adduct (3) that ultimately cyclize in an 8- 
hydroxypropano adduct (4). The latter exists in equilibrium with its ring-opened aldehyde 
form, and may undergo condensation with another guanine to form imine-linked bis- 
nucleoside (5) which in turn cyclizes to pyrimidopurinone (6) (Wang et al. 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some aldehydes may also induce hydroxyalkyl adducts in DNA, but the relevance of these 
DNA modifications for  mutagenicity is unclear (Speit et al. 2007). 
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Substituted n-Alkylcarboxylic Acids (nongenotoxic) 
 
 
or  
 
R1 – at least one aliphatic carbon, which is not in ring, not bonded to any O and except alkyl 
chains with C>8 
R2 = Any atom/group 
All carbons or oxygen between R1 and R2 are not in ring 
 
Substances belonging to this chemical class are potentially reactive as peroxisome proliferators 
(PPs). PPs are a diverse group of chemicals, including hypolipidemic drugs, plasticizers and 
herbicides, that were found to cause liver cancer when chronically administered to rats and mice 
(Reddy et al., 1979). These chemicals are considered nongenotoxic agents, given generally 
negative results in genotoxicity assays. Even if the mechanism by which these chemicals cause 
tumors is not fully understood, peroxisome proliferator-activated receptor alpha (PPAR a) is 
thought to mediate most of the PP effects in the rodent liver (Gonzalez et al., 1998). Two 
hypotheses have been proposed to account for PP induced hepatocarcinogenesis in rodents: (i) 
increase in DNA damage through induction of oxidative stress (Reddy and Rao, 1989) and (ii) 
alteration of hepatocyte growth control by enhanced cell proliferation or decreased apoptosis 
(Corton et al., 2000). 
Among alkylcarboxilic acids, 2-ethylhexanoic acid have shown to be an active PP. 2- 
ethylhexanoic acid was also identified as the proximate PP of several 2-ethylhexyl-containing 
compounds, such as di-(2-ethylhexyl)adipate (DEHA, see figure) (Cornu et al., 1992). 
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Literature search template 
 
Literature search 
 
Literature search for toxicological relevant data on theoretical bromated flame retardants in the databases: SciFinder, PubMed and Scopus 
Date Substance name and common 
synonyms 
Database
s & 
Search 
Engines  
Search terms 
(e.g. substance 
name, CAS No 
and 
combinations.etc) 
Limitations 
applied to 
search 
No. 
of 
'hits' 
No. of 
(potentially) 
relevant 
hits 
Structure Comments & follow-up 
actions 
21 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin 
SciFinder 96-21-9  385 See below 
 
 
21 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
SciFinder 96-21-9 Exclude 
Patents 
221 15   
2 
 
2 
 
21 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
PubMed 96-21-9  2 0   
21 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
PubMed Propanol AND 
dibromo 
 32 14   
28 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
Scopus Propanol AND 
dibromo 
 91 3   
3 
 
3 
 
21 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
PubMed hydroxypropane 
AND dibromo OR 
dibromohydrin OR 
dibromopropanol 
OR hydroxy AND 
dibromopropane 
OR dibromohydrin 
 4 0   
28 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
Scopus hydroxypropane 
AND dibromo  
 3 1   
28 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
Scopus dibromohydrin OR 
dibromopropanol  
 72 11   
4 
 
4 
 
28 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
Scopus hydroxy AND 
dibromopropane 
 8 0   
28 
July 
2015 
2-Propanol, 1,3-dibromo- 
1,3-Dibromo-2-
hydroxypropane; 
1,3-Dibromo-2-propanol; 
1,3-Dibromohydrin; 
1,3-Dibromopropanol; 
2-Hydroxy-1,3-
dibromopropane; 
Glycerol 1,3-dibromohydrin; 
Glycerol α,γ-dibromohydrin; 
α,γ-Dibromohydrin; 
α-Dibromohydrin  
Scopus dibromohydrin  17 0   
21 
July 
2015 
1-Butanol, 2,3,4-tribromo- SciFinder 855236-37-2  1 0 
 
 
23 
July 
2015 
1-Butanol, 2,3,4-tribromo- PubMed 855236-37-2  0 0   
23 1-Butanol, 2,3,4-tribromo- PubMed 1-butanol, 2,3,4-  0 0   
5 
 
5 
 
July 
2015 
tribromo- OR 
2,3,4-tribromo t-
butanol 
23 
July 
2015 
1-Butanol, 2,3,4-tribromo- PubMed Butanol tribromo  0 0   
28 
July 
2015 
1-Butanol, 2,3,4-tribromo- Scopus Butanol AND 
tribromo 
 1 0   
21 
July 
2015 
2-Butanol, 1,3,4-tribromo-; 
1,2,4-Tribromo-3-butanol 
SciFinder 87018-38-0  3 0 
 
 
21 
July 
2015 
1,2-Butanediol, 3,4-dibromo-; 
3,4-Dibromo-1,2-butanediol 
SciFinder 35330-59-7  4 0 
 
 
27 
July 
2015 
1,2-Butanediol, 3,4-dibromo-; 
3,4-Dibromo-1,2-butanediol 
PubMed Butanediol AND 
dibromo 
 7 0   
28 
July 
2015 
1,2-Butanediol, 3,4-dibromo-; 
3,4-Dibromo-1,2-butanediol 
Scopus Butanediol AND 
dibromo 
 7 0   
22 
July 
2015 
2,3-Butanediol, 1,4-dibromo-; 
1,4-Dibromo-2,3-butanediol 
SciFinder 14396-65-7  60 See below 
 
 
22 
July 
2015 
2,3-Butanediol, 1,4-dibromo-; 
1,4-Dibromo-2,3-butanediol 
SciFinder 14396-65-7 Exclude 
patents 
30 1 
 
 
22 
July 
2015 
2,3-Butanediol, 1,4-dibromo-; 
1,4-Dibromo-2,3-butanediol 
SciFinder 299-70-7  18 See below  Alternate CAS RN to 
14396-65-7 
22 
July 
2,3-Butanediol, 1,4-dibromo-; 
1,4-Dibromo-2,3-butanediol 
SciFinder 299-70-7 NOT 
14396-65-7 
11 2  Alternate CAS RN to 
14396-65-7 
6 
 
6 
 
2015 AND  
Exclude 
Patents 
22 
July 
2015 
2,3-Butanediol, 1,4-dibromo-; 
1,4-Dibromo-2,3-butanediol 
SciFinder 1947-59-7  9 See below  Alternate CAS RN to 
14396-65-7 
22 
July 
2015 
2,3-Butanediol, 1,4-dibromo-; 
1,4-Dibromo-2,3-butanediol 
SciFinder 1947-59-7 NOT 
14396-65-7 
NOT 299-
70-7 AND  
Exclude 
Patents 
4 0  Alternate CAS RN to 
14396-65-7 
22 
July 
2015 
2,3-Butanediol, 1,4-dibromo-; 
1,4-Dibromo-2,3-butanediol 
SciFinder 15410-44-3  6 1  Alternate CAS RN to 
14396-65-7 
22 
July 
2015 
1-propanol, 3-bromo-2-
(bromomethyl)-;  
3-Bromo-2-(bromomethyl)-1-
propanol 
SciFinder 106023-63-6  16 See below 
 
 
22 
July 
2015 
1-propanol, 3-bromo-2-
(bromomethyl)-;  
3-Bromo-2-(bromomethyl)-1-
propanol 
SciFinder 106023-63-6 Exclude 
Patents 
11 0   
27 
July 
2015 
1-propanol, 3-bromo-2-
(bromomethyl)-;  
3-Bromo-2-(bromomethyl)-1-
propanol 
PubMed Propanol AND 
bromo 
 184 3   
28 
July 
2015 
1-propanol, 3-bromo-2-
(bromomethyl)-;  
3-Bromo-2-(bromomethyl)-1-
propanol 
Scopus Propanol AND 
bromo 
 246 8   
22 
July 
2015 
2-Butanol, 1,4-dibromo;  
1,4-Dibromo-2-butanol;  
2-Hydroxy-1,4-dibromobutane 
SciFinder 19398-47-1  87 See below 
 
 
22 2-Butanol, 1,4-dibromo; 1,4- SciFinder 19398-47-1 Exclude 38 2   
7 
 
7 
 
July 
2015 
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
Patents 
22 
July 
2015 
2-Butanol, 1,4-dibromo; 1,4-
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
SciFinder 64028-90-6  9 See below  Alternate CAS RN to 
19398-47-1 
22 
July 
2015 
2-Butanol, 1,4-dibromo; 1,4-
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
SciFinder 64028-90-6 Exclude 
Patents 
5 0  Alternate CAS RN to 
19398-47-1 
22 
July 
2015 
2-Butanol, 1,4-dibromo; 1,4-
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
SciFinder 1360729-08-3  5 See below  Alternate CAS RN to 
19398-47-1 
22 
July 
2015 
2-Butanol, 1,4-dibromo; 1,4-
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
SciFinder 1360729-08-3 Exclude 
Patents 
2 0  Alternate CAS RN to 
19398-47-1 
27 
July 
2015 
2-Butanol, 1,4-dibromo; 1,4-
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
PubMed Butanol AND 
dibromo 
 5 1   
28 
July 
2015 
2-Butanol, 1,4-dibromo; 1,4-
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
Scopus Butanol AND 
dibromo 
 23 0   
28 
July 
2015 
2-Butanol, 1,4-dibromo; 1,4-
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
PubMed Hydroxy AND 
dibromobutane 
 2 0   
28 
July 
2015 
2-Butanol, 1,4-dibromo; 1,4-
Dibromo-2-butanol; 2-
Hydroxy-1,4-dibromobutane 
Scopus Hydroxy AND 
dibromobutane 
 10 0   
22 
July 
2015 
2-Butanol, 3,4-dibromo;  
3,4-Dibromo-2-butanol 
SciFinder 79033-40-2  7 See below 
 
 
22 
July 
2015 
2-Butanol, 3,4-dibromo;  
3,4-Dibromo-2-butanol 
SciFinder 79033-40-2 Exclude 
Patents 
6 1   
8 
 
8 
 
22 
July 
2015 
1-Butanol, 2,3-dibromo;  
2,3-Dibromo-1-butanol;  
2,3-Dibromobutanol 
SciFinder 4021-75-4  19 See below 
 
 
22 
July 
2015 
1-Butanol, 2,3-dibromo;  
2,3-Dibromo-1-butanol;  
2,3-Dibromobutanol 
SciFinder 4021-75-4 Exclude 
Patents 
10 0   
22 
July 
2015 
1-Butanol, 2,3-dibromo;  
2,3-Dibromo-1-butanol;  
2,3-Dibromobutanol 
SciFinder 54899-03-5  8 0  Alternate CAS RN to 
4021-75-4  
22 
July 
2015 
1-Butanol, 2,3-dibromo;  
2,3-Dibromo-1-butanol;  
2,3-Dibromobutanol 
SciFinder 70528-70-0  3 0  Alternate CAS RN to 
4021-75-4 
22 
July 
2015 
1-Butanol, 2,3-dibromo;  
2,3-Dibromo-1-butanol;  
2,3-Dibromobutanol 
SciFinder 70528-70-0 Exclude 
Patents 
1 0  Alternate CAS RN to 
4021-75-4 
22 
July 
2015 
1-Butanol, 3,4-dibromo-;  
3,4- Dibromobutanol 
SciFinder 87018-30-2  12 See below 
 
 
22 
July 
2015 
1-Butanol, 3,4-dibromo-;  
3,4- Dibromobutanol 
SciFinder 87018-30-2 Exclude 
Patents 
9 0   
22 
July 
2015 
1-Propanol, 3-bromo-2-
(bromomethyl-2-methyl-;  
2,2-Bis(bromomethyl)propanol 
SciFinder 105100-80-9 Exclude 
Patents 
0 0 
 
 
28 
July 
2015 
1-Propanol, 3-bromo-2-
(bromomethyl-2-methyl-;  
2,2-Bis(bromomethyl)propanol 
PubMed Dibromobutanoyl 
OR bis 
(bromomethyl)pro
panol 
 5 0   
28 
July 
2015 
1-Propanol, 3-bromo-2-
(bromomethyl-2-methyl-;  
2,2-Bis(bromomethyl)propanol 
Scopus Dibromobutanol 
OR 
Bis(bromomethyl)
propanol 
 0 0   
9 
 
9 
 
22 
July 
2015 
2-Pentanol, 4,5-dibromo- SciFinder 213821-22-8 Exclude 
Patents 
2 0  
 
 
27 
July 
2015 
2-Pentanol, 4,5-dibromo- PubMed Pentanol AND 
dibromo 
 1 0   
28 
July 
2015 
2-Pentanol, 4,5-dibromo- Scopus Pentanol AND 
dibromo 
 6 0   
22 
July 
2015 
3-Pentanol, 1,2-dibromo- SciFinder 408319-76-6 Exclude 
Patents 
3 0  
 
 
22 
July 
2015 
3-Pentanol, 1,4-dibromo-, 
(R*,R*)-(9CI) 
SciFinder 159475-15-7 Exclude 
Patents 
1 0  
 
 
22 
July 
2015 
3-Pentanol, 1,4-dibromo-, 
(R*,R*)-(9CI) 
SciFinder 159475-16-8 Exclude 
Patents 
1 0  
 
Alternate CAS RN to 
159475-15-7 
22 
July 
2015 
3-Pentanol, 2,4-dibromo-;  
2,4-Dibromo-3-pentanol 
SciFinder 343268-04-2 Exclude 
Patents 
1 0  
 
 
22 
July 
2015 
3-Pentanol, 2,4-dibromo-;  
2,4-Dibromo-3-pentanol 
SciFinder 72770-99-1 Exclude 
Patents 
1 0  
 
Alternate CAS RN to 
343268-04-2 
23 
July 
2015 
2-Pentanol, 3,4-dibromo-, (2R,
3S,4S)-rel-;  
2-Pentanol, 3,4-dibromo-, 
SciFinder 76377-07-6 Exclude 
Patents 
2 0   
10 
 
10 
 
(2R*,3S*,4S*)- (9CI);  
2-Pentanol, 3,4-dibromo-, 
(2R*,3S*,4S*)-(±)- 
 
23 
July 
2015 
2-Pentanol, 3,4-dibromo-, (2R,
3S,4S)-rel-;  
2-Pentanol, 3,4-dibromo-, 
(2R*,3S*,4S*)- (9CI);  
2-Pentanol, 3,4-dibromo-, 
(2R*,3S*,4S*)-(±)- 
SciFinder 76420-11-6 Exclude 
Patents 
1 0  
 
Alternate CAS RN to 
76377-07-6 
23 
July 
2015 
1-Pentanol, 4,5-dibromo-; 
1,2-Dibromo-5-pentanol; 
4,5-Dibromo-1-pentanol 
SciFinder 59287-66-0 Exclude 
Patents 
8 0 
 
 
 
23 
July 
2015 
1-Pentanol, 2,5-dibromo- SciFinder 856991-78-1 Exclude 
Patents 
0 0 
 
 
 
23 
July 
2015 
2-Pentanol, 1,5-dibromo-; 
1,5-Dibromo-2-pentanol 
SciFinder 100606-66-4 Exclude 
Patents 
8 1 
 
 
 
23 
July 
2015 
2-Pentanol, 1,5-dibromo-; 
1,5-Dibromo-2-pentanol 
SciFinder 1092554-97-6 Exclude 
Patents 
1 0  
 
Alternate CAS RN to 
100606-66-4 
23 
July 
2015 
2-Pentanol, 2,5-dibromo- SciFinder 213821-20-6 Exclude 
Patents 
1 0  
 
 
11 
 
11 
 
23 
July 
2015 
2-Pentanol, 2,5-dibromo- SciFinder 159475-17-9 Exclude 
Patents 
1 0  
 
Alternate CAS RN to 
213821-20-6 
23 
July 
2015 
2-Pentanol, 2,5-dibromo- SciFinder 159475-18-0 Exclude 
Patents 
1 0  
 
Alternate CAS RN to 
213821-20-6 
23 
July 
2015 
1-Butanol, 4-bromo-2-
(bromomethyl)- 
SciFinder 98069-26-2 Exclude 
Patents 
1 0  
 
 
27 
July 
2015 
1-Butanol, 4-bromo-2-
(bromomethyl)- 
PubMed Butanol AND 
bromo AND 
bromomethyl 
 0 0  
 
 
28 
July 
2015 
1-Butanol, 4-bromo-2-
(bromomethyl)- 
Scopus Butanol AND 
bromo AND 
bromomethyl 
 3 0  
 
 
23 
July 
2015 
1-Propanol, 3-bromo-2-
(bromomethyl)-2-methyl-; 
2,2-Bis(bromomethyl)propanol 
SciFinder 105100-80-9 Exclude 
Patents 
0 0  
 
 
27 
July 
2015 
1-Propanol, 3-bromo-2-
(bromomethyl)-2-methyl-; 
2,2-Bis(bromomethyl)propanol 
PubMed Propanol AND 
bromo AND 
bromomethyl 
 4 0  
 
 
28 
July 
2015 
1-Propanol, 3-bromo-2-
(bromomethyl)-2-methyl-; 
2,2-Bis(bromomethyl)propanol 
Scopus Propanol AND 
bromo AND 
bromomethyl 
 15 0  
 
 
23 
July 
2015 
1,3-Butanediol, 4-bromo-2-
(bromomethyl)- 
SciFinder 44804-46-8 Exclude 
Patents 
0 0   
12 
 
12 
 
 
27 
July 
2015 
1,3-Butanediol, 4-bromo-2-
(bromomethyl)- 
PubMed Butanediol AND 
bromo 
 6 0  
 
 
28 
July 
2015 
1,3-Butanediol, 4-bromo-2-
(bromomethyl)- 
Scopus Butanediol AND 
bromo 
 29 2  
 
 
23 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
SciFinder 1522-92-5 Exclude 
Patents 
109 5  
 
 
23 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
SciFinder 36483-57-5 Exclude 
Patents 
NOT 1522-
92-5 
0 0  
 
Alternate CAS RN to 
1522-92-5 
13 
 
13 
 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
28 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
PubMed Tris(bromomethyl)
ethanol OR 
bis(bromomethyl)p
ropanol OR 
bis(bromomethyl)p
ropyl OR 
Pentaerythritol OR 
Tribromoneopenta
nol OR 
Tribromoneopenty
l 
 983 See below  Tribromopentanol not 
found in PubMed 
28 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
PubMed Tris(bromomethyl)
ethanol (1) OR 
bis(bromomethyl)p
ropanol AND 
bromo (3) OR 
bis(bromomethyl)p
 509 See below  Numbers in (x) equals 
number of hits for each 
serach term 
14 
 
14 
 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
ropyl AND alcohol 
(0) OR 
Pentaerythritol 
(978) OR 
Tribromoneopenty
l AND alcohol (4) 
28 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
PubMed tris (bromomethyl) 
ethanol OR bis 
(bromomethyl) 
propanol AND 
bromo OR bis 
(bromomethyl) 
propyl AND 
alcohol OR 
pentaerythritol 
AND tribromide 
OR pentaerythritol 
AND bromohydrin 
OR 
tribromoneopentyl 
AND alcohol 
 4 0   
28 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
Scopus tris (bromomethyl) 
ethanol OR bis 
(bromomethyl) 
propanol AND 
bromo  
 Not 
valid 
_  Scopus rejects 
tris(bromomethyl)ethanol 
and 
bis(bromomethyl)propano
l 
Leaving out the brackets 
15 
 
15 
 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
does not yield any hits 
28 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
Scopus bisbromomethyl 
propyl AND 
alcohol  
 0 0   
28 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
Scopus pentaerythritol 
AND tribromide  
 4 0   
16 
 
16 
 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
28 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
Scopus pentaerythritol 
AND bromohydrin  
 0 0   
28 
July 
2015 
1-Propanol, 3-bromo-2,2-
bis(bromomethyl)-;  
2,2,2-
Tris(bromomethyl)ethanol; 
2,2-Bis(bromomethyl)-3-
bromo-1-propanol; 
Scopus tribromoneopentyl 
AND alcohol 
 0 0   
17 
 
17 
 
3-Bromo-2,2-
bis(bromomethyl)-1-propanol; 
3-Bromo-2,2-
bis(bromomethyl)propanol; 
3-Bromo-2,2-
bis(bromomethyl)propyl 
alcohol; 
Pentaerythritol tribromide; 
Pentaerythritol 
tribromohydrin; 
Tribromoneopentanol; 
Tribromoneopentyl alcohol 
23 
July 
2015 
1-Propanol, 2,3-dibromo-; 
1,2-Dibromopropan-3-ol; 
2,3-Dibromo-1-propanol; 
2,3-Dibromopropyl alcohol 
SciFinder 96-13-9 Exclude 
Patents 
327 92  
 
 
23 
July 
2015 
1-Propanol, 2,3-dibromo-; 
1,2-Dibromopropan-3-ol; 
2,3-Dibromo-1-propanol; 
2,3-Dibromopropyl alcohol 
SciFinder 83165-36-0 Exclude 
Patents 
9 1  
 
Alternate CAS RN to 96-
13-9 
23 
July 
2015 
1-Propanol, 2,3-dibromo-; 
1,2-Dibromopropan-3-ol; 
2,3-Dibromo-1-propanol; 
2,3-Dibromopropyl alcohol 
SciFinder 83165-35-9 Exclude 
Patents 
10 0  
 
Alternate CAS RN to 96-
13-9 
28 
July 
2015 
1-Propanol, 2,3-dibromo-; 
1,2-Dibromopropan-3-ol; 
2,3-Dibromo-1-propanol; 
2,3-Dibromopropyl alcohol 
PubMed dibromopropan 
OR dibromopropyl 
AND alcohol 
 18 0   
28 
July 
2015 
1-Propanol, 2,3-dibromo-; 
1,2-Dibromopropan-3-ol; 
2,3-Dibromo-1-propanol; 
2,3-Dibromopropyl alcohol 
Scopus dibromopropan 
OR 
(dibromopropyl 
AND alcohol) 
 53 8   
23 
July 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
SciFinder 3296-90-0 Exclude 
Patents 
284 53   
18 
 
18 
 
2015 1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Pentaerythritol dibromohydrin 
 
27 
July 
2015 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Pentaerythritol dibromohydrin 
PubMed Propanediol AND 
bromomethyl 
 26 10  
 
Belongs to CAS RN 
3296-90-0 
28 
July 
2015 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
Scopus Propanediol AND 
bromomethyl 
 47 4  
 
Belongs to CAS RN 
3296-90-0 
19 
 
19 
 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Pentaerythritol dibromohydrin 
27 
July 
2015 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Pentaerythritol dibromohydrin 
PubMed Bis(hydroxymethyl
)propane OR 
Dihydroxymethylpr
opane OR 
Dimethylolpropan
e AND Dibromo 
OR 
Bis(bromomethyl) 
AND Propanediol 
OR 
Dibromomethyl 
AND Propanediol 
OR 
Dibromoneopentyl 
glycol 
 28 14  
 
Belongs to CAS RN 
3296-90-0 
29 
July 
2015 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Scopus Bishydroxymethyl
propane OR 
Dihydroxymethylpr
opane  
 1 0  
 
Belongs to CAS RN 
3296-90-0 
20 
 
20 
 
Pentaerythritol dibromohydrin 
29 
July 
2015 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Pentaerythritol dibromohydrin 
Scopus Dimethylolpropan
e AND Dibromo  
 0 0  
 
Belongs to CAS RN 
3296-90-0 
29 
July 
2015 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Pentaerythritol dibromohydrin 
Scopus Bis(bromomethyl) 
AND Propanediol  
 0 0  
 
Belongs to CAS RN 
3296-90-0 
29 
July 
2015 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
Scopus Dibromomethyl 
AND Propanediol  
 7 0  
 
Belongs to CAS RN 
3296-90-0 
21 
 
21 
 
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Pentaerythritol dibromohydrin 
29 
July 
2015 
1,3-Propanediol, 2,2-
bis(bromomethyl)-; 
1,3-Dibromo-2,2-
bis(hydroxymethyl)propane; 
1,3-Dibromo-2,2-
dihydroxymethylpropane; 
1,3-Dibromo-2,2-
dimethylolpropane; 
2,2-Bis(bromomethyl)-1,3-
propanediol; 
2,2-Dibromomethyl-1,3-
propanediol; 
Dibromoneopentyl glycol; 
Pentaerythritol dibromide; 
Pentaerythritol dibromohydrin 
Scopus Dibromoneopentyl 
AND glycol 
 41 3  
 
Belongs to CAS RN 
3296-90-0 
22 
 
22 
 
Summary of literature search 
 Literature Search Results 
Search Term Dibromoneopentyl AND glycol 
Database Scopus 
Limitation(s)  
Relevant Papers 3 
Date July 29, 2015 
Comments Belongs to CAS RN 3296-90-0 
 
Bach, P. H., & Nguyen, T. K. T. (1998). Renal papillary necrosis - 40 years on. 
Toxicologic Pathology, 26(1), 73-91. 
 
Felter, S. P., Conolly, R. B., Bercu, J. P., Bolger, P. M., Boobis, A. R., Bos, P. M. J., 
Carthew, P., Doerrer, N. G., Goodman, J. I., Harrouk, W. A., Kirkland, D. J., Lau, S. 
S., Llewellyn, G. C., Preston, R. J., Schoeny, R., Schnatter, A. R., Tritscher, A., Van 
Velsen, F., & Williams, G. M. (2011). A proposed framework for assessing risk from 
less-than-lifetime exposures to carcinogens. Critical Reviews in Toxicology, 41(6), 
507-544. 
 
Thomas, R., Thomas, R. S., Auerbach, S. S., & Portier, C. J. (2013). Biological 
Networks for Predicting Chemical Hepatocarcinogenicity Using Gene Expression 
Data from Treated Mice and Relevance across Human and Rat Species. PLoS ONE, 
8(5). 
 
 Literature Search Results 
Search Term dibromopropan OR (dibromopropyl AND alcohol) 
Database Scopus 
Limitation(s)  
Relevant Papers 8 
Date July 28, 2015 
Comments Belongs to CAS RN 96-13-9 
 
2,3-Dibromopropan-1-ol. In. (2000) IARC Monographs on the Evaluation of 
Carcinogenic Risks to Humans, vol. 77 (pp. 439-453). 
 
Summary of final evaluations. In. (2000) IARC Monographs on the Evaluation of 
Carcinogenic Risks to Humans, vol. 77 (pp. 529). 
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Carcinogenic activity of the flame retardant, 2,2-
bis(bromomethyl)-1,3-propanediol in rodents, and 
comparison with the carcinogenicity of other NTP 
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Abstract 
Several brominated chemicals have been shown to be multisite-multispecies carcinogens in 
laboratory animals, and in this paper we report that the flame retardant, 2,2-
bis(bromomethyl)-1,3-propanediol (BMP) is also a multisite carcinogen in both sexes of 
Fischer 344 rats and B6C3F1 mice. BMP was administered continuously in the diet for up to 
2 yr to rats at doses of 0, 2,500, 5,000, or 10,000 ppm and to mice at doses of 0, 312, 625, or 
1,250 ppm. Interim groups of rats were examined at 15 mo. An additional recovery group of 
male rats received the chemical for 3 mo at 20,000 ppm in the feed, and then the control diet 
for the remainder of the study. Chemical exposure caused neoplasms of the skin, 
subcutaneous tissue, mammary gland, Zymbal's gland, oral cavity, esophagus, forestomach, 
small intestine, large intestine, mesothelium, kidney, urinary bladder, lung, thyroid gland, 
seminal vesicle, hematopoietic system, and pancreas in the male rat; mammary gland, oral 
cavity, esophagus, and thyroid gland in the female rat; lung, kidney, and Harderian gland in 
male mice; and subcutaneous tissue, lung, and Harderian gland in the female mouse. The 
recovery group of male rats presented with the same spectrum of treatment-related neoplasms 
as in the core study. In this recovery group, BMP (at 20,000 ppm) caused irreversible effects 
at numerous sites after 90 days of exposure that was not detectable by histologic examination, 
but without further exposure resulted in carcinogenic responses at 2 yr. BMP is mutagenic in 
the salmonella test, but it was not determined if the BMP-induced effects that eventually lead 
to development of neoplasms at multiple sites are the same in both species and in all organ 
systems affected. 
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Use of the Japanese medaka (Oryzias latipes) and guppy 
(Poecilia reticulata) in carcinogenesis testing under national 
toxicology program protocols. 
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Abstract 
A need exists for whole animal toxicity, mutagenesis, and carcinogenesis models that are 
alternative to the traditional rodent test models and that are economical, sensitive, and 
scientifically acceptable. Among small fish models, the Japanese medaka (Oryzias latipes) is 
preeminent for investigating effects of carcinogenic and/or toxic waterborne hazards to 
humans. The guppy (Poecilia reticulata), although less widely used, is valuable as a 
comparison species. Both species are easy to maintain and handle in the laboratory and there 
is a large body of background information on their responsiveness to a range of classes of 
carcinogens. There are considerable data on the occurrence of background diseases and on 
spontaneous neoplastic lesions, both of which occur relatively rarely. With few 
modifications, the medaka and guppy are amenable to carcinogenicity testing under the rigid 
standards established by the National Toxicology Program (NTP) for rodent tests. The 
advantages of the small fish in carcinogenesis studies are best realized in long-term studies 
that involve environmentally realistic exposures. Studies to identify chronic effects can be 
conducted in about 12 months, near the life span of medaka in our laboratory. Practically, 9-
month studies are optimal but shorter study cycles and a variety of exposure/growout and 
initiation/promotion scenarios are available. Studies on 3 compounds tested in medaka under 
NTP protocols are under review and preliminary analysis indicates that chronic 
carcinogenicity bioassays with medaka, guppy, and potentially with other small fish species 
are feasible and scientifically valid. 
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Author information 
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Abstract 
The NTP chose to initiate studies in fish as an exploration of alternate or additional models 
for examining chemical toxicity and carcinogenicity. The use of small fish species in 
carcinogenicity testing offered potential advantages as a bioassay test system, including 
significant savings in cost and time over rodent studies. Large numbers of small fish could be 
easily maintained in a limited area. The two species chosen for study were guppy (Poecilia 
reticulata) and medaka (Oryzias latipes), both of which are hardy, easily maintained, and 
have a low occurrence of background lesions. The three chemicals chosen for study in fish 
had already been studied by the NTP in rodents, permitting a comparison of results between 
the two models. Two of the chemicals used (2,2-bis(bromomethyl)-1,3-propanediol and 
1,2,3-trichloropropane) were mutagenic and multisite carcinogens in rats and mice. The third 
chemical, nitromethane, was nonmutagenic with a more modest carcinogenic response in 
rodents. Male and female guppies and medaka were exposed to 2,2-bis(bromomethyl)- 1,3-
propanediol (greater than 99% pure), nitromethane, (greater than 99% pure), or 1,2,3-
trichloropropane (99% pure) in aquaria water for up to 16 months. OVERALL STUDY 
DESIGN: Groups of approximately 220 guppies (two replicates of 110) were maintained in 
aquaria water containing nominal concentrations of 0, 24, 60, or 150 mg/L 2,2-
bis(bromomethyl)-1,3-propanediol; 0, 10, 30, or 70 mg/L nitromethane; or 0, 4.5, 9.0, or 18.0 
mg/L 1,2,3-trichloropropane. Groups of approximately 340 medaka (two replicates of 170) 
were maintained in aquaria water containing 0, 24, 60, or 150 mg/L 2,2-bis(bromomethyl)-
1,3-propanediol; 0, 10, 20, or 40 mg/L nitromethane; or 0, 4.5, 9.0, or 18.0 mg/L 1,2,3-
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trichloropropane. The overall study durations were 16 months for all guppy studies, 14 
months for 2,2-bis(bromomethyl)-1,3-propanediol-exposed medaka, and 13 months for 
nitromethane- and 1,2,3-trichloropropane-exposed medaka. Ten guppies and 10 medaka from 
each group replicate were sacrificed at 9 months for histopathologic analysis. Approximately 
one third of the remaining fish from each group were placed in chemical-free water at 9 
months and constituted a stop-exposure study component. The remainder of the fish were 
exposed for the duration of the study and constituted the core study component. A stop-
exposure component was added to determine if stopping the exposure at 9 months and 
transferring to chemical-free aquaria might allow for better survival and tumor development. 
The sex of guppies and medaka was determined at histopathologic analysis. 2,2-
BIS(BROMOMETHYL)-1,3-PROPANEDIOL - 16-MONTH STUDY IN GUPPIES: 2,2-
Bis(bromomethyl)-1,3-propanediol was chronically toxic to guppies in the 60 and 150 mg/L 
core and stop-exposure groups. Due to mortality, exposure of core study animals in the 150 
mg/L group was terminated on day 443, after approximately 64 weeks on study, and fish 
were maintained in 2,2-bis(bromomethyl)- 1,3-propanediol-free water in the exposure system 
until the end of the study at 69 weeks. Nominal exposure concentrations of 24, 60, and 150 
mg/L provided actual aquaria water exposure concentrations of 20.0, 53.5, and 139.0 mg/L 
2,2-bis(bromomethyl)- 1,3-propanediol, respectively. There were no treatment-related 
differences between the control and exposed groups in body weights or lengths. At 9 months, 
hepatocellular adenomas occurred in one 24 mg/L male and in one 150 mg/L male. In the 
core study, the incidence of hepatocellular adenoma or carcinoma (combined) in 150 mg/L 
males was greater than that in the controls; multiple adenomas occurred in two 150 mg/L 
males and in one 150 mg/L female. Cholangioma occurred in a small number of exposed 
males and females. In the stop-exposure study, incidences of hepatocellular adenoma 
(including multiple) and of hepatocellular carcinoma were greater in 150 mg/L males than in 
controls. One cholangioma and one cholangiocarcinoma occurred in the 150 mg/L female 
group. 14-MONTH STUDY IN MEDAKA: Exposure to 2,2-bis(bromomethyl)-1,3-
propanediol did not result in any significant reduction in survival, although the mortality of 
fish was somewhat greater in the 60 and 150 mg/L core study groups than in the control and 
24 mg/L groups. After reallocation, mortality of medaka in the 60 and 150 mg/L core groups 
was slightly increased over the corresponding stop-exposure groups. Nominal exposure 
concentrations of 24, 60, and 150 mg/L provided actual exposure concentrations of 19.4, 
56.9, and 137.8 mg/L 2,2-bis(bromomethyl)- 1,3-propanediol, respectively. Core study 
animals in the 60 and 150 mg/L groups were significantly larger, in both body length and 
weight, than control group fish. In the core study, the incidence of hepatocellular adenoma or 
carcinoma (combined) was increased in 150 mg/L males. Cholangiocarcinomas occurred in a 
few exposed males and females, with all but one occurring in 150 mg/L fish. One 
cholangioma occurred in a 150 mg/L female, and one occurred in a control female. In the 
stop-exposure study, incidences of hepatocellular adenoma or carcinoma (combined) were 
marginally increased in the 150 mg/L group of males and in the 60 and 150 mg/L groups of 
females as compared with controls. Cholangiocarcinoma occurred in one male and one 
female in the 150 mg/L groups and in one control female. NITROMETHANE - 16-MONTH 
STUDY IN GUPPIES: Although the cause of death could not be confirmed in many cases, 
mortality in the 70 mg/L groups appeared to indicate that this level of nitromethane exposure 
was chronically toxic. This is confirmed by the similar survival rate of guppies from all 
treatments following removal from treatment aquaria and placement in stop-exposure. Due to 
the high mortality of fish in the 70 mg/L core study groups, these fish were removed from 
treatment (day 396) and fixed for histological analyses after approximately 57 weeks on 
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study. The controls and other exposed groups were sacrificed at 70 weeks. Nominal exposure 
concentrations of 10, 30, and 70 mg/L provided actual exposure concentrations of 9.9, 28.7, 
and 66.4 mg/L nitromethane, respectively. There were no treatment-related differences 
between the control and exposed groups in body lengths or weights. 13-MONTH STUDY IN 
MEDAKA: Nitromethane in the aquaria supported a substantial microfaunal growth which, 
without frequent cleaning, affected water quality and treatment concentrations. To maintain 
acceptable water quality and treatment concentrations potentially affected by the rapid 
microfaunal growth, the study aquaria were brushed once and siphoned three times each day. 
Due to this frequent activity, a number of fish probably died due to mechanical injury. 
Unfortunately, the cause of death could not be confirmed in many cases; the mortality from 
this activity is believed to have been approximately uniform among treatments and should not 
have affected the comparison of survival between treatments. Based on mortality in this study 
and the previous life-span evaluation, the life phase of this study was terminated 
approximately 13.5 months after hatching. Nominal exposure concentrations of 10, 20, and 
40 mg/L resulted in actual exposure concentrations of 9.3, 20.8, and 41.7 mg/L nitromethane, 
respectively. No differences between control and exposed groups were found in body lengths 
or weights at the 9-month interim evaluation. Due to mortality, unequal numbers of fish were 
distributed among the core study and stop-exposure aquaria at 9 months. Differences in 
lengths and weights were found at 13 months. The biological significance of this finding is 
unknown. At 9 months, a single cholangiocarcinoma occurred in a 40 mg/L male. 
Hepatocellular adenomas occurred in two 20 mg/L males and in one 40 mg/L female. In the 
core study, one cholangioma occurred in a 20 mg/L male, and cholangiocarcinomas were 
seen in a few exposed males, but none occurred in control males. 1,2,3-
TRICHLOROPROPANE - 16-MONTH STUDY IN GUPPIES: The survival of exposed 
guppies was less than that of the control group at 9 months. Reduced survival was evident at 
6 months in the 18.0 mg/L groups and at 7 months in the 4.5 and 9.0 mg/L groups. Survival 
was significantly reduced in the 18.0 mg/L core study group within 1 month of the 9-month 
interim evaluation, and mortality in this group was 42.6% between 9 months and study 
termination. Nominal exposure concentrations of 4.5, 9.0, and 18.0 mg/L resulted in actual 
exposure concentrations of 4.4, 8.8, and 18.2 mg/L 1,2,3-trichloropropane, respectively. 
Guppies in the 18.0 mg/L core study group were significantly longer and weighed more than 
the controls. Fish in the 18.0 mg/L stop-exposure group also weighed more than the controls. 
Mortality of fish during the study resulted in unequal numbers of individuals distributed to 
core study and stop-exposure aquaria at 9 months. This appears to have influenced the length 
and weight of fish measured at study termination (i.e., the smaller tank population allowed 
the fish to grow more). Observed differences in weight and length between controls and 18.0 
mg/L fish was most likely an artifact of the reduced numbers of fish in the 18.0 mg/L aquaria. 
At 9 months, multiple hepatocellular adenomas occurred in one 4.5 mg/L male, and one 
hepatocellular adenoma occurred in a control male. In the core study, increased incidences of 
cholangiocellular (bile duct) and hepatocellular neoplasms occurred in exposed groups of 
males and females. Cholangioma and cholangiocarcinoma were seen in several exposed 
males and females. In the stop-exposure study, increased incidences of hepatocellular 
neoplasms occurred in 18.0 mg/L males and increased incidences of cholangiocellular (bile 
duct) neoplasms occurred in 18.0 mg/L females. (ABSTRACT TRUNCATED) 
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Abstract 
There has been considerable interest in the use of small fish models for detecting potential 
environmental carcinogens. In this study, both guppies (Poecilia reticulata) and medaka 
(Oryzias latipes) were exposed in the aquaria water to three known rodent carcinogens for up 
to 16 months. Nitromethane, which caused mammary gland tumors by inhalation exposure in 
female rats, harderian gland and lung tumors in male and female mice, and liver tumors in 
female mice by inhalation, failed to increase tumors in either guppies or medaka. 
Propanediol, which when given in the feed was a multisite carcinogen in both sexes of rats 
and mice, caused increased liver tumors in male guppies and male medaka. There was 
reduced survival in female guppies and no increased tumors in female medaka. 1,2,3-
Trichloropropane, which when administered by oral gavage was a multisite carcinogen in 
both sexes of rats and mice, caused an increased incidence of tumors in the liver of both male 
and female guppies and medaka and in the gallbladder of male and female medaka. The 
results of this study demonstrate that for these three chemicals, under these specific exposure 
conditions, the fish appear less sensitive and have a narrower spectrum of tissues affected 
than rodents. These results suggest that fish models are of limited utility in screening 
unknown chemicals for potential carcinogenicity. 
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Abstract 
2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant, previously 
shown to be a multisite carcinogen in experimental animals. Studies were performed to 
characterize the dispositional and metabolic fate of BMP after oral or intravenous 
administration to male Fischer-344 rats. After a single oral administration of [(14)C]BMP (10 
or 100 mg/kg) >80% of the low dose and 48% of the high dose were excreted by 12 h in the 
urine predominantly as a glucuronide metabolite. After repeated daily oral doses for 5 or 10 
days, route and rate of elimination were similar to those obtained after single administrations 
of BMP. In all studies, the radioactivity recovered in feces was low (<15%). The total amount 
of radioactivity remaining in tissues at 72 h after a single oral administration of BMP (100 
mg/kg) was less than 1% of the dose, and repeated daily dosing did not lead to retention in 
tissues. After intravenous administration, the radiolabel found in blood decreased rapidly. 
Excretion profiles were similar to those after oral administration. Parent BMP and BMP 
glucuronide were present in blood plasma after oral or intravenous dosing. After an 
intravenous dose of BMP (15 mg/kg) the hepatic BMP glucuronide was primarily exported 
into the bile (>50% within 6 h), but it underwent enterohepatic recycling with subsequent 
elimination in the urine. These data indicate that the extensive extraction and rapid 
glucuronidation by the liver limits exposure of internal tissues to BMP by greatly reducing its 
systemic bioavailability after oral exposure. 
 
Drug Metab Dispos. 2010 Jun;38(6):957-62. doi: 10.1124/dmd.110.032110. Epub 
2010 Mar 3. 
In vitro glucuronidation of 2,2-bis(bromomethyl)-1,3-
propanediol by microsomes and hepatocytes from rats and 
humans. 
Rad G1, Hoehle SI, Kuester RK, Sipes IG. 
Author information 
 
1Department of Clinical Pharmacology, College of Medicine, The University of 
Arizona, P.O. Box 245050, Tucson, AZ 85724-5050, USA. 
Abstract 
2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant used in 
unsaturated polyester resins. In a 2-year bioassay BMP was shown to be a multisite 
carcinogen in rats and mice. Because glucuronidation is the key metabolic transformation of 
BMP by rats, in this study the in vitro hepatic glucuronidation of BMP was compared across 
several species. In addition, the glucuronidation activities of human intestinal microsomes 
and specific human hepatic UDP-glucuronosyltransferase (UGT) enzymes for BMP were 
determined. To explore other possible routes of metabolism for BMP, studies were conducted 
with rat and human hepatocytes. Incubation of hepatic microsomes with BMP in the presence 
of UDP-glucuronic acid resulted in the formation of a BMP monoglucuronide. The order of 
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hepatic microsomal glucuronidation activity of BMP was rats, mice >> hamsters > monkeys 
>>> humans. The rate of glucuronidation by rat hepatic microsomes was 90-fold greater than 
that of human hepatic microsomes. Human intestinal microsomes converted BMP to BMP 
glucuronide at a rate even lower than that of human hepatic microsomes. Among the human 
UGT enzymes tested, only UGT2B7 had detectable glucuronidation activity for BMP. BMP 
monoglucuronide was the only metabolite formed when BMP was incubated with 
suspensions of freshly isolated hepatocytes from male F-344 rats or with cryopreserved 
human hepatocytes. Glucuronidation of BMP in human hepatocytes was extremely low. 
Overall, the results support in vivo studies in rats in which BMP glucuronide was the only 
metabolite found. The poor glucuronidation capacity of humans for BMP suggests that the 
pharmacokinetic profile of BMP in humans will be dramatically different from that of 
rodents. 
 
Rep Carcinog. 2011;12:70-1. 
2,2-Bis(bromomethyl)-1,3-propanediol (technical grade). 
National Toxicology Program. 
 
Toxicology. 2011 Dec 18;290(2-3):271-7. doi: 10.1016/j.tox.2011.10.006. Epub 2011 
Oct 14. 
Induction of DNA damage in human urothelial cells by the 
brominated flame retardant 2,2-bis(bromomethyl)-1,3-
propanediol: role of oxidative stress. 
Kong W1, Kuester RK, Gallegos A, Sipes IG. 
Author information 
 
1Department of Pharmacology, College of Medicine, The University of 
Arizona, Tucson, AZ 85724, USA. 
Abstract 
2,2-bis(bromomethyl)-1,3-propanediol (BMP) is an extensively used brominated flame 
retardant found in urethane foams and polyester resins. In a 2-year dietary study conducted 
by the National Toxicology Program, BMP caused neoplastic lesions at multiple sites 
including the urinary bladder in both rats and mice. The mechanism of its carcinogenic effect 
is unknown. In the present study, using SV-40 immortalized human urothelial cells 
(UROtsa), endpoints associated with BMP induced DNA damage and oxidative stress were 
investigated. The effects of time (1-24h) and concentration (5-100 μM) on BMP induced 
DNA strand breaks were assessed via the alkaline comet assay. The results revealed evidence 
of DNA strand breaks at 1 and 3h following incubation of cells with non-cytotoxic 
concentrations of BMP. Strand breaks were not present after 6h of incubation. Evidences for 
BMP associated oxidative stress include: an elevation of intracellular ROS formation as well 
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as induction of Nrf2 and HSP70 protein levels. In addition, DNA strand breaks were 
attenuated when cells were pre-treated with N-acetyl-l-cysteine (NAC) and oxidative base 
modifications were revealed when a lesion specific endonuclease, human 8-hydroxyguanine 
DNA glycosylase 1 (hOGG1) was introduced into the comet assay. In conclusion, these 
results demonstrate that BMP induces DNA strand breaks and oxidative base damage in 
UROtsa cells. Oxidative stress is a significant, determinant factor in mediating these DNA 
lesions. These early genotoxic events may, in part, contribute to BMP-induced carcinogenesis 
observed in rodents. 
 
Reprod Toxicol. 2012 Jun;33(3):269-79. doi: 10.1016/j.reprotox.2012.01.002. Epub 
2012 Jan 18. 
Occupational exposures to chemicals as a possible etiology in 
premature ovarian failure: a critical analysis of the literature. 
Béranger R1, Hoffmann P, Christin-Maitre S, Bonneterre V. 
Author information 
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Abstract 
Premature ovarian failure (POF) is a cause of infertility that affects about 1% of women 
under 40, and is considered as idiopathic in 75% of cases. An occupational chemical origin 
has been identified at least once with 2-bromopropane, but human studies are rare and 
experimental data are sparse. This review aims to carry out a critical synthesis of knowledge 
of the chemical agents likely to affect follicular stock in humans and/or animals, by direct 
toxicity to follicles, or by increasing their recruitments. Of 140 chemical agents (or groups) 
studied, 20 have been identified as potentially damaging to the ovarian reserve. For the 
majority of toxic agents, only experimental data are currently available. At least four of these 
agents are likely to lead to POF in descendents (ethylene glycol methyl ether; 2,2-
bis(bromomethyl)-1,3-propanediol; benzo[a]pyrene; dimethylbenzantracene). We propose a 
strategy aiming to encourage progress in identifying occupational factors responsible for 
POF. 
 
 
Toxicol Lett. 2013 Oct 9;222(3):273-9. doi: 10.1016/j.toxlet.2013.07.026. Epub 2013 
Aug 13. 
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Comparison of 2,2-bis(bromomethyl)-1,3-propanediol 
induced genotoxicity in UROtsa cells and primary rat 
hepatocytes: relevance of metabolism and oxidative stress. 
Kong W1, Gu P, Knudsen GA, Sipes IG. 
Author information 
 
1Department of Pharmacology, College of Medicine, The University of 
Arizona, Tucson, AZ 85724, United States. Electronic address: 
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Abstract 
2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant used in 
urethane foams and polyester resins. In a two year dietary study, BMP caused neoplastic 
lesions at multiple sites including the urinary bladder of both rats and mice. However, liver 
was not a target tissue. We previously reported that BMP elicited oxidative DNA damage in a 
human uroepithelial cell line (UROtsa). The present in vitro study investigated the 
susceptibility of target (UROtsa cells) and non-target cells (primary rat hepatocytes) to BMP-
induced genotoxicity. In contrast to hepatocytes, BMP exhibited greater genotoxic potential 
in UROtsa cells as evidenced by the concentration dependent increase in DNA strand breaks 
and DNA binding. Total content of intracellular GSH quantified in UROtsa cells 
(2.7±1.0nmol/mg protein) was 4 fold lower than that in hepatocytes (10.7±0.3nmol/mg 
protein). HPLC analysis indicated BMP was not metabolized and/or consumed in UROtsa 
cells at any of the concentrations tested (10-250μM) but was extensively converted to a 
mono-glucuronide in hepatocytes. These results demonstrate that a target cell line such as 
UROtsa cells are more susceptible to BMP-induced DNA damage when compared to non-
target cells. This increased susceptibility may relate to the deficiency of antioxidant and/or 
metabolic capabilities in UROtsa cells.  
 
 
Mutat Res Genet Toxicol Environ Mutagen. 2014 Jul 15;769:1-6. doi: 
10.1016/j.mrgentox.2014.04.015. Epub 2014 May 10. 
Effects of seven chemicals on DNA damage in the rat urinary 
bladder: a comet assay study. 
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Abstract 
The in vivo comet assay has been used for the evaluation of DNA damage and repair in 
various tissues of rodents. However, it can give false-positive results due to non-specific 
DNA damage associated with cell death. In this study, we examined whether the in vivo 
comet assay can distinguish between genotoxic and non-genotoxic DNA damage in urinary 
bladder cells, by using the following seven chemicals related to urinary bladder 
carcinogenesis in rodents: N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN), glycidol, 2,2-
bis(bromomethyl)-1,3-propanediol (BMP), 2-nitroanisole (2-NA), benzyl isothiocyanate 
(BITC), uracil, and melamine. BBN, glycidol, BMP, and 2-NA are known to be Ames test-
positive and they are expected to produce DNA damage in the absence of cytotoxicity. BITC, 
uracil, and melamine are Ames test-negative with metabolic activation but have the potential 
to induce non-specific DNA damage due to cytotoxicity. The test chemicals were 
administered orally to male Sprague-Dawley rats (five per group) for each of two consecutive 
days. Urinary bladders were sampled 3h after the second administration and urothelial cells 
were analyzed by the comet assay and subjected to histopathological examination to evaluate 
cytotoxicity. In the urinary bladders of rats treated with BBN, glycidol, and BMP, DNA 
damage was detected. In contrast, 2-NA induced neither DNA damage nor cytotoxicity. The 
non-genotoxic chemicals (BITC, uracil, and melamine) did not induce DNA damage in the 
urinary bladders under conditions where some histopathological changes were observed. The 
results indicate that the comet assay could distinguish between genotoxic and non-genotoxic 
chemicals and that no false-positive responses were obtained.  
Copyright © 2014 Elsevier B.V. All rights reserved. 
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Automated solid phase extraction and quantitative measurement of 
2,3-dibromo-1-propanol in urine using gas chromatography-mass 
spectrometry. 
De Alwis GK1, Needham LL, Barr DB. 
Author information 
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Abstract 
2,3-Dibromo-1-propanol (DBP) was used as an active flame retardant in the 1970s. It was also used 
as an intermediate in the preparation of insecticide formulations, pharmaceuticals and the flame 
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retardants tris(2,3-dibromopropyl) phosphate (Tris-BP) and tetrabromobisphenol A bis (2,3-
dibromopropyl ether). DBP is also produced in vivo as a metabolic product of Tris-BP in humans. In 
1977, sleepwear containing DBP and Tri-BP was banned because of evidence of carcinogenicity 
animal studies. Although the production of DBP was reduced after 1977, studies show that DBP is still 
detected in indoor air and dust; hence, the U.S. population may be exposed potentially to DBP. Only a 
few methods have been reported in the literature for assessing exposure to DBP or Tris-BP by 
measuring DBP in urine. These methods are based on a labor-intensive and time-consuming liquid-
liquid extraction for the isolation of DBP from the urine matrix. To measure urinary DBP in humans, a 
fast, accurate, and sensitive method was developed with a limit of detection of 0.1 ng/mL and 
extraction recovery of 96%. This method involves enzymatic cleavage of the DBP-glucuronide or 
sulfate conjugate, automated solid phase extraction, and analysis by gas chromatography-mass 
spectrometry using 1,4-dibromo-2-butanol as the internal standard. 
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Abstract 
1-bromopropane (1-BrP) induces dose- and time-dependent reproductive organ toxicity and 
reduced sperm motility in rodents. The contribution of cytochrome P4502E1 (CYP2E1) to 
both 1-BrP metabolism and the induction of male reproductive toxicity was investigated 
using wild-type (WT) and Cyp2e1-/- mice. In gas uptake inhalation studies, the elimination 
half-life of [1,2,3-(13)C]-1-BrP was longer in Cyp2e1-/- mice relative to WT (3.2 vs. 1.3 h). 
Urinary metabolites were identified by 13C nuclear magnetic resonance. The mercapturic 
acid of 1-bromo-2-hydroxypropane (2OHBrP) was the major urinary metabolite in WT mice, 
and products of conjugation of 1-BrP with glutathione (GSH) were insignificant. The ratio of 
GSH conjugation to 2-hydroxylation increased 5-fold in Cyp2e1-/- mice relative to WT. 
After 1-BrP exposure, hepatic GSH was decreased by 76% in WT mice vs. 47% in Cyp2e1-/- 
mice. Despite a 170% increase in 1-BrP exposure in Cyp2e1-/- vs. WT mice, sperm motility 
in exposed Cyp2e1-/- mice did not change relative to unexposed matched controls. This 
suggests that metabolites produced through CYP2E1-mediated oxidation may be responsible 
for 1-BrP-induced sperm toxicity. Both 1-BrP and 2OHBrP inhibited the motility of sperm 
40 
 
40 
 
obtained from WT mice in vitro. However, only 2OHBrP reduced the motility of sperm 
obtained from Cyp2e1-/- mice in vitro, suggesting that conversion of parent compound to 
2OHBrP within the spermatozoa may contribute, at least in part, to reduced motility. Overall, 
these data suggest that metabolism of 1-BrP is mediated in part by CYP2E1, and activation of 
1BrP via this enzyme may contribute to the male reproductive toxicity of this chemical. 
Toxicol Appl Pharmacol. 2006 Aug 15;215(1):23-36. Epub 2006 Mar 2. 
Metabolism and disposition of 1-bromopropane in rats and 
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Abstract 
Workplace exposure to 1-bromopropane (1-BrP) can potentially occur during its use in spray 
adhesives, fats, waxes, and resins. 1-BrP may be used to replace ozone depleting solvents, 
resulting in an increase in its annual production in the US, which currently exceeds 1 million 
pounds. The potential for human exposure to 1-BrP and the reports of adverse effects 
associated with potential occupational exposure to high levels of 1-BrP have increased the 
need for the development of biomarkers of exposure and an improved understanding of 1-BrP 
metabolism and disposition. In this study, the factors influencing the disposition and 
biotransformation of 1-BrP were examined in male F344 rats and B6C3F1 mice following 
inhalation exposure (800 ppm) or intravenous administration (5, 20, and 100 mg/kg). [1,2,3-
(13)C]1-BrP and [1-(14)C]1-BrP were administered to enable characterization of urinary 
metabolites using NMR spectroscopy, LC-MS/MS, and HPLC coupled radiochromatography. 
Exhaled breath volatile organic chemicals (VOC), exhaled CO(2), urine, feces, and tissues 
were collected for up to 48 h post-administration for determination of radioactivity 
distribution. Rats and mice exhaled a majority of the administered dose as either VOC (40-
72%) or (14)CO(2) (10-30%). For rats, but not mice, the percentage of the dose exhaled as 
VOC increased between the mid ( approximately 50%) and high ( approximately 71%) dose 
groups; while the percentage of the dose exhaled as (14)CO(2) decreased (19 to 10%). The 
molar ratio of exhaled (14)CO(2) to total released bromide, which decreased as dose 
increased, demonstrated that the proportion of 1-BrP metabolized via oxidation relative to 
pathways dependent on glutathione conjugation is inversely proportional to dose in the rat. 
[(14)C]1-BrP equivalents were recovered in urine (13-17%, rats; 14-23% mice), feces (<2%), 
or retained in the tissues and carcass (<6%) of rats and mice administered i.v. 5 to 100 mg/kg 
[(14)C]1-BrP. Metabolites characterized in urine of rats and mice include N-acetyl-S-
propylcysteine, N-acetyl-3-(propylsulfinyl)alanine, N-acetyl-S-(2-hydroxypropyl)cysteine, 1-
bromo-2-hydroxypropane-O-glucuronide, N-acetyl-S-(2-oxopropyl)cysteine, and N-acetyl-3-
[(2-oxopropyl)sulfinyl]alanine. These metabolites may be formed following oxidation of 1-
bromopropane to 1-bromo-2-propanol and bromoacetone and following subsequent 
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glutathione conjugation with either of these compounds. Rats pretreated with 1-
aminobenzotriazole (ABT), a potent inhibitor of P450 excreted less in urine (down 30%), 
exhaled as (14)CO2 (down 80%), or retained in liver (down 90%), with a concomitant 
increase in radioactivity expired as VOC (up 52%). Following ABT pretreatment, rat urinary 
metabolites were reduced in number from 10 to 1, N-acetyl-S-propylcysteine, which 
accounted for >90% of the total urinary radioactivity in ABT pretreated rats. Together, these 
data demonstrate a role for cytochrome P450 and glutathione in the dose-dependent 
metabolism and disposition of 1-BrP in the rat. 
Experientia. 1974 Nov 15;30(11):1238-9. 
The comparative metabolism of 3-bromo-propane-1,2-diol 
and 3-bromopropanol in the rat. 
Jones AR, Bashir AA, Low SJ. 
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Use of historical controls in time-adjusted trend tests for carcinogenicity 
Quick ViewOther Sources 
 By Ibrahim J G; Ryan L M  
 From Biometrics (1996), 52(4), 1478-85. | Language: English, Database: MEDLINE  
 We develop a method for incorporating historical control information into time-
adjusted tests for dose effects in carcinogenicity studies. After discretizing the time scale, we use 
a multinomial distribution to model the number of animals dying with tumor in each interval. 
Data from past studies are used to estimate the parameters characterizing the prior. A score test 
derived from the resulting Dirichlet-multinomial generalizes the test of Tarone (1982, Biometrics 
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38, 215-220) and reduces, in the limit, to the log-rank test in the case of a diffuse prior. The 
methodology is illustrated with data from a study of the fire retardant 2,2-Bis(bromomethyl)-1,3-
propanediol. 
 
Reproductive toxicology. 2,2-bis(bromomethyl)-1,3-propanediol 
Quick ViewOther Sources 
 By Anonymous  
 From Environmental health perspectives (1997), 105 Suppl 1, 271-2. | Language: English, Database: 
MEDLINE 
 
2,2-Bis(bromomethyl)propane-1,3-diol 
Quick ViewOther Sources 
 By Anonymous  
 From IARC monographs on the evaluation of carcinogenic risks to humans / World Health 
Organization, International Agency for Research on Cancer (2000), 77, 455-68. | Language: English, Database: 
MEDLINE 
 
On the use of historical control data for trend test in carcinogenicity studies 
Quick ViewOther Sources 
 By Sun J  
 From Biometrics (1999), 55(4), 1273-6. | Language: English, Database: MEDLINE  
 Historical control data are often available in carcinogenicity studies and are included 
for testing dose effects in current studies. A new method is developed for incorporating the 
historical control information into a dose effect test. The method generalizes the test procedures 
proposed by Tarone (1982, Biometrics 38, 215-220) and Ibrahim and Ryan (1996, Biometrics 52, 
1478-1485) by taking into account the variation resulting from parameter estimation based on 
historical data. Two examples are discussed for illustrating the proposed method. 
 
Use of the Japanese medaka (Oryzias latipes) and guppy (Poecilia reticulata) in carcinogenesis 
testing under national toxicology program protocols 
Quick ViewOther Sources 
 By Hawkins William E; Walker William W; Fournie John W; Manning C Steve; Krol Rena M  
 From Toxicologic pathology (2003), 31 Suppl, 88-91. | Language: English, Database: MEDLINE  
 A need exists for whole animal toxicity, mutagenesis, and carcinogenesis models that 
are alternative to the traditional rodent test models and that are economical, sensitive, and 
scientifically acceptable. Among small fish models, the Japanese medaka (Oryzias latipes) is 
preeminent for investigating effects of carcinogenic and/or toxic waterborne hazards to humans. 
The guppy (Poecilia reticulata), although less widely used, is valuable as a comparison species. 
Both species are easy to maintain and handle in the laboratory and there is a large body of 
background information on their responsiveness to a range of classes of carcinogens. There are 
considerable data on the occurrence of background diseases and on spontaneous neoplastic 
lesions, both of which occur relatively rarely. With few modifications, the medaka and guppy are 
amenable to carcinogenicity testing under the rigid standards established by the National 
Toxicology Program (NTP) for rodent tests. The advantages of the small fish in carcinogenesis 
studies are best realized in long-term studies that involve environmentally realistic exposures. 
Studies to identify chronic effects can be conducted in about 12 months, near the life span of 
medaka in our laboratory. Practically, 9-month studies are optimal but shorter study cycles and a 
variety of exposure/growout and initiation/promotion scenarios are available. Studies on 3 
compounds tested in medaka under NTP protocols are under review and preliminary analysis 
indicates that chronic carcinogenicity bioassays with medaka, guppy, and potentially with other 
small fish species are feasible and scientifically valid. 
 
2,2-bis(Bromomethyl)-1,3-propanediol (technical grade) 
Quick ViewOther Sources 
 No Author and Editor data available 
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 From Report on carcinogens : carcinogen profiles / U.S. Dept. of Health and Human Services, Public 
Health Service, National Toxicology Program (2002), 10, 35-6. | Language: English, Database: MEDLINE 
 
NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-
trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and 
medaka (Oryzias latipes) (Waterborne Studies) 
Quick ViewOther Sources 
 No Author and Editor data available 
 From National Toxicology Program technical report series (2005), (528), 1-190. | Language: English, 
Database: MEDLINE  
 The NTP chose to initiate studies in fish as an exploration of alternate or additional 
models for examining chemical toxicity and carcinogenicity. The use of small fish species in 
carcinogenicity testing offered potential advantages as a bioassay test system, including 
significant savings in cost and time over rodent studies. Large numbers of small fish could be 
easily maintained in a limited area. The two species chosen for study were guppy (Poecilia 
reticulata) and medaka (Oryzias latipes), both of which are hardy, easily maintained, and have a 
low occurrence of background lesions. The three chemicals chosen for study in fish had already 
been studied by the NTP in rodents, permitting a comparison of results between the two models. 
Two of the chemicals used (2,2-bis(bromomethyl)-1,3-propanediol and 1,2,3-trichloropropane) 
were mutagenic and multisite carcinogens in rats and mice. The third chemical, nitromethane, 
was nonmutagenic with a more modest carcinogenic response in rodents. Male and female 
guppies and medaka were exposed to 2,2-bis(bromomethyl)- 1,3-propanediol (greater than 99% 
pure), nitromethane, (greater than 99% pure), or 1,2,3-trichloropropane (99% pure) in aquaria 
water for up to 16 months. OVERALL STUDY DESIGN: Groups of approximately 220 guppies (two 
replicates of 110) were maintained in aquaria water containing nominal concentrations of 0, 24, 
60, or 150 mg/L 2,2-bis(bromomethyl)-1,3-propanediol; 0, 10, 30, or 70 mg/L nitromethane; or 
0, 4.5, 9.0, or 18.0 mg/L 1,2,3-trichloropropane. Groups of approximately 340 medaka (two 
replicates of 170) were maintained in aquaria water containing 0, 24, 60, or 150 mg/L 2,2-
bis(bromomethyl)-1,3-propanediol; 0, 10, 20, or 40 mg/L nitromethane; or 0, 4.5, 9.0, or 18.0 
mg/L 1,2,3-trichloropropane. The overall study durations were 16 months for all guppy studies, 
14 months for 2,2-bis(bromomethyl)-1,3-propanediol-exposed medaka, and 13 months for 
nitromethane- and 1,2,3-trichloropropane-exposed medaka. Ten guppies and 10 medaka from 
each group replicate were sacrificed at 9 months for histopathologic analysis. Approximately one 
third of the remaining fish from each group were placed in chemical-free water at 9 months and 
constituted a stop-exposure study component. The remainder of the fish were exposed for the 
duration of the study and constituted the core study component. A stop-exposure component 
was added to determine if stopping the exposure at 9 months and transferring to chemical-free 
aquaria might allow for better survival and tumor development. The sex of guppies and medaka 
was determined at histopathologic analysis. 2,2-BIS(BROMOMETHYL)-1,3-PROPANEDIOL - 16-
MONTH STUDY IN GUPPIES: 2,2-Bis(bromomethyl)-1,3-propanediol was chronically toxic to 
guppies in the 60 and 150 mg/L core and stop-exposure groups. Due to mortality, exposure of 
core study animals in the 150 mg/L group was terminated on day 443, after approximately 64 
weeks on study, and fish were maintained in 2,2-bis(bromomethyl)- 1,3-propanediol-free water 
in the exposure system until the end of the study at 69 weeks. Nominal exposure concentrations 
of 24, 60, and 150 mg/L provided actual aquaria water exposure concentrations of 20.0, 53.5, 
and 139.0 mg/L 2,2-bis(bromomethyl)- 1,3-propanediol, respectively. There were no treatment-
related differences between the control and exposed groups in body weights or lengths. At 9 
months, hepatocellular adenomas occurred in one 24 mg/L male and in one 150 mg/L male. In 
the core study, the incidence of hepatocellular adenoma or carcinoma (combined) in 150 mg/L 
males was greater than that in the controls; multiple adenomas occurred in two 150 mg/L males 
and in one 150 mg/L female. Cholangioma occurred in a small number of exposed males and 
females. In the stop-exposure study, incidences of hepatocellular adenoma (including multiple) 
and of hepatocellular carcinoma were greater in 150 mg/L males than in controls. One 
cholangioma and one cholangiocarcinoma occurred in the 150 mg/L female group. 14-MONTH 
STUDY IN MEDAKA: Exposure to 2,2-bis(bromomethyl)-1,3-propanediol did not result in any 
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significant reduction in survival, although the mortality of fish was somewhat greater in the 60 
and 150 mg/L core study groups than in the control and 24 mg/L groups. After reallocation, 
mortality of medaka in the 60 and 150 mg/L core groups was slightly increased over the 
corresponding stop-exposure groups. Nominal exposure concentrations of 24, 60, and 150 mg/L 
provided actual exposure concentrations of 19.4, 56.9, and 137.8 mg/L 2,2-bis(bromomethyl)- 1,
3-propanediol, respectively. Core study animals in the 60 and 150 mg/L groups were significantly 
larger, in both body length and weight, than control group fish. In the core study, the incidence 
of hepatocellular adenoma or carcinoma (combined) was increased in 150 mg/L males. 
Cholangiocarcinomas occurred in a few exposed males and females, with all but one occurring in 
150 mg/L fish. One cholangioma occurred in a 150 mg/L female, and one occurred in a control 
female. In the stop-exposure study, incidences of hepatocellular adenoma or carcinoma 
(combined) were marginally increased in the 150 mg/L group of males and in the 60 and 150 mg
/L groups of females as compared with controls. Cholangiocarcinoma occurred in one male and 
one female in the 150 mg/L groups and in one control female. NITROMETHANE - 16-MONTH 
STUDY IN GUPPIES: Although the cause of death could not be confirmed in many cases, 
mortality in the 70 mg/L groups appeared to indicate that this level of nitromethane exposure 
was chronically toxic. This is confirmed by the similar survival rate of guppies from all treatments 
following removal from treatment aquaria and placement in stop-exposure. Due to the high 
mortality of fish in the 70 mg/L core study groups, these fish were removed from treatment (day 
396) and fixed for histological analyses after approximately 57 weeks on study. The controls and 
other exposed groups were sacrificed at 70 weeks. Nominal exposure concentrations of 10, 30, 
and 70 mg/L provided actual exposure concentrations of 9.9, 28.7, and 66.4 mg/L nitromethane, 
respectively. There were no treatment-related differences between the control and exposed 
groups in body lengths or weights. 13-MONTH STUDY IN MEDAKA: Nitromethane in the aquaria 
supported a substantial microfaunal growth which, without frequent cleaning, affected water 
quality and treatment concentrations. To maintain acceptable water quality and treatment 
concentrations potentially affected by the rapid microfaunal growth, the study aquaria were 
brushed once and siphoned three times each day. Due to this frequent activity, a number of fish 
probably died due to mechanical injury. Unfortunately, the cause of death could not be 
confirmed in many cases; the mortality from this activity is believed to have been approximately 
uniform among treatments and should not have affected the comparison of survival between 
treatments. Based on mortality in this study and the previous life-span evaluation, the life phase 
of this study was terminated approximately 13.5 months after hatching. Nominal exposure 
concentrations of 10, 20, and 40 mg/L resulted in actual exposure concentrations of 9.3, 20.8, 
and 41.7 mg/L nitromethane, respectively. No differences between control and exposed groups 
were found in body lengths or weights at the 9-month interim evaluation. Due to mortality, 
unequal numbers of fish were distributed among the core study and stop-exposure aquaria at 9 
months. Differences in lengths and weights were found at 13 months. The biological significance 
of this finding is unknown. At 9 months, a single cholangiocarcinoma occurred in a 40 mg/L 
male. Hepatocellular adenomas occurred in two 20 mg/L males and in one 40 mg/L female. In 
the core study, one cholangioma occurred in a 20 mg/L male, and cholangiocarcinomas were 
seen in a few exposed males, but none occurred in control males. 1,2,3-TRICHLOROPROPANE - 
16-MONTH STUDY IN GUPPIES: The survival of exposed guppies was less than that of the 
control group at 9 months. Reduced survival was evident at 6 months in the 18.0 mg/L groups 
and at 7 months in the 4.5 and 9.0 mg/L groups. Survival was significantly reduced in the 18.0 
mg/L core study group within 1 month of the 9-month interim evaluation, and mortality in this 
group was 42.6% between 9 months and study termination. Nominal exposure concentrations of 
4.5, 9.0, and 18.0 mg/L resulted in actual exposure concentrations of 4.4, 8.8, and 18.2 mg/L 1,
2,3-trichloropropane, respectively. Guppies in the 18.0 mg/L core study group were significantly 
longer and weighed more than the controls. Fish in the 18.0 mg/L stop-exposure group also 
weighed more than the controls. Mortality of fish during the study resulted in unequal numbers 
of individuals distributed to core study and stop-exposure aquaria at 9 months. This appears to 
have influenced the length and weight of fish measured at study termination (i.e., the smaller 
tank population allowed the fish to grow more). Observed differences in weight and length 
between controls and 18.0 mg/L fish was most likely an artifact of the reduced numbers of fish 
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in the 18.0 mg/L aquaria. At 9 months, multiple hepatocellular adenomas occurred in one 4.5 mg
/L male, and one hepatocellular adenoma occurred in a control male. In the core study, 
increased incidences of cholangiocellular (bile duct) and hepatocellular neoplasms occurred in 
exposed groups of males and females. Cholangioma and cholangiocarcinoma were seen in 
several exposed males and females. In the stop-exposure study, increased incidences of 
hepatocellular neoplasms occurred in 18.0 mg/L males and increased incidences of 
cholangiocellular (bile duct) neoplasms occurred in 18.0 mg/L females. (ABSTRACT TRUNCATED) 
 
The utility of the guppy (Poecilia reticulata) and medaka (Oryzias latipes) in evaluation of 
chemicals for carcinogenicity 
Quick ViewOther Sources 
 By Kissling Grace E; Bernheim Naomi J; Hawkins William E; Wolfe Marilyn J; Jokinen Micheal P; 
Smith Cynthia S; Herbert Ronald A; Boorman Gary A  
 From Toxicological sciences : an official journal of the Society of Toxicology (2006), 92(1), 143-56. | 
Language: English, Database: MEDLINE  
 There has been considerable interest in the use of small fish models for detecting 
potential environmental carcinogens. In this study, both guppies (Poecilia reticulata) and medaka 
(Oryzias latipes) were exposed in the aquaria water to three known rodent carcinogens for up to 
16 months. Nitromethane, which caused mammary gland tumors by inhalation exposure in 
female rats, harderian gland and lung tumors in male and female mice, and liver tumors in 
female mice by inhalation, failed to increase tumors in either guppies or medaka. Propanediol, 
which when given in the feed was a multisite carcinogen in both sexes of rats and mice, caused 
increased liver tumors in male guppies and male medaka. There was reduced survival in female 
guppies and no increased tumors in female medaka. 1,2,3-Trichloropropane, which when 
administered by oral gavage was a multisite carcinogen in both sexes of rats and mice, caused 
an increased incidence of tumors in the liver of both male and female guppies and medaka and 
in the gallbladder of male and female medaka. The results of this study demonstrate that for 
these three chemicals, under these specific exposure conditions, the fish appear less sensitive 
and have a narrower spectrum of tissues affected than rodents. These results suggest that fish 
models are of limited utility in screening unknown chemicals for potential carcinogenicity. 
 
2,2-bis(Bromomethyl)-1,3-propanediol (technical grade) 
Quick ViewOther Sources 
 By Anonymous  
 From Report on carcinogens : carcinogen profiles / U.S. Dept. of Health and Human Services, Public 
Health Service, National Toxicology Program (2004), 11, III36-7. | Language: English, Database: MEDLINE 
 
2,2-Bis(bromomethyl)-1,3-propanediol (technical grade) 
Quick ViewOther Sources 
 No Author and Editor data available 
 From Report on carcinogens : carcinogen profiles / U.S. Dept. of Health and Human Services, Public 
Health Service, National Toxicology Program (2011), 12, 70-1. | Language: English, Database: MEDLINE 
 
Induction of DNA damage in human urothelial cells by the brominated flame retardant 2,2-
bis(bromomethyl)-1,3-propanediol: role of oxidative stress 
Quick ViewOther Sources 
 By Kong Weixi; Kuester Robert K; Gallegos Alfred; Sipes I Glenn  
 From Toxicology (2011), 290(2-3), 271-7. | Language: English, Database: MEDLINE  
 2,2-bis(bromomethyl)-1,3-propanediol (BMP) is an extensively used brominated flame 
retardant found in urethane foams and polyester resins. In a 2-year dietary study conducted by 
the National Toxicology Program, BMP caused neoplastic lesions at multiple sites including the 
urinary bladder in both rats and mice. The mechanism of its carcinogenic effect is unknown. In 
the present study, using SV-40 immortalized human urothelial cells (UROtsa), endpoints 
associated with BMP induced DNA damage and oxidative stress were investigated. The effects of 
time (1-24h) and concentration (5-100 μM) on BMP induced DNA strand breaks were assessed 
via the alkaline comet assay. The results revealed evidence of DNA strand breaks at 1 and 3h 
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following incubation of cells with non-cytotoxic concentrations of BMP. Strand breaks were not 
present after 6h of incubation. Evidences for BMP associated oxidative stress include: an 
elevation of intracellular ROS formation as well as induction of Nrf2 and HSP70 protein levels. In 
addition, DNA strand breaks were attenuated when cells were pre-treated with N-acetyl-l-
cysteine (NAC) and oxidative base modifications were revealed when a lesion specific 
endonuclease, human 8-hydroxyguanine DNA glycosylase 1 (hOGG1) was introduced into the 
comet assay. In conclusion, these results demonstrate that BMP induces DNA strand breaks and 
oxidative base damage in UROtsa cells. Oxidative stress is a significant, determinant factor in 
mediating these DNA lesions. These early genotoxic events may, in part, contribute to BMP-
induced carcinogenesis observed in rodents. 
 
Results of a two-year toxicity and oncogenic study of rats ingesting diets containing 
dibromoneopentyl glycol (FR-1138) 
Quick ViewOther Sources 
 By Keyes, D. G.; Kociba, R. J.; Schwetz, R. W.; Wade, C. E.; Dittenber, D. A.; Quinn, T.; Gorzinski, 
S. J.; Hermann, E. A.; Momany, J. J.; Schwetz, B. A.  
 From Journal of Combustion Toxicology (1980), 7(May), 77-98. | Language: English, Database: 
CAPLUS  
 A lifetime toxicity dietary study of FR 1138 [3296-90-0] was conducted in rats to 
assess the potential for chronic toxicity and possible oncogenesis. Rats ingesting the lower 
dietary level of 5 mg FR 1138/kg/day had no effects related to the lifetime treatment. Rats 
ingesting a higher dietary level of 100 mg FR 1138/kg/day had some evidence of toxicity, 
including degenerative changes in the liver, eye, and possibly thyroid gland; however, there was 
no oncogenic response, even when FR 1138 was administered at a high dosage to induce some 
toxicity. Anal. of selected tissues, indicated an increase in bromide content in the tissues of rats 
ingesting the higher dose, (100 mg FR 1138/kg/day). At the lower dose (5 mg FR 1138/kg/day), 
there was only a marginal increase in bromide content of some of the tissues, with most values 
in the same range as the controls. 
 
A collection of guinea pig sensitization test results grouped by chemical class 
Quick ViewOther Sources 
 By Rao, K. S.; Betso, J. E.; Olson, K. J.  
 From Drug and Chemical Toxicology (1977) (1981), 4(4), 331-51. | Language: English, Database: 
CAPLUS  
 Various chem. groups were evaluated for their skin sensitization potential in the 
guinea pig. In general, amines, acetanilides, pyridines, piperidines, and sulfones were pos. in the 
guinea pig test. Since these tests were done over a period of years, any further structural-related 
correlations or predictions should be made with caution due to variability of sample purity or 
differences in methodol. It is important to realize that every chem. which is pos. in the guinea 
pig should not be construed as definitive evidence of human skin sensitization. 
 
Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals 
Quick ViewOther Sources 
 By Mortelmans, Kristien; Haworth, Steve; Lawlor, Timothy; Speck, William; Tainer, Beth; Zeiger, 
Errol  
 From Environmental Mutagenesis (1986), 8(Suppl. 7), 1-119. | Language: English, Database: 
CAPLUS  
 This publication includes data of Salmonella mutagenicity results on 270 coded 
chems., encompassing 329 tests performed by 3 labs. under contract to the National Toxicol. 
Program. The preincubation modification of the Salmonella/mammalian microsome assay was 
used to test chems. in up to 5 Salmonella strains in the presence and absence of rat and 
hamster liver S-9. With a few exceptions, inter- and intralab. reproducibility was good. 
 
2,2-Bis(bromomethyl)-1,3-propanediol: reproduction and fertility assessment in CD-1 mice when 
administered in feed (revised January 1986) 
Quick ViewOther Sources 
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 By Gulati, D. K.; Mounce, R. C.; Shaver, S.; Russell, S.; Poonacha, K. B.  
 From Report (1986), (NTP-86-063; Order No. PB86-168341/GAR), 522 pp.. | Language: English, 
Database: CAPLUS  
 Rats ingesting 5 mg/kg 2,2-bis(bromomethyl)-1,3-propanediol (BBMP) [3296-90-0] 
showed no symptoms of toxicity. Treatment at 100 mg/kg resulted in significant toxicity, 
including degenerative changes in the liver, eyes, and possibly the thyroid gland. BBMP 
administered in feed at the 0.4% dose level adversely affected reprodn. in mice. The continued 
BBMP treatment at this dose level also resulted in a significant drop in body wt. When female 
mice exposed to 0.4% BBMP were mated with control male mice, the fertility index was reduced 
by almost 60%. The no. of live pups/litter delivered by these breeding pairs was also significantly 
lower than the 0.4% male X control female pairs. 
 
Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: 
evaluations of 108 chemicals 
Quick ViewOther Sources 
 By Galloway, S. M.; Armstrong, M. J.; Reuben, C.; Colman, S.; Brown, B.; Cannon, C.; Bloom, A. D.; 
Nakamura, F.; Ahmed, M.; et al.  
 From Environmental and Molecular Mutagenesis (1987), 10(Suppl. 10), 1-175. | Language: English, 
Database: CAPLUS  
 Results from the testing of 108 coded chems. in CHO cells for the induction of 
chromosome aberrations and sister chromatid exchanges (SCEs) are presented. All chems. were 
tested with and without exogenous metabolic activation, using protocols designed to allow 
testing up to toxic doses. Cell harvest times could also be extended if chem.-induced cell cycle 
delay was seen. Chromosome aberrations were induced by 43 of the chems., and 66 induced 
SCEs; 37 of the chems. were pos. for both endpoints. 
 
Evaluation of rodent sperm, vaginal cytology, and reproductive organ weight data from national 
toxicology program 13-week studies 
Quick ViewOther Sources 
 By Morrissey, Richard E.; Schwetz, Bernard A.; Lamb, James C., IV; Ross, Monica D.; Teague, Janet 
L.; Morris, Richard W.  
 From Fundamental and Applied Toxicology (1988), 11(2), 343-58. | Language: English, Database: 
CAPLUS  
 Sperm morphol. and vaginal cytol. examns. (SMVCEs), which include evaluations of 
motility, concn. and head morphol. of sperm from the cauda epididymis, and male reproductive 
organ wt. data, were developed by the National Toxicol. Program as a screening system for 
reproductive toxicants. An anal. was conducted of SMVCE studies carried out at the end of fifty 
13-wk studies (25 for rats, 25 for mice) over a 3-yr period. Statistically significant changes in 
these studies were summarized, as were control data for each male endpoint (mean, SD, 95% 
confidence limits around the mean, median, and statistical power). Reproductive organ wts. 
(testis, epididymis, cauda epididymis) and sperm motility were the most statistically powerful 
endpoints evaluated; sperm head morphol. may also be a sensitive endpoint for detecting 
reproductive toxicants. For 24 chems. tested in both rats and mice, the concordance of results 
[i.e., no adverse effect in either species, or at least one SMVCE endpoint (not necessarily the 
same one) adversely affected in both species] was 58%. These data suggest that detection of 
potential reproductive toxicants might be best when both species are used. Types of sperm head 
abnormalities and their relative proportion of the total did not differ among control and 
treatment groups. Estrous cycle data were obtained in the final week of forty-six 13-wk studies 
(23 for mice, 23 for rats). Only 3 chems. caused an increase in mean cycle length compared with 
the control group. More data from breeding studies in which female estrous cycle length is 
measured are needed to assess fully the assocn. of cycle length with reproductive outcome; 
stages of the estrous cycle are so variable that they may not be useful in assessing potential 
toxicity. Interlab. variability in SMVCE values for many endpoints was documented. 
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Association of sperm, vaginal cytology, and reproductive organ weight data with results of 
continuous breeding reproduction studies in Swiss (CD-1) mice 
Quick ViewOther Sources 
 By Morrissey, Richard E.; Lamb, James C., IV; Schwetz, Bernard A.; Teague, Janet L.; Morris, 
Richard W.  
 From Fundamental and Applied Toxicology (1988), 11(2), 359-71. | Language: English, Database: 
CAPLUS  
 In continuous breeding reprodn. studies in which an adverse effect on fertility was 
detected over an 18-wk treatment period, a crossover mating trial was then conducted to det. 
the affected sex. Results of 25 crossover breeding studies conducted using Swiss (CD-1) mice 
were compared with results of sperm morphol. and vaginal cytol. examns. (SMVCEs) conducted 
at the conclusion of the mating trial. SMVCE endpoints include sperm concn., motility, and 
morphol., vaginal cytol., and male reproductive organ wts. In most SMVCE studies multiple 
endpoints were adversely affected. For male reproductive toxicants, sperm motility was 
decreased in 89% of the studies, and abs. right epididymis and right testis wts. were affected 
less frequently (80% each). Among studies with no detectable redn. in male breeding 
performance, 87% exhibited no detectable decrease in epididymis wt. Eighty-two percent had no 
change in cauda epididymis wt. and 80% had no significant change in sperm concn. An increase 
in female cycle length was assocd. (100%) with an effect on breeding due to female dysfunction. 
Overall accuracy, defined as correct identification of toxicants and nontoxicants, was highest for 
epididymis wt. (84%), followed by cauda epididymis wt. and sperm motility (79% each), and 
sperm concn. (76%). Female cycle length was so variable that the overall accuracy of the 
parameter in 13 studies was 69%. With the variety of chems. used in this anal., the assocn. of 
abnormal sperm morphol. with reproductive outcome was 71%. The statistical sensitivity was 
relatively high for reproductive organ wts., although it was less for smaller organs such as the 
prostate. On the basis of both the biol. and statistical analyses, it is recommended that multiple 
SMVCE endpoints, including sperm measures, be included in screens for reproductive toxicants. 
 
Kidney and urinary bladder lesions in F344/N rats and B6C3F1 mice after 13 weeks of 2,2-
bis(bromomethyl)-1,3-propanediol administration 
Quick ViewOther Sources 
 By Elwell, M. R.; Dunnick, J. K.; Brown, H. R.; Montgomery, C. A.  
 From Fundamental and Applied Toxicology (1989), 12(3), 480-90. | Language: English, Database: 
CAPLUS  
 Thirteen-week toxicity studies of the flame retardant 2,2-bis(bromomethyl)-1,3-
propanediol (BMP) were conducted in male and female rats and mice. The chem. was 
administered by oral gavage in corn oil 5 days per wk for 13 wk to rats at doses of 0-800 mg/kg 
and to mice at doses of 0-400 mg/kg, or in the feed for 13 wk at concns. of 0-20,000 ppm for 
rats and at 0-10,000 ppm for mice. There was a dose-related decrease in body wt. gain in rats 
and mice after chem. administration. Mortality attributed to toxicity of BMP was seen in the 
gavage study in 2/10 high-dose (800 mg/kg) male rats and 3010 high-dose (400 mg/kg) male 
mice; no dose-related mortality occurred in the feed study. Minimal degeneration in the renal 
papilla was seen in male rats at 800 mg/kg in the gavage study and at doses of 5000 ppm or 
more in the feed study. This was also present in one female rat at 20,000 ppm dose. In male 
mice renal papillary necrosis occurred at 400 mg/kg after dosing by the gavage route and at 
2500, 5000, and 10,000 ppm in the dosed-feed study. In female mice papillary necrosis occurred 
only at the 10,000 ppm dose in the feed study. Tubular cell regeneration of the renal cortex was 
also present in mice at the same dose levels at which the papillary necrosis was obsd. 
Transitional cell hyperplasia of the urinary bladder was seen in male rats at 400 and 800 mg/kg 
and in both sexes of mice at 200 and 400 mg/kg. Hyperplasia of the urinary bladder was also 
seen when BMP was administered in the feed at doses of 20,000 ppm to male rats; at doses of 
2500, 5000, and 10,000 ppm to male mice; and at doses of 5000 and 10,000 ppm to female 
mice. The kidney and urinary bladder are target organs when BMP is administered by gavage or 
the dosed-feed route; mice were more sensitive than rats for the development of kidney and 
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bladder lesions. Male rats and mice were more sensitive than females for the development of 
renal papillary degeneration or necrosis. 
 
Reproductive toxicity of 2,2-bis(bromomethyl)-1,3-propanediol in a continuous breeding protocol 
in Swiss (CD-1) mice 
Quick ViewOther Sources 
 By Treinen, Kimberley A.; Chapin, Robert E.; Gulati, Dushyant K.; Mounce, Robin; Morris, Lisa Z.; 
Lamb, James C., IV  
 From Fundamental and Applied Toxicology (1989), 13(2), 245-55. | Language: English, Database: 
CAPLUS  
 The effect of 2,2-bis(bromomethyl)-1,3-propanediol (BMP) on reprodn. in Swiss CD-1 
mice was evaluated by use of a continuous breeding protocol. BMP was administered in the feed 
at 0.1, 0.2, and 0.4% concns. Both male and female F0 mice (20 pairs/treatment group, 40 pairs 
of control animals) were dosed 7 days prior to and during a 98-day cohabitation period. Although 
the fertility index was unchanged in the high-dose group, BMP exposure significantly decreased 
the nos. of litters/pair, pups born alive/litter, and pup wt. when adjusted for litter size. Crossover 
mating between treated and control F0 animals indicated a specific effect only on female 
reproductive capacity. At the high dose, BMP caused a body wt. decrease in the F0 animals of 
both sexes with no effects on relative organ wts. Sperm concn., motility, morphol., and estrual 
cyclicity were unaffected by BMP exposure. Histopathol. in the F0 animals revealed specific kidney 
lesions in both sexes; males were more sensitive than females. The last litter born in the 98-day 
breeding phase was reared to age 74 days and then mated to nonsiblings of the same treatment 
group. The effect of high-dose BMP exposure on F1 fertility, body and organ wts., sperm 
parameters, and estrual cyclicity was the same as that for the F0 animals, with the exception of 
the lack of renal lesions seen in the F1 females. Thus, BMP impaired fertility in female mice in 
both generations in the absence of an effect on reproductive organ wts. and estrual cyclicity. 
 
Prediction of probability of carcinogenicity for a set of ongoing NTP bioassays 
Quick ViewOther Sources 
 By Enslein, Kurt; Blake, Benjamin W.; Borgstedt, Harold  
 From Mutagenesis (1990), 5(4), 305-6. | Language: English, Database: CAPLUS  
 Forty-four compds. currently undergoing carcinogenesis bioassay by the National 
Toxicol. Program were submitted to the Toxicity Prediction by Komputer-Assisted Technol. 
(TOPKAT) program for prediction of their potential carcinogenicity. Sixteen compds. could not be 
handled by TOPKAT. Of the 28 for which predictions were made, 26 (93%) had a confidence 
level in the est. of at least moderate. Seventeen were predicted to be carcinogens and 11 
noncarcinogens. 
 
Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals 
Quick ViewOther Sources 
 By Zeiger, Errol; Anderson, Beth; Haworth, Steve; Lawlor, Timothy; Mortelmans, Kristien  
 From Environmental and Molecular Mutagenesis (1992), 19(Suppl. 21), 2-141. | Language: English, 
Database: CAPLUS  
 Three hundred eleven chems. were tested under code, for mutagenicity, in S. 
typhimurium; 35 of the chems. were tested more than once in the same or different labs. The 
tests were conducted using a preincubation protocol in the absence of exogenous metabolic 
activation, and in the presence of liver S-9 from Aroclor-induced male Sprague-Dawley rats and 
Syrian hamsters. Some of the volatile chems. were also tested in desiccators. A total of 120 
chems. were mutagenic or weakly mutagenic, 3 were judged questionable, and 172 were 
nonmutagenic. The remaining 16 chems. produced different responses in the two or three labs. 
in which they were tested. The results and data from these tests are presented. 
 
Comparison between rodent carcinogenicity test results of 44 chemicals and a number of predictive 
systems 
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Quick ViewOther Sources 
 By Lewis, David F. V.  
 From Regulatory Toxicology and Pharmacology (1994), 20(3, Pt. 1), 215-22. | Language: English, 
Database: CAPLUS  
 A comparison is made between a no. of predictive systems including bacterial 
mutagenicity, structure alert and chronic toxicity (R. W. Tennant et al., 1990), COMPACT, 
Hazardexpert, and DEREK, with the outcome of the two species rodent carcinogenicity bioassay 
for 44 chems. conducted under the NTP protocol. Following minor updating of the rodent data in 
the light of pathol. reports, there is a generally good agreement between various predictions and 
the actual carcinogenicity results. In particular, a combination of two methods of prediction 
produces an over 80% concordance with the rodent bioassay. Possible reasons for various 
discrepancies are discussed in light of xenobiotic metab. and activation mechanisms of chem. 
carcinogenesis. 
 
Toxicology and carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol (FR-1138) (CAS 
no. 3296-90-0) in F344/N rats and B6C3F1 mice (feed studies) 
Quick ViewOther Sources 
 By U.S. Department of Health and Human Services  
 From National Toxicology Program Technical Report Series (1996), (452), 376 pp.. | Language: 
English, Database: CAPLUS  
 2,2-Bis(bromomethyl)-1,3-propanediol is used as a fire retardant in unsatd. polyester 
resins, in molded products, and in rigid polyurethane foam. 2,2-Bis(bromomethyl)-1,3-
propanediol was chosen for study because it is a widely used flame retardant and little toxicity 
and carcinogenicity data were available. Groups of male and female F344/N rats and B6C3F1 
mice were exposed to tech. grade 2,2-bis(bromomethyl)-1,3-propanediol (78.6% pure) in feed 
for 13 wk or 2 yr. Genetic toxicol. studies were conducted in Salmonella typhimurium, cultured 
Chinese hamster ovary cells, mouse bone marrow, and mouse peripheral blood. Under the 
conditions of these 2-yr feed studies, there was clear evidence of the carcinogenicity and 
genotoxicity of 2,2-bis(bromomethyl)-1,3-propanediol. 
 
Prioritization of NTP reproductive toxicants for field studies 
Quick ViewOther Sources 
 By Moorman, W. J.; Ahlers, H. W.; Chapin, R. E.; Daston, G. P.; Foster, P. M. D.; Kavlock, R. J.; 
Morawetz, J. S.; Schnorr, T. M.; Schrader, S. M.  
 From Reproductive Toxicology (2000), 14(4), 293-301. | Language: English, Database: CAPLUS  
 Population studies that evaluate human reproductive impairment are time consuming, 
expensive, logistically difficult, and with limited resources must be prioritized to effectively 
prevent the adverse health effects in humans. Interactions among health scientists, unions, and 
industry can serve to identify populations exposed to potential hazards and develop strategies to 
evaluate and apply appropriate controls. This report describes a systematic method for 
prioritizing chems. that may need human reproductive health field studies. Rodent reproductive 
toxicants identified from the National Toxicol. Program (NTP) Reproductive Assessment by 
Continuous Breeding (RACB) protocol were prioritized on the basis of potency of toxic effect and 
population at risk. This model for prioritization links NTP findings with data from the National 
Occupational Exposure Survey (NOES) and the Hazardous Substance Data Base (HSDB) or the 
High Prodn. Vol. Chem. Database (HPVC) to prioritize chems. for their potential impact on worker 
populations. The chems. with the highest priority for field study were: di-Bu phthalate, boric 
acid, tricresyl phosphate, and N,N-dimethylformamide. 
 
Micronucleated erythrocyte frequency in peripheral blood of B6C3F1 mice from short-term, 
prechronic, and chronic studies of the NTP carcinogenesis bioassay program 
Quick ViewOther Sources 
 By Witt, Kristine L.; Knapton, Alan; Wehr, Carol M.; Hook, Graham J.; Mirsalis, Jon; Shelby, Michael 
D.; MacGregor, James T.  
52 
 
52 
 
 From Environmental and Molecular Mutagenesis (2000), 36(3), 163-194. | Language: English, 
Database: CAPLUS  
 The mouse peripheral blood micronucleus (MN) test was performed on samples 
collected from 20 short-term, 67 subchronic, and 5 chronic toxicity and carcinogenicity studies 
conducted by the National Toxicol. Program (NTP). Data are presented for studies not previously 
published. Aspects of protocol that distinguish this test from conventional short-term bone 
marrow MN tests are duration of exposure and absence of repeat tests and concurrent pos. 
controls. Furthermore, in contrast to short-term bone marrow MN tests where scoring is limited 
to polychromatic erythrocytes (PCE), longer-term studies using peripheral blood may evaluate 
MN in both, or either, the normochromatic (NCE) or PCE populations. The incidence of MN-PCE 
provides an index of damage induced within 72 h of sampling whereas the incidence of MN in 
the NCE population at steady state provides an index of av. damage during the 30-day period 
preceding sampling. The mouse peripheral blood MN test has been proposed as a useful adjunct 
to rodent toxicity tests and has been effectively incorporated as a routine part of overall toxicity 
testing by the NTP. Data derived from peripheral blood MN analyses of dosed animals provide a 
useful indication of the in vivo potential for induced genetic damage and supply an important 
piece of evidence to be considered in the overall assessment of toxicity and health risk of a 
particular chem. Although results indicate that the test has low sensitivity for prediction of 
carcinogenicity, a convincingly pos. result in this assay appears to be highly predictive of rodent 
carcinogenicity. 
 
Reevaluating cancer risk estimates for short-term exposure scenarios 
Quick ViewOther Sources 
 By Halmes, N. Christine; Roberts, Stephen M.; Tolson, J. Keith; Portier, Christopher J.  
 From Toxicological Sciences (2000), 58(1), 32-42. | Language: English, Database: CAPLUS  
 Ests. of cancer risk from short-term exposure to carcinogens generally rely on cancer 
potency values derived from chronic, lifetime-exposure studies and assume that exposures of 
limited duration are assocd. with a proportional redn. in cancer risk. The validity of this approach 
was tested empirically using data from both chronic lifetime and stop-exposure studies of 
carcinogens conducted by the National Toxicol. Program. Eleven compds. were identified as 
having data sufficient for comparison of relative cancer potencies from short-term vs. lifetime 
exposure. The data were modeled using the chronic data alone, and also using the chronic and 
the stop-exposure data combined, where stop-exposure doses were adjusted to av. lifetime 
exposure. Maximum likelihood ests. of the dose corresponding to a 1% added cancer risk (ED01) 
were calcd. along with their assocd. 95% upper and lower confidence bounds. Statistical 
methods were used to evaluate the degree to which adjusted stop-exposures produced risks 
equal to those estd. from the chronic exposures. For most chem./cancer endpoint combinations, 
inclusion of stop-exposure data reduced the ED01, indicating that the chem. had greater apparent 
potency under stop-exposure conditions. For most chems. and endpoints, consistency in potency 
between continuous and stop-exposure studies was achieved when the stop-exposure doses 
were averaged over periods of less than a lifetime-in some cases as short as the exposure 
duration itself. While the typical linear adjustments for less-than-lifetime exposure in cancer risk 
assessment can theor. result in under- or overestimation of risks, empirical observations in this 
anal. suggest that an underestimation of cancer risk from short-term exposures is more likely. 
 
Predominant K-ras Codon 12 G → A Transition in Chemically Induced Lung Neoplasms in B6C3F1 
Mice 
Quick ViewOther Sources 
 By Ton, Thai-Vu T.; Hong, Hue-Hua L.; Anna, Colleen H.; Dunnick, June K.; Devereux, Theodora R.; 
Sills, Robert C.; Kim, Yongbaek  
 From Toxicologic Pathology (2004), 32(1), 16-21. | Language: English, Database: CAPLUS  
 Based on long-term toxicity and carcinogenicity studies in B6C3F1 mice conducted by 
the National Toxicol. Program, 2,2-Bis(bromomethyl)-1,3-propanediol (BMP) and 
tetranitromethane (TNM) have been identified as carcinogens. Following 2 yr of exposure to 312, 
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625, or 1,250 ppm BMP in feed, or exposure to 0.5 or 2 ppm TNM by inhalation, increased 
incidences of lung neoplasms were obsd. in B6C3F1 mice at all exposure concns. compared to 
unexposed mice. The present study characterizes genetic alterations in the K-ras protooncogene 
in BMP- and TNM-induced lung neoplasms, resp., and compares the findings to spontaneous 
lung neoplasms from corresponding control mice. The frequencies of the K-ras mutations were 
57% (29/51) in BMP-induced lung neoplasms compared to 15% (3/20) in lung neoplasms from 
dosed feed control mice, and 54% (14/26) in TNM-induced lung neoplasms compared to 60% (3
/5) in lung neoplasms from inhalation control mice. G → A transitions at the second base of the 
K-ras codon 12 (GGT GAT) were the most frequent pattern of K-ras mutations identified in BMP-
induced (20/29) and TNM-induced lung neoplasms (13/14), which differed from the mutational 
patterns identified in the lung neoplasms from unexposed control mice. These results indicate 
that mutations in the K-ras gene are involved in B6C3F1 lung carcinogenesis following BMP- and 
TNM-exposure, and the high frequency and specificity of the ras mutation profile in lung 
neoplasms (G → A transition) may be due to in vivo genotoxicity by the parent compds. or their 
metabolites. 
 
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent 
carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity 
Quick ViewOther Sources 
 By Kirkland, David; Aardema, Marilyn; Henderson, Leigh; Mueller, Lutz  
 From Mutation Research, Genetic Toxicology and Environmental Mutagenesis (2005), 584(1-2), 1-
256. | Language: English, Database: CAPLUS  
 The performance of a battery of three of the most commonly used in vitro 
genotoxicity tests, i.e., Ames + mouse lymphoma assay (MLA) + in vitro micronucleus (MN) or 
chromosomal aberrations (CA) test, was evaluated for its ability to discriminate rodent 
carcinogens and non-carcinogens, from a large database of over 700 chems. compiled from the 
CPDB ("Gold"), NTP, IARC and other publications. We re-evaluated many (113 MLA and 30 CA) 
previously published genotoxicity results in order to categories the performance of these assays 
using the response categories we established. The sensitivity of the three-test battery was high. 
Of the 553 carcinogens for which there were valid genotoxicity data, 93% of the rodent 
carcinogens evaluated in at least one assay gave pos. results in at least one of the three tests. 
Combinations of two and three test systems had greater sensitivity than individual tests resulting 
in sensitivities of around 90% or more, depending on test combination. Only 19 carcinogens (out 
of 206 tested in all three tests, considering CA and MN as alternatives) gave consistently neg. 
results in a full three-test battery. Most were either carcinogenic via a non-genotoxic mechanism 
(liver enzyme inducers, peroxisome proliferators, hormonal carcinogens) considered not 
necessarily relevant for humans, or were extremely weak (presumed) genotoxic carcinogens 
(e.g. N-nitrosodiphenylamine). Two carcinogens (5-chloro-o-toluidine, 1,1,2,2-tetrachloroethane) 
may have a genotoxic element to their carcinogenicity and may have been expected to produce 
pos. results somewhere in the battery. We identified 183 chems. that were non-carcinogenic 
after testing in both male and female rats and mice. There were genotoxicity data on 177 of 
these. The specificity of the Ames test was reasonable (73.9%), but all mammalian cell tests had 
very low specificity (i.e. below 45%), and this declined to extremely low levels in combinations of 
two and three test systems. When all three tests were performed, 75-95% of non-carcinogens 
gave pos. (i.e. false pos.) results in at least one test in the battery. The extremely low specificity 
highlights the importance of understanding the mechanism by which genotoxicity may be 
induced (whether it is relevant for the whole animal or human) and using wt. of evidence 
approaches to assess the carcinogenic risk from a pos. genotoxicity signal. It also highlights 
deficiencies in the current prediction from and understanding of such in vitro results for the in 
vivo situation. It may even signal the need for either a reassessment of the conditions and 
criteria for pos. results (cytotoxicity, soly., etc.) or the development and use of a completely new 
set of in vitro tests (e.g. mutation in transgenic cell lines, systems with inherent metabolic 
activity avoiding the use of S9, measurement of genetic changes in more cancer-relevant genes 
or hotspots of genes, etc.). It was very difficult to assess the performance of the in vitro MN test, 
particularly in combination with other assays, because the published database for this assay is 
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relatively small at this time. The specificity values for the in vitro MN assay may improve if data 
from a larger proportion of the known non-carcinogens becomes available, and a larger 
published database of results with the MN assay is urgently needed if this test is to be 
appreciated for regulatory use. However, specificity levels of <50% will still be unacceptable. 
Despite these issues, by adopting a relative predictivity (RP) measure (ratio of real:false results), 
it was possible to establish that pos. results in all three tests indicate the chem. is greater than 
three times more likely to be a rodent carcinogen than a non-carcinogen. Likewise, neg. results 
in all three tests indicate the chem. is greater than two times more likely to be a rodent non-
carcinogen than a carcinogen. This RP measure is considered a useful tool for industry to assess 
the likelihood of a chem. possessing carcinogenic potential from batteries of pos. or neg. results. 
 
Human toxicological effect and damage factors of carcinogenic and noncarcinogenic chemicals for 
life cycle impact assessment 
Quick ViewOther Sources 
 By Huijbregts, Mark A. J.; Rombouts, Linda J. A.; Ragas, Ad M. J.; van de Meent, Dik  
 From Integrated Environmental Assessment and Management (2005), 1(3), 181-244. | Language: 
English, Database: CAPLUS  
 Chem. fate, effect, and damage should be accounted for in the anal. of human health 
impacts by toxic chems. in life cycle assessment (LCA). The goal of this article is to present a 
new method to derive human damage and effect factors of toxic pollutants, starting from a 
lognormal dose-response function. Human damage factors are expressed as disability-adjusted 
life-years (DALYs). Human effect factors contain a disease-specific and a substance-specific 
component. The disease-specific component depends on the probability of disease occurrence 
and the distribution of sensitivities in the human population. The substance-specific component, 
equal to the inverse of the ED50, represents the toxic potency of a substance. The new method 
has been applied to calc. combined human damage and effect factors for 1192 substances. The 
total range of 7-9 orders of magnitude between the substances is dominated by the range in 
toxic potencies. For the combined factors, the typical uncertainty, represented by the square root 
of the ratio of the 97.5th and 2.5th percentiles, is a factor of 25 for carcinogenic effects and a 
factor of 125 for noncarcinogenic effects. The interspecies conversion factor, the (non)cancer 
effect conversion factor, and the av. noncancer damage factor dominate the overall uncertainty. 
 
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent 
carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. [Erratum to 
document cited in CA143:243161] 
Quick ViewOther Sources 
 By Kirkland, David; Aardema, Marilyn; Henderson, Leigh; Mueller, Lutz  
 From Mutation Research, Genetic Toxicology and Environmental Mutagenesis (2005), 588(1), 70. | 
Language: English, Database: CAPLUS  
 On the title page, the URL of the website address in the open star footnote should 
read: www.lhasalimited.org/cgx. This is where the appendixes have been posted. 
 
Carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-
trichloropropane (CAS NOS. 3296-90-0, 75-75-5, and 96-18-4) in guppies (Poecilia reticulata) and 
medaka (Oryzias latipes) 
Quick ViewOther Sources 
 By Bernheim, N. J.; Boorman, G. A.; Herbert, R. A.; Bristol, D. W.; Bucher, J. R.; Hailey, J. R.; 
Haseman, J. K.; Kissling, G. E.; Maronpot, R. R.; Nyska, A.; et al 
 From National Toxicology Program Technical Report Series (2005), (528), 1-190. | Language: 
English, Database: CAPLUS  
 The National Toxicol. Program has used rats and mice to test if chems. can cause 
cancer in animals. We wanted to see if fish could be used as a test animal for cancer testing. In 
this study, we exposed two species of fish, guppies and medaka, to three different chems. that 
caused cancer in rodents to see if fish had the same response. Methods We held groups of 
approx. 110 guppies or 170 medaka in aquaria each contg. a specific concn. of a chem. Three 
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different chems. were tested, and three different concns. of each chem. were used. Similar 
groups of fish were held in aquaria contg. only clean water and served as the control groups. 
The three chems. used were 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, or 1,2,3-
trichloropropane. After nine months of exposure, some of the fish were transferred into aquaria 
with just clean water, and the others remained exposed to chem. for another four to seven 
months. At the end of the studies, about 20 tissue sites from each fish were examd. 
microscopically. At higher concns., 2,2-bis(bromomethyl)-1,3-propanediol was toxic to guppies, 
and many of the females died. Some of the male guppies and male medaka developed liver 
cancer, but few female medaka did. Nitromethane in the water promoted the growth of algae in 
the aquaria, and the tanks had to be cleaned often. The cleaning process may have resulted in 
the death of several of the fish. Not enough male guppies were left to evaluate, and very few 
tumors were seen in the surviving female guppies or male or female medaka. Male and female 
guppies exposed to 1,2,3-trichloropropane had higher rates of liver tumors than the control 
guppies did, and male and female medaka developed tumors of the liver and gallbladder. While 
all three test chems. caused cancer in several different tissues in lab. rodents, the response in 
fish was not as consistent, as cancer was seen only mainly in the liver. Fish that died during the 
study often were eaten by the other fish or dissolved and could not be evaluated. We conclude 
that several tech. problems remain to be solved before fish can be a reliable replacement for 
rodents in cancer testing. 
 
Increasing efficiency of QSAR-analysis of carcinogenic activity of halogenated hydrocarbons 
Quick ViewOther Sources 
 By Tarasov, A. V.; Abilev, S. K.; Velibekov, R. M.; Tarasov, V. A.  
 From Ekologicheskaya Genetika (2005), 3(2), 5-14. | Language: Russian, Database: CAPLUS  
 The new principle of anal. of structure activity of carcinogenic compds. is offered. It 
is based on the use of compd. structural descriptors representing a combination unrelated 
among themselves of structural fragments of a mol. The computer program is developed, 
allowing to generate every possible structural fragments of mols. of chem. compds. and their 
combinations and to carry out selection of the compd. descriptors statistically significantly 
influencing their biol. activity. It was used for 79 halogenated hydrocarbons for which their 
carcinogenic activity on rodents is investigated. 
 
Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent 
cancer bioassays 
Quick ViewOther Sources 
 By Thomas, Russell S.; Pluta, Linda; Yang, Longlong; Halsey, Thomas A. 
 From Toxicological Sciences (2007), 97(1), 55-64. | Language: English, Database: CAPLUS  
 Rodent cancer bioassays are part of a legacy of safety testing that has not changed 
significantly over the past 30 years. The bioassays are expensive, time consuming, and use 
hundreds of animals. Fewer than 1500 chems. have been tested in a rodent cancer bioassay 
compared to the thousands of environmental and industrial chems. that remain untested for 
carcinogenic activity. In this study, we used existing data generated by the National Toxicol. 
Program (NTP) to identify gene expression biomarkers that can predict results from a rodent 
cancer bioassay. A set of 13 diverse chems. was selected from those tested by the NTP. Seven 
chems. were pos. for increased lung tumor incidence in female B6C3F1 mice and six were neg. 
Female mice were exposed subchronically to each of the 13 chems., and microarray anal. was 
performed on the lung. Statistical classification anal. using the gene expression profiles identified 
a set of eight probe sets corresponding to six genes whose expression correctly predicted the 
increase in lung tumor incidence with 93.9% accuracy. The sensitivity and specificity were 95.2 
and 91.8%, resp. Among the six genes in the predictive signature, most were enzymes involved 
in endogenous and xenobiotic metab., and one gene was a growth factor receptor involved in 
lung development. The results demonstrate that increases in chem. induced lung tumor 
incidence in female mice can be predicted using gene biomarkers from a subchronic exposure 
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and may form the basis of a more efficient and economical approach for evaluating the 
carcinogenic activity of chems. 
 
Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose 
approach 
Quick ViewOther Sources 
 By Bokkers, Bas G. H.; Slob, Wout  
 From Critical Reviews in Toxicology (2007), 37(5), 355-373. | Language: English, Database: CAPLUS  
 A review. In deriving human health-based exposure limits from animal data, 
differences in sensitivity to a compd. between animals and humans must be taken into account. 
These interspecies differences can be caused by differences in toxicokinetics and/or 
toxicodynamics. Apart from that, species differ in body size, and this is usually accounted for by 
scaling doses to body wt. (i.e., expressed as mg/kg body wt.1.0/day). A default assessment factor 
(AF) of 10 is commonly applied to this dose metric to account for potential toxicokinetic and 
toxicodynamic differences. However, both proportional body wt. (BW) scaling and the default AF 
as often applied are not directly based on empirical findings. Attempts have been made to derive 
data-based assessment factors and allometric scaling powers using various toxicol. values such 
as no-obsd.-adverse-effect-levels (NOAELs). In this study both the NOAEL approach and the 
benchmark dose (BMD) approach are applied to derive NOAEL ratios and BMD ratios from mouse 
and rat studies and, based on that information, to est. an allometric scaling power and an 
interspecies AF. To account for interspecies differences in body size, our results confirm earlier 
findings that allometric body wt. scaling with a power of around 0.7 is appropriate. The factor 
needed to rescale the dose in terms of mg/kg BW to the allometric dose scale ranges from 
around 1.7 (for dogs) to 10 (for mice), similar to other findings. The addnl. factor required for 
taking into account interspecies toxicokinetic and toxicodynamic differences, when based on the 
95th percentile of the relevant ratio distribution, would be 3.1 for a lower Confidence limit of the 
BMD (BMDL), and 8.3 for a NOAEL (to be applied to the allometrically scaled dose). These 
results indicate that the generally used default AF of 10 may not cover potential interspecies 
differences, in particular when applied to results from smaller test species. Therefore, using the 
default AF of 10 could lead to human exposure limits that are insufficiently protective. Further, 
our results show that a data-based AF that would be needed for interspecies extrapolation is 
smaller when the point of departure is a BMDL rather than a NOAEL. In the context of a 
probabilistic hazard characterization, our results indicate that the (geometric) SD of the 
interspecies AF distribution should be around 2.0 when the BMDL (or BMD uncertainty 
distribution) is used, and around 3.4 when the NOAEL is used as a point of departure for further 
risk assessment. 
 
Structure-Activity Relationship Analysis of Rat Mammary Carcinogens 
Quick ViewOther Sources 
 By Cunningham, Albert R.; Moss, Shanna T.; Iype, Seena A.; Qian, Gefei; Qamar, Shahid; 
Cunningham, Suzanne L.  
 From Chemical Research in Toxicology (2008), 21(10), 1970-1982. | Language: English, Database: 
CAPLUS  
  
Structure-activity relationship (SAR) models are powerful tools to investigate the mechanisms of 
action of chem. carcinogens and to predict the potential carcinogenicity of untested compds. We 
describe here the application of the cat-SAR (categorical-SAR) program to two learning sets of rat 
mammary carcinogens. One set of developed models was based on a comparison of rat mammary 
carcinogens to rat noncarcinogens (MC-NC), and the second set compared rat mammary carcinogens 
to rat nonmammary carcinogens (MC-NMC). On the basis of a leave-one-out validation, the best rat 
MC-NC model achieved a concordance between exptl. and predicted values of 84%, a sensitivity of 79
%, and a specificity of 89%. Likewise, the best rat MC-MNC model achieved a concordance of 78%, a 
sensitivity of 82%, and a specificity of 74%. The MC-NMC model was based on a learning set that 
contained carcinogens in both the active (i.e., mammary carcinogens) and the inactive (i.e., 
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carcinogens to sites other than the mammary gland) categories and was able to distinguish between 
these different types of carcinogens (i.e., tissue specific), not simply between carcinogens and 
noncarcinogens. On the basis of a structural comparison between this model and one for Salmonella 
mutagens, there was, as expected, a significant relationship between the two phenomena since a 
high proportion of breast carcinogens are Salmonella mutagens. However, when analyzing the 
specific structural features derived from the MC-NC learning set, a dichotomy was obsd. between 
fragments assocd. with mammary carcinogenesis and mutagenicity and others that were assocd. with 
estrogenic activity. Overall, these findings suggest that the MC-NC and MC-NMC models are able to 
identify structural attributes that may in part address the question of "why do some carcinogens 
cause breast cancer", which is a different question than "why do some chems. cause cancer". 
 
Absorption, distribution, metabolism, and excretion of 2,2-bis(bromomethyl)-1,3-propanediol in 
male Fischer-344 rats 
Quick ViewOther Sources 
 By Hoehle, Simone I.; Knudsen, Gabriel A.; Sanders, J. Michael; Sipes, I. Glenn  
 From Drug Metabolism and Disposition (2009), 37(2), 408-416. | Language: English, Database: 
CAPLUS  
 2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant, 
previously shown to be a multisite carcinogen in exptl. animals. Studies were performed to 
characterize the dispositional and metabolic fate of BMP after oral or i.v. administration to male 
Fischer-344 rats. After a single oral administration of [14C]BMP (10 or 100 mg/kg) >80% of the 
low dose and 48% of the high dose were excreted by 12 h in the urine predominantly as a 
glucuronide metabolite. After repeated daily oral doses for 5 or 10 days, route and rate of 
elimination were similar to those obtained after single administrations of BMP. In all studies, the 
radioactivity recovered in feces was low (<15%). The total amt. of radioactivity remaining in 
tissues at 72 h after a single oral administration of BMP (100 mg/kg) was less than 1% of the 
dose, and repeated daily dosing did not lead to retention in tissues. After i.v. administration, the 
radiolabel found in blood decreased rapidly. Excretion profiles were similar to those after oral 
administration. Parent BMP and BMP glucuronide were present in blood plasma after oral or i.v. 
dosing. After an i.v. dose of BMP (15 mg/kg) the hepatic BMP glucuronide was primarily exported 
into the bile (>50% within 6 h), but it underwent enterohepatic recycling with subsequent 
elimination in the urine. These data indicate that the extensive extn. and rapid glucuronidation 
by the liver limits exposure of internal tissues to BMP by greatly reducing its systemic 
bioavailability after oral exposure. 
 
Use of Short-term Transcriptional Profiles to Assess the Long-term Cancer-Related Safety of 
Environmental and Industrial Chemicals 
Quick ViewOther Sources 
 By Thomas, Russell S.; Bao, Wenjun; Chu, Tzu-Ming; Bessarabova, Marina; Nikolskaya, Tatiana; 
Nikolsky, Yuri; Andersen, Melvin E.; Wolfinger, Russell D.  
 From Toxicological Sciences (2009), 112(2), 311-321. | Language: English, Database: CAPLUS  
 The process for evaluating chem. safety is inefficient, costly, and animal intensive. 
There is growing consensus that the current process of safety testing needs to be significantly 
altered to improve efficiency and reduce the no. of untested chems. In this study, the use of 
short-term gene expression profiles was evaluated for predicting the increased incidence of 
mouse lung tumors. Animals were exposed to a total of 26 diverse chems. with matched vehicle 
controls over a period of 3 years. Upon completion, significant batch-related effects were obsd. 
Adjustment for batch effects significantly improved the ability to predict increased lung tumor 
incidence. For the best statistical model, the estd. predictive accuracy under honest fivefold 
cross-validation was 79.3% with a sensitivity and specificity of 71.4 and 86.3%, resp. A learning 
curve anal. demonstrated that gains in model performance reached a plateau at 25 chems., 
indicating that the size of current data set was sufficient to provide a robust classifier. The 
classification results showed that a small subset of chems. contributed disproportionately to the 
misclassification rate. For these chems., the misclassification was more closely assocd. with 
genotoxicity status than with efficacy in the original bioassay. Statistical models were also used 
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to predict dose-response increases in tumor incidence for methylene chloride and naphthalene. 
The av. posterior probabilities for the top models matched the results from the bioassay for 
methylene chloride. For naphthalene, the av. posterior probabilities for the top models 
overpredicted the tumor response, but the variability in predictions was significantly higher. The 
study provides both a set of gene expression biomarkers for predicting chem. induced mouse 
lung tumors and a broad assessment of important exptl. and anal. criteria for developing 
microarray-based predictors of safety-related end points. 
 
Addition to national toxicology program carcinogens: Community right-to-know toxic chemical 
release reporting 
Quick ViewOther Sources 
 By Environmental Protection Agency  
 From Federal Register (2010), 75(65), 17333-17349. | Language: English, Database: CAPLUS  
 SUMMARY: EPA is proposing to add sixteen chems. to the list of toxic chems. subject 
to reporting under section 313 of the Emergency Planning and Community Right-to-Know Act 
(EPCRA) of 1986 and section 6607 of the Pollution Prevention Act of 1990 (PPA). These sixteen 
chems. have been classified by the National Toxicol. Program (NTP) in their Report on 
Carcinogens (RoC) as "reasonably anticipated to be a human carcinogen." EPA believes that 
these sixteen chems. meet the EPCRA section 313(d)(2)(B) criteria because they can reasonably 
be anticipated to cause cancer in humans. As in past chem. reviews, EPA adopted a prodn. vol. 
screen for the development of this proposed rule to screen out those chems. for which no 
reports are expected to be submitted. Based on a review of the available prodn. and use 
information, these sixteen chems. are expected to be manufd., processed, or otherwise used in 
quantities that would exceed the EPCRA section 313 reporting thresholds. 
 
In vitro glucuronidation of 2,2-bis(bromomethyl)-1,3-propanediol by microsomes and hepatocytes 
from rats and humans 
Quick ViewOther Sources 
 By Rad, Golriz; Hoehle, Simone I.; Kuester, Robert K.; Sipes, I. Glenn  
 From Drug Metabolism and Disposition (2010), 38(6), 957-962. | Language: English, Database: 
CAPLUS  
 2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant used in 
unsatd. polyester resins. In a 2-yr bioassay BMP was shown to be a multisite carcinogen in rats 
and mice. Because glucuronidation is the key metabolic transformation of BMP by rats, in this 
study the in vitro hepatic glucuronidation of BMP was compared across several species. In addn., 
the glucuronidation activities of human intestinal microsomes and specific human hepatic UDP-
glucuronosyltransferase (UGT) enzymes for BMP were detd. To explore other possible routes of 
metab. for BMP, studies were conducted with rat and human hepatocytes. Incubation of hepatic 
microsomes with BMP in the presence of UDP-glucuronic acid resulted in the formation of a BMP 
monoglucuronide. The order of hepatic microsomal glucuronidation activity of BMP was rats, 
mice >> hamsters > monkeys >>> humans. The rate of glucuronidation by rat hepatic 
microsomes was 90-fold greater than that of human hepatic microsomes. Human intestinal 
microsomes converted BMP to BMP glucuronide at a rate even lower than that of human hepatic 
microsomes. Among the human UGT enzymes tested, only UGT2B7 had detectable 
glucuronidation activity for BMP. BMP monoglucuronide was the only metabolite formed when 
BMP was incubated with suspensions of freshly isolated hepatocytes from male F-344 rats or 
with cryopreserved human hepatocytes. Glucuronidation of BMP in human hepatocytes was 
extremely low. Overall, the results support in vivo studies in rats in which BMP glucuronide was 
the only metabolite found. The poor glucuronidation capacity of humans for BMP suggests that 
the pharmacokinetic profile of BMP in humans will be dramatically different from that of rodents. 
 
SMILES-based optimal descriptors: QSAR modeling of carcinogenicity by balance of correlations 
with ideal slopes 
Quick ViewOther Sources 
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 By Toropov, A. A.; Toropova, A. P.; Benfenati, E.  
 From European Journal of Medicinal Chemistry (2010), 45(9), 3581-3587. | Language: English, 
Database: CAPLUS  
 Optimal descriptors which are calcd. using the simplified mol. input line entry system 
(SMILES) were utilized to build quant. structure-activity relationships (QSAR) of carcinogenicity 
(log TD50). Three schemes of the modeling have been examd.: 1. The most traditional "classic" 
training-test system, i.e., models are built with training set and validated with external test set; 
2. The correlation balance, i.e., models are built with preliminary estn. of the predictability of the 
model with the calibration set (this set plays a role of preliminary test set); and 3. The extended 
correlation balance that takes into account the slopes of regression lines in plots exptl. vs. 
predicted values of carcinogenicity (in ideal, these slopes should be similar). It has been shown 
that the extended correlation balance with the ideal slopes gives most robust prediction of 
carcinogenicity for external test set. These models have been built by Monte Carlo method for 
three splits into subtraining set, calibration set, and test set. The no. of the N-nitroso groups 
(i.e., R1-N(R2)-N= O) in a mol. system has been examd. as an addnl. descriptor. 
 
Addition of national toxicology program carcinogens; community right-to-know toxic chemical 
release reporting 
Quick ViewOther Sources 
 By Bushman, Daniel R.  
 From Federal Register (2010), 75(227), 72727-72734. | Language: English, Database: CAPLUS  
 USEPA is adding 16 chems. to the list of toxic chems. subject to reporting under 
Section 313 of the Emergency Planning and Community Right-to-Know Act (EPCRA) of 1986 and 
Section 6607 of the Pollution Prevention Act of 1990. These 16 chems. were classified by the 
National Toxicol. Program in their Report on Carcinogens as: reasonably anticipated to be a 
human carcinogen. EPA detd. these 16 chems. meet EPCRA Section 313(d)(2)(B) criteria 
because they can reasonably be anticipated to cause cancer in humans. 
 
Induction of DNA damage in human urothelial cells by the brominated flame retardant 2,2-
bis(bromomethyl)-1,3-propanediol: Role of oxidative stress 
Quick ViewOther Sources 
 By Kong, Weixi; Kuester, Robert K.; Gallegos, Alfred; Sipes, I. Glenn  
 From Toxicology (2011), 290(2-3), 272-278. | Language: English, Database: CAPLUS  
 2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is an extensively used brominated 
flame retardant found in urethane foams and polyester resins. In a 2-yr dietary study conducted 
by the National Toxicol. Program, BMP caused neoplastic lesions at multiple sites including the 
urinary bladder in both rats and mice. The mechanism of its carcinogenic effect is unknown. In 
the present study, using SV-40 immortalized human urothelial cells (UROtsa), endpoints assocd. 
with BMP induced DNA damage and oxidative stress were investigated. The effects of time (1-24 
h) and concn. (5-100 μM) on BMP induced DNA strand breaks were assessed via the alk. comet 
assay. The results revealed evidence of DNA strand breaks at 1 and 3 h following incubation of 
cells with non-cytotoxic concns. of BMP. Strand breaks were not present after 6 h of incubation. 
Evidences for BMP assocd. oxidative stress include: an elevation of intracellular ROS formation as 
well as induction of Nrf2 and HSP70 protein levels. In addn., DNA strand breaks were attenuated 
when cells were pre-treated with N-acetyl-L-cysteine (NAC) and oxidative base modifications 
were revealed when a lesion specific endonuclease, human 8-hydroxyguanine DNA glycosylase 1 
(hOGG1) was introduced into the comet assay. In conclusion, these results demonstrate that 
BMP induces DNA strand breaks and oxidative base damage in UROtsa cells. Oxidative stress is a 
significant, determinant factor in mediating these DNA lesions. These early genotoxic events 
may, in part, contribute to BMP-induced carcinogenesis obsd. in rodents. 
 
First report on development of quantitative interspecies structure-carcinogenicity relationship 
models and exploring discriminatory features for rodent carcinogenicity of diverse organic 
chemicals using OECD guidelines 
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Quick ViewOther Sources 
 By Kar, Supratik; Roy, Kunal  
 From Chemosphere (2012), 87(4), 339-355. | Language: English, Database: CAPLUS  
 Different regulatory agencies in food and drug administration and environmental 
protection worldwide are employing quant. structure-activity relationship (QSAR) models to fill 
the data gaps related with properties of chems. affecting the environment and human health. 
Carcinogenicity is a toxicity endpoint of major concern in recent times. Interspecies toxicity 
correlations may provide a tool for estg. sensitivity towards toxic chem. exposure with known 
levels of uncertainty for a diversity of wildlife species. In this background, we have developed 
quant. interspecies structure-carcinogenicity correlation models for rat and mouse [rodent 
species according to the Organization for Economic Cooperation and Development (OECD) 
guidelines] based on the carcinogenic potential of 166 org. chems. with wide diversity of mol. 
structures, spanning a large no. of chem. classes and biol. mechanisms. All the developed 
models have been assessed according to the OECD principles for the validation of QSAR models. 
Consensus predictions for carcinogenicity of the individual compds. are presented here for any 
one species when the data for the other species are available. Informative illustrations of the 
contributing structural fragments of chems. which are responsible for specific carcinogenicity 
endpoints are identified by the developed models. The models have also been used to predict 
mouse carcinogenicities of 247 org. chems. (for which rat carcinogenicities are present) and rat 
carcinogenicities of 150 chems. (for which mouse carcinogenicities are present). Discriminatory 
features for rat and mouse carcinogenicity values have also been explored. 
 
Scientific opinion on emerging and novel brominated flame retardants (BFRs) in food 
Quick ViewOther Sources 
 By Benford, Diane; Ceccatelli, Sandra; Cottrill, Bruce; DiNovi, Michael; Dogliotti, Eugenia; Edler, 
Lutz; Farmer, Peter; Furst, Peter; Hoogenboom, Laurentius; Knutsen, Helle Katrine; et al 
 From EFSA Journal (2012), 10(10), 2908, 125 pp.. | Language: English, Database: CAPLUS  
 EFSA was asked to deliver a scientific opinion on brominated flame retardants (BFRs) 
other than PBDEs, PBBs, HBCDDs, TBBPA and brominated phenols and their derivs. The BFRs 
that are the subject of the current opinion, were classified in groups termed 'emerging' and 
'novel' BFRs. Information on 17 emerging and 10 novel BFRs was collected. The information 
varied widely for these BFRs. There is a lack of exptl. data on physico-chem. characteristics, 
stability/reactivity and current use and prodn. vol. of all the emerging and novel BFRs. Due to 
the very limited information on occurrence, exposure and toxicity, the CONTAM Panel could not 
perform a risk characterization for any of the BFRs considered. Instead, an attempt was made to 
identify those BFRs that could be a potential health concern and should be considered first for 
future investigations. For this purpose the Panel first evaluated the available exptl. data on 
occurrence in food, behavior in the environment and toxicity. Secondly, a modeling exercise was 
performed focussing on the potential of the emerging and novel BFRs for persistence in the 
environment and for their possible bioaccumulation potential. There is convincing evidence that 
tris(2,3-dibromopropyl) phosphate (TDBPP) and dibromoneopentyl glycol (DBNPG) are genotoxic 
and carcinogenic, warranting further surveillance of their occurrence in the environment and in 
food. Based on the limited exptl. data on environmental behavior, 1,2-bis(2,4,6-
tribromophenoxy)ethane (BTBPE) and hexabromobenzene (HBB) were identified as compds. that 
could raise a concern for bioaccumulation. For the modeling exercise, the CONTAM Panel 
selected two environmental characteristics, overall persistence and potential for bioaccumulation, 
as being most relevant to provide insight into the possibility that emerging or novel BFRs might 
accumulate in the food chain, and thus might appear in food intended for human consumption. 
The modeling exercise identified ten addnl. BFRs that should be subjected to further in-depth 
studies. 
 
Carcinogenicity Prediction of Noncongeneric Chemicals by a Support Vector Machine 
Quick ViewOther Sources 
 By Zhong, Min; Nie, Xianglei; Yan, Aixia; Yuan, Qipeng  
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 From Chemical Research in Toxicology (2013), 26(5), 741-749. | Language: English, Database: 
CAPLUS  
  
The ability to identify carcinogenic compds. is of fundamental importance to the safe application of 
chems. In this study, the authors generated an array of in silico models allowing the classification of 
compds. into carcinogenic and noncarcinogenic agents based on a data set of 852 noncongeneric 
chems. collected from the Carcinogenic Potency Database (CPDBAS). Twenty-four mol. descriptors 
were selected by Pearson correlation, F-score, and stepwise regression anal. These descriptors cover 
a range of physicochem. properties, including electrophilicity, geometry, mol. wt., size, and soly. The 
descriptor mutagenic showed the highest correlation coeff. with carcinogenicity. On the basis of these 
descriptors, a support vector machine-based (SVM) classification model was developed and fine-tuned 
by a 10-fold cross-validation approach. Both the SVM model (Model A1) and the best model from the 
10-fold cross-validation (Model B3) runs gave good results on the test set with prediction accuracy 
over 80%, sensitivity over 76%, and specificity over 82%. In addn., extended connectivity 
fingerprints (ECFPs) and the Toxtree software were used to analyze the functional groups and 
substructures linked to carcinogenicity. It was found that the results of both methods are in good 
agreement. 
 
Oxidative DNA damage and DNA binding induced by 2, 2-bis (bromomethyl)-1, 3-propanediol: 
Possible mode of action implicated in its carcinogenicity 
Quick ViewOther Sources 
 By Kong, Weixi  
 No Corporate Source data available | (2012), 169 pp.. | Language: English, Database: CAPLUS 
 
Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor Signaling Assays 
Quick ViewOther Sources 
 By Sipes, Nisha S.; Martin, Matthew T.; Kothiya, Parth; Reif, David M.; Judson, Richard S.; Richard, 
Ann M.; Houck, Keith A.; Dix, David J.; Kavlock, Robert J.; Knudsen, Thomas B.  
 From Chemical Research in Toxicology (2013), 26(6), 878-895. | Language: English, Database: 
CAPLUS  
  
Understanding potential health risks is a significant challenge due to the large nos. of diverse chems. 
with poorly characterized exposures and mechanisms of toxicities. The present study analyzes 976 
chems. (including failed pharmaceuticals, alternative plasticizers, food additives, and pesticides) in 
Phases I and II of the U.S. EPA's ToxCast project across 331 cell-free enzymic and ligand-binding 
high-throughput screening (HTS) assays. Half-maximal activity concns. (AC50) were identified for 729 
chems. in 256 assays (7135 chem.-assay pairs). Some of the most commonly affected assays were 
CYPs (CYP2C9 and CYP2C19), transporters (mitochondrial TSPO, norepinephrine, and dopaminergic), 
and GPCRs (aminergic). Heavy metals, surfactants, and dithiocarbamate fungicides showed 
promiscuous but distinctly different patterns of activity, whereas many of the pharmaceutical compds. 
showed promiscuous activity across GPCRs. Literature anal. confirmed >50% of the activities for the 
most potent chem.-assay pairs (54) but also revealed 10 missed interactions. Twenty-two chems. 
with known estrogenic activity were correctly identified for the majority (77%), missing only the 
weaker interactions. In many cases, novel findings for previously unreported chem.-target 
combinations clustered with known chem.-target interactions. Results from this large inventory of 
chem.-biol. interactions can inform read-across methods as well as link potential targets to mol. 
initiating events in adverse outcome pathways for diverse toxicities. 
 
Comparison of 2,2-bis(bromomethyl)-1,3-propanediol induced genotoxicity in UROtsa cells and 
primary rat hepatocytes: Relevance of metabolism and oxidative stress 
Quick ViewOther Sources 
 By Kong, Weixi; Gu, Pengfei; Knudsen, Gabriel A.; Sipes, I. Glenn  
 From Toxicology Letters (2013), 222(3), 273-279. | Language: English, Database: CAPLUS  
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 2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant used in 
urethane foams and polyester resins. In a two year dietary study, BMP caused neoplastic lesions 
at multiple sites including the urinary bladder of both rats and mice. However, liver was not a 
target tissue. The authors previously reported that BMP elicited oxidative DNA damage in a 
human uroepithelial cell line (UROtsa). The present in vitro study investigated the susceptibility 
of target (UROtsa cells) and non-target cells (primary rat hepatocytes) to BMP-induced 
genotoxicity. In contrast to hepatocytes, BMP exhibited greater genotoxic potential in UROtsa 
cells as evidenced by the concn. dependent increase in DNA strand breaks and DNA binding. 
Total content of intracellular GSH quantified in UROtsa cells (2.7 nmol/mg protein) was 4-fold 
lower than that in hepatocytes (10.7 nmol/mg protein). HPLC anal. indicated BMP was not 
metabolized and/or consumed in UROtsa cells at any of the concns. tested (10-250 μM) but was 
extensively converted to a mono-glucuronide in hepatocytes. These results demonstrate that a 
target cell line such as UROtsa cells are more susceptible to BMP-induced DNA damage when 
compared to non-target cells. This increased susceptibility may relate to the deficiency of 
antioxidant and/or metabolic capabilities in UROtsa cells. 
 
Assessing the persistence, bioaccumulation potential and toxicity of brominated flame retardants: 
Data availability and quality for 36 alternative brominated flame retardants 
Quick ViewOther Sources 
 By Stieger, Greta; Scheringer, Martin; Ng, Carla A.; Hungerbuhler, Konrad  
 From Chemosphere (2014), 116, 118-123. | Language: English, Database: CAPLUS  
 Polybrominated diphenylethers (PBDEs) and hexabromocyclododecane (HBCDD) are 
major brominated flame retardants (BFRs) that are now banned or under restrictions in many 
countries because of their persistence, bioaccumulation potential and toxicity (PBT properties). 
However, there is a wide range of alternative BFRs, such as decabromodiphenyl ethane and 
tribromophenol, that are increasingly used as replacements, but which may possess similar 
hazardous properties. This necessitates hazard and risk assessments of these compds. For a set 
of 36 alternative BFRs, we searched 25 databases for chem. property data that are needed as 
input for a PBT assessment. These properties are degrdn. half-life, bioconcn. factor (BCF), 
octanol-water partition coeff. (Kow), and toxic effect concns. in aquatic organisms. For 17 of the 
36 substances, no data at all were found for these properties. Too few persistence data were 
available to even assess the quality of these data in a systematic way. The available data for K ow 
and toxicity show surprisingly high variability, which makes it difficult to identify the most reliable 
values. We propose methods for systematic evaluations of PBT-related chem. property data that 
should be performed before data are included in publicly available databases. Using these 
methods, we evaluated the data for Kow and toxicity in more detail and identified several 
inaccurate values. For most of the 36 alternative BFRs, the amt. and the quality of the PBT-
related property data need to be improved before reliable hazard and risk assessments of these 
substances can be performed. 
 
Effects of seven chemicals on DNA damage in the rat urinary bladder: A comet assay study 
Quick ViewOther Sources 
 By Wada, Kunio; Yoshida, Toshinori; Takahashi, Naofumi; Matsumoto, Kyomu  
 From Mutation Research, Genetic Toxicology and Environmental Mutagenesis (2014), 769, 1-6. | 
Language: English, Database: CAPLUS  
 The in vivo comet assay has been used for the evaluation of DNA damage and repair 
in various tissues of rodents. However, it can give false-pos. results due to non-specific DNA 
damage assocd. with cell death. In this study, we examd. whether the in vivo comet assay can 
distinguish between genotoxic and non-genotoxic DNA damage in urinary bladder cells, by using 
the following seven chems. related to urinary bladder carcinogenesis in rodents: N-butyl-N-(4-
hydroxybutyl)nitrosamine (BBN), glycidol, 2,2-bis(bromomethyl)-1,3-propanediol (BMP), 2-
nitroanisole (2-NA), benzyl isothiocyanate (BITC), uracil, and melamine. BBN, glycidol, BMP, and 
2-NA are known to be Ames test-pos. and they are expected to produce DNA damage in the 
absence of cytotoxicity. BITC, uracil, and melamine are Ames test-neg. with metabolic activation 
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but have the potential to induce non-specific DNA damage due to cytotoxicity. The test chems. 
were administered orally to male Sprague-Dawley rats (five per group) for each of two 
consecutive days. Urinary bladders were sampled 3 h after the second administration and 
urothelial cells were analyzed by the comet assay and subjected to histopathol. examn. to 
evaluate cytotoxicity. In the urinary bladders of rats treated with BBN, glycidol, and BMP, DNA 
damage was detected. In contrast, 2-NA induced neither DNA damage nor cytotoxicity. The non-
genotoxic chems. (BITC, uracil, and melamine) did not induce DNA damage in the urinary 
bladders under conditions where some histopathol. changes were obsd. The results indicate that 
the comet assay could distinguish between genotoxic and non-genotoxic chems. and that no 
false-pos. responses were obtained. 
 
Predictive Endocrine Testing in the 21st Century Using in Vitro Assays of Estrogen Receptor 
Signaling Responses 
Quick ViewOther Sources 
 By Rotroff, Daniel M.; Martin, Matt T.; Dix, David J.; Filer, Dayne L.; Houck, Keith A.; Knudsen, 
Thomas B.; Sipes, Nisha S.; Reif, David M.; Xia, Menghang; Huang, Ruili; et al 
 From Environmental Science & Technology (2014), 48(15), 8706-8716. | Language: English, 
Database: CAPLUS  
  
Thousands of environmental chems. are subject to regulatory review for their potential to be 
endocrine disruptors (ED). In vitro high-throughput screening (HTS) assays have emerged as a 
potential tool for prioritizing chems. for ED-related whole-animal tests. In this study, 1814 chems. 
including pesticide active and inert ingredients, industrial chems., food additives, and pharmaceuticals 
were evaluated in a panel of 13 in vitro HTS assays. The panel of in vitro assays interrogated multiple 
end points related to estrogen receptor (ER) signaling, namely binding, agonist, antagonist, and cell 
growth responses. The results from the in vitro assays were used to create an ER Interaction Score. 
For 36 ref. chems., an ER Interaction Score >0 showed 100% sensitivity and 87.5% specificity for 
classifying potential ER activity. The magnitude of the ER Interaction Score was significantly related 
to the potency classification of the ref. chems. ERα/ERβ selectivity was also evaluated, but relatively 
few chems. showed significant selectivity for a specific isoform. When applied to a broader set of 
chems. with in vivo uterotrophic data, the ER Interaction Scores showed 91% sensitivity and 65% 
specificity. Overall, this study provides a novel method for combining in vitro concn. response data 
from multiple assays and, when applied to a large set of ER data, accurately predicted estrogenic 
responses and demonstrated its utility for chem. prioritization. 
 
Physical-chemical properties and evaluative fate modelling of 'emerging' and 'novel' brominated 
and organophosphorus flame retardants in the indoor and outdoor environment 
Quick ViewOther Sources 
 By Liagkouridis, Ioannis; Cousins, Anna Palm; Cousins, Ian T.  
 From Science of the Total Environment (2015), 524-525, 416-426. | Language: English, Database: 
CAPLUS  
 Several groups of flame retardants (FR) entered the market in recent years as 
replacements for polybrominated di-Ph ethers (PBDE), but little is known about their 
physicochem. properties or their environmental transport and fate. This work made best ests. of 
physicochem. properties and evaluative modeling assessments (indoors and outdoors) for 35 
novel and emerging brominated flame retardants (BFR) and 22 organophosphorus flame 
retardants (OPFR). A quant. structure-property relationship-based technique reduced uncertainty 
in physicochem. properties and aided property selection for modeling, but it was evident that 
more, high quality property data are required to improve future assessments. Evaluative 
modeling results showed many alternative FR, mainly alternative BFR and some halogenated 
OPFR, behave similarly to PBDE under indoor and outdoor conditions. Alternative FR exhibited 
high overall persistence (Pov), long-range transport potential (LRTP), and persistent org. 
pollutant-like behavior, and on that basis, cannot be regarded as suitable replacements for PBDE. 
A group of low mol. wt. alternative BFR and non-halogenated OPFR demonstrated potentially 
better environmental performance based on Pov and LRTP metrics. Results must be interpreted 
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with caution because there are significant uncertainties and limited data to allow for thorough 
model evaluation. Addnl. environmental parameters (toxicity, bioaccumulative potential, 
functionality issues) should be considered for an industrial substitution strategy. 
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Comparison between rodent carcinogenicity test results of 44 chemicals and a number of predictive 
systems 
Quick ViewOther Sources 
 By Lewis, David F. V.  
 From Regulatory Toxicology and Pharmacology (1994), 20(3, Pt. 1), 215-22. | Language: English, 
Database: CAPLUS  
 A comparison is made between a no. of predictive systems including bacterial 
mutagenicity, structure alert and chronic toxicity (R. W. Tennant et al., 1990), COMPACT, 
Hazardexpert, and DEREK, with the outcome of the two species rodent carcinogenicity bioassay 
for 44 chems. conducted under the NTP protocol. Following minor updating of the rodent data in 
the light of pathol. reports, there is a generally good agreement between various predictions and 
the actual carcinogenicity results. In particular, a combination of two methods of prediction 
produces an over 80% concordance with the rodent bioassay. Possible reasons for various 
discrepancies are discussed in light of xenobiotic metab. and activation mechanisms of chem. 
carcinogenesis. 
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2-Haloacrylic acids as indicators of mutagenic 2-haloacrolein intermediates in mammalian 
metabolism of selected promutagens and carcinogens 
Quick ViewOther Sources 
 By Marsden P J; Casida J E  
 From Journal of agricultural and food chemistry (1982), 30(4), 627-31. | Language: English, 
Database: MEDLINE 
 
2,3-Dibromopropan-1-ol 
Quick ViewOther Sources 
 By Anonymous  
 From IARC monographs on the evaluation of carcinogenic risks to humans / World Health 
Organization, International Agency for Research on Cancer (2000), 77, 439-53. | Language: English, Database: 
MEDLINE 
 
2,3-Dibromo-1-propanol 
Quick ViewOther Sources 
 No Author and Editor data available 
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 From Report on carcinogens : carcinogen profiles / U.S. Dept. of Health and Human Services, Public 
Health Service, National Toxicology Program (2002), 10, 82-3. | Language: English, Database: MEDLINE 
 
2,3-Dibromo-1-propanol 
Quick ViewOther Sources 
 By Anonymous  
 From Report on carcinogens : carcinogen profiles / U.S. Dept. of Health and Human Services, Public 
Health Service, National Toxicology Program (2004), 11, III84. | Language: English, Database: MEDLINE 
 
2,3-Dibromo-1-propanol 
Quick ViewOther Sources 
 No Author and Editor data available 
 From Report on carcinogens : carcinogen profiles / U.S. Dept. of Health and Human Services, Public 
Health Service, National Toxicology Program (2011), 12, 138-9. | Language: English, Database: MEDLINE 
 
Influence of some aliphatic compounds on rat liver glutathione levels 
Quick ViewOther Sources 
 By Johnson, M. K.  
 From Biochemical Pharmacology (1965), 14(9), 1383-5. | Language: English, Database: CAPLUS  
 Oral administration of bromobutane to rats caused moderate depression of liver 
glutathione (GSH) levels. Iodomethane has a much greater effect, and has been shown to S-
methylate GSH under the influence of a liver enzyme, glutathione S-alkyl transferase, in vivo and 
in vitro. Examn. of the liver enzyme showed that it had a fairly wide specificity for substrates 
other than GSH, and reports are given on the effect on rat liver GSH of some aliphatic compds. 
administered orally. Discrepancies between effects seen in vivo and in vitro are discussed. 
 
Studies of possible absorption of a flame retardant from treated fabrics worn by rats and humans 
Quick ViewOther Sources 
 By St. John, L. E., Jr.; Eldefrawi, M. E.; Lisk, D. J.  
 From Bulletin of Environmental Contamination and Toxicology (1976), 15(2), 192-7. | Language: 
English, Database: CAPLUS  
 When tris(2,3-dibromopropyl) phosphate [126-72-7] was applied to the skin of a rat, 
its hydrolysis product, 2,3-dibromopropanol [96-13-9], was detected in the urine. Rat liver 
supernatant hydrolyzed the phosphate to dibromopropanol. No dibromopropanol was detected in 
the urine of a rat, a man, and a boy who wore fabrics contg. the flame retardant for up to 9 
days. 
 
Tris(2,3-dibromopropyl) phosphate: mutagenicity of a widely used flame retardant 
Quick ViewOther Sources 
 By Prival, Michael J.; McCoy, Elena C.; Gutter, Bezalel; Rosenkranz, Herbert S.  
 From Science (Washington, DC, United States) (1977), 195(4273), 76-8. | Language: English, 
Database: CAPLUS  
 Tris(2,3-dibromopropyl) phosphate [126-72-7], a widely used flame-retardant 
additive for textiles, was mutagenic to histidine-requiring strains of Salmonella typhimurium. 
Exts. of fabrics treated with this compd. were also capable of inducing mutations in these 
bacterial strains. 
 
Mutagenicity of derivatives of the flame retardant tris(2,3-dibromopropyl)phosphate: halogenated 
propanols 
Quick ViewOther Sources 
 By Carr, Howard S.; Rosenkranz, Herbert S.  
 From Mutation Research, Genetic Toxicology Testing (1978), 57(3), 381-4. | Language: English, 
Database: CAPLUS  
 Genetic tests on 6 halogenated propanols which are potential derivs. of TBPP (tris(2,
3-dibromopropyl)phosphate) [126-72-7] showed that all except 3-chloro-1-propanol [627-30-5] 
were mutagenic to Salmonella typhimurium through direct base substitution. The mutagenic 
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activities of 3-bromo-1-propanol [627-18-9], 2,3-dibromo-1-propanol [96-13-9], and TBPP were 
increased in the presence of rat liver microsomes. Caution is indicated in the selection of flame 
retardants which are capable of being hydrolyzed to mutagenic alcs. The possibility of developing 
a flame retardant based on nonmutagenic 3-chloro-1-propanol is suggested. 
 
Children absorb tris-BP flame retardant from sleepwear: urine contains the mutagenic metabolite, 
2,3-dibromopropanol 
Quick ViewOther Sources 
 By Blum, Arlene; Gold, Marian Deborah; Ames, Bruce N.; Kenyon, Christine; Jones, Frank R.; Hett, 
Eva A.; Dougherty, Ralph C.; Horning, Evan C.; Dzidic, Ismet; et al.  
 From Science (Washington, DC, United States) (1978), 201(4360), 1020-3. | Language: English, 
Database: CAPLUS  
 The flame retardant, tris(2,3-dibromopropyl)phosphate (tris-BP) [126-72-7], which is 
a mutagen and causes cancer and sterility in animals, was absorbed from fabric by people. 2,3-
Dibromopropanol [96-13-9], a metabolite of tris-BP and a mutagen itself, was found in the 
urine samples of 10 children who were wearing or who had worn tris-BP-treated sleepwear. 
Eight of these children were wearing well-washed sleepwear and the possibility of absorption of 
tris-BP from well-washed sleepwear is discussed. 2,3-Dibromopropanol was not found in the 
urines of 1 child and 1 adult who had never worn tris-BP-treated garments. 
 
The mutagenicity of halogenated alkanols and their phosphoric acid esters for Salmonella 
typhimurium 
Quick ViewOther Sources 
 By Nakamura, Akitada; Tateno, Noriyuki; Kojima, Shigeo; Kaniwa, Masaaki; Kawamura, Taro  
 From Mutation Research, Genetic Toxicology Testing (1979), 66(4), 373-80. | Language: English, 
Database: CAPLUS  
 Nine halogenated alkanols, 9 corresponding tris(haloalkyl)phosphates, and 2 bis-(2,3-
dibromopropyl)phosphate salts were evaluated for mutagenicity against S. typhimurium TA98, 
TA100, TA1535, TA1537, and TA1538, with and without rat liver in vitro metabolic activation 
system (S9 mix). Most of the test samples showed mutagenic activity in the strains TA100 and 
TA1535, but not in the strains TA98, TA1537, and TA1538. In general, the mutagenic activities 
of the phosphates obtained with S9 mix were greater than the activities obtained without S9 mix. 
Among the phosphates, several structure-activity relations were found; i.e., the bromoalkyl 
derivs. were more mutagenic than the corresponding chloroalkyl derivs., the β-haloethyl derivs. 
were more mutagenic than the γ-halopropyl derivs., the phosphates having adjacent β and γ 
halogen atoms in the alkyl moiety, e.g., tris-(2,3-dibromopropyl)phosphate (I) [126-72-7], were 
particularly potent mutagens, the branched C chain reduced the mutagenic activities in spite of 
the presence of β-halogen atoms, e.g., tris(1-bromomethyl-2-bromoethyl)phosphate [18713-51-
4]. However, such relations did not necessarily apply to the halogenated alkanols. Apparently, 
the metabolic activation pathway via haloalkanols to mutagens must not be in common with all 
of I-like phosphates. 
 
Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative 
metabolism 
Quick ViewOther Sources 
 By Soederlund, Erik J.; Nelson, Sidney D.; Dybing, Erik  
 From Acta Pharmacologica et Toxicologica (1979), 45(2), 112-21. | Language: English, Database: 
CAPLUS  
 The flame retardant tris(2,3-dibromopropyl)phosphate (Tris-BP) [126-72-7] was 
converted to products which were mutagenic for Salmonella typhimurium TA 100 in the presence 
of rat liver microsomes, NADPH, and O. Other bromopropyl compds. were also mutagenic; 2,3-
dibromopropene [513-31-5] and 2,3-dibromopropionic acid [600-05-5] were directly mutagenic, 
whereas 2,3-dibromopropanol [96-13-9] and tris(2-bromopropyl)phosphate [31858-09-0] were 
weakly mutagenic after addn. of liver microsomes and cofactors. Typical in vivo and in vitro 
inhibitors of cytochrome P-450 inhibited Tris-BP mutagenicity. The effects of inducers of 
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cytochrome P-450 on Tris-BP mutagenicity was dependent on the concn. of mutagen and 
microsomal protein in the assay, indicating complexity in the kinetics involved when dealing with 
possible multiple paths that lead to mutagenicity. Addn. of glutathione strongly inhibited Tris-BP 
mutagenicity. Tris-BP may be oxidized to a reactive electrophile, possibly the 2-keto deriv., which 
could react with nucleophilic groups in DNA and thus lead to mutagenic events. 
 
The Escherichia coli Pol A1- assay. A quantitative procedure for diffusible and nondiffusible 
chemicals 
Quick ViewOther Sources 
 By Hyman, Julie; Leifer, Zev; Rosenkranz, Herbert S.  
 From Mutation Research, Environmental Mutagenesis and Related Subjects (1980), 74(2), 107-11. | 
Language: English, Database: CAPLUS  
 A procedure is described for detg. the preferential killing of DNA repair-deficient E. 
coli. Dil. suspensions of DNA repair-proficient and -deficient bacteria are exposed to a graded 
series of test chem. concns. Survivors are detd. by enumeration on agar plates. An expression 
used to express preferential killing (or lack thereof) is shown to be dose-dependent and 
potentially useful for detg. genotoxic potencies. 
 
Mutagenicity of 2- and 3-carbon halogenated compounds in the Salmonella/mammalian-
microsome test 
Quick ViewOther Sources 
 By Stolzenberg, S. J.; Hine, C. H.  
 From Environmental Mutagenesis (1980), 2(1), 59-66. | Language: English, Database: CAPLUS  
 Short-chain, 2- and 3-carbon halogenated hydrocarbons were tested for mutagenicity 
for Salmonella typhimurium strain TA 100 both with and without the presence of S-9. Without 
exception, all brominated derivs. were more mutagenic than the chlorinated derivs., usually by a 
substantial order of magnitude. 2-Fluoroethanol [371-62-0] showed little or no mutagenic activity 
up to 100 μmol/plate. Trihalogenated compds. with a halogen atom on each of the 3 carbon 
atoms required metabolic activation with S-9 for full expression of mutagenic activity. The 
presence of a double bond in the case of 1,2,3-trichloropropene [96-19-5] resulted in a higher 
level of direct mutagenic activity than 1,2,3-trichloropropane [96-18-4], but activation with S-9 
resulted in a further increase in mutagenic activity with the former compd. On the other hand, S-
9 caused a substantial decrease in mutagenic activity of most compds. contg. a double bond. 
With the presence of an alc. group in a compd., the addn. of S-9 caused variable responses, 
increasing the no. of his+ revertant colonies due to 2,3-dibromopropanol [96-13-9] but had little 
or no effect with other compds. contg. an alc. group. Evidence is also presented that the position 
of a double bond in relation to the halogen atoms may influence mutagenic activity. 
 
The relation between the structure of vicinal dihalogen compounds and their mutagenic activation 
via conjugation to glutathione 
Quick ViewOther Sources 
 By Van Bladeren, P. J.; Breimer, D. D.; Rotteveel-Smijs, G. M. T.; De Knijff, P.; Mohn, G. R.; Van 
Meeteren-Walchli, B.; Buijs, W.; Van der Gen, A.  
 From Carcinogenesis (1981), 2(6), 499-505. | Language: English, Database: CAPLUS  
 Vicinal dihalogen compds. may be activated to mutagenic 2-halogenothioethers by 
conjugation to glutathione [70-18-8]. This type of metabolic activation was studied in vitro in 
relation to the chem. structure of such compds. The specific activity of rat liver glutathione 
transferases catalyzing the conjugation of a series of vicinal dihalogen compds. with glutathione 
was detd. The results were employed to define optimal conditions for the assessment of the 
relative mutagenic activity of these compds. towards Salmonella typhimurium TA 100 in the 
presence of rat liver 100,000 g supernatant. A series of model intermediates, N-acetyl-S-2-
halogenalkyl-L-cysteine Me esters, was synthesized and their mutagenic activity was detd. in 
Salmonella strain TA 100. Alkyl substitution at the halogen-bearing carbon atoms reduces both 
glutathione transferase activity and mutagenicity of vicinal dihalogen compds. considerably. In 
the case of Ph substitution, glutathione transferase activity is increased without concomitant 
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enhancement of the mutagenic activity. Introduction of alkyl substituents into the model 
conjugates also results in a lower mutagenic activity. The specific activity of the glutathione 
transferases follows the halide order for leaving group ability, i.e., I > Br > Cl. For the mutagenic 
activity, however, a different result is obtained: the diiodo and dichloro derivs. are less active 
than the corresponding chloro-bromo and dibromo compds. The 2-chloroethylthioether is most 
mutagenic, the 2-bromoethylthioether deriv. is somewhat less active, and the 2-
iodoethylthioether is the least mutagenic compd. A major factor in detg. the mutagenicity of 
such intermediates is presumably their stability in aq. solns., the more reactive compds. having a 
shorter life-time and thus a lower probability to reach genetically relevant macromols. 
 
In vitro and in vivo covalent binding of the kidney toxicant and carcinogen tris(2,3-dibromopropyl)-
phosphate 
Quick ViewOther Sources 
 By Soederlund, Erik J.; Nelson, Sidney D.; Dybing, Erik  
 From Toxicology (1981), 21(4), 291-304. | Language: English, Database: CAPLUS  
 Tris(2,3-dibromopropyl)phosphate (Tris-BP) [126-72-7] is activated to products which 
bind covalently to microsomal protein by a cytochrome P 450 [9035-51-2]-dependent oxidn. 
reaction. Binding to rat liver microsomes proceeds 15 times faster than with kidney microsomes. 
The binding in liver microsomes is markedly increased by phenobarbital pretreatment, the 
apparent Vmax of the reaction is 175 pmol/mg microsomal protein/min with control microsomes 
and 1053 pmol/mg protein/min with induced microsomes. Binding with kidney microsomes is 
doubled after pretreatment with polychlorinated biphenyls. 2,3-Dibromopropanol [96-13-9], an 
hydrolysis product of Tris-BP, is also activated to covalently protein-bound products, but at a 
much slower rate than Tris-BP. Administration of Tris-BP to rats leads to its covalent binding to 
proteins in liver and kidney, with 5 times higher binding levels in kidney than in liver, correlating 
with its relative organotoxic potential in single dose expts. Binding to proteins in the kidney was 
increased by pretreatment of animals with polychlorinated biphenyls. A covalent interaction of 
Tris-BP could also be demonstrated to DNA, both when DNA was added to liver microsomal 
incubations in vitro and to DNA extd. from liver and kidney after administration of Tris-BP in vivo. 
The binding levels were 4 times higher to kidney DNA than to liver DNA. 
 
Nephrotoxicity of the flame retardant, tris(2,3-dibromopropyl) phosphate, and its metabolites 
Quick ViewOther Sources 
 By Elliott, W. Clayton; Lynn, Robert K.; Houghton, Donald C.; Kennish, John M.; Bennett, William M.  
 From Toxicology and Applied Pharmacology (1982), 62(1), 179-82. | Language: English, Database: 
CAPLUS  
 A single i.p. injection of tris(2,3-dibromopropyl) phosphate (TRIS-BP) [126-72-7], 
when administered to male rats, caused polyuric acute renal failure with tubular necrosis 
involving the late proximal tubule. Glomerular filtration rate and in vitro transport of the org. 
acid, p-aminohippurate, and the org. base, N-[14C]methylnicotinamide, were depressed. An 
approx. equimolar dose of the TRIS-BP metabolite, bis(2,3-dibromopropyl) phosphate (BIS-BP) 
[5412-25-9], caused significantly more severe renal failure. In contrast, the metabolite, 2,3-
dibromopropanol [96-13-9], was nonnephrotoxic. Thus, TRIS-BP nephrotoxicity is mediated via 
its metabolite BIS-BP. 
 
Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate 
(Tris-BP) in the rat: identification of mutagenic and nephrotoxic metabolites 
Quick ViewOther Sources 
 By Lynn, Robert K.; Garvie-Gould, Clare; Wong, Kenneth; Kennish, John M.  
 From Toxicology and Applied Pharmacology (1982), 63(1), 105-19. | Language: English, Database: 
CAPLUS  
 The mutagenic, nephrotoxic, and carcinogenic flame retardant Tris-BP [126-72-7] 
underwent rapid and extensive metab. in the rat. Five days after administration of [14C]Tris-BP, 
86% of the radiolabel was excreted in the form of metabolites in the urine (58%), feces (9%), 
and expired air (19% as 14CO2); 9% was recovered in the body. [14C]Tris-BP and its metabolites 
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were analyzed by high-pressure liq. chromatog. and liq. scintillation counting. Tris-BP was not 
detected in the excreta. A metabolite present in urine, feces, bile, and tissues was identified by 
mass spectrometry as bis(2,3-dibromopropyl) phosphate (Bis-BP) [5412-25-9]. 2,3-
dibromopropanol (DBP) [96-13-9] was also identified in tissues and in urine. Biliary excretion 
and enterohepatic recirculation were major routes in the disposition of Tris-BP. All tissues 
contained Tris-BP-derived radioactivity; however, the concn. of radiolabel in kidney was 11 times 
the av. body concn. 5 days after dosing. Bis-BP was mutagenic to Salmonella typhimurium (TA 
100) in the presence of Aroclor-induced liver homogenates. The mutagenic potency was greater 
than that of DBP but less than that of Tris-BP. Also, Bis-BP was an acute nephrotoxin and more 
potent than Tris-BP itself. Thus, the tissues toward which Tris-BP was selectively toxic, kidney 
and colon, were also the tissues which were exposed to selectively high concns. of Tris-BP-
derived radioactivity. Tris-BP, which has a short in vivo half-life, was metabolized to a long-acting 
mutagenic and nephrotoxic metabolite, Bis-BP. 
 
The mei-9a test for chromosome loss/breakage in Drosophila is positive in assays of acetin and 2,
3-dibromo-1-propanol 
Quick ViewOther Sources 
 By Zimmering, S.  
 From Mutation Research Letters (1982), 105(5), 329-31. | Language: English, Database: CAPLUS  
 acetin [26446-35-5] Gave a pos. response with mei-9a for complete loss (CL) and 
partial loss (PL), being ∼5.8 and 5.1%, resp. Similarly, 2,3-dibromo-1-propanol (I) [96-13-9] 
was pos. measured by induced CL or PL and had a total loss of ∼3.4 and 2.2% following 
exposure for 48 or 24 h, resp. In comparison, there was no evidence that the st mus302 strain 
had lost its repair-deficient characteristics. No significant increase in chromosome loss for either 
compd. tested was obsd. from mating with ordinary y2 v females. Thus, chromosome loss
/breakage is demonstrable in F1 progeny from assays of acetin and I in the mei-9a test for 
chromosome loss. 
 
Metabolism and disposition of the flame retardant tris(2,3-dibromopropyl)phosphate in the rat 
Quick ViewOther Sources 
 By Nomeir, Amin A.; Matthews, H. B.  
 From Toxicology and Applied Pharmacology (1983), 67(3), 357-69. | Language: English, Database: 
CAPLUS  
 The metab. and disposition of the flame retardant, tris(2,3-dibromopropyl) phosphate 
(Tris-BP) [126-72-7] were studied after oral and i.v. administration of the 14C-labeled compd. to 
the male rat. Tris-BP was readily absorbed from the gastrointestinal tract and rapidly distributed 
throughout the body. The distribution and excretion of Tris-BP derived radioactivity were similar 
after either oral or i.v. administration. The only effects of route of administration on tissue 
distribution were slightly higher concns. in liver after oral administration and in lung after i.v. 
administration. The initial elimination of Tris-BP derived radioactivity in urine, feces, and as CO2 
accounted for approx. 50% of the dose in 24 h. An anal. of Tris-BP derived radioactivity 
remaining in the tissues 1 day after administration indicated that most of the radioactivity in all 
tissues was in the form of various metabolites rather than the parent compd. The terminal 
clearance of Tris-BP derived radioactivity from most of the tissues was best described by a single 
component exponential decay with a half-life of approx. 2.5 days. Clearance from liver and 
kidney was somewhat slower having a half-life of approx. 3.8 days. Approx. 33% of the 
radioactivity excreted in urine and approx. 50% of the radioactivity excreted in bile were 
identified by cochromatog. with synthesized stds. on high performance liq. chromatog. Six 
metabolites and a trace of the parent compd. were identified in urine and bile by this method. 
The 6 metabolites represent products of dealkylation and dehydrobromination of the parent 
compd. The metabolites of Tris-BP isolated from urine and bile were also formed in vitro by 
NADPH-dependent microsomal enzymes from rat liver. The sol. enzymes from liver metabolized 
Tris-BP to least 3 unidentified polar metabolites. 
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The mei-9a test for chromosome loss in Drosophila: a review of assays of 21 chemicals for 
chromosome breakage 
Quick ViewOther Sources 
 By Zimmering, S.  
 From Environmental Mutagenesis (1983), 5(6), 907-21. | Language: English, Database: CAPLUS  
 Of 21 compds. (17 carcinogens and 4 unknown), all were pos. for complete loss (CL) 
of the X or Y chromosome + partial loss (PL) of the Y and all for PL in the mei-9a test. Only 10 of 
20 compds.. were pos. for CL and PL, and 2 of 21 for PL with repair proficient females; the mei-
9a test being clearly more sensitive than the former (conventional test) for chromosome 
breakage. Therefore, the mei-9a test is a more rapid and sensitive test for chromosome 
breakage, both published and unpublished data on the 21 compds is presented. 
 
Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and 
possible metabolites 
Quick ViewOther Sources 
 By Holme, Joern A.; Soederlund, Erik J.; Hongslo, Jan K.; Nelson, Sidney D.; Dybing, Erik  
 From Mutation Research, Genetic Toxicology Testing (1983), 124(3-4), 213-24. | Language: English, 
Database: CAPLUS  
 Tris(2,3-dibromopropyl)phosphate (Tris-BP) [126-72-7] was activated to mutagens in 
the Salmonella/microsome quant. test system. Liver microsomes from rats pretreated with 
phenobarbital (PB) increased the mutagenicity of 0.05 mM Tris-BP to 186% of the activity 
obtained with liver microsomes from untreated rats. The addn. of 0.02 mM Tris-BP to V79 
Chinese hamster cells coincubated with liver microsomes from PB-pretreated rats increased the 
no. of mutants by a factor of 9.7. Tris-BP also caused genotoxic and cytotoxic responses in 
primary monolayers of rat hepatocytes. The relative increase in unscheduled DNA synthesis after 
treatment with 0.05 mM Tris-BP was 2.3-fold as measured by scintillation counting of 
radiolabeled thymidine incorporated into DNA of isolated nuclei. The use of hepatocytes isolated 
from PB-pretreated rats reduced the increases in DNA repair synthesis relatively to that in control 
cells. Monolayers of hepatocytes from untreated rats cocultured with S. typhimurium TA100 
activated Tris-BP to mutagenic intermediates which were released into the culture medium. 
Apparently, the reactive intermediates formed from Tris-BP are sufficiently stable and lipophilic 
to traverse the various membranes from the site of generation to the resp. cellular targets. The 
relative degree of genotoxic responses of bis(2,3-dibromopropyl)phosphate [5412-25-9], (2,3-
dibromopropyl)phosphate [126-72-7], tris(3-bromopropyl)phosphate [70555-33-8], tris(2-
bromopropyl)phosphate [31858-09-0], and 2,3-dibromopropanol [96-13-9] in the systems 
studied did not indicate that these compds. were proximate or ultimate reactive metabolites of 
Tris-BP in liver-derived activation systems. 
 
Chemical mutagenesis testing in Drosophila. IV. Results of 45 coded compounds tested for the 
National Toxicology Program 
Quick ViewOther Sources 
 By Yoon, J. S.; Mason, J. M.; Valencia, R.; Woodruff, R. C.; Zimmering, S.  
 From Environmental Mutagenesis (1985), 7(3), 349-67. | Language: English, Database: CAPLUS  
 Results from Drosophila mutagenicity tests of 45 chem. compds. assayed for the 
National Toxicol. Program are presented. Nine compds. were judged pos. and 4 equivocal in the 
sex-linked recessive lethal test. The nine pos. compds. were acetin [26446-35-5], allyl glycidyl 
ether (I) [106-92-3], cyclophosphamide [50-18-0], 1,2-dibromo-3-chloropropane [96-12-8], 2,3-
dibromo-1-propanol [96-13-9], dimethylcarbamyl chloride [79-44-7], 1,2-epoxybutane [106-88-
7], lasiocarpine [303-34-4], and N-nitrosopiperidine [100-75-4]. The results for chloral hydrate 
[302-17-0], maleic hydrazide [123-33-1], propantheline bromide [50-34-0], and trifluralin [1582-
09-8] were equivocal. Of the 9 compds. pos. in recessive lethal induction, only I and 
dimethylcarbamyl chloride failed to induce translocations. The remaining 32 were judged to be 
nonmutagenic under the conditions used. 
 
Structure-activity-relationship of organic substances and bioindication 
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Quick ViewOther Sources 
 By Schmidt, Christian; Schnabl, Heide  
 From Vom Wasser (1988), 70, 21-32. | Language: German, Database: CAPLUS  
 Anilines, phenolic and aliph. compds. were tested with 4 different bioassays with 
respect to possible structure-activity-relationship to octanol-water partition coeff., water-soly., 
and bioassay results. Several structure-activity relationships can be verified, a classification of 
structure-dependent effects for a possible prediction of toxicity is not possible. 
 
Yeast - an unicellular model system in ecotoxicology and xenobiochemistry 
Quick ViewOther Sources 
 By Ahlers, Jan; Benzing, Martin; Gies, Andreas; Pauli, Wilfried; Roesick, Erika  
 From Chemosphere (1988), Volume Date1987, 17(8), 1603-15. | Language: English, Database: 
CAPLUS  
 The effects of 57 phenols, anilines, and aliph. compds. on yeast (Saccharomyces 
cerevisiae) growth rate as well as on structural and functional properties of the plasma 
membrane were examd. The different systems correlated with each other and with data from 
higher eukaryotic organisms. Close relations between the activity of the chems. in the different 
biol. test systems and structural parameters, esp. hydrophobicity, were obsd. 
 
Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 
chemicals by the National Toxicology Program 
Quick ViewOther Sources 
 By Tennant, Raymond W.; Spalding, Judson; Stasiewicz, Stanley; Ashby, John  
 From Mutagenesis (1990), 5(1), 3-14. | Language: English, Database: CAPLUS  
 This paper was written to enable evaluation of the concept that knowledge about 
chem. structure combined with limited short-term genotoxicity and toxicity test results can be 
used to predict potential carcinogens. Previous attempts have been potentially biased by prior 
knowledge about the tumorigenicity of chems. in animals or humans, but the 44 chems. that are 
currently being bioassayed for carcinogenicity by the National Toxicol. Program provide an 
opportunity prospectively to evaluate factors that may be predictive of chem. carcinogencity. 
Predictions of rodent carcinogenicity for these 44 agents are presented as an example of what is 
believed to be the best available approach at this time. This publication will also enable others to 
make their own predictions (using whatever methods they believe to have high predictive value) 
before the results of the animal assays are known. 
 
A prospective toxicity evaluation (COMPACT) on 40 chemicals currently being tested by the 
National Toxicology Program 
Quick ViewOther Sources 
 By Lewis, David F. V.; Ioannides, Costas; Parke, Dennis V.  
 From Mutagenesis (1990), 5(5), 433-5. | Language: English, Database: CAPLUS  
 The computer-optimized mol. parametric anal. of chem. toxicity (COMPACT) 
procedure was used to det. the mol. conformation and electronic structure of a series of 40 
chems. (out of a total of 44). The procedure can evaluate whether they interact with the active 
site of cytochrome P 450 I or to the binding site of the Ah receptor, and hence to manifest 
carcinogenicity/toxicity. This is in response to the recent publication by R. W. Tennant, et al. 
(1990) and their invitation to participate in a prospective identification of potential mutagenicity
/carcinogenicity of these 44 chems. Correlation of COMPACT with potential genotoxicity was 25
/40 (63%): COMPACT also predicted toxicity/carcinogenicity in 10 chems. (25%) considered to 
be potentially nongenotoxic [naphthalene, promethazine, resorcinol, p-nitrophenol, tricresyl 
phosphate, bis(bromoethyl)propanediol, 3,4-dihydrocoumarin, theophylline, triamterene and 
chloramine] and predicted the absence of toxicity in four chems. (10%) considered to be 
potentially genotoxic (Me bromide, hydrazoic acid, 2,3-dibromo-1-propanol, and 1,2,3-
trichloropropane). 
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Prediction of the carcinogenicity in rodents of chemicals currently being tested by the US National 
Toxicology Program: structure-activity correlations 
Quick ViewOther Sources 
 By Rosenkranz, Herbert S.; Klopman, Gilles  
 From Mutagenesis (1990), 5(5), 425-32. | Language: English, Database: CAPLUS  
 CASE, an artificial intelligence structure-activity relation system, was used to predict 
the carcinogenicity of a group of chems. currently being tested in rodent bioassays by the US 
National Toxicol. Program. The learning set for the CASE predictions consisted of the results of 
previous 252 rodent carcinogenicity bioassays. 
 
Evaluating the ability of CASE, an artificial intelligence structure-activity relational system, to 
predict structural alerts for genotoxicity 
Quick ViewOther Sources 
 By Rosenkranz, Herbert S.; Klopman, Gilles  
 From Mutagenesis (1990), 5(6), 525-7. | Language: English, Database: CAPLUS  
 CASE, a structure-activity relational system, correctly predicts the presence of 
structural alerts in 36 of 39 mols. (sensitivity, 1.00; specificity, 0.83; concordance, 92%). The 
misclassification of two of the mols. is due to either ambiguous or previously unenunciated rules 
for defining structural alerts. 
 
Computer prediction of possible toxic action from chemical structure; the DEREK system 
Quick ViewOther Sources 
 By Sanderson, D. M.; Earnshaw, C. G.  
 From Human & Experimental Toxicology (1991), 10(4), 261-73. | Language: English, Database: 
CAPLUS  
 The development of DEREK, a computer-based expert system (derived from the 
LHASA chem. synthesis design program) for the qual. prediction of possible toxic action of 
compds. on the basis of their chem. structure is described. The system is able to perceive chem. 
sub-structures within mols. and relate these to a rulebase linking the sub-structures with likely 
types of toxicity. Structures can be drawn in directly at a computer graphics terminal or retrieved 
automatically from a suitable inhouse database. The system is intended to aid the selection of 
compds. based on toxicol. considerations, or sep. to indicate specific toxicol. properties to be 
tested for early in the evaluation of a compd., so saving time, money and some lab. animals and 
resources. 
 
QSAR prediction of rodent carcinogenicity for a set of chemicals currently bioassayed by the US 
National Toxicology Program 
Quick ViewOther Sources 
 By Benigni, R.  
 From Mutagenesis (1991), 6(5), 423-5. | Language: English, Database: CAPLUS  
 A QSAR model based on the combination of two mol. descriptors-estd. electrophilic 
reactivity and Ashby's structural alerts-was used to predict the carcinogenicity of 44 chems. 
currently bioassayed by the US National Toxicol. Program. These predictions will be compared 
with the rodent carcinogenicity assay results as the assays are completed. 
 
Nonisocyanate exposures in three flexible polyurethane manufacturing facilities 
Quick ViewOther Sources 
 By Boeniger, Mark F.  
 From Applied Occupational and Environmental Hygiene (1991), 6(11), 945-52. | Language: English, 
Database: CAPLUS  
 Although toluene diisocyanate (I) is widely used for about 50 yr, industrial hygiene 
characterizations of other chem. exposures used in conjunction with TDI have generally received 
much less attention. As part of a retrospective, cohort mortality study, industrial hygiene 
evaluations were performed in three facilities manufg. flexible I-based foam. This report is 
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concerned only with nonisocyanate exposures in that industry. In each facility, the concn. of 
several air contaminants, other than I, were assessed, including aliph. amines, nitrosamines, 
NO2, thermal degrdn. products, org. solvents, polyurethane dust, and retardants. Air samples 
were also collected for subsequent assay of mutagenic activity using Salmonella bacterial tester 
strains TA98 and TA100. Workers had respiratory and probably dermal exposure to CH2Cl2 in 
each facility. Tracers of NO2 and some aliph. amines were evident. However, N-nitrosamines 
were not found. Exposure to thermal degrdn. products, polyurethane dust, and to flame 
retardants is not a problem under reasonable hygienic conditions. However, evidence for the 
existence of acrolein and acrylonitrile was found in one facility due to the thermal degrdn. of 
finished foam. Mutagenic activity, appearing only in the particulate fraction, appeared highest 
when the total isocyanate group air concns. were also high. In one facility, the mutagenic activity 
was up to 75 times higher than the mutagenic activity of the outside air. The methods used to 
characterize each of the exposures are provided and the results are discussed. 
 
On the rodent bioassays currently being conducted on 44 chemicals: a RASH analysis to predict test 
results from the National Toxicology Program 
Quick ViewOther Sources 
 By Jones, Troyce D.; Easterly, Clay E.  
 From Mutagenesis (1991), 6(6), 507-14. | Language: English, Database: CAPLUS  
 A method of relative potency comparisons was used to rank the potential strength of 
44 compds. being tested in rodent carcinogenicity bioassays. All previous hazard evaluations 
have been for human conditions where great nos. of simultaneous and serial exposures may act 
in combination to produce a neoplasm comprised of 220 to 230 cells commonly expected to derive 
from a single precancerous cell. For human exposures, an initiated target tissue contg. at least 
one transformed but subcarcinogenic cell per organ was assumed. Thus, for man, the focus was 
on empirical correspondences that may help to index the monoclonal growth of a particular cell 
lineage during cancer expansion. In contrast to humans, initiation of target tissues in animals 
subjected to National Toxicity Program (NTP) bioassays may not be a given condition, because of 
extensive precautions taken to minimize exposures to contaminates in food, water, and cage 
environments. For this evaluation, categorical assignments of unlikely, possible, and probable 
carcinogens adapted from NTP tests were used. Rank ordering, of compds. according to max. 
doses tested in male mice and male rats, is coded according to the 3 outcomes taken from the 
NTP tests, but the magnitude of potency depends completely upon the particular method of 
comparing toxicol. data. A relative potency based anal. of a diversity of toxicol. data may be 
useful for rank ordering potentially hazardous compds. to be tested by the NTP and for range 
finding of their effective test doses to be administered during chronic test protocols. 
 
Prospective ke screening of potential carcinogens being tested in rodent bioassays by the US 
National Toxicology Program 
Quick ViewOther Sources 
 By Bakale, George; McCreary, Richard D.  
 From Mutagenesis (1992), 7(2), 91-4. | Language: English, Database: CAPLUS  
 Values of ke, the rate const. of electron attachment, were measured in cyclohexane 
for 31 of 44 chems. now being screened for carcinogenicity in rodent bioassays conducted by the 
US National Toxicol. Program. Thes kes provide a physicochem. measure of electron-solute 
interaction in a nonpolar medium which had been found to be correlated with solute 
carcinogenicity in earlier studies of the kes of chem. carcinogens and putative noncarcinogens. 
The ke test yields 15 neg. and 16 pos. responses for the 31 chems. that were screened in this 
study. These ke results are compared with the predictions of other carcinogen-screening methods 
that have been applied to the same chems. 
 
Application of the group contribution method for predicting the toxicity of organic chemicals 
Quick ViewOther Sources 
 By Gao, Chao; Govind, Rakesh; Tabak, Henry H.  
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 From Environmental Toxicology and Chemistry (1992), 11(5), 631-6. | Language: English, Database: 
CAPLUS  
 A group contribution method was developed that uses the LC50 values (measured for 
fathead minnow) for 130 diverse org. compds. The 130 selected compds. were constituted from 
16 chem. groups with -log(LC50) values ranging from 0.85 to 6.09. The method was then used to 
predict the LC50 values for 10 addnl. compds., not in the training set, with good agreement 
between the predicted and measured values. 
 
Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal 
mitotic recombination 
Quick ViewOther Sources 
 By Vogel, Ekkehart W.; Nivard, Madeleine J. M.  
 From Mutagenesis (1993), 8(1), 57-81. | Language: English, Database: CAPLUS  
 An evaluation is presented on the effects of 181 chems. in the (white/white) (w/w+) 
eye mosaic assay, an in vivo short-term test measuring genetic damage in somatic cells of 
Drosophila after treatment of larvae. The principal outcome of this anal. is the necessity for 
classification of responses into 3 categories. (1) Pos., ++. The 92 chems. falling into this 
category were clearly recombinagenic in the assay, meaning that dose-response relations were 
obtained (or could have been established as was evident from the strong responses obtained at 
one or two exposure doses). Among the 92 chems. were 49 promutagens including volatile 
chems. such as vinyl bromide and vinyl chloride. (2) Marginally pos., +w. The 40 chems. 
belonging to this category mainly represented 4 distinct types, including (a) procarcinogens, (b) 
electrophilic chems. of high nucleophilic selectivity, (c) spindle poisons, and (d) nongenotoxic 
carcinogens. (3) Inactive, -. Among the 49 chems. inactive in the assay were the carcinogens 
acetamide, auramine-O, chloramphenicol, chloroform, di(2-ethylhexyl) phthalate, DMF, ethylene 
thiourea, and testosterone - chems. for which DNA reactivity is unlikely. Among the most 
effective recombinagens were three of the four aflatoxins tested, of which aflatoxin B 1 represents 
the key chem. in this bioassay. Since cytotoxic effects to the developing organism apparently put 
a limit to the selection of high-dose levels, the consequence is that the use of nonphysiol. high 
concns. is largely avoided in this in vivo system. 
 
Detecting membrane impairment caused by xenobiotics 
Quick ViewOther Sources 
 By Pauli, W.; Berger, S.; Koehler, M.; Gies, A.  
 From Environmental Toxicology and Water Quality (1993), 8(2), 173-89. | Language: English, 
Database: CAPLUS  
 The toxicity of 14 substituted anilines and 15 aliph. alcs. was assessed by the 
electrorotation of yeast cells. Depending on the applied frequency, control cells exhibit both anti- 
and cofield rotation. From this spectrum, a frequency was selected at which untreated cells do 
not rotate, but impaired cells rotate with the field. The exptl. spectra are fully in accord with 
theor. models of the rotational response, calcd. on the basis of changes in membrane 
permeability. High correlations exist between rotational data and physiol. and biochem. end 
points (growth rate, plasma membrane ATPase, purine transport of yeast cells, and antihemolytic 
assays with human erythrocytes). A quant. structure-activity relationship anal. was made, 
whereby rotation data from 23 phenols were included. The effects of all chems. on cell rotation 
could be predicted by their lipophilicity. Some residuals and deviations could be accounted for by 
the inclusion of mol. wt. or connectivity in the anal. 4-Nitrophenol was an outlier, having an 
effect at least one order of magnitude higher than predicted, suggesting a specific toxic 
mechanism. Based on lipophilicity and rotation data, the antihemolytic effect on erythrocytes 
could be accurately estd. 
 
The relationship between use of the maximum tolerated dose and study sensitivity for detecting 
rodent carcinogenicity 
Quick ViewOther Sources 
 By Haseman, Joseph K.; Lockhart, Ann  
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 From Fundamental and Applied Toxicology (1994), 22(3), 382-91. | Language: English, Database: 
CAPLUS  
 The relationship between max. tolerated dose (MTD) and study sensitivity for 
detecting rodent carcinogenicity was evaluated for 216 chems. found to be carcinogens in lab. 
animal studies conducted by the National Cancer Institute (NCI) and the National Toxicol. 
Program (NTP). Approx. two-thirds of these rodent carcinogens would have been detected even 
without the top dose (estd. MTD), but in many of these studies, some site-specific carcinogenic 
effects would have been missed. Among the remaining one-third of the rodent carcinogens that 
required the top dose for statistical significance, approx. 80% had numerically elevated rates of 
the same site-specific tumors at lower doses as well. Only 13 of the NCI/NTP rodent carcinogens 
had increased tumor rates limited to the top dose for all sites of carcinogenicity. Alternatively, of 
the 838 site-specific carcinogenic effects obsd. in the NCI/NTP studies, 447 (53%) would have 
been detected even without the top dose. Of the remaining effects, 75% (294/391) showed 
numerically elevated site-specific tumor rates at lower doses. The authors' evaluation indicates 
that most carcinogenic effects obsd. at the top dose in rodent studies are also present (with 
reduced incidence that might or might not be statistically significant) at the lower doses typically 
employed (1/2MTD, 1/4MTD). 
 
Predictions of the carcinogenicity in rodents of chemicals currently under test by the U.S. National 
Toxicology Program: an update and some considerations 
Quick ViewOther Sources 
 By Rosenkranz, Herbert S.; Klopman, Gilles  
 From Life Science Advances: Biochemistry (1991), 10(3-4), 151-8. | Language: English, Database: 
CAPLUS  
 The authors have demonstrated that the predictive performance of CASE, a structure 
activity relational expert system is a function of the size and quality of the "learning set" (i.e. the 
database). Recently the authors predicted the carcinogenicity in rodents of chems. undergoing 
testing by the U.S. National Toxicol. Program (NTP) (1990). These predictions were based on the 
reported NTP cancer bioassay results of 252 chems. The availability now of the bioassay results 
for an addnl. 39 chems. (R. W. Tennant and J. Ashby; 1991) enabled the authors to update the 
"learning set" and make new predictions regarding the carcinogenicity of the same group of 
chems. currently being tested by the NTP. Although the majority of the predictions were not 
altered significantly, a no. of them did change. 
 
Mechanism-based comparisons of acute toxicities elicited by industrial organic chemicals in 
procaryotic and eucaryotic systems 
Quick ViewOther Sources 
 By Jaworska, Joanna S.; Schultz, T. Wayne  
 From Ecotoxicology and Environmental Safety (1994), 29(2), 200-13. | Language: English, 
Database: CAPLUS  
 Comparisons of toxicities elicited by nonpolar and polar narcotics, weak acid 
uncouplers of oxidative phosphorylation, and bioreactive chems. between the eucaryotic systems 
Pimephales promelas and Tetrahymena pyriformis and the procaryotic systems Escherichia coli 
and Photobacterium phosphoreum were performed. Each chem. had been a priori assigned a 
mechanism/mode of action based n the results from previous studies with eucaryotic systems. 
Hydrophobicity-dependent QSARs for nonpolar narcosis for both the E. coli and the P. 
phosphoreum endpoints were developed. However, due to the lack of a significant relationship 
between P. phosphoreum toxicity and log Kow, such a QSAR for polar narcosis was developed only 
for the E. coli endpoint. Except for 4-nitroaniline (the only chem. in the examd. group that 
required activation to become the Michael receptor), all chems. contg. reactive substructures 
revealed excess toxicity over polar narcosis QSAR for E. coli endpoints. Moreover, chloroacidic 
acid and Et chloroacetate in this system also appear to be bioreactive. The only mechanism that 
seemed to not exist in the procaryotic system was uncoupling of oxidative phosphorylation. 
Chems. from this group, except 2,4-dinitroaniline, did not exhibit excess toxicity over polar 
narcosis QSAR. This was thought to be explained by the lack of mitochondria in prokaryotes, the 
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target site of uncoupling agents in eukaryotes. In addn., evaluation of toxicities of halogen-
substituted short-chain carboxylic alcs. indicated that their mechanisms vary, depending upon 
the type of substitution and the system. 
 
Enhancement of Bacterial Mutagenicity of Bifunctional Alkylating Agents by Expression of 
Mammalian Glutathione S-Transferase 
Quick ViewOther Sources 
 By Thier, Ricarda; Muller, Michael; Taylor, John B.; Pemble, Sally E.; Ketterer, Brian; Guengerich, F. 
Peter  
 From Chemical Research in Toxicology (1995), 8(3), 465-72. | Language: English, Database: 
CAPLUS  
 Recently, we inserted the plasmid vector pKK233-2 contg. rat GSH S-transferase 
(GST) 5-5 cDNA into Salmonella typhimurium TA1535 and found that these bacteria [GST 5-5(+)
] expressed the protein and produced mutations when ethylene or methylene dihalides were 
added [Thier, R., Taylor, J. B., Pemble, S. E., Ketterer, B., Persmark, M., Humphreys, W. G., and 
Guengerich, F. P. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 8576-8580]. After exposure to the 
known GST 5-5 substrate 1,2-epoxy-3-(4'-nitrophenoxy)propane, the GST 5-5(+) strain showed 
fewer mutants than the bacteria transfected with the cDNA clone in a reverse orientation [GST 5-
5(-)], suggesting a protective role of GST 5-5. However, mutations were considerably enhanced 
in the GST 5-5(+) strain [as compared to GST 5-5(-)] when 1,2,3,4-diepoxybutane (butadiene 
diepoxide) or 1,2-epoxy-4-bromobutane was added. The GST 5-5(+) and GST 5-5(-) bacterial 
stains showed similar responses to 1,2-epoxypropane, 3,4-epoxy-1-butene, and 1,4-
dibromobutane. The results suggest that some bifunctional activated butanes are transformed to 
mutagenic products through GSH conjugation. We also found that the GST 5-5(+) strain showed 
enhanced mutagenicity with 1,4-dibromo-2,3-epoxybutane, 1,2-epoxy-3-bromopropane 
(epibromohydrin), and (±)-1,4-dibromo-2,3-dihydroxybutane. The possibility was considered that 
a 5-membered thialonium ion may be involved in the mutagenicity. Model thialonium compds. 
were rather stable to hydrolysis in aq. soln. at pH 7.4 and slowly alkylated 4-(4-nitrobenzyl)
pyridine. The presence of a hydroxyl group β to the sulfur did not enhance reactivity. 
Mechanisms involving episulfonium ions are considered more likely. Potential oxidn. products of 
the toxic pesticide 1,2-dibromo-3-chloropropane (DBCP) were also considered in this system. 
DBCP itself gave rather similar results in the two strains. Others have reported that oxidn. of 
DBCP is required for mutagenicity, along with GST-catalyzed GSH conjugation [Simula, T. P., 
Glancey, M. J., Soederlund, E. J., Dybing, E., and Wolf, C. R. (1993) Carcinogenesis 14, 2303-
2307]. The putative oxidn. product 1,2-dibromopropional did not show a difference between the 
two strains. However, 1,3-dichloroacetone, a model for the putative oxidn. product 1-bromo-3-
chloroacetone, was considerably more mutagenic in the GST 5-5(+) strain. 
 
Toxicity and carcinogenicity of 2,3-dibromo-1-propanol in F344/N rats and B6C3F1 mice 
Quick ViewOther Sources 
 By Eustis, Scot L.; Haseman, Joseph K.; Mackenzie, William F.; Abdo, Kamal M.  
 From Fundamental and Applied Toxicology (1995), 26(1), 41-50. | Language: English, Database: 
CAPLUS  
 Toxicol. and carcinogenesis studies of 2,3-dibromo-1-propanol were conducted by 
applying the chem. in 95% ethanol to the interscapular skin of male and female F344/N rats and 
B6C3F1 mice 5 days a week for 13 wk in the prechronic study and 48-55 wk (rats) or 36-42 wk 
(mice) in the carcinogenicity study. In the 13-wk study, 10 rats and 10 mice of each sex received 
doses of 0, 44, 88, 177, 375, or 750 mg/kg. Deaths assocd. with chem. application occurred only 
in the high-dose (750 mg/kg) male mice. Chem.-related lesions were seen in the kidney of male 
rats, liver of female rats, and liver and lung of both sexes of mice. Based on the toxicity obsd. in 
the 13-wk study, 50 rats of each sex received doses of 0, 188, or 375 mg/kg and 50 mice of 
each sex received 0, 88, or 177 mg/kg in the carcinogenicity study. The planned 2-yr study was 
terminated early because of reduced survival of rats related to chem.-induced neoplasia and 
because of the appearance of antibodies to lymphocytic choriomeningitis virus in sentinel mice. 
Nearly all dosed rats had malignant neoplasms at one or more sites, while only one control male 
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and one control female had malignant neoplasms. In rats, neoplasms induced by 2,3-dibromo-1-
propanol occurred in the skin, nasal mucosa, Zymbal's gland, oral mucosa, esophagus, 
forestomach, intestines, liver, kidney, mammary gland (females), clitoral gland (females), spleen 
(males), and mesothelium (males). In mice, chem.-induced neoplasms occurred in the skin, 
forestomach, liver (males), and lung (males). 
 
NTP technical report on the toxicology and carcinogenesis studies of 2,3-dibromo-1-propanol (CAS 
No. 96-13) in F344/N rats and B6C3F1 mice (Dermal studies) 
Quick ViewOther Sources 
 By National Toxicology Program  
 From Report (1993), (NRP-TR-400; Order No. PB94-206687), 206 pp.. | Language: English, 
Database: CAPLUS  
 2,3-Dibromo-1-propanol, a colorless liq., has been used as a flame retardant and as 
an intermediate in the manuf. of pesticides and pharmaceutical prepns. Toxicol. and 
carcinogenicity studies were conducted by applying 2,3-dibromo-1-propanol (∼98% pure) in 
ethanol to the subscapular area of the skin of male and female F344/N rats and B6C3F1 mice 5 
days per wk for 16 days, 13 wk, 48-51 wk (male rats), 52-55 wk (female rats), 36-39 wk (male 
mice), or 39-42 wk (female mice). Under the conditions of these long-term dermal studies, there 
was clear evidence of the carcinogenic activity of 2,3-dibromo-1-propanol in male and female 
F344/N rats based on increased incidences of neoplasms of the skin, nose, oral mucosa, 
esophagus, forestomach, small and large intestine, Zymbal's gland, liver, and kidney. There was 
clear evidence of the carcinogenic activity of 2,3-dibromo-1-propanol in male B6C3F1 mice based 
on increased incidences of neoplasms of the skin, forestomach, liver, and lung. There was clear 
evidence of the carcinogenic activity of 2,3-dibromo-1-propanol in female B6C3F1 mice based on 
increased incidences of neoplasms of the skin and the forestomach. 
 
Predictions of rodent carcinogenicity testing results: interpretation in light of the Lave-Omenn 
value-of-information model 
Quick ViewOther Sources 
 By Omenn, Gilbert S.; Stuebbe, Seth; Lave, Lester B.  
 From Molecular Carcinogenesis (1995), 14(1), 37-45. | Language: English, Database: CAPLUS  
 The recent National Institute of Environmental Health Sciences/National Toxicol. 
Program Carcinogen Prediction Challenge elicited a value array of predictions of the 
carcinogenicity of chems. tested in the lifetime rodent bioassay. The data warrant addnl. 
analyses of the similarities and differences of the predictive methods. The authors provide here 
analyses of the sensitivity, specificity, and false-pos./false-neg. tendencies of the different sets of 
predictions. The value-of-information model provides guidance to testing agencies and regulatory 
agencies in detg. the social value of addnl. information and setting up the framework for 
assessing the social consequences of different test strategies and nontest predictive methods. 
These considerations deserve attention in the second round of the Carcinogen Prediction 
Challenge. 
 
Activation and Inactivation of Carcinogenic Dihaloalkanes and Other Compounds by Glutathione S-
Transferase 5-5 in Salmonella typhimurium Tester Strain NM5004 
Quick ViewOther Sources 
 By Shimada, Tsutomu; Yamazaki, Hiroshi; Oda, Yoshimitsu; Hiratsuka, Akira; Watabe, Tadashi; 
Guengerich, F. Peter  
 From Chemical Research in Toxicology (1996), 9(1), 333-40. | Language: English, Database: 
CAPLUS  
 A newly developed tester Salmonella typhimurium NM5004 strain was constructed by 
introducing a plasmid contg. both rat GSH S-transferase (GST) 5-5 cDNA and the umuC''lacZ 
operon into the host strain Salmonella typhimurium TA1535 and used to examine whether or not 
GST modified the genotoxic activities of several dihaloalkanes and other compds. Twenty-nine 
chems. that were suggested to be conjugated by GST were compared with regard to their 
abilities to induce umu gene expression and cause cytotoxicity responses in both the NM5004 
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strain and the original tester strain (S. typhimurium TA1535/pSK1002, which is devoid of GST 
activity toward 1,2-epoxy-3-(4'-nitrophenoxy)propane). Ten chems.-1,2-dibromoethane, N-(2,3-
epoxypropyl)phthalimide, 1,3-dichloroacetone, CH2I2, 1,2-epoxy-3-phenoxypropane, 2,3-
epoxypropyl p-methoxyphenyl ether, 1-bromo-2-chloroethane, 1-bromo-2,3-dichloropropane, 
CH2BrCl, and CH2Br2-were found to enhance induction of umu gene expression in the NM5004 
strain as compared with the TA1535/pSK1002 strain. 1,2-Epoxy-3-(4'-nitrophenoxy)propane and 
2,3-dibromo-1-chloropropane were inactivated by GST 5-5 in the NM5004 tester strain, although 
these chems. were cytotoxic in both tester strains. Roles of GST 5-5 were also examd. for the 
inactivation of reactive metabolites of several procarcinogens that were formed through oxidn. 
by liver microsomes of polychlorinated biphenyl-treated rats. The results suggest that reactive 
metabolites (possibly epoxides) of aflatoxin B1, sterigmatocystin, 1,2-dihydro-1,2-dihydroxy-6-
aminochrysene, and (+)- and (-)-enantiomers of 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene could 
be trapped as inactivated GSH conjugates in the NM5004 strain. High-performance liq. 
chromatog. anal. suggested that exo-aflatoxin B1 8,9-oxide-GSH conjugate was formed during 
the oxidn. of aflatoxin B1 by rat and human liver microsomes in the presence of GSH and several 
GST enzymes including purified rat theta class GST Yrs-Yrs and rat liver GST (a mixt. of alpha and 
mu class enzymes). Thus, the present results support the view that the theta class rat GST 5-5 
enzyme participates in the activation and inactivation of potential environmental carcinogenic 
chems. This newly developed NM5004 tester strain is of use in the elucidation of roles of GST 5-
5 in transformations. 
 
The potential of organ specific toxicity for predicting rodent carcinogenicity 
Quick ViewOther Sources 
 By Lee, Yongwon; Buchanan, Bruce G.; Klopman, Gilles; Dimayuga, Mario; Rosenkranz, Herbert S.  
 From Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis (1996), 358(1), 
37-62. | Language: English, Database: CAPLUS  
 Relationships between organ specific toxicity (specifications of the presence or 
absence of 43 morphol. effects in 32 organs) obsd. from 13-wk subchronic studies and rodent 
carcinogenicity were investigated by manually measuring the concordance of each feature and 
also automatically using the RL (Rule Learner) induction program. Of the 32 organs, the 
presence or absence of any effect in liver or kidney was found very relevant to rodent 
carcinogenicity. While the concordance of Salmonella genotoxicity with rodent carcinogenicity 
was only 60%, the battery of liver and kidney was 74% accurate with 75% sensitivity and 71% 
specificity. Further, using the RL program, rule sets based on organ specific toxicity together with 
the default predictions based on Salmonella mutagenicity were on av. 80% accurate with 83% 
sensitivity and 82% specificity. 
 
Prediction of rodent carcinogenicity bioassays from molecular structure using inductive logic 
programming 
Quick ViewOther Sources 
 By King, Ross D.; Srinivasan, Ashwin  
 From Environmental Health Perspectives Supplements (1996), 104(5), 1031-1040. | Language: 
English, Database: CAPLUS  
 The machine learning program Progol was applied to the problem of forming the 
structure-activity relation (SAR) for a set of compds. tested for carcinogenicity in rodent 
bioassays by the U.S. National Toxicol. Program (NTP). Progol is the first inductive logic 
programming (ILP) algorithm to use a fully relational method for describing chem. structure in 
SARs, based on using atoms and their bond connectivities. Progol is well suited to forming SARs 
for carcinogenicity as it is designed to produce easily understandable rules (structural alerts) for 
sets of noncongeneric compds. The Progol SAR method was tested by prediction of a set of 
compds. that have been widely predicted by other SAR methods (the compds. used in the NTP's 
first round of carcinogenesis predictions). For these compds. no method (human or machine) 
was significantly more accurate than Progol. Progol was the most accurate method that did not 
use data from biol. tests on rodents (however, the difference in accuracy is not significant). The 
Progol predictions were based solely on chem. structure and the results of tests for Salmonella 
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mutagenicity. Using the full NTP database, the prediction accuracy of Progol was estd. to be 63
% (±3%) using 5-fold cross validation. A set of structural alerts for carcinogenesis was 
automatically generated and the chem. rationale for them investigated-these structural alerts are 
statistically independent of the Salmonella mutagenicity. Carcinogenicity is predicted for the 
compds. used in the NTP's second round of carcinogenesis predictions. The results for prediction 
of carcinogenesis, taken together with the previous successful applications of predicting 
mutagenicity in nitroarom. compds., and inhibition of angiogenesis by suramin analogs, show 
that Progol has a role to play in understanding the SARs of cancer-related compds. 
 
Structure-mutagenic activity relationships in the Salmonella typhimurium TA100 strain in a series 
of short-chain halogenated hydrocarbons and alcohols. 
Quick ViewOther Sources 
 By Kharchevnikova, N. V.; Zholdakova, Z. I.; Zhurkov, V. S.; Polyakova, E. E.; Novikov, S. M.  
 From Russian Journal of Genetics (Translation of Genetika (Moscow)) (1997), 33(5), 594-597. | 
Language: English, Database: CAPLUS  
 Structure-mutagenic activity relationships in a series of short-chain halogenated 
hydrocarbons and alcs. were detd. with the use of the energy difference parameter of frontier 
mol. orbitales of compds. that was calcd. by the quantum-chem. method. 
 
T25: a simplified carcinogenic potency index: description of the system and study of correlations 
between carcinogenic potency and species/site specificity and mutagenicity 
Quick ViewOther Sources 
 By Dybing, Erik; Sanner, Tore; Roelfzema, Henk; Kroese, Dinant; Tennant, Raymond W.  
 From Pharmacology & Toxicology (Copenhagen) (1997), 80(6), 272-279. | Language: English, 
Database: CAPLUS  
 A simplified carcinogenic potency index, the T25, is proposed as a practical method 
for the inclusion of potency considerations in carcinogen classification systems. The T25 is the 
chronic daily dose in mg per kg bodyweight which will give 25% of the animals tumors at a 
specific tissue site, after correction for spontaneous incidence, within the std. life span of that 
species. Calcd. T25 values of a set of 113 US National Cancer Institute/National Toxicol. Program 
(NC/NTP) carcinogens showed excellent correlation (correlation coeff. 0.96) with the 
carcinogenic potency index TD50 of R. Peto et al. (1984). The mean of T25 values for 51 
transspecies, multiple common site NCI/NTP carcinogens were 10-fold lower than those for 62 
NCI/NTP single species, single site carcinogens. For these 113 carcinogens, the mean T25 values 
were approx. 3-fold lower for agents that were also mutagenic in Salmonella compared to the 
nonmutagenic agents. 
 
An update of the National Toxicology Program database on nasal carcinogens 
Quick ViewOther Sources 
 By Haseman, J. K.; Hailey, J. R.  
 From Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis (1997), 380(1,2), 
3-11. | Language: English, Database: CAPLUS  
 Nearly 500 long-term rodent carcinogenicity studies carried out by the National 
Cancer Institute and the National Toxicol. Program were examd., and 12 chems. were identified 
that produced nasal tumors: allyl glycidol ether, p-cresidine, 1,2-dibromo-3-chloropropane, 1,2-
dibromoethane, 2,3-dibromo-1-propanol, dimethylvinyl chloride, 1,4-dioxane, 1,2-epoxybutane, 
iodinated glycerol, procarbazine, propylene oxide, and 2,6-xylidine. All 12 of these chems. 
produced nasal tumors in rats, and 5 also produced nasal tumors in mice. Most of the nasal 
carcinogens (1) produced tumor increases in both sexes, (2) produced tumors at other sites as 
well, (3) had significantly reduced survival at doses that were carcinogenic, and (4) were 
genotoxic. Only 5 of the 12 nasal carcinogens were administered by inhalation. A variety of 
different types of nasal cavity tumors were produced, and specific tumor rates are given for 
those chems. causing multiple tumor types. Increased incidences of nasal neoplasms were often 
accompanied by suppurative/acute inflammation, epithelial/focal hyperplasia, and squamous 
metaplasia. However, high incidences of these nonneoplastic nasal lesions were also frequently 
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seen in inhalation studies showing no evidence of nasal carcinogenicity, suggesting that in 
general nasal carcinogenesis is not assocd. with the magnitude of chronic toxicity obsd. at this 
site. 
 
Allergic contact sensitizing chemicals as environmental carcinogens 
Quick ViewOther Sources 
 By Albert, Roy E.  
 From Environmental Health Perspectives (1997), 105(9), 940-948. | Language: English, Database: 
CAPLUS  
 Chems. that were bioassayed by the National Toxicol. Program (NTP) and that also 
produce allergic dermatitis (ACD) in humans were evaluated for their tumorigenic characteristics. 
The impetus for the study was that most contact sensitizers, i.e., those that produce ACD, and 
genotoxic carcinogens are chem. similar in that they are electrophilic, thereby producing adducts 
on macro-mols. including protein and DNA. This similarity in chem. behavior suggests that many 
contact sensitizers might be environmental carcinogens. All of the published NTP bioassays by 
early 1996 that had both genotoxicity and carcinogenicity studies were included in this anal. The 
NTP chems. had been chosen for bioassay without regard to their ability to produce ACD. Of the 
209 chems. that were bioassayed, there were 36 (17%) that were known to be human contact 
sensitizers; about half of these were pos. on tumor bioassays. The contact sensitizers differed 
from the NTP sample as a whole by having a proportionately larger no. of nongenotoxic chems. 
by the Ames Salmonella assay, presumably because more of them were selected on the basis of 
widespread usage rather than structural resemblance to known carcinogens. Compared to the 
nongenotoxic chems., the genotoxics were stronger carcinogens in that they had a higher 
incidence of pos. tumor bioassays, with twice the no. of organs in which tumors were induced. 
The nongenotoxic chems. had a preference for tumor induction in parenchymal tissues in 
contrast to epithelial tissues. The contact sensitizers showed essentially the same characteristics 
as the whole NTP sample when stratified according to genotoxicity. Judging by the chems. that 
were chosen primarily for their widespread use rather than for their structural resemblance to 
carcinogens, the addn. of a test for contact sensitization to the Ames test as a screening tool 
would increase the tumorigenic detection efficiency by about 40% because of the nongenotoxic 
tumorigens. A ballpark est. suggests that there could be several thousand contact sensitizers for 
humans in com. use that are rodent tumorigens. 
 
 
Comparisons on chemically-induced mutation among four bacterial strains, Salmonella 
typhimurium TA102 and TA2638, and Escherichia coli WP2/pKM101 and WP2 uvrA/pKM101: 
collaborative study II 
Quick ViewOther Sources 
 By Watanabe, Kazuko; Sakamoto, Kyoko; Sasaki, Toshiaki  
 From Mutation Research, Genetic Toxicology and Environmental Mutagenesis (1998), 412(1), 17-31. 
| Language: English, Database: CAPLUS  
 A collaborative study of chem.-induced mutation was performed using the four 
bacterial strains Salmonella typhimurium TA102 and TA2638, and Escherichia coli WP2/pKM101 
and WP2 uvrA/pKM101, used in the previous successive studies in order to compare the specific 
spectrum of response to chems. among the four strains and to det. the usefulness (sensitivity) of 
each strain. Twenty-two labs. participated in this study. Following the previous study, 28 
compds. were selected consisting of oxidative agents or crosslinking agents. These compds. 
were tested for mutagenicity using the plate incorporation method with or without metabolic 
activation. The tests were performed in two labs. per chem. The no. of chems. which showed 
pos. results were 18, 17, 16 and 14 with WP2 uvrA/pKM101, TA2638, TA102 and WP2/pKM101, 
resp. In all four strains 19/28 chems. (68%) were either pos. or neg. while the remaining 9 
chems. showed a heterogeneous response. With TA102 and TA2638 89% (25/28) of the test 
chems. showed the same response, while 75-79% (21-22/28) showed the same response in 
these two S. typhimurium strains and in WP2 uvrA/pKM101. In conclusion, WP2/pKM101 strain 
showed the least sensitivity to the chems. used. Among the other three strains, WP2 uvrA
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/pKM101 was the most sensitive strain, although the difference in the no. of chems. which 
showed pos. results was minor. Concerning the spectrum of response to chems., it is apparent 
that TA102 and TA2638 have almost the same sensitivity, but some chems. induce different 
responses between the two S. typhimurium strains and WP2 uvrA/pKM101. 
 
Carcinogenic activity of the flame retardant, 2,2-bis(bromomethyl)-1,3-propanediol in rodents, and 
comparison with the carcinogenicity of other NTP brominated chemicals 
Quick ViewOther Sources 
 By Dunnick, June K.; Heath, James E.; Farnell, Daniel R.; Prejean, J. David; Haseman, Joseph K.; 
Elwell, Michael R.  
 From Toxicologic Pathology (1997), 25(6), 541-548. | Language: English, Database: CAPLUS  
 Several brominated chems. have been shown to be multisite-multispecies 
carcinogens in lab. animals, and in this paper we report that the flame retardant, 2,2-
bis(bromomethyl)-1,3-propanediol (BMP) is also a multisite carcinogen in both sexes of Fischer 
344 rats and B6C3F1 mice. BMP was administered continuously in the diet for up to 2 yr to rats at 
doses of 0, 2,500, 5,000 or 10,000 ppm and to mice at doses of 0, 312, 625, or 1,250 ppm.. 
Interim groups of rats were examd. at 15 mo. An addnl. recovery group off male rats received 
the chem. for 3 mo at 20,000 ppm in the feed, and then the control diet for the remainder of the 
study. Chem. exposure caused neoplasms of the skin, s.c. tissue, mammary gland, Zymbal's 
gland, oral cavity, esophagus, forestomach, small intestine, large intestine, mesothelium, kidney, 
urinary bladder, lung, thyroid gland, seminal vesicle, hematopoietic system, and pancreas in the 
male rat; mammary gland, oral cavity, esophagus, and thyroid gland in the female rat; lung, 
kidney, and Harderian gland in male mice; and s.c. tissue, lung, and Harderian gland in the 
female mouse. The recovery group of male rats presented with the same spectrum of treatment-
related neoplasms as in the core study. In this recovery group, BMP (at 20,000 ppm) caused 
irreversible effects at numerous sites after 90 days of exposure that was not detectable by histol. 
examn., but without further exposure resulted in carcinogenic responses at 2 yr. BMP is 
mutagenic in the salmonella test, but is was not detd. if the BMP-induced effects that eventually 
lead to development of neoplasms at multiple sites are the same in both species and in all organ 
systems affected. 
 
A New Highly Specific Method for Predicting the Carcinogenic Potential of Pharmaceuticals in 
Rodents Using Enhanced MCASE QSAR-ES Software 
Quick ViewOther Sources 
 By Matthews, Edwin J.; Contrera, Joseph F.  
 From Regulatory Toxicology and Pharmacology (1998), 28(3), 242-264. | Language: English, 
Database: CAPLUS  
 This report describes in detail a new quant. structure-activity relational expert system 
(QSAR-ES) method for predicting the carcinogenic potential of pharmaceuticals and other org. 
chems. in rodents, and a beta-test evaluation of its performance. The method employs an 
optimized, computer-automated structure evaluation (MCASE) software program and new 
database modules which were developed under a Cooperative Research and Development 
Agreement (CRADA) between FDA and Multicase, Inc. The beta-test utilized 126 compds. with 
carcinogenicity studies not included in control database modules and three sets of modules, 
including: A07-9 (Multicase, Inc.), AF1-4 (FDA-OTR/Multicase, Inc.), and AF5-8 (FDA-OTR
/proprietary). The investigation demonstrated that the std. MCASE(A07-9) system which had a 
small data-set, detected few structure alerts (SA) for carcinogenicity, and had poor coverage for 
beta-test compds. (51%). Conversely, the new, optimized FDA-OTR/MCASE(AF5-8) system had a 
large data-set, detected many SA and had good coverage (94%). In addn., the study showed 
the std. MCASE(A07-9) software had poor predictive value for carcinogens and specificity for 
noncarcinogens (50 and 42%), detected many false positives (58%), and exhibited poor 
concordance (46%). Conversely, the new, FDA-OTR/MCASE(AF5-8) system demonstrated 
excellent predictive value for carcinogens and specificity for non-carcinogens (97%, 98%), 
detected only one false pos. (2%), and exhibited good concordance (75%). The dramatic 
improvements in the performance of the MCASE were due to numerous modifications, including: 
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(a) enhancement of the size of the control database modules, (b) optimization of MCASE SAR 
assay evaluation criteria, (c) incorporation of a carcinogenic potency scale for control compd. 
activity and MCASE biophores, (d) construction of individual rodent gender- and species-specific 
modules, and (e) defining assay acceptance criteria for query and control database compds. (c) 
1998 Academic Press. 
 
Chemical carcinogenicity: can it be predicted from knowledge of mutagenicity and allergic contact 
dermatitis? 
Quick ViewOther Sources 
 By Rosenkranz, Herbert S.; Karol, Meryl H.  
 From Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis (1999), 431(1), 
81-91. | Language: English, Database: CAPLUS  
 We investigated the suggestion [R.E. Albert, (1997)] that results of mutagenicity 
testing in Salmonella combined with allergic contact dermatitis (ACD) testing in humans would be 
predictive of carcinogenicity in rodents. Using the cancer bioassay results of the US National 
Toxicol. Program (NTP), Salmonella mutagenicity tests and a highly predictive structure-activity 
relational model of ACD, we conclude that the combination is not more predictive than the 
results of the Salmonella mutagenicity assay alone. 
 
Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals 
Quick ViewOther Sources 
 By Prival, Michael J.  
 From Environmental and Molecular Mutagenesis (2001), 37(1), 55-69. | Language: English, 
Database: CAPLUS  
 The TOPKAT computer-based system for predicting chem. carcinogens was evaluated 
by detg. its ability to predict the carcinogenicity of chems. tested by the National Toxicol. 
Program. TOPKAT was not effective in identifying potential rodent carcinogens and 
noncarcinogens in the data set analyzed. The chems. in the TOPKAT database of known 
carcinogens and noncarcinogens that the software identifies as most "similar" to unknown 
chems. are illustrated using six examples. These "similar" chems. generally bear no apparent 
relationship to the chem. of interest with regard to metab. or potential mechanism of 
carcinogenicity. 
 
A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose 
descriptor T25 
Quick ViewOther Sources 
 By Sanner, Tore; Dybing, Erik; Willems, Marianne I.; Kroese, E. Dinant  
 From Pharmacology & Toxicology (Copenhagen, Denmark) (2001), 88(6), 331-341. | Language: 
English, Database: CAPLUS  
 This report provides guidance for using the dose-descriptor T25 from animal studies 
as a basis for quant. risk characterization of non-threshold carcinogens. T25 is presently used 
within the European Union for setting specific concn. limits for carcinogens in relation to labeling 
of prepns. (formulations). The T25 is defined as the chronic dose rate which will give 25% of the 
animals tumors at a specific tissue site, after correction for spontaneous incidence, within the 
std. life-time of that species. The T25 is converted to the corresponding human dose descriptor, 
HT25, by dividing it with the appropriate scaling factor for interspecies dose scaling based on 
comparative metabolic rates. Subsequently, the human dose (expressed in mg per kg body-wt. 
per day) is calcd. from the available exposure data. The corresponding human life-time cancer 
risk is then obtained by using linear extrapolation by dividing the exposure dose with the coeff. 
(HT25/0.25). The results with this new method, which can easily be calcd. without computer 
programs, are in excellent agreement with results from computer-based extrapolation methods 
such as the linearised multistage model and the benchmark method using LED10, even though the 
present method only takes into consideration one single dose-response point. To overcome 
possible shortcomings of the present method, the estd. life-time risks are proposed to be 
accompanied by a commentary statement giving an overall evaluation of data that may have 
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bearing on the carcinogenic risk and that may indicate whether the real human risk is likely to be 
higher or lower than the calcd. life-time risk. By using the present guidance and a harmonized 
set of criteria and default values, the calcn. of life-time cancer risk should be transparent and 
easy to comprehend. 
 
Artificial neural network for predicting the toxicity of organic molecules 
Quick ViewOther Sources 
 By Admans, Gary; Takahashi, Yoshimasa; Ban, Satoshi; Kato, Hiroaki; Abe, Hidetsugu; Hanai, 
Sosuke  
 From Bulletin of the Chemical Society of Japan (2001), 74(12), 2451-2461. | Language: English, 
Database: CAPLUS  
 Structure-activity relationships for aquatic toxicity were studied using neural networks 
and linear regression anal. The structural features contributing to toxicity were identified in mols. 
exhibiting a level of toxicity greater than that of non-reactive org. mols. A neural network was 
trained for the toxicity of non-polar narcotics, polar narcotics, or reactive toxicants. Quant. 
structure-activity relationships (QSARs) were developed, relating a mol. aquatic toxicity to its log 
P and to a set of 16 structural descriptors based upon the presence of selected structural 
features. The inclusion of these structural descriptors into a QSAR was found to enhance the 
correlation of the equation, and thus to improve its ability for predicting aquatic toxicity. 
 
Quantitative structure-activity relationships based on functional and structural characteristics of 
organic compounds 
Quick ViewOther Sources 
 By Kulkarni, S. A.; Raje, D. V.; Chakrabarti, T.  
 From SAR and QSAR in Environmental Research (2001), 12(6), 565-591. | Language: English, 
Database: CAPLUS  
 In the present quant. structure-activity relationship (QSAR) modeling, org. compds., 
including priority pollutants, have been considered and classified based on their functional and 
structural characteristics. Five physico-chem. characteristics have been used to develop a QSAR 
model for Pimephales promelas, by means of multiple regression anal. Collinearity diagnostics 
was carried out using two different approaches based on condition index and K correlation index. 
The outlier anal. was carried out using the variable subsets obtained through both the 
approaches. An attempt has been made to justify the deletion of outliers in each group referring 
to their physico-chem. characteristics. The expressions obtained by using both approaches 
provide almost the same prediction accuracy, however, the latter approach resulted in 
expressions with reduced no. of mol. descriptors. The QSARs obtained through this exercise 
would certainly assist in designing environment-friendly mols. with lower toxicity. 
 
Characteristics of the spectrum of proliferative lesions observed in the kidney and urinary bladder 
of Fischer 344 rats and B6C3F1 mice 
Quick ViewOther Sources 
 By Wolf, Jeffrey C.  
 From Toxicologic Pathology (2002), 30(6), 657-662. | Language: English, Database: CAPLUS  
 Many rodent renal and bladder carcinogens rely upon epigenetic mechanisms of 
carcinogenesis; such mechanisms are likely to influence the spectrum of urinary tract tumors 
obsd. in control and treated animals. This is reflected in several features of chem. induced rodent 
urinary tract neoplasms, including a low overall tumor incidence, an increased prevalence of 
urinary tract tumors in rats compared to mice and males compared to females, the tendency for 
epithelial tumors to predominate over nonepithelial types, and demonstrated links to chronic 
progressive nephropathy and urolithiasis. Such tendencies are also characteristic of spontaneous 
urinary tract tumors in rodents. Data to support these observations can be derived from large 
historical databases such as the Toxicol. Data Management System, maintained by National 
Toxicol. Program. 
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Development of Binary Classification of Structural Chromosome Aberrations for a Diverse Set of 
Organic Compounds from Molecular Structure 
Quick ViewOther Sources 
 By Serra, J. R.; Thompson, E. D.; Jurs, P. C.  
 From Chemical Research in Toxicology (2003), 16(2), 153-163. | Language: English, Database: 
CAPLUS  
 Classification models are generated to predict in vitro cytogenetic results for a diverse 
set of 383 org. compds. Both k-nearest neighbor and support vector machine models are 
developed. They are based on calcd. mol. structure descriptors. Endpoints used are the labels 
clastogenic or nonclastogenic according to an in vitro chromosomal aberration assay with 
Chinese hamster lung cells. Compds. that were tested with both a 24 and 48 h exposure are 
included. Each compd. is represented by calcd. mol. structure descriptors encoding the topol., 
electronic, geometrical, or polar surface area aspects of the structure. Subsets of informative 
descriptors are identified with genetic algorithm feature selection coupled to the appropriate 
classification algorithm. The overall classification success rate for a k-nearest neighbor classifier 
built with just 6 topol. descriptors is 81.2% for the training set and 86.5% for an external 
prediction set. The overall classification success rate for a 3-descriptor support vector machine 
model is 99.7% for the training set, 92.1% for the cross-validation set, and 83.8% for an 
external prediction set. 
 
An exploratory study of the use of multivariate techniques to determine mechanisms of toxic action 
Quick ViewOther Sources 
 By Ren, Shijin; Frymier, Paul D.; Schultz, T. Wayne  
 From Ecotoxicology and Environmental Safety (2003), 55(1), 86-97. | Language: English, Database: 
CAPLUS  
 The most successful quant. structure-activity relationships have been developed by 
sepg. compds. by their mechanisms of toxic action (MOAs). However, to correctly det. the MOA 
of a compd. is often not easy. The authors investigated the usefulness of discriminant anal. and 
logistic regression in detg. MOAs. The discriminating variables used were the logarithm of 
octanol-water partition coeffs. (log Kow) and the exptl. toxicity data obtained from Pimephales 
promelas and Tetrahymena pyriformis assays. Small total error rates were obtained when sepg. 
nonpolar narcotic compds. from other compds., however, relatively high total error rates were 
obtained when sepg. less reactive compds. (polar, ester, and amine narcotics) from more 
reactive compds. (electrophiles, proelectrophiles, and nucleophiles). 
 
Phthalates, Alkylphenols, Pesticides, Polybrominated Diphenyl Ethers, and Other Endocrine-
Disrupting Compounds in Indoor Air and Dust 
Quick ViewOther Sources 
 By Rudel, Ruthann A.; Camann, David E.; Spengler, John D.; Korn, Leo R.; Brody, Julia G.  
 From Environmental Science and Technology (2003), 37(20), 4543-4553. | Language: English, 
Database: CAPLUS  
 Endocrine-disrupting compds. (EDC) have widespread consumer uses, yet little is 
known about indoor exposure. Indoor air and dust was sampled in 120 homes and analyzed for 
89 org. EDC: 52 compds. were detected in air and 66 were detected in dust. These are the first 
reported measurements in residential environments for >30 of these compds., including several 
detected at highest concns. The no. of compds. detected/home was 13-28 in air and 6-42 in 
dust. The most abundant compds. in air included phthalates (plasticizers, emulsifiers), o-
phenylphenol (disinfectant), 4-nonylphenol (detergent metabolite), and 4-tert-butylphenol 
(adhesive), with typical concns. of 50-1500 ng/m3. Penta- and tetrabrominated di-Ph ethers 
(flame retardants) were frequently detected in dust, and 2,3-dibromo-1-propanol, the 
carcinogenic intermediate of a flame retardant banned in 1977, was detected in air and dust. A 
total of 23 pesticides were detected in air and 27 were detected in dust; the most abundant 
were permethrins and the synergist, piperonyl butoxide; banned pesticides (heptachlor, 
chlordane, methoxychlor, DDT) were also frequently detected, suggesting limited indoor degrdn. 
Detected concns. exceeded government health-based guidelines for 15 compds.; however, no 
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guidelines are available for 28 compds. and existing guidelines do not consider endocrine effects. 
Results provided a basis to prioritize toxicol. and exposure research for individual EDC and mixts. 
and provided new tools for exposure assessment in health studies. 
 
Prediction of Rodent Carcinogenesis: An Evaluation of Prechronic Liver Lesions as Forecasters of 
Liver Tumors in NTP Carcinogenicity Studies 
Quick ViewOther Sources 
 By Allen, D. G.; Pearse, G.; Haseman, J. K.; Maronpot, R. R.  
 From Toxicologic Pathology (2004), 32(4), 393-401. | Language: English, Database: CAPLUS  
 The National Toxicol. Program (NTP) developed the chronic 2-yr bioassay as a 
mechanism for predicting the carcinogenic potential of chems. in humans. The cost and duration 
of these studies has limited their use to small nos. of selected chems. Many different short-term 
methods aimed at increasing predictive accuracy and the no. of chems. evaluated have been 
developed in attempts to successfully correlate their results with evidence of carcinogenicity (or 
lack of carcinogenicity) are assessed. Using NTP studies, the effectiveness of correlating 
prechronic liver lesions with liver cancer encompassing multiple studies using mice (83 compds.) 
and rats (87 compds.). These lesions include hepatocellular necrosis, hepatocellular hypertrophy, 
hepatocellular cytomegaly, bile duct hyperplasia, and hepatocellular degeneration, along with 
increased liver wt. These results indicate that pooling 3 of these prechronic data points 
(hepatocellular necrosis, hepatocellular hypertrophy, and hepatocellular cytomegaly) can be very 
predictive of carcinogenicity in the 2-yr study (p < 0.05). The inclusion of increased liver wt. as 
an endpoint in the pool of data points increases the no. of rodent liver carcinogens that are 
successfully predicted (p < 0.05), but also results in the prediction of increased nos. of 
noncarcinogenic chems. as carcinogens. The use of multiple prechronic study endpoints provides 
supplementary information that enhances the predictivity of identifying chems. with carcinogenic 
potential. 
 
Description of the Electronic Structure of Organic Chemicals Using Semiempirical and Ab Initio 
Methods for Development of Toxicological QSARs 
Quick ViewOther Sources 
 By Netzeva, Tatiana I.; Aptula, Aynur O.; Benfenati, Emilio; Cronin, Mark T. D.; Gini, Giuseppina; 
Lessigiarska, Iglika; Maran, Uko; Vracko, Marjan; Schueuermann, Gerrit  
 From Journal of Chemical Information and Computer Sciences (2005), 45(1), 106-114. | Language: 
English, Database: CAPLUS  
 The quality of quant. structure-activity relationship (QSAR) models depends on the 
quality of their constitutive elements including the biol. activity, statistical procedure applied, and 
the physicochem. and structural descriptors. The aim of this study was to assess the comparative 
use of ab initio and semiempirical quantum chem. calcns. for the development of toxicol. QSARs 
applied to a large and chem. diverse data set. A heterogeneous collection of 568 org. compds. 
with 96 h acute toxicity measured to the fish fathead minnow (Pimephales promelas) was 
utilized. A total of 162 descriptors were calcd. using the semiempirical AM1 Hamiltonian, and 121 
descriptors were compiled using an ab initio (B3LYP/6-31G**) method. The QSARs were derived 
using multiple linear regression (MLR) and partial least squares (PLS) analyses. Statistically 
similar models were obtained using AM1 and B3LYP calcd. descriptors supported by the use of 
the logarithm of the octanol-water partition coeff. (log Kow). The main difference between the 
models derived by both MLR and PLS with the two sets of quantum chem. descriptors was 
concd. on the type of descriptors selected. It was concluded that for large-scale predictions, 
irresp. of the mechanism of toxic action, the use of precise but time-consuming ab initio methods 
does not offer considerable advantage compared to the semiempirical calcns. and could be 
avoided. 
 
A topological substructural approach applied to the computational prediction of rodent 
carcinogenicity 
Quick ViewOther Sources 
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 By Helguera, Aliuska Morales; Cabrera Perez, Miguel Angel; Gonzalez, Maykel Perez; Ruiz, Reinaldo 
Molina; Gonzalez Diaz, Humberto 
 From Bioorganic & Medicinal Chemistry (2005), 13(7), 2477-2488. | Language: English, Database: 
CAPLUS  
 The carcinogenic activity has been investigated by using a topol. substructural mol. 
approach (TOPS-MODE). A discriminant model was developed to predict the carcinogenic and 
noncarcinogenic activity on a data set of 189 compds. The percentage of correct classification 
was 76.32%. The predictive power of the model was validated by three tests: an external test 
set (compds. not used in the develop of the model, with a 72.97% of good classification), a 
leave-group-out cross-validation procedure (4-fold full cross-validation, removing 20% of 
compds. in each cycle, with a good prediction of 76.31%) and two external prediction sets (the 
first and second exercises of the National Toxicol. Program). This methodol. evidenced that the 
hydrophobicity increase the carcinogenic activity and the dipole moment of the mol. decrease it; 
suggesting the capacity of the TOPS-MODE descriptors to est. this property for new drug 
candidates. Finally, the pos. and neg. fragment contributions to the carcinogenic activity were 
identified (structural alerts) and their potentialities in the lead generation process and in the 
design of safer' chems. were evaluated. 
 
Electrophilicity as a possible descriptor for toxicity prediction 
Quick ViewOther Sources 
 By Roy, D. R.; Parthasarathi, R.; Maiti, B.; Subramanian, V.; Chattaraj, P. K.  
 From Bioorganic & Medicinal Chemistry (2005), 13(10), 3405-3412. | Language: English, Database: 
CAPLUS  
 Electrophilicity is one of the cardinal chem. reactivity descriptors successfully 
employed in various mol. reactivity studies within a structure-activity relationship parlance. The 
applications of this quantity in the modeling of toxicol. properties have inspired the authors to 
perform a more exhaustive study to test and/or to validate the application of electrophilicity in 
assessing its chem. and toxicol. potential. For this reason the toxicity of a large data set of mols. 
comprising 252 aliph. compds. on the Tetrahymena pyriformis is studied. A quant. structure-
activity relationship anal. enabled the authors to model toxicity in terms of global and local 
electrophilicities, which provide a reasonably good prediction of aliph. toxicity. It is heartening to 
note that the global and local electrophilicity values together can explain the toxicity of a large 
variety of aliph. compds. nicely without resorting to any other descriptor or other microscopic
/macroscopic physicochem. properties as is the situation in all other QSAR studies. 
 
Validation of a QSAR model for acute toxicity 
Quick ViewOther Sources 
 By Pavan, M.; Netzeva, T. I.; Worth, A. P.  
 From SAR and QSAR in Environmental Research (2006), 17(2), 147-171. | Language: English, 
Database: CAPLUS  
 In the present study, a quant. structure - activity relationship (QSAR) model has been 
developed for predicting acute toxicity to the fathead minnow (Pimephales promelas), the aim 
being to demonstrate how statistical validation and domain definition are both required to 
establish model validity and to provide reliable predictions. A dataset of 408 heterogeneous 
chems. was modeled by a diverse set of theor. mol. descriptors by using multivariate linear 
regression (MLR) and Genetic Algorithm - Variable Subset Selection (GA-VSS). This QSAR model 
was developed to generate reliable predictions of toxicity for org. chems. not yet tested, so 
particular emphasis was given to statistical validity and applicability domain. External validation 
was performed by using OECD Screening Information Data Set (SIDS) data for 177 High Prodn. 
Vol. (HPV) chems., and a good predictivity was obtained (Q2ext = 72.1). The model was evaluated 
according to the OECD principles for QSAR validation, and compliance with all five principles was 
established. The model could therefore be useful for the regulatory assessment of chems. For 
example, it could be used to fill data gaps within its chem. domain and contribute to the 
prioritization of chems. for aquatic toxicity testing. 
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Automatic extraction of structural alerts for predicting chromosome aberrations of organic 
compounds 
Quick ViewOther Sources 
 By Estrada, Ernesto; Molina, Enrique  
 From Journal of Molecular Graphics & Modelling (2006), 25(3), 275-288. | Language: English, 
Database: CAPLUS  
 We use the topol. sub-structural mol. design (TOPS-MODE) approach to formulate 
structural alert rules for chromosome aberration (CA) of org. compds. First, a classification model 
was developed to group chems. as active/inactive respect to CA. A procedure for extg. structural 
information from orthogonalized TOPS-MODE descriptors was then implemented. The 
contributions of bonds to CA in all the mols. studied were then generated using the 
orthogonalized classification model. Using this information we propose 22 structural alert rules 
which are ready to be implemented in expert systems for the automatic prediction of CA. They 
include, among others, structural alerts for N-nitroso compds. (ureas, urethanes, guanidines, 
triazines), nitro compds. (arom. and heteroarom.), alkyl esters or phosphoric acids, alkyl 
methanesulfonates, sulfonic acids and sulfonamides, epoxides, arom. amines, azaphenanthrene 
hydrocarbons, etc. The chemico-biol. anal. of some of the structural alerts found is also carried 
out showing the potential of TOPS-MODE as a knowledge generator. 
 
 
Identification of the Structural Requirements for Mutagenicity, by Incorporating Molecular 
Flexibility and Metabolic Activation of Chemicals. II. General Ames Mutagenicity Model 
Quick ViewOther Sources 
 By Serafimova, R.; Todorov, M.; Pavlov, T.; Kotov, S.; Jacob, E.; Aptula, A.; Mekenyan, O.  
 From Chemical Research in Toxicology (2007), 20(4), 662-676. | Language: English, Database: 
CAPLUS  
  
The tissue metabolic simulator (TIMES) modeling approach is a hybrid expert system that couples a 
metabolic simulator together with structure toxicity rules, underpinned by structural alerts, to predict 
interaction of chems. or their metabolites with target macromols. Some of the structural alerts 
representing the reactivity pattern-causing effect could interact directly with the target whereas 
others necessitated a combination with two- or three-dimensional quant. structure-activity 
relationship models describing the firing of the alerts from the rest of the mols. Recently, TIMES has 
been used to model bacterial mutagenicity (O. Mekenyan, O., et al.,2004). The original model was 
derived for a single tester strain, Salmonella typhimurium (TA100), using the Ames test by the 
National Toxicol. Program (NTP). The model correctly identified 82% of the primary acting mutagens, 
94% of the nonmutagens, and 77% of the metabolically activated chems. in a training set. The 
identified high correlation between activities across different strains changed the initial strategic 
direction to look at the other strains in the next modeling developments. In this respect, the focus of 
the present work was to build a general mutagenicity model predicting mutagenicity with respect to 
any of the Ames tester strains. The use of all reactivity alerts in the model was justified by their 
interaction mechanisms with DNA, found in the literature. The alerts identified for the current model 
were analyzed by comparison with other established alerts derived from human experts. In the new 
model, the original NTP training set with 1341 structures was expanded by 1626 proprietary chems. 
provided by BASF AG. Eventually, the training set consisted of 435 chems., which are mutagenic as 
parents, 397 chems. that are mutagenic after S9 metabolic activation, and 2012 nonmutagenic 
chems. The general mutagenicity model was found to have 82% sensitivity, 89% specificity, and 88% 
concordance for training set chems. The model applicability domain was introduced accounting for 
similarity (structural, mechanistic, etc.) between predicted chems. and training set chems. for which 
the model performs correctly. 
 
 
A Novel Logic-Based Approach for Quantitative Toxicology Prediction 
Quick ViewOther Sources 
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 By Amini, Ata; Muggleton, Stephen H.; Lodhi, Huma; Sternberg, Michael J. E.  
 From Journal of Chemical Information and Modeling (2007), 47(3), 998-1006. | Language: English, 
Database: CAPLUS  
  
There is a pressing need for accurate in silico methods to predict the toxicity of mols. that are being 
introduced into the environment or are being developed into new pharmaceuticals. Predictive toxicol. 
is in the realm of structure activity relationships (SAR), and many approaches have been used to 
derive such SAR. Previous work has shown that inductive logic programming (ILP) is a powerful 
approach that circumvents several major difficulties, such as mol. superposition, faced by some other 
SAR methods. The ILP approach reasons with chem. substructures within a relational framework and 
yields chem. understandable rules. Here, we report a general new approach, support vector inductive 
logic programming (SVILP), which extends the essentially qual. ILP-based SAR to quant. modeling. 
First, ILP is used to learn rules, the predictions of which are then used within a novel kernel to derive 
a support-vector generalization model. For a highly heterogeneous dataset of 576 mols. with known 
fathead minnow fish toxicity, the cross-validated correlation coeffs. (R2CV) from a chem. descriptor 
method (CHEM) and SVILP are 0.52 and 0.66, resp. The ILP, CHEM, and SVILP approaches correctly 
predict 55, 58, and 73%, resp., of toxic mols. In a set of 165 unseen mols., the R2 values from the 
com. software TOPKAT and SVILP are 0.26 and 0.57, resp. In all calcns., SVILP showed significant 
improvements in comparison with the other methods. The SVILP approach has a major advantage in 
that it uses ILP automatically and consistently to derive rules, mostly novel, describing fragments that 
are toxicity alerts. The SVILP is a general machine-learning approach and has the potential of tackling 
many problems relevant to chemoinformatics including in silico drug design. 
 
 
Absorption, distribution, metabolism and excretion of intravenously and orally administered 
tetrabromobisphenol A [2,3-dibromopropyl ether] in male Fischer-344 rats 
Quick ViewOther Sources 
 By Knudsen, G. A.; Jacobs, L. M.; Kuester, R. K.; Sipes, I. G.  
 From Toxicology (2007), 237(1-3), 158-167. | Language: English, Database: CAPLUS 
 Tetrabromobisphenol A bis[2,3-dibromopropyl ether], 2,2-bis[3,5-dibromo-4-(2,3-
dibromopropoxy)phenyl]propane is a brominated flame retardant with substantial U.S. prodn. 
Due to the likelihood of human exposure to TBBPA-DBPE and its probable metabolites, studies 
regarding the absorption, distribution, metab., and excretion were conducted. Male Fischer-344 
rats were dosed with TBBPA-DBPE (20 mg/kg) by oral gavage or i.v. administration. Following a 
single oral administration of TBBPA-DBPE, elimination of [14C] equiv. in the feces was extensive 
and rapid (95% of dose by 36 h). Following repeated daily oral doses for 5 or 10 days, route and 
rate of elimination was similar to single administrations of TBBPA-DBPE. After i.v. administration, 
fecal excretion of [14C] equiv. was much slower (27% of dose eliminated by 36 h, 71% by 96 h). 
Urinary elimination was minimal (<0.1%) following oral or i.v. administration. A single peak that 
co-eluted with the std. of TBBPA-DBPE was detected in exts. of whole blood following oral or IV 
administration. TBBPA-DBPE elimination from the blood was slow. Kinetic consts. following i.v. 
dosing were-t1/2β: 24.8 h; CLb: 0.1 mL min-1. Kinetic consts. following oral dosing were: t1/2α: 2.5 h; 
t1/2β: 13.9 h; CLb: 4.6 mL min-1. Systemic bioavailability was 2.2%. Liver was the major site of 
disposition following oral or IV administration. After oral administration, 1% of the dose was 
eliminated in bile in 24 h (as metabolites). In in vitro expts. utilizing hepatocytes or liver 
microsomal protein, no detectable metab. of TBBPA-DBPE occurred. These data indicate that 
TBBPA-DBPE is poorly absorbed from the gastrointestinal tract. Compd. which is absorbed is 
sequestered in the liver, slowly metabolized, and eliminated in the feces. 
 
 
Identification of the Structural Requirements for Mutagenicity, by Incorporating Molecular 
Flexibility and Metabolic Activation of Chemicals. II. General Ames Mutagenicity Model. [Erratum to 
document cited in CA146:516278] 
Quick ViewOther Sources 
 By Serafimova, R.; Todorov, M.; Pavlov, T.; Kotov, S.; Jacob, E.; Aptula, A.; Mekenyan, O.  
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 From Chemical Research in Toxicology (2007), 20(8), 1225. | Language: English, Database: CAPLUS  
 On page 673, in the conclusion section, the text, "As a comparative exercise, the 
alerts used in the present work were compared with three alert lists of Ashby, Kazius, and 
Benigni," should read: "As a comparative exercise, the alerts used in the present work were 
compared with alert lists of Ashby and Kazius, as well as the lists reported by Benigni in his 
review.". 
 
 
Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) 
mutagenicity 
Quick ViewOther Sources 
 By Perez-Garrido, Alfonso; Gonzalez, Maykel Perez; Escudero, Amalio Garrido  
 From Bioorganic & Medicinal Chemistry (2008), 16(10), 5720-5732. | Language: English, Database: 
CAPLUS  
 The risk of the presence of haloacetic acids in drinking water as chlorination 
byproducts and the shortage of exptl. mutagenicity data for most of them requires a research 
work. This paper describes a QSAR model to predict direct mutagenicity for these chems. The 
model, able to describe more than 90% of the variance in the exptl. activity, was developed with 
the use of the spectral moment descriptors. The model, using these descriptors with 
multiplicative effects provides better results than other linear descriptors models based on 
Geometrical, RDF, WHIM, eigenvalue-based indexes, 2D-autocorrelation ones, and information 
descriptors, taking into account the statistical parameters of the model and the cross-validation 
results. The structural alerts and the mutagenicity-predicted values from the model output are in 
agreement with refs. from other authors. The mutagenicity predicted values for the three 
haloacetic acids, which have available exptl. data (TCAA-Trichloroacetic acid, BDCAA-
Bromodichloroacetic acid, and TBAA-Tribromoacetic acid), are reasonably close to their exptl. 
values, specially for the latest two. 
 
Summary of chemically induced pulmonary lesions in the National toxicology program (NTP) 
toxicology and carcinogenesis studies 
Quick ViewOther Sources 
 By Dixon, Darlene; Herbert, Ronald A.; Kissling, Grace E.; Brix, Amy E.; Miller, Rodney A.; Maronpot, 
Robert R.  
 From Toxicologic Pathology (2008), 36(3), 428-439. | Language: English, Database: CAPLUS  
 A review. The lung is the second most common target site of neoplasia of chems. 
tested by the National Toxicol. Program (NTP). Of all peer-reviewed NTP studies to date (N = 
545), a total of sixty-four chems. in sixty-six reports produced significant site-specific neoplasia 
in the lungs of rats and/or mice. Of the studies assocd. with lung tumor induction, approx. 35% 
were inhalation and 35% were gavage studies, with dosed-feed, dosed-water, topical, i.p., or in 
utero routes of chem. administration accounting for 18%, 6%, 3%, 1%, and 1% of the studies, 
resp. The most commonly induced lung tumors were alveolar/bronchiolar (A/B) adenoma and/or 
carcinoma for both species. The most frequently obsd. nonneoplastic lesions included 
hyperplasia and inflammation in both species. The liver was the most common primary site of 
origin of metastatic lesions to the lungs of mice; however, skin was most often the primary site 
of origin of metastatic lesions to the lungs of rats. In summary, A/B adenoma and carcinoma 
were the most frequently diagnosed chem. induced tumors in the lungs of both rats and mice in 
the NTP toxicol. and carcinogenesis bioassays, and hyperplasia and inflammation were the most 
common nonneoplastic changes obsd. 
 
Quantitative structure toxicity relationship (QSTR) study on a series of aliphatic alcohol derivatives 
Quick ViewOther Sources 
 By Singh, R. K.; Khan, A. K. R.  
 From Organic Chemistry: An Indian Journal (2008), 4(2), 91-98. | Language: English, Database: 
CAPLUS  
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 The quant. structure toxicity relationship of 89 derivs. of alc. have been studied with 
the help of total energy, abs. hardness and electronegativity. The alcs. have been divided into 
four groups. The first group consists of derivs. of amino alc., second consists of derivs. of diol, 
the third and fourth resp. consist of derivs. of halogenated and unsatd. alcs. A direct relationship 
between the toxicity of all groups of alcs. and electronegativity has been obsd. The QSTR model 
of all the four sets have been developed. The best QSTR model of first and second set of 
compds. have correlation coeff. value above 0.94 and 0.7 resp., which has been derived by 
combination of all the three descriptors. The best QSTR model of third set and fourth set of 
compds. have correlation coeff. value above 0.86 and 0.65 resp., which has been derived by 
combination of descriptors consisting total energy, abs. hardness and electronegativity. 
 
Quantum mechanical quantitative structure-activity relationships to avoid mutagenicity 
Quick ViewOther Sources 
 By Holder, Andrew J.; Ye, Lin 
 From Dental Materials (2009), 25(1), 20-25. | Language: English, Database: CAPLUS  
 Objective: The purpose of this work is to develop a quantum mech. based quant. 
structure-activity relationship (QMQSAR or QSAR hereafter) adequate to predict and explain 
Ames TA100-derived mutagenicities for a no. of org. mols. Methods: A set of 35 structurally 
similar mols. with epoxide (oxirane) functionalities and systematic, reliable exptl. data were 
selected to construct a QSAR model. The SAM1 quantum mech. method was used to perform 
conformational anal. and properties calcns. This QM information was used to compute a variety 
of descriptors. From this a two-descriptor regression model was constructed. Results: The two 
descriptors are ESP-HACA-1/TMSA and HOMO-LUMO energy gap. Statistical results for the 
model: R 2 = 0.857, R adj 2 = 0.818 , R cv 2 = 0.848 , s 2 = 0.0618. The variance inflation factor 
and significance for both descriptors were 1.082 and <0.001, resp. The descriptors are related to 
transport across a membrane and to reactivity. Significance: The model we have presented here 
facilitates design of non-mutagenic monomers that may be useful for dental restorative 
composites. The model also serves as a screening tool for rating the mutagenicity of new 
candidate materials. 
 
Comparative QSTR study of a series of alcohol derivatives against Tetrahymena pyriformis 
Quick ViewOther Sources 
 By Singh, R. K.; Khan, A. K. R.; Sahu, V. K.; Singh, P. P.  
 From International Journal of Quantum Chemistry (2008), Volume Date2009, 109(2), 185-195. | 
Language: English, Database: CAPLUS  
 The quant. structure toxicity relationship (QSTR) models of 89 alc. derivs. have been 
made with the help of quantum chem. and topol. descriptors. The mol. modeling and geometry 
optimization have been carried out with CAChe pro software. The calcns. of quantum chem. 
descriptors have been done by MOPAC 2002 of topol. descriptors by Dragon software. The study 
indicates that quantum chem. descriptors better predict the toxicity of amino, halogenated and 
unsatd. alc. derivs., while toxicity of acetylenic, diols, and satd. alc. derivs. are better predicted 
by topol. descriptors as indicated by correlation coeff. and cross validation coeff. (rCV%2) values 
of the QSTR models. The predicted toxicity (PT) values obtained by these QSTR models are close 
to obsd. toxicity. 
 
 
Comparative QSTR study of saturated alcohols based on topological, constitutional, geometrical, 
and getaway descriptors 
Quick ViewOther Sources 
 By Khan, A. K. R.; Sahu, V. K.; Singh, R. K.; Khan, S. A.  
 From Medicinal Chemistry Research (2009), 18(9), 770-781. | Language: English, Database: CAPLUS  
 Comparative quant. structure-toxicity relationship (QSTR) models of a series of satd. 
alcs. were constructed based on topol., constitutional, geometrical, and getaway descriptors. In 
the first step, all groups of descriptors were applied to 29 satd. alc. derivs. Mol. modeling and 
geometry optimization was carried out with CAChe Pro software. Calcn. of descriptors was done 
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by using Dragon software and multilinear regression anal. by using Project Leader software. 
Various QSTR models for each set of descriptor in different combinations were then developed, 
and only the top five models for each set of descriptors were chosen. Of the top five, the best 
QSTR model of each set of descriptors was used for comparative study. The study shows that 
the best QSTR model (CRE5 = -0.0795186 MW + 0.110997 AMW + 23.0915 SV - 4.62153 Se - 
11.9932 Sp - 0.613194 Ss + 5.68544) is made from constitutional descriptors. The best model 
was selected on the basis of values of correlation coeff. (r2 = 0.853) followed by other regression 
quality parameters such as cross-validation coeff. (rCV2 = 0.453), std. error (SE = 0.453) and std. 
error of estn. (SEE = 0.346), F-statistic (F = 25.57), and p values (p = 0.00) that were calcd. by 
statistical software. Secondly, it has been reported that there is a direct relationship between 
reported biol. toxicity of the alcs. and the sum of Kier-Hall electrotopol. states (Ss) descriptor of 
the constitutional group. Sum of Kier-Hall electrotopol. states (Ss) can alone be helpful for 
searching for alcs. of reliable toxicities before their synthesis. 
 
Quantitative structure-toxicity models for heterogeneous aliphatic compounds 
Quick ViewOther Sources 
 By Duchowicz, Pablo R.; Ocsachoque, Marco A.  
 From QSAR & Combinatorial Science (2009), 28(3), 281-295. | Language: English, Database: 
CAPLUS  
 The presented work deals with the Quant. Structure - Activity Relationships (QSAR) 
anal. for the growth inhibition of the ciliated protozoan Tetrahymena pyriformis by a 
mechanistically diverse set of aliph. org. compds. A pool of 1509 theor. descriptors coding for 
lipophilic, constitutional, steric, and electronic properties of these mols. is calcd. with the Dragon 
software. The simultaneous linear regression analyses on 370 compds. led to a five-parameter 
model characterized by R = 0.909 and leave more out R l-30%-o = 0.843. An external test set of 100 
structurally related derivs. that is not employed during the model development demonstrates 
that the relationship found shows good predictive power, with Rval = 0.881. Finally, the 
application of this subset of descriptors on the complete set of 470 aliph. structures outperforms 
previous reported results. The authors' study corroborates that hydrophobicity, calcd. among 
more than a thousand of structural variables, represents an important factor for predicting the 
toxicity of aliph. compds. 
 
Quantitative structure toxicity relationship (QSTR) study on a series of aliphatic alcohol derivatives 
with the help of topological descriptors 
Quick ViewOther Sources 
 By Kumar, Dinesh; Singh, R. N.; Khan, A. K. R.; Singh, P. P.  
 From Organic Chemistry: An Indian Journal (2008), 4(5), 339-343. | Language: English, Database: 
CAPLUS  
 In this present work, we have taken a series of aliph. alc. derivs. and developed 
QSTR models with the help of topol. descriptors. The values of topol. descriptors are directly 
obtained by Dragon software. The first set contains amino alc. derivs. and the correlation coeff. 
of this set is above 0.80. The second set contains acetylenic and diol derivs. The correlation 
coeff. of this set is above 0.83. The third and fourth set contains satd. and unsatd. alcs. resp. 
The correlation coeff. of these sets are above 0.80. 
 
Molecular descriptors based comparative QSTR study of saturated alcohols derivatives 
Quick ViewOther Sources 
 By Singh, Satyenrdra; Khan, A. K. R.; Singh, R. K.  
 From Organic Chemistry: An Indian Journal (2008), 4(6-8), 401-407. | Language: English, Database: 
CAPLUS  
 In this present work, we have taken satd. alc. derivs. and comparative QSTR model 
have been made with the help of few important groups of descriptors like topol., constitutional 
descriptors, geometrical and getaway descriptors have been tested and to final QSTR model has 
been made with the help of the most significant descriptors. The values of these descriptors 
have been calcd. by Dragon software. Finally, we have made direct relationship between most 
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significant descriptors (Se) and obsd. toxicity. The cross validation coeff. and correlation coeff. of 
best model are 0.453139 and 0.852744 resp. 
 
A segmented principal component analysis-regression approach to quantitative structure-activity 
relationship modeling 
Quick ViewOther Sources 
 By Hemmateenejad, Bahram; Elyasi, Maryam  
 From Analytica Chimica Acta (2009), 646(1-2), 30-38. | Language: English, Database: CAPLUS  
 The major problem assocd. with application of principal component regression (PCR) 
in QSAR studies is that this model exts. the eigenvectors solely from the matrix of descriptors, 
which might not have essentially good relationship with the biol. activity. This article describes a 
novel segmentation approach to PCR (SPCAR), in which the descriptors are firstly segmented to 
different blocks and then principal component anal. (PCA) is applied on each segment to ext. 
significant principal components (PCs). In this way, the PCs having useful and redundant 
information are sepd. A linear regression anal. based on stepwise selection of variables is then 
employed to connect a relationship between the informative extd. PCs and biol. activity. The 
proposed method was first applied to model the aq. toxicity of aliph. compds. The effect of the 
no. of segments on the prediction ability of the method was investigated. Finally, a correlation 
anal. was achieved to identify those descriptors having significant contribution in the selected 
PCs and in aq. toxicity. The proposed method was further validated by the anal. of Selwood data 
set consisting of 31 compds. and 53 descriptors. A comparison between the conventional PCR 
algorithm and SPCAR reveals the superiority of the latter. For external prediction set, SPCAR 
represented all requirements to be considered as predicted model, whereas PCR did not. In 
addn., a comparison was made between the models obtained by SPCAR and those reported 
previously. 
 
 
Prediction of chemical carcinogenicity by machine learning approaches 
Quick ViewOther Sources 
 By Tan, N. X.; Rao, H. B.; Li, Z. R.; Li, X. Y.  
 From SAR and QSAR in Environmental Research (2009), 20(1-2), 27-75. | Language: English, 
Database: CAPLUS  
 In this paper, the authors report a successful application of machine learning 
approaches to the prediction of chem. carcinogenicity. Two different approaches, namely, a 
support vector machine (SVM) and artificial neural network (ANN), were evaluated for predicting 
chem. carcinogenicity from mol. structure descriptors. A diverse set of 844 compds., including 
600 carcinogenic (CG+) and 244 noncarcinogenic (CG-) mols., was used to est. the accuracies of 
these approaches. The database was divided into 2 sets: the model construction set and the 
independent test set. Relevant mol. descriptors were selected by a hybrid feature selection 
method combining Fischer's score and Monte Carlo simulated annealing from a wide set of mol. 
descriptors, including physiochem. properties, constitutional, topol., and geometrical descriptors. 
The first model validation method was based on a 5-fold cross-validation method, in which the 
model construction set is split into 5 subsets. The 5-fold cross-validation was used to select 
descriptors and optimize the model parameters by maximizing the averaged overall accuracy. 
The final SVM model gave an averaged prediction accuracy of 90.7% for CG+ compds., 81.6% 
for CG- compds., and 88.1% for the overall accuracy, while the corresponding ANN model 
provided an averaged prediction accuracy of 86.1% for CG+ compds., 79.3% for CG- compds., 
and 84.2% for the overall accuracy. These results indicate that the hybrid feature selection 
method is very efficient and the selected descriptors are truly relevant to the carcinogenicity of 
compds. Another model validation method, i.e., a hold-out method, was used to build the 
classification model using the selected descriptors and the optimized model parameters, in which 
the whole model construction set was used to build the classification model and the independent 
test set was used to test the predictive ability of the model. The SVM model gave a prediction 
accuracy of 87.6% for CG+ compds., 79.1% for CG- compds., and 85.0% for the overall 
accuracy. The ANN model gave a prediction accuracy of 85.6% for CG+ compds., 79.1% for CG- 
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compds., and 83.6% for the overall accuracy. The results indicate that the built models are 
potentially useful for facilitating the prediction of chem. carcinogenicity of untested compds. 
 
Semivolatile Endocrine-Disrupting Compounds in Paired Indoor and Outdoor Air in Two Northern 
California Communities 
Quick ViewOther Sources 
 By Rudel, Ruthann A.; Dodson, Robin E.; Perovich, Laura J.; Morello-Frosch, Rachel; Camann, David 
E.; Zuniga, Michelle M.; Yau, Alice Y.; Just, Allan C.; Brody, Julia Green  
 From Environmental Science & Technology (2010), 44(17), 6583-6590. | Language: English, 
Database: CAPLUS  
 Interest in the health effects of potential endocrine-disrupting compds. which are 
high prodn. vol. chems. used in consumer products has made exposure assessment and source 
identification a priority. The authors collected paired indoor and outdoor air samples in 40 non-
smoking homes in urban, industrial Richmond, California, and 10 in rural Bolinas, California. 
Samples were analyzed by gas chromatog.-mass spectrometry for 104 analytes, including 
phthalates (11), alkylphenols (3), parabens (3), polybrominated di-Ph ether (PBDE) flame 
retardants (3), polychlorinated biphenyls (PCB, 3), polycyclic arom. hydrocarbons (PAH, 24), 
pesticides (38), and phenolic compds. (19). In total, 39 analytes were detected in outdoor air 
and 63 in indoor air. For many phenolic, alkylphenol, phthalate, and PBDE compds., these 
represent some of the first outdoor measures and first analyses of the relative importance of 
indoor and outdoor sources in paired samples. Data demonstrated higher indoor concns. for 32 
analytes, suggesting primarily indoor sources vs. only 2 which were higher outdoors. Outdoor air 
concns. were higher in Richmond than Bolinas for 3 phthalates, 10 PAH, and o-phenylphenol; 
indoor air concns. were more similar between communities, except differences obsd. outdoors 
were also obsd. indoors. Indoor concns. of the most ubiquitous chems. were generally correlated 
with each other (4-t-butylphenol, o-phenylphenol, nonylphenol, several phthalates, Me 
phenanthrenes; Kendall correlation coeffs. 0.2-0.6, p <0.05), indicating possible shared sources 
and highlighting the importance of considering mixts. in health studies. 
 
 
A comparative study of two quantum chemical descriptors in predicting toxicity of aliphatic 
compounds towards Tetrahymena pyriformis 
Quick ViewOther Sources 
 By Pandith, Altaf Hussain; Giri, S.; Chattaraj, P. K.  
 From Organic Chemistry International (2010), 545087, 17 pp.. | Language: English, Database: 
CAPLUS  
 Quantum chem. parameters such as LUMO energy, HOMO energy, ionization energy 
(I), electron affinity (A), chem. potential (μ), hardness (η) electronegativity (χ), philicity (ωα), and 
electrophilicity (ω) of a series of aliph. compds. are calcd. at the B3LYP/6-31G(d) level of theory. 
Quant. structure-activity relationship (QSAR) models are developed for predicting the toxicity 
(pIGC50) of 13 classes of aliph. compds., including 171 electron acceptors and 81 electron donors, 
towards Tetrahymena pyriformis. The multiple linear regression modeling of toxicity of these 
compds. is performed by using the mol. descriptor log P (1-octanol/water partition coeff.) in 
conjunction with two other quantum chem. descriptors, electrophilicity (ω) and energy of the 
LUMO (ELUMO). A comparison is made towards the toxicity predicting the ability of electrophilicity 
(ω) vs. ELUMO as a global chem. reactivity descriptor in addn. to log P. The former works marginally 
better in most cases. There is a slight improvement in the quality of regression by changing the 
unit of IGC50 from mg/L to molarity and by removing the racemates and the diastereoisomers 
from the data set. 
 
Hardness based quantitative structure toxicity relationship (QSTR) study on a series of aliphatic 
alcohol derivatives 
Quick ViewOther Sources 
 By Kumar, Dinesh; Singh, R. N.; Sahu, Sangeeta; Baboo, Vikas  
 From Organic Chemistry: An Indian Journal (2011), 7(1), 41-47. | Language: English, Database: 
CAPLUS  
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 The quant. structure toxicity relationship of 89 derivs. of alc. have been studied with 
the help of total energy, abs. hardness and electronegativity. The alcs. have been divided into 
four groups. The first group consists of derivs. of amino alc., second consists of derivs. of diol, 
the third and fourth resp. consist of derivs. of halogenated and unsatd. alcs. A direct relationship 
between the toxicity of all groups of alcs. and electronegativity has been obsd. The QSTR model 
of all the four sets have been developed. The best QSTR model of first and second set of 
compds. have correlation coeff. value above 0.94 and 0.7 resp., which has been derived by 
combination of all the three descriptors. The best QSTR model of third set and fourth set of 
compds. have correlation coeff. value above 0.86 and 0.65 resp., which has been derived by 
combination of descriptors consisting total energy, abs. hardness and electronegativity. The abs. 
hardness is one of the most significant descriptor for searching the low toxicity of alcs. 
 
The use of ex vivo human skin tissue for genotoxicity testing 
Quick ViewOther Sources 
 By Reus, Astrid A.; Usta, Mustafa; Krul, Cyrille A. M.  
 From Toxicology and Applied Pharmacology (2012), 261(2), 154-163. | Language: English, 
Database: CAPLUS  
 As a result of the chem. legislation concerning the registration, evaluation, 
authorization and restriction of chems. (REACH), and the Seventh Amendment to the Cosmetics 
Directive, which prohibits animal testing in Europe for cosmetics, alternative methods for safety 
evaluation of chems. are urgently needed. Current in vitro genotoxicity assays are not sufficiently 
predictive for the in vivo situation, resulting in an unacceptably high no. of misleading positives. 
For many chems. and ingredients of personal care products the skin is the first site of contact, 
but there are no in vitro genotoxicity assays available in the skin for addnl. evaluation of pos. or 
equivocal responses obsd. in regulatory in vitro genotoxicity assays. In the present study ex vivo 
human skin tissue obtained from surgery was used for genotoxicity evaluation of chems. by 
using the comet assay. Fresh ex vivo human skin tissue was cultured in an air-liq. interface and 
topically exposed to 20 chems., including true pos., misleading pos. and true neg. genotoxins. 
Based on the results obtained in the present study, the sensitivity, specificity and accuracy of the 
ex vivo skin comet assay to predict in vivo genotoxicity were 89%, 90% and 89%, resp. Donor 
and exptl. variability were mainly reflected in the magnitude of the response and not the 
difference between the presence and absence of a genotoxic response. The present study 
indicates that human skin obtained from surgery is a promising and robust model for safety 
evaluation of chems. that are in direct contact with the skin. 
 
Gender differences in the incidence of background and chemically induced primary pulmonary 
neoplasms in B6C3F1 mice: A retrospective analysis of the National Toxicology Program (NTP) 
carcinogenicity bioassays 
Quick ViewOther Sources 
 By Moore, Nigel P.; McFadden, Lisa G.; Landenberger, Bryce D.; Thomas, Johnson  
 From Experimental and Toxicologic Pathology (2013), 65(7-8), 1109-1115. | Language: English, 
Database: CAPLUS  
 The National Toxicol. Program (NTP) database of tech. reports on carcinogenicity 
bioassays has been interrogated for the incidence of primary pulmonary neoplasms in B6C3F1 
mice. A total of 170 study reports were selected, from studies that completed the in-life phase 
during 1983-2007, which included neoplasm incidence data for 180 control groups comprising 
both male and female mice. The incidence (median and inter-quartile range) of males with 
alveolar/bronchiolar adenoma was 16% (12-20%), and for females it was 5% (2-8%); the 
incidence of males with alveolar/bronchiolar carcinoma was 8% (4-12%), and for females it was 
2% (0-4%); and the incidence of males with combined alveolar/bronchiolar adenoma or 
carcinoma was 24% (18-30%), and for females it was 8% (6-12%). Comparing the incidence of 
animals bearing these lesions on a per study basis showed the median incidence in males to be 
3.0-fold, 2.0-fold, and 2.8-fold higher than in females. The incidence of other primary pulmonary 
neoplasms was <10% of the alveolar/bronchiolar neoplasms. Comparison of gender-specific 
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response to lung tumorigens showed that the increase in incidence of tumors above control 
levels was greater in females than in males. 
 
Framework for Identifying Chemicals with Structural Features Associated with the Potential to Act 
as Developmental or Reproductive Toxicants 
Quick ViewOther Sources 
 By Wu, Shengde; Fisher, Joan; Naciff, Jorge; Laufersweiler, Michael; Lester, Cathy; Daston, George; 
Blackburn, Karen  
 From Chemical Research in Toxicology (2013), 26(12), 1840-1861. | Language: English, Database: 
CAPLUS  
  
Developmental and reproductive toxicity (DART) end points are important hazard end points that 
need to be addressed in the risk assessment of chems. to det. whether or not they are the crit. 
effects in the overall risk assessment. These hazard end points are difficult to predict using current in 
silico tools because of the diversity of mechanisms of action that elicit DART effects and the potential 
for narrow windows of vulnerability. DART end points have been projected to consume the majority 
of animals used for compliance with REACH; thus, addnl. nonanimal predictive tools are urgently 
needed. This article presents an empirically based decision tree for detg. whether or not a chem. has 
receptor-binding properties and structural features that are consistent with chem. structures known 
to have toxicity for DART end points. The decision tree is based on a detailed review of 716 chems. 
(664 pos., 16 neg., and 36 with insufficient data) that have DART end-point data and are grouped 
into defined receptor binding and chem. domains. When tested against a group of chems. not 
included in the training set, the decision tree is shown to identify a high percentage of chems. with 
known DART effects. It is proposed that this decision tree could be used both as a component of a 
screening system to identify chems. of potential concern and as a component of wt.-of-evidence 
decisions based on structure-activity relationships (SAR) to fill data gaps without generating addnl. 
test data. In addn., the chem. groupings generated could be used as a starting point for the 
development of hypotheses for in vitro testing to elucidate mode of action and ultimately in the 
development of refined SAR principles for DART that incorporate mode of action (adverse outcome 
pathways). 
 
 
Topological structural alerts modulations of mammalian cell mutagenicity for halogenated 
derivatives 
Quick ViewOther Sources 
 By Perez-Garrido, A.; Giron-Rodriguez, F.; Helguera, A. Morales; Borges, F.; Combes, R. D.  
 From SAR and QSAR in Environmental Research (2014), 25(1), 17-33. | Language: English, 
Database: CAPLUS  
 Genotoxicity is a key toxicity endpoint for current regulatory requirements regarding 
new and existing chems. However, genotoxicity testing is time-consuming and costly, and 
involves the use of lab. animals. This has motivated the development of computational 
approaches, designed to predict genotoxicity without the need to conduct lab. tests. Currently, 
many existing computational methods, like quant. structure-activity relationship (QSAR) models, 
provide limited information about the possible mechanisms involved in mutagenicity or 
predictions based on structural alerts (SAs) do not take statistical models into account. This 
paper describes an attempt to address this problem by using the TOPol. Substructural Mol. 
Design (TOPS-MODE) approach to develop and validate improved QSAR models for predicting 
the mutagenicity of a range of halogenated derivs. Our most predictive model has an accuracy of 
94.12̂, exhibits excellent cross-validation and external set statistics. A reasonable interpretation 
of the model in term of SAs was achieved by means of bond contributions to activity. The results 
obtained led to the following conclusions: primary halogenated derivs. are more mutagenic than 
secondary ones; and substitution of chlorine by bromine increases mutagenicity while 
polyhalogenation decreases activity. The paper demonstrates the potential of the TOPS-MODE 
approach in developing QSAR models for identifying structural alerts for mutagenicity, combining 
high predictivity with relevant mechanistic interpretation. 
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Methods for assigning confidence to toxicity data with multiple values - Identifying experimental 
outliers 
Quick ViewOther Sources 
 By Steinmetz, Fabian P.; Enoch, Steven J.; Madden, Judith C.; Nelms, Mark D.; Rodriguez-Sanchez, 
Neus; Rowe, Phil H.; Wen, Yang; Cronin, Mark T. D.  
 From Science of the Total Environment (2014), 482-483, 358-365. | Language: English, Database: 
CAPLUS  
 The assessment of data quality is a crucial element in many disciplines such as 
predictive toxicol. and risk assessment. Currently, the reliability of toxicity data is assessed on 
the basis of testing information alone (adherence to Good Lab. Practice (GLP), detailed testing 
protocols, etc.). Common practice is to take one toxicity data point per compd. - usually the one 
with the apparently highest reliability. All other toxicity data points (for the same expt. and 
compd.) from other sources are neglected. To show the benefits of incorporating the "less 
reliable" data, a simple, independent, statistical approach to assess data quality and reliability on 
a math. basis was developed. A large data set of toxicity values to Aliivibrio fischeri was 
assessed. The data set contained 1813 data points for 1227 different compds., including 203 
identified as non-polar narcotic. Log KOW values were calcd. and non-polar narcosis quant. 
structure-activity relationship (QSAR) models were built. A statistical approach to data quality 
assessment, which is based on data outlier omission and confidence scoring, improved the linear 
QSARs. The results indicate that a beneficial method for using large data sets contg. multiple 
data values per compd. and highly variable study data has been developed. Furthermore this 
statistical approach can help to develop novel QSARs and support risk assessment by obtaining 
more reliable values for biol. endpoints. 
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Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals 
Quick ViewOther Sources 
 By Mortelmans, Kristien; Haworth, Steve; Lawlor, Timothy; Speck, William; Tainer, Beth; Zeiger, 
Errol  
 From Environmental Mutagenesis (1986), 8(Suppl. 7), 1-119. | Language: English, Database: 
CAPLUS  
 This publication includes data of Salmonella mutagenicity results on 270 coded 
chems., encompassing 329 tests performed by 3 labs. under contract to the National Toxicol. 
Program. The preincubation modification of the Salmonella/mammalian microsome assay was 
used to test chems. in up to 5 Salmonella strains in the presence and absence of rat and 
hamster liver S-9. With a few exceptions, inter- and intralab. reproducibility was good. 
 
 
Structure-mutagenic activity relationships in the Salmonella typhimurium TA100 strain in a series 
of short-chain halogenated hydrocarbons and alcohols. 
Quick ViewOther Sources 
 By Kharchevnikova, N. V.; Zholdakova, Z. I.; Zhurkov, V. S.; Polyakova, E. E.; Novikov, S. M.  
 From Russian Journal of Genetics (Translation of Genetika (Moscow)) (1997), 33(5), 594-597. | 
Language: English, Database: CAPLUS  
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 Structure-mutagenic activity relationships in a series of short-chain halogenated 
hydrocarbons and alcs. were detd. with the use of the energy difference parameter of frontier 
mol. orbitales of compds. that was calcd. by the quantum-chem. method. 
 
 
Identification of the Structural Requirements for Mutagenicity, by Incorporating Molecular 
Flexibility and Metabolic Activation of Chemicals. II. General Ames Mutagenicity Model. [Erratum to 
document cited in CA146:516278] 
Quick ViewOther Sources 
 By Serafimova, R.; Todorov, M.; Pavlov, T.; Kotov, S.; Jacob, E.; Aptula, A.; Mekenyan, O.  
 From Chemical Research in Toxicology (2007), 20(8), 1225. | Language: English, Database: CAPLUS  
 On page 673, in the conclusion section, the text, "As a comparative exercise, the 
alerts used in the present work were compared with three alert lists of Ashby, Kazius, and 
Benigni," should read: "As a comparative exercise, the alerts used in the present work were 
compared with alert lists of Ashby and Kazius, as well as the lists reported by Benigni in his 
review.". 
 
 
Identification of the Structural Requirements for Mutagenicity, by Incorporating Molecular 
Flexibility and Metabolic Activation of Chemicals. II. General Ames Mutagenicity Model 
Quick ViewOther Sources 
 By Serafimova, R.; Todorov, M.; Pavlov, T.; Kotov, S.; Jacob, E.; Aptula, A.; Mekenyan, O.  
 From Chemical Research in Toxicology (2007), 20(4), 662-676. | Language: English, Database: 
CAPLUS 
  
The tissue metabolic simulator (TIMES) modeling approach is a hybrid expert system that couples a 
metabolic simulator together with structure toxicity rules, underpinned by structural alerts, to predict 
interaction of chems. or their metabolites with target macromols. Some of the structural alerts 
representing the reactivity pattern-causing effect could interact directly with the target whereas 
others necessitated a combination with two- or three-dimensional quant. structure-activity 
relationship models describing the firing of the alerts from the rest of the mols. Recently, TIMES has 
been used to model bacterial mutagenicity (O. Mekenyan, O., et al.,2004). The original model was 
derived for a single tester strain, Salmonella typhimurium (TA100), using the Ames test by the 
National Toxicol. Program (NTP). The model correctly identified 82% of the primary acting mutagens, 
94% of the nonmutagens, and 77% of the metabolically activated chems. in a training set. The 
identified high correlation between activities across different strains changed the initial strategic 
direction to look at the other strains in the next modeling developments. In this respect, the focus of 
the present work was to build a general mutagenicity model predicting mutagenicity with respect to 
any of the Ames tester strains. The use of all reactivity alerts in the model was justified by their 
interaction mechanisms with DNA, found in the literature. The alerts identified for the current model 
were analyzed by comparison with other established alerts derived from human experts. In the new 
model, the original NTP training set with 1341 structures was expanded by 1626 proprietary chems. 
provided by BASF AG. Eventually, the training set consisted of 435 chems., which are mutagenic as 
parents, 397 chems. that are mutagenic after S9 metabolic activation, and 2012 nonmutagenic 
chems. The general mutagenicity model was found to have 82% sensitivity, 89% specificity, and 88% 
concordance for training set chems. The model applicability domain was introduced accounting for 
similarity (structural, mechanistic, etc.) between predicted chems. and training set chems. for which 
the model performs correctly. 
 
Scientific opinion on emerging and novel brominated flame retardants (BFRs) in food 
Quick ViewOther Sources 
 By Benford, Diane; Ceccatelli, Sandra; Cottrill, Bruce; DiNovi, Michael; Dogliotti, Eugenia; Edler, 
Lutz; Farmer, Peter; Furst, Peter; Hoogenboom, Laurentius; Knutsen, Helle Katrine; et al 
 From EFSA Journal (2012), 10(10), 2908, 125 pp.. | Language: English, Database: CAPLUS  
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 EFSA was asked to deliver a scientific opinion on brominated flame retardants (BFRs) 
other than PBDEs, PBBs, HBCDDs, TBBPA and brominated phenols and their derivs. The BFRs 
that are the subject of the current opinion, were classified in groups termed 'emerging' and 
'novel' BFRs. Information on 17 emerging and 10 novel BFRs was collected. The information 
varied widely for these BFRs. There is a lack of exptl. data on physico-chem. characteristics, 
stability/reactivity and current use and prodn. vol. of all the emerging and novel BFRs. Due to 
the very limited information on occurrence, exposure and toxicity, the CONTAM Panel could not 
perform a risk characterization for any of the BFRs considered. Instead, an attempt was made to 
identify those BFRs that could be a potential health concern and should be considered first for 
future investigations. For this purpose the Panel first evaluated the available exptl. data on 
occurrence in food, behavior in the environment and toxicity. Secondly, a modeling exercise was 
performed focussing on the potential of the emerging and novel BFRs for persistence in the 
environment and for their possible bioaccumulation potential. There is convincing evidence that 
tris(2,3-dibromopropyl) phosphate (TDBPP) and dibromoneopentyl glycol (DBNPG) are genotoxic 
and carcinogenic, warranting further surveillance of their occurrence in the environment and in 
food. Based on the limited exptl. data on environmental behavior, 1,2-bis(2,4,6-
tribromophenoxy)ethane (BTBPE) and hexabromobenzene (HBB) were identified as compds. that 
could raise a concern for bioaccumulation. For the modeling exercise, the CONTAM Panel 
selected two environmental characteristics, overall persistence and potential for bioaccumulation, 
as being most relevant to provide insight into the possibility that emerging or novel BFRs might 
accumulate in the food chain, and thus might appear in food intended for human consumption. 
The modeling exercise identified ten addnl. BFRs that should be subjected to further in-depth 
studies. 
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Hydroxylation of pentamidine by rat liver microsomes 
Quick ViewOther Sources 
 By Berger, B. J.; Reddy, V. V.; Le, S. T.; Lombardy, R. J.; Hall, James Edwin; Tidwell, R. R.  
 From Journal of Pharmacology and Experimental Therapeutics (1991), 256(3), 883-9. | Language: 
English, Database: CAPLUS  
 The antiprotozoal/antifungal drug pentamidine is metabolized by rat liver fractions to 
at least 6 metabolites detectable by HPLC. Two minor metabolites have been identified as N-
hydroxypentamidine and N,N'-dihydroxypentamidine. The two major microsomal metabolites 
have been identified as 1,5-di(4-amidinophenoxy)-2-pentanol and 1,5-bis(4-amidinophenoxy)-3-
pentanol. A seventh putative metabolite has been identified as p-hydroxybenzamidine, a 
fragment of the original drug. Whereas the cytochromes P 450 enzyme system is responsible for 
pentamidine metab., hydroxylation of the drug was not inducible by phenobarbital, β-
naphthoflavone, clofibrate, isosafrole, pregnenolone-16α-carbonitrile, ethanol, or pentamidine 
pretreatment of rats. The kinetics of the prodn. of the two major microsomal metabolites has Km 
= 56 μM and Vmax = 126 pmol/min/mg microsomal protein for the 2-pentanol analog, and Km = 28 
μM and Vmax = 195 pmol/min/mg microsomal protein for the 3-pentanol analog. Therefore, the 
mixed-function oxidases readily convert pentamidine to hydroxylated metabolites, but that which 
isoenzyme(s) of cytochrome P 450 is responsible is not clear. 
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Synthesis and mutagenicity of selectively methylated analogs of tris(2,3-dibromopropyl) phosphate 
and 1,2-dibromo-3-chloropropane 
Quick ViewOther Sources 
 By Omichinski, James G.; Soederlund, Erik J.; Bausano, James A.; Dybing, Erik; Nelson, Sidney D.  
 From Mutagenesis (1987), 2(4), 287-92. | Language: English, Database: CAPLUS  
 Five selectively methylated analogs of the flame retardant tris(2,3-dibromopropyl) 
phosphate (Tris-BP) and of the nematocide, 1,2-dibromo-3-chloropropane (DBCP), were 
synthesized and their relative mutagenicities detd. in Salmonella typhimurium TA 100 in the 
presence of rat liver microsomes. In all cases, ethylation decreased mutagenicity relative to the 
parent compd., but the relative degree of reduced mutagenicity varied considerably depending 
on the position of the Me substitution. The mutagenicity studies with the selectively methylated 
analogs and with suspected mutagenic metabolites (2-bromocrotonaldehyde and Me 1-
dibromovinyl ketone) supported earlier work with selectively deuterated analogs of Tris-BP and 
DBCP. Initial oxidn. at C3, followed by spontaneous dehydrohalogenation and 
dehydrophosphorylation, was the major route of formation of mutagenic metabolites from Tris 
BP. In the case of DBCP, formation of mutagenic metabolites can result following initial oxidn. at 
either C1 or C3. 
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Haloalcohols deplete glutathione when incubated with fortified liver fractions 
Quick ViewOther Sources 
 By Garle, M. J.; Sinclair, C.; Thurley, P.; Fry, J. R.  
 From Xenobiotica (1999), 29(5), 533-545. | Language: English, Database: CAPLUS  
 This study has examd. the ability of dichloropropanols, haloalcs. and their putative 
metabolites to deplete glutathione when incubated with liver fractions obtained from untreated 
and differentially induced rats. 1,3-Dichloropropan-2-ol and 2,3-dichloropropan-1-ol (0-1000 μM) 
both depleted glutathione in a dose-dependent manner when incubated with cofactors (NADPH 
generating system) and liver microsomes from the untreated rat. The extent of GSH depletion 
was significantly enhanced when liver microsomes from the isoniazid- or isosafrole-treated rat 
were used. Epichlorohydrin produced a moderate, dose-dependent depletion of GSH. By 
contrast, 1,3-dichloroacetone (identified by TLC as a metabolite of 1,3-dichloropropanol) was a 
potent depletor of glutathione. N-acetylcysteine was less efficient than glutathione as a 
nucleophile trap for epichlorohydrin, 1,3-dichloroacetone or reactive metabolites derived from 1,
3-dichloropropan-2-ol. 1,3-Dibromopropan-2-ol and 1,4-dibromobutan-2-ol were potent depletors 
of GSH but 1-bromopropan-2-ol produced less GSH depletion. Both dibromoalcs. depleted GSH 
when incubated with dialyzed cytosol derived from the livers of untreated rats. The GSH 
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depletion mediated by 1,3-dichloropropan-2-ol, 1,3-dibromopropan-2-ol, 1,4-dibromobutan-2-ol 
and 1-bromopropan-2-ol was inhibited by inclusion of pyridine (1 mM) or cofactor omission. 1,3-
Difluoropropanol did not deplete GSH under any of the conditions examd. 
 
The Nature of Halogen Substitution Determines the Mode of Cytotoxicity of Halopropanols 
Quick ViewOther Sources 
 By Hammond, Alison H.; Garle, Michael J.; Fry, Jeffrey R.  
 From Toxicology and Applied Pharmacology (1999), 155(3), 287-291. | Language: English, 
Database: CAPLUS  
 The cytochrome P 450-dependent generation of reactive metabolites from 1,3-
dichloropropanol and 1,3-dibromopropanol was assessed in a microsomal thiol depletion assay, 
while the toxicity of these compds. was assessed in rat hepatocyte cultures and in the 3T3 cell 
line. Thiol-depleting metabolites of both compds. were generated in the microsomal assay; 
however, only dibromopropanol extensively depleted glutathione when glutathione S-transferase 
was used as the enzyme source. The cytotoxicity of dichloropropanol was both cytochrome P 
450- and glutathione-dependent, whereas that of dibromopropanol was glutathione-dependent 
but largely independent of cytochrome P 450. These results indicate that the mechanisms 
underlying the cytotoxicity of halopropanols are dependent on the nature of the halogen 
substitution and that microsomal and cellular assays for reactive metabolite generation may yield 
conflicting results. (c) 1999 Academic Press. 
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In Vitro Metabolism of Chloroprene: Species Differences, Epoxide Stereochemistry and a De-
chlorination Pathway 
Quick ViewOther Sources 
 By Cottrell, Lisa; Golding, Bernard T.; Munter, Tony; Watson, William P.  
 From Chemical Research in Toxicology (2001), 14(11), 1552-1562. | Language: English, Database: 
CAPLUS  
 Chloroprene was metabolized by liver microsomes from Sprague-Dawley rats, Fischer 
344 rats, B6C3F1 mice, and humans to the monoepoxides, (1-chloro-ethenyl)oxirane (I; a/b), 
and 2-chloro-2-ethenyloxirane (II; a/b). The formation of II a/b was inferred from the 
identification of their degrdn. products. With male Sprague-Dawley and Fischer 344 rat liver 
microsomes, there was a ∼3:2 preference for the formation of (R)-(1-chloroethenyl)oxirane (Ia) 
compared to the (S)-enantiomer (Ib). A smaller but distinct enantioselectivity in the formation of 
(S)-(1-chloro-ethenyl)oxirane occurred with liver microsomes from male mouse (R:S, 0.90:1) or 
male human (R:S, 0.86:1). 2-Chloro-2-ethenyloxirane was very unstable in the presence of the 
microsomal mixt. and was rapidly converted to 1-hydroxybut-3-en-2-one and 1-chlorobut-3-en-2-
one. An addnl. rearrangement pathway of 2-chloro-2-ethenyloxirane gave rise to 2-chlorobut-3-
en-1-al and 2-chlorobut-2-en-1-al. Further reductive metab. of these metabolites occurred to 
form 1-hydroxybutan-2-one and 1-chlorobutan-2-one. In the absence of an epoxide hydrolase 
inhibitor, the microsomal incubations converted (1-chloroethenyl)oxirane to 3-chlorobut-3-ene-1,
2-diol. When microsomal incubations were supplemented with glutathione, 1-hydroxybut-3-en-2-
one was not detected because of its rapid conjugation with this thiol scavenger. 
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Biological action of D,L-1,4-dibromo-2,3-butanediol 
Quick ViewOther Sources 
 By Myuller, N. R.; Remizov, A. L.; Belogorodskii, V. V.; Filov, V. A.  
 From Farmakologiya i Toksikologiya (Moscow) (1975), 38(5), 590-1. | Language: Russian, Database: 
CAPLUS  
 DL-1,4-dibromo-2,3-butanediol (I) [299-70-7] given i.p. to mice (100-120 mg/kg/day) 
and to rats (100-140 mg/kg/day) with transplantable tumors showed significant antitumor 
activity against ascitic Ehrlich, sarcoma 37, and lymphoma NK/Ly tumors, solid sarcoma 180, 
Walker carcinosarcoma, and sarcoma 45; it was ineffective against solid sarcoma 37. Chronic 
administration of I to normal or tumor-bearing animals did not produce leukopenia, but instead 
increased blood leukocyte levels. 
 
Enhancement of Bacterial Mutagenicity of Bifunctional Alkylating Agents by Expression of 
Mammalian Glutathione S-Transferase 
Quick ViewOther Sources 
 By Thier, Ricarda; Muller, Michael; Taylor, John B.; Pemble, Sally E.; Ketterer, Brian; Guengerich, F. 
Peter  
 From Chemical Research in Toxicology (1995), 8(3), 465-72. | Language: English, Database: 
CAPLUS  
 Recently, we inserted the plasmid vector pKK233-2 contg. rat GSH S-transferase 
(GST) 5-5 cDNA into Salmonella typhimurium TA1535 and found that these bacteria [GST 5-5(+)
] expressed the protein and produced mutations when ethylene or methylene dihalides were 
added [Thier, R., Taylor, J. B., Pemble, S. E., Ketterer, B., Persmark, M., Humphreys, W. G., and 
Guengerich, F. P. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 8576-8580]. After exposure to the 
known GST 5-5 substrate 1,2-epoxy-3-(4'-nitrophenoxy)propane, the GST 5-5(+) strain showed 
fewer mutants than the bacteria transfected with the cDNA clone in a reverse orientation [GST 5-
5(-)], suggesting a protective role of GST 5-5. However, mutations were considerably enhanced 
in the GST 5-5(+) strain [as compared to GST 5-5(-)] when 1,2,3,4-diepoxybutane (butadiene 
diepoxide) or 1,2-epoxy-4-bromobutane was added. The GST 5-5(+) and GST 5-5(-) bacterial 
stains showed similar responses to 1,2-epoxypropane, 3,4-epoxy-1-butene, and 1,4-
dibromobutane. The results suggest that some bifunctional activated butanes are transformed to 
mutagenic products through GSH conjugation. We also found that the GST 5-5(+) strain showed 
enhanced mutagenicity with 1,4-dibromo-2,3-epoxybutane, 1,2-epoxy-3-bromopropane 
(epibromohydrin), and (±)-1,4-dibromo-2,3-dihydroxybutane. The possibility was considered that 
a 5-membered thialonium ion may be involved in the mutagenicity. Model thialonium compds. 
were rather stable to hydrolysis in aq. soln. at pH 7.4 and slowly alkylated 4-(4-nitrobenzyl)
pyridine. The presence of a hydroxyl group β to the sulfur did not enhance reactivity. 
Mechanisms involving episulfonium ions are considered more likely. Potential oxidn. products of 
the toxic pesticide 1,2-dibromo-3-chloropropane (DBCP) were also considered in this system. 
DBCP itself gave rather similar results in the two strains. Others have reported that oxidn. of 
DBCP is required for mutagenicity, along with GST-catalyzed GSH conjugation [Simula, T. P., 
Glancey, M. J., Soederlund, E. J., Dybing, E., and Wolf, C. R. (1993) Carcinogenesis 14, 2303-
2307]. The putative oxidn. product 1,2-dibromopropional did not show a difference between the 
two strains. However, 1,3-dichloroacetone, a model for the putative oxidn. product 1-bromo-3-
chloroacetone, was considerably more mutagenic in the GST 5-5(+) strain. 
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Activation and Inactivation of Carcinogenic Dihaloalkanes and Other Compounds by Glutathione S-
Transferase 5-5 in Salmonella typhimurium Tester Strain NM5004 
Quick ViewOther Sources 
 By Shimada, Tsutomu; Yamazaki, Hiroshi; Oda, Yoshimitsu; Hiratsuka, Akira; Watabe, Tadashi; 
Guengerich, F. Peter  
 From Chemical Research in Toxicology (1996), 9(1), 333-40. | Language: English, Database: 
CAPLUS  
 A newly developed tester Salmonella typhimurium NM5004 strain was constructed by 
introducing a plasmid contg. both rat GSH S-transferase (GST) 5-5 cDNA and the umuC''lacZ 
operon into the host strain Salmonella typhimurium TA1535 and used to examine whether or not 
GST modified the genotoxic activities of several dihaloalkanes and other compds. Twenty-nine 
chems. that were suggested to be conjugated by GST were compared with regard to their 
abilities to induce umu gene expression and cause cytotoxicity responses in both the NM5004 
strain and the original tester strain (S. typhimurium TA1535/pSK1002, which is devoid of GST 
activity toward 1,2-epoxy-3-(4'-nitrophenoxy)propane). Ten chems.-1,2-dibromoethane, N-(2,3-
epoxypropyl)phthalimide, 1,3-dichloroacetone, CH2I2, 1,2-epoxy-3-phenoxypropane, 2,3-
epoxypropyl p-methoxyphenyl ether, 1-bromo-2-chloroethane, 1-bromo-2,3-dichloropropane, 
CH2BrCl, and CH2Br2-were found to enhance induction of umu gene expression in the NM5004 
strain as compared with the TA1535/pSK1002 strain. 1,2-Epoxy-3-(4'-nitrophenoxy)propane and 
2,3-dibromo-1-chloropropane were inactivated by GST 5-5 in the NM5004 tester strain, although 
these chems. were cytotoxic in both tester strains. Roles of GST 5-5 were also examd. for the 
inactivation of reactive metabolites of several procarcinogens that were formed through oxidn. 
by liver microsomes of polychlorinated biphenyl-treated rats. The results suggest that reactive 
metabolites (possibly epoxides)oke of aflatoxin B1, sterigmatocystin, 1,2-dihydro-1,2-dihydroxy-6-
aminochrysene, and (+)- and (-)-enantiomers of 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene could 
be trapped as inactivated GSH conjugates in the NM5004 strain. High-performance liq. 
chromatog. anal. suggested that exo-aflatoxin B1 8,9-oxide-GSH conjugate was formed during 
the oxidn. of aflatoxin B1 by rat and human liver microsomes in the presence of GSH and several 
GST enzymes including purified rat theta class GST Yrs-Yrs and rat liver GST (a mixt. of alpha and 
mu class enzymes). Thus, the present results support the view that the theta class rat GST 5-5 
enzyme participates in the activation and inactivation of potential environmental carcinogenic 
chems. This newly developed NM5004 tester strain is of use in the elucidation of roles of GST 5-
5 in transformations. 
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Influence of the chemical structure on the biological tendency of cytostatic compounds related to 
dibromomannitol. I. Structure-activity correlations 
Quick ViewOther Sources 
 By Institoris, Laszlo; Horvath, Irene P.; Csanyi, Endre  
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 From Arzneimittel-Forschung (1967), 17(2), 145-9. | Language: English, Database: CAPLUS  
 The relation between cytostatic activity and chem. structure was investigated in a 
series of α,ω-substituted alkanes and polyalcs. The tested compds. were injected into rats and 
mice i.p. The inhibitory effect was expressed as the percentage inhibition of the tumor growth 
related to untreated groups. Among the polyalcs., bromo derivs. such as 1,6-dibromomannitol 
(DBM) and 1,6-dibromodulcitol (DBD) had strong cytostatic activity, while dichloromannitol 
(DCM) and diiodomannitol (DIM) were less effective than DBM and DBD. In the alkanes, 
dimethyloxyesters such as 1,4-dimethylsulfonyloxybutane were highly inhibitory to tumor growth, 
whereas dibromoalkanes were inactive. Thus, the structural conditions of cytostatic activity in the 
Br and methylsulfonyloxy series were not similar. 
 
The mutagenicity of halogenated alkanols and their phosphoric acid esters for Salmonella 
typhimurium 
Quick ViewOther Sources 
 By Nakamura, Akitada; Tateno, Noriyuki; Kojima, Shigeo; Kaniwa, Masaaki; Kawamura, Taro  
 From Mutation Research, Genetic Toxicology Testing (1979), 66(4), 373-80. | Language: English, 
Database: CAPLUS  
 Nine halogenated alkanols, 9 corresponding tris(haloalkyl)phosphates, and 2 bis-(2,3-
dibromopropyl)phosphate salts were evaluated for mutagenicity against S. typhimurium TA98, 
TA100, TA1535, TA1537, and TA1538, with and without rat liver in vitro metabolic activation 
system (S9 mix). Most of the test samples showed mutagenic activity in the strains TA100 and 
TA1535, but not in the strains TA98, TA1537, and TA1538. In general, the mutagenic activities 
of the phosphates obtained with S9 mix were greater than the activities obtained without S9 mix. 
Among the phosphates, several structure-activity relations were found; i.e., the bromoalkyl 
derivs. were more mutagenic than the corresponding chloroalkyl derivs., the β-haloethyl derivs. 
were more mutagenic than the γ-halopropyl derivs., the phosphates having adjacent β and γ 
halogen atoms in the alkyl moiety, e.g., tris-(2,3-dibromopropyl)phosphate (I) [126-72-7], were 
particularly potent mutagens, the branched C chain reduced the mutagenic activities in spite of 
the presence of β-halogen atoms, e.g., tris(1-bromomethyl-2-bromoethyl)phosphate [18713-51-
4]. However, such relations did not necessarily apply to the halogenated alkanols. Apparently, 
the metabolic activation pathway via haloalkanols to mutagens must not be in common with all 
of I-like phosphates. 
 
Epoxides as obligatory intermediates in the metabolism of α-halohydrins 
Quick ViewOther Sources 
 By Jones, A. R.; Fakhouri, G.  
 From Xenobiotica (1979), 9(10), 595-9. | Language: English, Database: CAPLUS  
 Metab. of 1,3-dibromopropan-2-ol [96-21-9], 1,3-dichloropropan-2-ol [96-23-1], 1-
bromo-3-chloropropan-2-ol [4540-44-7], 1,2-dibromopropan-3-ol [96-13-9], and 2 halohydrins 
by rats (50 mg/kg orally, daily for 5 days) resulted in the same 2 mercapturic acid metabolites in 
urine. These were N,N'-bis(acetyl)-S,S'-[1,3-bis(cysteinyl)]propan-2-ol [71038-56-7] and N-
acetyl-S-(2,3-dihydroxypropyl)cysteine [23255-33-6]. Depending on the halogen present, each 
dihalopropanol produced β-chlorolactate [1713-85-5] or β-bromolactate [32777-03-0] as 
oxidative metabolites. An epoxide is probably an intermediate of the metabolic path, and this 
was confirmed by the metab. of 2-chloropropane-1,3-diol [96-24-2] which produced one 
mercapturic acid, N-acetyl-S-(2,3-dihydroxypropyl)cysteine. 
 
Mutagenicity of 2- and 3-carbon halogenated compounds in the Salmonella/mammalian-
microsome test 
Quick ViewOther Sources 
 By Stolzenberg, S. J.; Hine, C. H.  
 From Environmental Mutagenesis (1980), 2(1), 59-66. | Language: English, Database: CAPLUS  
 Short-chain, 2- and 3-carbon halogenated hydrocarbons were tested for mutagenicity 
for Salmonella typhimurium strain TA 100 both with and without the presence of S-9. Without 
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exception, all brominated derivs. were more mutagenic than the chlorinated derivs., usually by a 
substantial order of magnitude. 2-Fluoroethanol [371-62-0] showed little or no mutagenic activity 
up to 100 μmol/plate. Trihalogenated compds. with a halogen atom on each of the 3 carbon 
atoms required metabolic activation with S-9 for full expression of mutagenic activity. The 
presence of a double bond in the case of 1,2,3-trichloropropene [96-19-5] resulted in a higher 
level of direct mutagenic activity than 1,2,3-trichloropropane [96-18-4], but activation with S-9 
resulted in a further increase in mutagenic activity with the former compd. On the other hand, S-
9 caused a substantial decrease in mutagenic activity of most compds. contg. a double bond. 
With the presence of an alc. group in a compd., the addn. of S-9 caused variable responses, 
increasing the no. of his+ revertant colonies due to 2,3-dibromopropanol [96-13-9] but had little 
or no effect with other compds. contg. an alc. group. Evidence is also presented that the position 
of a double bond in relation to the halogen atoms may influence mutagenic activity. 
 
DNA synthesis inhibition in mammalian cells as a test for mutagenic carcinogens 
Quick ViewOther Sources 
 By Painter, Robert B.  
 Edited by Stich, Hans F.; San, R. H. C  
 From Short-Term Tests Chem. Carcinog. (1981), 59-64. | Language: English, Database: CAPLUS  
 Of 30 chems. including ascorbic acid (I) [50-81-7] tested in the mammalian cell DNA 
synthesis inhibition test, 23 were pos. The EDs and whether or not they require S9 activation are 
given. The principle of the method and its usefulness are discussed. 
 
The HeLa DNA-synthesis inhibition test as a rapid screen for mutagenic carcinogens 
Quick ViewOther Sources 
 By Painter, Robert B.; Howard, Ricci  
 From Mutation Research (1982), 92(1-2), 427-37. | Language: English, Database: CAPLUS  
 Ninety agents were tested in the HeLa DNA-synthesis inhibition test. This test 
detected strong mutagens and carcinogens except when difficulties with metabolic activation 
were encountered. Weaker DNA-damaging agents were generally pos. in the test but required 
relatively high concns. (≥1 mM). Very weak agents, such as saccharin [81-07-2], were not pos. 
Only 1 false pos. was encountered and the dose response for it (cytochalasin B [14930-96-2]) 
was atypical. The test was not suitable for complex mixts., probably because ingredients that did 
not damage DNA but inhibited DNA synthesis by another mechanism could mask the action of a 
DNA-damaging agent. Inhibition of DNA synthesis in HeLa and other mammalian cells is best 
used as a rapid and inexpensive screening procedure to detect relatively strong mutagenic 
carcinogens. 
 
Toxic activity of seventeen industrial solvents and halogenated compounds on human lymphocytes 
cultured in vitro 
Quick ViewOther Sources 
 By Perocco, Paolo; Bolognesi, Silvana; Alberghini, William  
 From Toxicology Letters (1983), 16(1-2), 69-75. | Language: English, Database: CAPLUS  
 Of 17 compds. examd. Me Et ketone, CHCl3, and 1,2-dichloropropane were not toxic 
in human lymphocyte cultures (as measured by cell viability and [3H]thymidine uptake). 
chloromethyl Me ether [107-30-2], n-hexane [110-54-3], 1,2-dibromopropane [78-75-1], 1,3-
dibromopropane [109-64-8], Chloromethyl Me ether, n-hexane, 1,2-dibromopropane, 1,3-
dibromopropane, 1,3-dibromopropanol, 1,2-diiodoethane, tetrachloroethylene, and 1,4-
dichlorobenzene (I) were toxic in the absence of an S9 mix. The cytotoxicity of these compds. 
disappeared in the presence of the metabolizing system. The cytotoxic effects of 1,2-
dichlorobenzene and 1,3-dichlorobenzene were not completely inhibited by the S9 mix. EtOAc, 
benzene, cyclohexane, and cyclohexanone inhibited [3H]thymidine uptake in the absence of the 
S9 mix, but had no effect on cell viability. Apparently these chems. exercise a cytotoxic action 
which is not immediately followed by cellular death. Chloromethyl Me ether elevated [3H]
thymidine uptake in the presence of the S9 mix. 
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Effect of bromine and chlorine positioning in the induction of renal and testicular toxicity by 
halogenated propanes 
Quick ViewOther Sources 
 By Laag, Marit; Soederlund, Erik J.; Omichinski, James G.; Brunborg, Gunnar; Holme, Joern A.; Dahl, 
Jon E.; Nelson, Sidney D.; Dybing, Erik  
 From Chemical Research in Toxicology (1991), 4(5), 528-34. | Language: English, Database: 
CAPLUS  
 A series of halogenated propanes were studied for renal and testicular necrogenic 
effects in the rat and correlated to their ability to induce in vivo renal and testicular DNA damage 
and in vitro testicular DNA damage. 1,2-Dibromo-3-chloropropane (DBCP) and 1,2,3-
tribromopropane were most potent in causing organ damage in both kidney and testes. 
Extensive necrosis was evident at 85 μmol/kg in kidney and at 170 μmol/kg in testis. The 
dibromomonochlorinated analog 1,3-dibromo-2-chloropropane was less organ toxic than DBCP 
and 1,2,3-tribromopropane but induced more organ damage than the dichloromonobrominated 
analogs 1-bromo-2,3-dichloropropane and 1,3-dichloro-2-bromopropane. Dihalogenated 
propanes were even less necrogenic. These obsd. differences in toxic potency between the 
halogenated propanes could not be explained by relative differences in tissue concns. The ability 
of the halogenated propanes to induce DNA damage in vivo correlated well with their ability to 
induce organ damage. However, DNA damage occurred at lower doses and at a shorter period of 
exposure than organ necrosis. This indicates that DNA damage might be an initial event in the 
development of organ necrosis by halogenated propanes in general. Further, testicular DNA 
damage induced by the halogenated propanes in vivo correlated well with the DNA damage 
obsd. in isolated testicular cells in vitro, showing that toxicity was due to in situ activation. The 
nos., positions, and the types of halogen substituents appear to be important determinants in 
causing DNA damage and necrogenic effects. The toxic potential of the halogenated propanes 
was in the following order: 1,2,3-tribromopropane ≥ 1,2-dibromo-3-chloropropane > 1,3-
dibromo-2-chloropropane > 1,3-dichloro-2-bromopropane ≃ 1-bromo-2,3-dichloropropane > 1,2,
3-trichloropropane ≃ 1,2-dibromopropane ≥ 1,3-dibromopropane ≥ 1-bromo-3-chloropropane. 
The most toxic analogs contain three halogens with at least two vicinal bromines. 
 
 
Enhancement of Bacterial Mutagenicity of Bifunctional Alkylating Agents by Expression of 
Mammalian Glutathione S-Transferase 
Quick ViewOther Sources 
 By Thier, Ricarda; Muller, Michael; Taylor, John B.; Pemble, Sally E.; Ketterer, Brian; Guengerich, F. 
Peter  
 From Chemical Research in Toxicology (1995), 8(3), 465-72. | Language: English, Database: 
CAPLUS  
 Recently, we inserted the plasmid vector pKK233-2 contg. rat GSH S-transferase 
(GST) 5-5 cDNA into Salmonella typhimurium TA1535 and found that these bacteria [GST 5-5(+)
] expressed the protein and produced mutations when ethylene or methylene dihalides were 
added [Thier, R., Taylor, J. B., Pemble, S. E., Ketterer, B., Persmark, M., Humphreys, W. G., and 
Guengerich, F. P. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 8576-8580]. After exposure to the 
known GST 5-5 substrate 1,2-epoxy-3-(4'-nitrophenoxy)propane, the GST 5-5(+) strain showed 
fewer mutants than the bacteria transfected with the cDNA clone in a reverse orientation [GST 5-
5(-)], suggesting a protective role of GST 5-5. However, mutations were considerably enhanced 
in the GST 5-5(+) strain [as compared to GST 5-5(-)] when 1,2,3,4-diepoxybutane (butadiene 
diepoxide) or 1,2-epoxy-4-bromobutane was added. The GST 5-5(+) and GST 5-5(-) bacterial 
stains showed similar responses to 1,2-epoxypropane, 3,4-epoxy-1-butene, and 1,4-
dibromobutane. The results suggest that some bifunctional activated butanes are transformed to 
mutagenic products through GSH conjugation. We also found that the GST 5-5(+) strain showed 
enhanced mutagenicity with 1,4-dibromo-2,3-epoxybutane, 1,2-epoxy-3-bromopropane 
(epibromohydrin), and (±)-1,4-dibromo-2,3-dihydroxybutane. The possibility was considered that 
a 5-membered thialonium ion may be involved in the mutagenicity. Model thialonium compds. 
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were rather stable to hydrolysis in aq. soln. at pH 7.4 and slowly alkylated 4-(4-nitrobenzyl)
pyridine. The presence of a hydroxyl group β to the sulfur did not enhance reactivity. 
Mechanisms involving episulfonium ions are considered more likely. Potential oxidn. products of 
the toxic pesticide 1,2-dibromo-3-chloropropane (DBCP) were also considered in this system. 
DBCP itself gave rather similar results in the two strains. Others have reported that oxidn. of 
DBCP is required for mutagenicity, along with GST-catalyzed GSH conjugation [Simula, T. P., 
Glancey, M. J., Soederlund, E. J., Dybing, E., and Wolf, C. R. (1993) Carcinogenesis 14, 2303-
2307]. The putative oxidn. product 1,2-dibromopropional did not show a difference between the 
two strains. However, 1,3-dichloroacetone, a model for the putative oxidn. product 1-bromo-3-
chloroacetone, was considerably more mutagenic in the GST 5-5(+) strain. 
 
Thermal Degradation and Decomposition Products of Electronic Boards Containing BFRs 
Quick ViewOther Sources 
 By Barontini, Federica; Marsanich, Katia; Petarca, Luigi; Cozzani, Valerio 
 From Industrial & Engineering Chemistry Research (2005), 44(12), 4186-4199. | Language: English, 
Database: CAPLUS  
 Prodn. of electronic boards contg. brominated flame retardants is constantly 
increasing, posing important problems with disposal of products contg. these materials. The 
present study studied the thermal degrdn. behavior of electronic boards manufd. using 
tetrabromobisphenol A and diglycidyl ether of bisphenol A epoxy resins. Qual. and quant. 
information was obtained on the products formed in the thermal degrdn. process, and the 
bromine distribution in the different product fractions was detd. The more important decompn. 
products included hydrogen bromide, phenol, polybrominated phenols, and polybrominated 
bisphenol A species. The formation of considerable amts. of hydrogen bromide and high-mol.-wt. 
organobrominated compds., and the potential formation of limited quantities of polybrominated 
dibenzo-p-dioxins and dibenzofurans, is an important element of concern in the safety and 
environmental assessment of the thermal degrdn. processes of electronic boards contg. 
brominated flame retardants. 
 
Prediction of Aquatic Toxicity: Use of Optimization of Correlation Weights of Local Graph Invariants 
Quick ViewOther Sources 
 By Toropov, Andrey Andreevich; Schultz, Terry Wayne  
 From Journal of Chemical Information and Computer Sciences (2003), 43(2), 560-567. | Language: 
English, Database: CAPLUS  
 Quant. structure-activity relationships (QSARs) were developed for three sets of 
toxicity data. Chems. in each set represented a no. of narcoses and electrophilic mechanisms of 
toxic action. A series of quant. structure-toxicity models correlating toxic potency with a no. of 
optimization of correlation wts. of local graph invariants were developed. In the case of the 
toxicity of a heterogeneous set of benzene derivs. to Tetrahymena pyriformis, the QSARs were 
based on the Descriptor of Correlation Wts. (DCW) using atoms and extended connectivity (EC) 
graph invariants. The model [log (IGC50-1) = 0.0813 DCW(ak,3ECk) + 2.636; n = 157, r2 = 0.883, s 
= 0.27, F = 1170, Pr > F = 0.0001] based on third-order EC of 89 descriptors was obsd. to be 
best for the benzene data. However, fits for these data of > 0.800 were achieved ECs with as 
few as 23 variables. The relationship between the toxicity predicted by this model and exptl. 
toxicity values for the test set [obs. log(IGC50-1) = 0.991 (pred. (log(IGC50-1)) - 0.012); n = 60, r2 = 
0.863, s = 0.28, F = 372, Pr > F = 0.0001] is excellent. The utility of the approach was 
demonstrated by the model [log (IGC50-1) = 0.1744(DCW (ak, 2EC) - 3.505); n = 39, r2 = 0.900, s 
= 0.35, F = 333, Pr > F = 0.0001] for the toxicity data for T. pyriformis exposed to halo-
substituted aliph. compds. and the model [log (IC50-1) = 0.1699(DCW (ak, 2EC)) - 2.610; n = 66, r2 
= 0.901, s = 0.31, F = 583, Pr > F = 0.0001] for the Vibrio fischeri toxicity data. 
 
Modulation of hepatocyte thiol content by medium composition: implications for toxicity studies 
Quick ViewOther Sources 
 By Hammond, A. H.; Garle, M. J.; Sooriakumaran, P.; Fry, J. R.  
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 From Toxicology in Vitro (2002), 16(3), 259-265. | Language: English, Database: CAPLUS  
 Toxicity of compds. requiring glutathione for detoxification, thiol content and 
synthesis were detd. in 24-h rat hepatocytes cultured in medium contg. different concns. of the 
sulfur amino acids. Glutathione synthesis was detd. following prior depletion of glutathione with 
diethylmaleate. L-15 medium, which has high levels of cysteine and methionine (1 mm of each), 
provided some protection against dichloroacetone, dibromopropanol and dichloropropanol 
toxicity, and had a small effect on increasing glutathione content and synthesis, relative to 
Williams' medium E (WE) which has low levels (less than 0.5 mm) of both amino acids. However, 
WE contg. N-acetylcysteine (NAC) (1 mm final cysteine concn.), with or without methionine (final 
concn. 1 mm), was a better cytoprotectant medium than L-15, markedly reducing toxicity of all 
three compds., and rapidly (within 1.5 h) increasing cellular glutathione content. WE 
supplemented with methionine alone stimulated glutathione synthesis after an initial lag phase, 
and protected cultures against dichloropropanol, but not dibromopropanol or dichloroacetone, 
both of which are highly reactive in these cultures. There was a clear assocn. between 
glutathione content at early time points in culture and toxicity obsd. at later time points, and 
overall these results indicate that differences in culture medium compn. can alter intracellular 
glutathione content and xenobiotic toxicity. 
 
Haloalcohols deplete glutathione when incubated with fortified liver fractions 
Quick ViewOther Sources 
 By Garle, M. J.; Sinclair, C.; Thurley, P.; Fry, J. R.  
 From Xenobiotica (1999), 29(5), 533-545. | Language: English, Database: CAPLUS  
 This study has examd. the ability of dichloropropanols, haloalcs. and their putative 
metabolites to deplete glutathione when incubated with liver fractions obtained from untreated 
and differentially induced rats. 1,3-Dichloropropan-2-ol and 2,3-dichloropropan-1-ol (0-1000 μM) 
both depleted glutathione in a dose-dependent manner when incubated with cofactors (NADPH 
generating system) and liver microsomes from the untreated rat. The extent of GSH depletion 
was significantly enhanced when liver microsomes from the isoniazid- or isosafrole-treated rat 
were used. Epichlorohydrin produced a moderate, dose-dependent depletion of GSH. By 
contrast, 1,3-dichloroacetone (identified by TLC as a metabolite of 1,3-dichloropropanol) was a 
potent depletor of glutathione. N-acetylcysteine was less efficient than glutathione as a 
nucleophile trap for epichlorohydrin, 1,3-dichloroacetone or reactive metabolites derived from 1,
3-dichloropropan-2-ol. 1,3-Dibromopropan-2-ol and 1,4-dibromobutan-2-ol were potent depletors 
of GSH but 1-bromopropan-2-ol produced less GSH depletion. Both dibromoalcs. depleted GSH 
when incubated with dialyzed cytosol derived from the livers of untreated rats. The GSH 
depletion mediated by 1,3-dichloropropan-2-ol, 1,3-dibromopropan-2-ol, 1,4-dibromobutan-2-ol 
and 1-bromopropan-2-ol was inhibited by inclusion of pyridine (1 mM) or cofactor omission. 1,3-
Difluoropropanol did not deplete GSH under any of the conditions examd. 
 
Structure-toxicity relationships for selected halogenated aliphatic chemicals 
Quick ViewOther Sources 
 By Akers, Kevin S.; Sinks, Glendon D.; Schultz, T. Wayne  
 From Environmental Toxicology and Pharmacology (1999), 7(1), 33-39. | Language: English, 
Database: CAPLUS  
 Toxicity to the ciliate Tetrahymena pyriformis (log (IGC50-1)) for 39 halogen-substituted 
alkanes, alkanols, and alkanitriles were obtained exptl. Log (IGC50-1) along with the hydrophobic 
term, log Kow (1-octanol/water partition coeff.) and the electrophilic parameter, E lumo (the energy of 
the LUMO) were used to develop quant. structure-activity relationships (QSARs). Two strong 
hydrophobic dependent relationships were obtained: one for the haloalkanes and a second for 
the haloalcs. The relationship for the haloalkanes [log(IGC50-1) = 0.92 (logKow) -2.58; n = 4, r2 = 
0.993, s = 0.063, f = 276, Pr >f = 0.0036] was not different from baseline toxicity. With the 
rejection of 1,3-dibromo-2-propanol as a statistical outlier, the relationship [log (IGC50-1) = 
0.63(log Kow) - 1.18; n = 19, r2 = 0.860, s = 0.274, f = 104, Pr > f = 0.0001] was obsd. for the 
haloalcs. No hydrophobicity-dependent model (r2 = 0.165) was obsd. for the halonitriles. 
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However, an electrophilicity-dependent model [log (IGC50-1) = - 1.245(Elumo) + 0.73; n = 15, r2 = 
0.588, s = 0.764, F = 18.6, Pr > f = 0.0009] was developed for the halonitriles. Addnl. anal. 
designed to examine surface-response modeling of all three chem. classes met with some 
success. Following rejection of statistical outliers, the plane [log (IGC5p-1) = 0.60(log Kow) - 
0.747(Elumo) -0.37; n = 34, r2 = 0.915, s = 0.297, F = 162, Pr > F= 0.0001] was developed. The 
halogenated alcs. and nitriles tested all had obsd. toxicity in excess of non-reactive baseline 
toxicity (non-polar narcosis). This observation along with the complexity of the structure-toxicity 
relationships developed in this study suggests that the toxicity of haloalcs. and halonitriles is by 
multiple and/or mixed mechanisms of action which are electro(nucleo)philic in character. 
 
The Nature of Halogen Substitution Determines the Mode of Cytotoxicity of Halopropanols 
Quick ViewOther Sources 
 By Hammond, Alison H.; Garle, Michael J.; Fry, Jeffrey R.  
 From Toxicology and Applied Pharmacology (1999), 155(3), 287-291. | Language: English, 
Database: CAPLUS  
 The cytochrome P 450-dependent generation of reactive metabolites from 1,3-
dichloropropanol and 1,3-dibromopropanol was assessed in a microsomal thiol depletion assay, 
while the toxicity of these compds. was assessed in rat hepatocyte cultures and in the 3T3 cell 
line. Thiol-depleting metabolites of both compds. were generated in the microsomal assay; 
however, only dibromopropanol extensively depleted glutathione when glutathione S-transferase 
was used as the enzyme source. The cytotoxicity of dichloropropanol was both cytochrome P 
450- and glutathione-dependent, whereas that of dibromopropanol was glutathione-dependent 
but largely independent of cytochrome P 450. These results indicate that the mechanisms 
underlying the cytotoxicity of halopropanols are dependent on the nature of the halogen 
substitution and that microsomal and cellular assays for reactive metabolite generation may yield 
conflicting results. (c) 1999 Academic Press. 
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substances 
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Substance 2,3-Dibromo-1-
propanol (2,3-
DBPA), CAS RN 
96-13-9 
1,3-Dibromo-2-
propanol (1,3-
DBPA), CAS RN 
96-21-9 
2,2-
Bis(bromomethyl
)-1,3-propanediol 
(DBNPG), CAS 
RN 3296-90-0 
2,2-Bis-
(bromomethyl)-
3-bromo-1-
propanol 
(TBNPA), CAS 
RN 36483-57-5 
Structure 
 
 
 
 
    
Included in the 
preliminary 
structural 
grouping  
Yes No Yes Yes 
REACH 
registration / 
pre-registration 
REACH 
registered 
REACH pre-
registered 
REACH pre-
registered 
REACH 
registered 
Harmonized 
cancer/mutagen
icity 
classification 
Carc. 1B H350    
Notified 
cancer/mutagen
icity 
classification 
 Carc. 2 H351 
 
Muta. 1B H340 / 
Muta. 2 H341 
Carc. 1B H350 / 
Carc. 2 H351 
Muta. 1B H340 / 
Muta. 2 H341 
Carc. 1B H350 
ADME 
experimental 
information 
NA NA Available NA 
(Q)SAR 
predictions of 
bioavailability 
Bioavailable according to Lipinski’s rule of 5, and predicted high Human 
intestinal absorption  
Ames 
Salmonella t. 
experimental 
mutagenicity 
Positive NA Positive  Positive 
- Strains 
tested 
positiv
e  
TA100, TA1535 
(base-pair) with 
and without 
exogenous 
metabolic system  
 
TA102 (cross-
linking) tested 
only with 
exogenous 
metabolic system 
 TA100 (base-
pair) with 
exogenous 
metabolic system 
(Syrian Hamster) 
TA100, TA1535 
(base-pair) with 
exogenous 
metabolic system 
(hamster) 
Other 
experimental 
genotoxicity 
results 
Positive ML in 
vitro (without 
exogenous 
metabolic 
system) 
 
Positive CHO 
SCE in vitro (with 
and without 
exogenous 
metabolic 
system) 
 
Positive CHO CA 
in vitro (with and 
NA Negative/equivoc
al CHO SCE in 
vitro  
 
Positive CHO CA 
in vitro (with 
exogenous 
metabolic 
system) at doses 
causing 
cytotoxicity 
 
Positive MN in 
vivo Mouse 
(peripheral 
Positive ML in 
vitro (with 
exogenous 
metabolic 
system) 
 
Positive CA in 
vitro (cultured 
peripheral 
human 
lymphocytes , 
with exogenous 
metabolic 
system, however 
also without at 
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without 
exogenous 
metabolic 
system) 
 
Positive 
Drosophila m. 
SLRL and 
reciprocal 
translocation 
 
Negative MN in 
vivo male Mouse 
(bone marrow) 
blood) 
 
Equivocal MN in 
vivo Mouse (bone 
marrow) 
 
highest tested 
concentration ) 
 
Negative UDS in 
vivo Rat (liver) 
 
Negative MN in 
vivo Mouse 
(bone marrow) 
Critical effects 
conclusions 
from chapter 4. 
Multi-site, 
multispecies 
carcinogenic 
effect, most 
probably caused 
by a direct 
genotoxic action 
of the parent 
compound 
NA Multi-site, 
multispecies 
carcinogenic 
effect, most 
probably caused 
by a genotoxic 
metabolite of the 
parent compound 
Possible 
carcinogenic 
effect, most 
probably caused 
by a genotoxic 
metabolite of the 
parent 
compound 
Positive 
predictions in 
AD in (Q)SAR 
models for 
CU Ashby 
structural alerts 
 
CU SALM, 
Salmonella 
mutagenicity 
(TA97,98,100,153
5-1538) (in vitro) 
 
DTU Ames 
Salmonella 
(TA98, 100, 1535 
and either 
TA1537 or TA97) 
(in vitro) 
 
DTU Ames sub-
model Direct (not 
requiring S9) (in 
vitro) 
 
DTU Ames sub-
model Base-pair 
(in vitro) 
 
DTU Ames sub-
model Frame 
shift (in vitro) 
 
DTU 
Chromosomal 
aberrations CHL 
(in vitro) 
 
DTU UDS rat 
hepatocytes (in 
vitro) 
 
DTU SHE cell 
transformation 
(in vitro) 
 
DTU SCE mouse 
(in vivo) 
 
CU Ashby 
structural alerts 
 
CU SALM, 
Salmonella 
mutagenicity 
(TA97,98,100,153
5-1538) (in vitro) 
 
DTU Ames sub-
model Base-pair 
(in vitro) 
 
DTU SCE mouse 
(in vivo) 
 
DTU Drosophila 
SLRL (in vivo) 
 
CU FDA RCA 
cancer male rat 
(in vivo) 
 
CU FDA RCA 
cancer female rat 
(in vivo) 
 
CU FDA RCA 
cancer male 
mouse (in vivo) 
 
CU FDA RCA 
cancer female 
mouse (in vivo) 
 
CU FDA RCA 
cancer rodent (in 
vivo) 
 
CU FDA RCA 
cancer rat (in 
vivo) 
 
CU FDA RCA 
cancer mice (in 
CU Ashby 
structural alerts 
 
CU SALM, 
Salmonella 
mutagenicity 
(TA97,98,100,153
5-1538) (in vitro) 
 
DTU Ames 
Salmonella 
(TA98, 100, 1535 
and either 
TA1537 or TA97) 
(in vitro) 
 
DTU Ames sub-
model Direct (not 
requiring S9) (in 
vitro) 
 
DTU SCE mouse 
(in vivo) 
 
CU FDA RCA 
cancer male rat 
(in vivo) 
 
CU FDA RCA 
cancer female rat 
(in vivo) 
 
CU FDA RCA 
cancer male 
mouse (in vivo) 
 
CU FDA RCA 
cancer female 
mouse (in vivo) 
 
CU FDA RCA 
cancer rodent (in 
vivo) 
 
CU FDA RCA 
CU Ashby 
structural alerts 
 
CU SALM, 
Salmonella 
mutagenicity 
(TA97,98,100,15
35-1538) (in 
vitro) 
 
DTU Ames 
Salmonella 
(TA98, 100, 1535 
and either 
TA1537 or TA97) 
(in vitro) 
 
DTU SCE mouse 
(in vivo) 
 
CU FDA RCA 
cancer male rat 
(in vivo) 
 
CU FDA RCA 
cancer female rat 
(in vivo) 
 
CU FDA RCA 
cancer male 
mouse (in vivo) 
 
CU FDA RCA 
cancer female 
mouse (in vivo) 
 
CU FDA RCA 
cancer rodent (in 
vivo) 
 
CU FDA RCA 
cancer rat (in 
vivo) 
 
CU FDA RCA 
100 Category approach for selected brominated flame retardants 
 
DTU Drosophila 
SLRL (in vivo) 
 
DTU Comet assay 
(in vivo) 
 
CU FDA RCA 
cancer male rat 
(in vivo) 
 
CU FDA RCA 
cancer female rat 
(in vivo) 
 
CU FDA RCA 
cancer male 
mouse (in vivo) 
 
CU FDA RCA 
cancer female 
mouse (in vivo) 
 
CU FDA RCA 
cancer rodent (in 
vivo) 
 
CU FDA RCA 
cancer rat (in 
vivo) 
 
CU FDA RCA 
cancer mice (in 
vivo) 
 
CU FDA RCA 
overall cancer call 
 
vivo) 
 
CU FDA RCA 
overall cancer call 
 
 
cancer rat (in 
vivo) 
 
CU FDA RCA 
cancer mice (in 
vivo) 
 
CU FDA RCA 
overall cancer call 
 
 
cancer mice (in 
vivo) 
 
CU FDA RCA 
overall cancer 
call 
 
 
Negative 
predictions in 
AD in (Q)SAR 
models for 
DTU Ames sub-
model Potency > 
10x ctrl. (in vitro) 
 
CU Chromosomal 
aberrations CHO 
(in vitro) 
 
DTU Mouse 
micronucleus 
(bone marrow) 
(in vivo) 
 
DTU Dominant 
lethal (in vivo) 
DTU Ames sub-
model Potency > 
10x ctrl. (in vitro) 
 
DTU Ames sub-
model Frame 
shift (in vitro) 
 
CU Chromosomal 
aberrations CHO 
(in vitro) 
 
DTU 
Chromosomal 
aberrations CHL 
(in vitro) 
 
DTU Mouse 
micronucleus 
(bone marrow) 
(in vivo) 
 
DTU Dominant 
lethal (in vivo) 
 
DTU Ames sub-
model Frame 
shift (in vitro) 
 
CU Chromosomal 
aberrations CHO 
(in vitro) 
 
DTU Mouse 
micronucleus 
(bone marrow) 
(in vivo) 
 
DTU Ames sub-
model Direct (not 
requiring S9) (in 
vitro) 
 
DTU Ames sub-
model Potency > 
10x ctrl. (in vitro) 
 
DTU Ames sub-
model Frame 
shift (in vitro) 
 
CU 
Chromosomal 
aberrations CHO 
(in vitro) 
 
DTU Mouse 
micronucleus 
(bone marrow) 
(in vivo) 
 
OECD (Q)SAR 
Application 
Toolbox 
profiler: DNA 
binding by 
OECD identified 
Aliphatic halides 
 
1,2-Dihaloalkanes 
 
Mono aldehydes 
 
Aliphatic halides 
 
Mono aldehydes 
 
Epoxides 
Aliphatic halides 
 
Mono aldehydes 
Aliphatic halides 
 
Mono aldehydes 
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alerts (parent or 
mammalian 
metabolites) 
Epoxides 
OECD (Q)SAR 
Application 
Toolbox 
profiler: DNA 
binding by 
OASIS v.1.3 
identified alerts 
(parent or 
mammalian 
metabolites) 
Haloalkanes  
Containing 
Heteroatom 
 
Haloalkane 
Derivatives with 
Labile Halogen 
 
Vicinal 
Dihaloalkanes 
 
Epoxides and 
Aziridines 
 
Haloalcohols 
Haloalkanes 
Containing 
Heteroatom 
 
Haloalkane 
Derivatives with 
Labile Halogen 
 
Epoxides and 
Aziridines 
 
Haloalcohols 
Haloalkane 
Derivatives with 
Labile Halogen 
Haloalkane 
Derivatives with 
Labile Halogen 
OECD (Q)SAR 
Application 
Toolbox 
profiler: Protein 
binding alerts 
for 
Chromosomal 
aberration by 
OASIS v1.1 
identified alerts 
(parent or 
mammalian 
metabolites) 
Halogenated 
Vicinal 
Hydrocarbons 
 
Alpha-Activated 
Haloalkanes 
   
OECD (Q)SAR 
Application 
Toolbox 
profiler: in vitro 
mutagenicity 
(Ames test) 
alerts by ISS 
identified alerts 
(parent or 
mammalian 
metabolites) 
Aliphatic 
halogens 
 
Simple aldehyde 
 
Epoxides and 
aziridines 
Aliphatic 
halogens 
 
Simple aldehyde 
 
Epoxides and 
aziridines 
Aliphatic 
halogens 
 
Simple aldehyde 
Aliphatic 
halogens 
 
Simple aldehyde 
OECD (Q)SAR 
Application 
Toolbox 
profiler: DNA 
alerts for AMES, 
MN and CA by 
OASIS v.1.3 
identified alerts 
(parent or 
mammalian 
metabolites) 
Haloalkane 
Derivatives with 
Labile Halogen 
 
Vicinal 
Dihaloalkanes 
 
Haloalcohols 
 
Epoxides and 
Aziridines 
Haloalkane 
Derivatives with 
Labile Halogen 
 
Haloalcohols 
 
Epoxides and 
Aziridines 
  
OECD (Q)SAR 
Application 
Toolbox 
profiler: in vivo 
mutagenicity 
(Micronucleus) 
alerts by ISS 
identified alerts 
(parent or 
mammalian 
metabolites) 
Aliphatic halogen 
 
Epoxides and 
aziridines 
 
H-acceptor-
path3-H-acceptor 
 
Simple aldehyde 
Aliphatic halogen 
 
Epoxides and 
aziridines 
 
H-acceptor-
path3-H-acceptor 
 
Simple aldehyde 
Aliphatic halogen 
 
H-acceptor-
path3-H-acceptor 
 
Simple aldehyde 
Aliphatic halogen 
 
H-acceptor-
path3-H-
acceptor 
 
Simple aldehyde 
OECD (Q)SAR 
Application 
Toolbox 
Aldehyde Type 
Compounds 
 
Aldehyde Type 
Compounds 
 
Aldehyde Type 
Compounds 
Aldehyde Type 
Compounds 
102 Category approach for selected brominated flame retardants 
 
profiler: 
Oncologic 
Primary 
Classification 
identified alerts 
(parent or 
mammalian 
metabolites) 
Alpha, beta-
Haloether 
Reactive 
Functional 
Groups 
 
Epoxide Reactive 
Functional 
Groups 
Alpha, beta-
Haloether 
Reactive 
Functional 
Groups 
 
Reactive Ketone 
Reactive 
Functional 
Groups 
 
Epoxide Reactive 
Functional 
Groups 
OECD (Q)SAR 
Application 
Toolbox 
profiler: 
Carcinogenicity 
(genotox and 
nongenotox) 
alerts by ISS 
identified alerts 
(parent or 
mammalian 
metabolites) 
Aliphatic 
halogens 
(Genotox) 
 
(Poly) 
Halogenated 
Cycloalkanes 
(Nongenotox) 
 
Epoxides and 
aziridines 
(Genotox) 
 
Simple aldehyde 
(Genotox) 
Aliphatic 
halogens 
(Genotox) 
 
Epoxides and 
aziridines 
(Genotox) 
 
Simple aldehyde 
(Genotox) 
Aliphatic 
halogens 
(Genotox) 
 
Simple aldehyde 
(Genotox) 
 
Aliphatic 
halogens 
(Genotox) 
 
Simple aldehyde 
(Genotox) 
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Category approach for selected brominated flame retardants 
The aim of this project was to attempt grouping of a number of identified brominated flame retardants 
(BFRs). The grouping was performed for 67 brominated flame retardants based on their chemical structures 
and resulted in 15 preliminary structural groups and 7 substances remaining as “singletons”. (Q)SAR 
predictions for a number of environmental and health effects within these initial groups were generated and 
investigated. 
 
One of the groups; small linear and branched brominated alkyl alcohols, was chosen for further investigation 
as a category, in which all compounds having 3-5 carbons, 2-3 bromine atoms and 1-2 alcohol groups were 
included.  The category comprises 61 members, including 3 members with relevant experimental data on 
human health effects.  
 
Possible read-across for the critical effect from the three category members with experimental data and one 
further member with a notified classification for the identified critical effect to the remaining 57 structurally 
similar target analogues in the category is supported by the following observations: 
 
• The toxicity profile of the 3 members with relevant experimental data is comparable and the critical 
effect is the multiple-organ carcinogenic effect, most probably exerted by a mutagenic/genotoxic mode of 
action either by the parent compound itself (2,3-DBPA) or by a metabolite of the parent compound (DBNPG 
and TBNPA). 
• The classifications (harmonized or notified) as Muta. 1B H340 / Muta. 2 H341 and/or Carc. 1B 
H350 / Carc. 2 H351 for these three members and for 1,3-DBPA.  
• The (Q)SAR predictions indicate that the 61 category members have a carcinogenic potential with a 
possible mutagenic/genotoxic mode of action.  
 
